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Chapter 1
Atrial fibrillation (AF) has been labeled ‘the next epidemic’ in patients with congenital 
heart disease (CHD).1-3 Because of improved surgical techniques and perioperative 
care, the population of CHD patients is rapidly growing.4,5 The improved survival of CHD 
patients goes hand in hand with an increasing prevalence of atrial tachyarrhythmias, 
including AF.6,7 Nevertheless, the underlying mechanisms of AF in these patients are 
yet incompletely understood and outcomes of treatment of atrial tachyarrhythmias 
are suboptimal.
This chapter introduces the indisputable relation between CHD and atrial 
tachyarrhythmias, including epidemiology, etiology, and potential treatment 
strategies.
Epidemiology of congenital heart disease
CHD is the most common cause of major congenital anomalies and is reported in 
around 9 per 1000 live births and 4 per 1000 adults.4,8 In 2017, nearly 12 million people 
were estimated to be living with CHD.9 The most common types of CHD are ventricular 
septal defect (2.6 per 1000 live births) and atrial septal defect (ASD; 1.6 per 1000 live 
births). More complex defects including transposition of the great arteries (0.31 per 
1000 live births) and hypoplastic left heart syndrome (0.2 per 1000 live births) are less 
often observed.8,10 A commonly applied classification of the different types of CHD is 
based on complexity of the underlying lesion: simple (e.g. isolated small ventricular 
septal defect, repaired secundum or sinus venosus ASD), moderate (e.g. total/partial 
abnormal pulmonary venous return, complete/partial atrioventricular septal defect, 
tetralogy of Fallot, Ebstein’s anomaly) and complex (e.g. transposition of the great 
arteries, univentricular hearts).11
As a result of amongst others improved surgical techniques and perioperative care, 
significant changes in mortality have occurred over the past decades. Fifty years ago, 
only 25% patients of patients survived beyond the first year of life, whereas in 2017, 
survival in this age group had increased to >99%.9 Overall, the mortality rate of CHD 
has declined substantially over the last three decades.9 Nowadays >90% of patients is 
expected to survive into adulthood.5 These changes have led to a growing population 
of adult CHD patients, who now outnumber children with CHD.12
A considerable number of patients with CHD require surgical correction or palliation 
of the defect at a young age. Data from the CONCOR database, a large nationwide 
database of adult CHD patients, showed that 46% of the 10300 patients included in 
the database had undergone surgery in childhood.13 Nearly 30% of patients underwent 
an intervention (either primary intervention or a redo procedure) in adulthood (20% 
surgical, 8% percutaneous). Overall, the risk of cardiovascular surgery at adult age was 
22% up to age 40 years, and 43% up to age 60 years.14
Atrial septal defect
An ASD results in an interatrial communication, allowing shunting of blood from the 
left atrium to the right atrium. The most common type is the ostium secundum defect, 
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which occurs as an isolated anomaly in 5% to 10% of all CHD.10 This defect is located 
at the site of the foramen ovale and results from inadequate growth of the septum 
secundum or excessive absorption of the septum primum. The second most common 
type of ASD is the ostium primum defect, which occurs if the septum primum does not 
fuse with the endocardial cushions. This defect is usually located low in the interatrial 
septum and is often associated with clefts in the mitral and/or tricuspid valve. Less 
common is the sinus venosus defect, which occurs in about 10% of all ASDs and is 
most often located at the entry of the superior vena cava into the right atrium. This 
defect is commonly associated with abnormal pulmonary venous return. Rare forms 
of ASD include sinus venosus defects at the entry of the inferior vena cava and defects 
between the coronary sinus wall and the left atrium.15
Spontaneous closure may occur during infancy or early childhood in patients with 
a small ostium secundum ASD. Surgical ASD repair requires cardiopulmonary bypass 
and usually a median sternotomy (in contrast to a less often used minimally invasive 
approach). Access to the right atrium is obtained with a right atriotomy. The ASD can 
be closed by direct suturing or using a synthetic or pericardial patch. Transcatheter 
device closure has become the preferred method for closur e of ostium secundum ASD, 
provided the indications are met. Figure 1 shows images of transcatheter ASD closure 
under fluoroscopy guidance.
A B C
Figure 1. Transcatheter ASD closure
Fluoroscopy images of transcatheter ASD closure in a 29-year old patient with a secundum ASD. 
A: the size of the ASD is measured. B: placement of the ASD closure device (arrows). C: ASD 
closure device in situ.
Atrial tachyarrhythmias, including atrial flutter and AF, are well-known sequelae of 
ASD, and their occurrence is associated with age at the time of ASD repair. Benefits 
of early ASD repair were initially demonstrated by Murphy et al., who showed that 
the incidence of atrial tachyarrhythmias was lower when ASD repair was performed 
at a younger age.16 Long-term follow-up of 30-41 years after ASD repair in childhood 
showed excellent survival and low morbidity, including a low incidence of atrial 
tachyarrhythmias.17 In pediatric and adult patients undergoing percutaneous ASD 
closure, electrocardiographic changes (decrease in P-wave amplitude and shortening of 
PQ- and QRS-duration) occurred directly after closure or at later follow-up, suggesting 
1
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(partly) reverse remodeling.18 However, a recent study showed that despite closure 
of the ASD in childhood, the risk of AF and stroke was higher than in healthy control 
subjects.19 In this study, the method of ASD closure (surgical or transcatheter) did not 
affect the risk of AF. These observations suggest that an ASD already causes significant 
changes early in life, which may persist after ASD repair20 and may thereby contribute 
to the risk of developing AF decades later. In line with this, ASD repair at older age (>40 
years) does not seem to prevent the development of atrial tachyarrhythmias, suggestive 
of irreversible damage caused by the ASD over the years.21
Atrioventricular septal defect
Complete atrioventricular septal defect occurs in 2% of CHD. The majority of patients 
have Down syndrome (70%).10 Complete atrioventricular septal defect is a result of 
complete failure of fusion between the superior and inferior endocardial cushions. It 
is characterized by a primum ASD that is contiguous with an inlet ventricular septal 
defect and a common AV valve. In addition, the anatomy of the conduction system is 
abnormal, with a more posterior position of the AV node and His bundle compared to 
patients with a structurally normal heart.22
As an atrioventricular septal defect usually results in hemodynamic deterioration 
early in life, surgical repair of the defect is most often performed before the age 
of 6 months. Typically, a two-patch technique is applied to close the atrial and 
ventricular component of the defect, but use of a single patch or direct suturing is 
also performed.23,24 If an atrioventricular septal defect is left untreated for too long, 
irreversible changes in the pulmonary vascular bed take place, leading to pulmonary 
hypertension and subsequently resulting in reversal of the left-to-right to a right-to-left 
shunt, causing cyanosis. In this stage, called Eisenmenger’s syndrome, surgical repair 
is no longer possible.
Literature regarding development of postoperative arrhythmias in this population is 
rather limited.25-27 Fortunately, as a result of improved knowledge on the anatomy of the 
conduction system, the incidence of postoperative 3rd degree AV block has decreased 
dramatically over the past decades.22
Transposition of the great arteries
Transposition of the great arteries accounts for 5% to 7% of CHD.10 The hallmark of 
transposition of the great arteries is atrioventricular concordance and ventriculoarterial 
discordance. The aorta arises from the right ventricle and the pulmonary artery from 
the left ventricle, resulting in complete separation of the pulmonary and systemic 
circulations. A connection between the two circulations (e.g. an ASD, ventricular septal 
defect or patent ductus arteriosus) is required for initial survival.
Up until several decades ago, transposition of the great arteries was corrected by 
the Mustard or Senning procedures, which were aimed at switching the blood flow at 
atrial level using a pericardial or synthetic baffle (Mustard) or the patient’s own atrial 
tissue (Senning) to redirect venous returns. After these procedures, the risk of atrial 
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tachyarrhythmias is high due to the extensive atrial surgery.28,29 Other complications 
include sinus node dysfunction, right ventricular (i.e. systemic ventricular) dysfunction 
and heart failure.30 The atrial switch procedures have largely been replaced by the 
arterial switch operation, which is now the procedure of first choice: after the coronary 
arteries are transplanted to the pulmonary artery trunk, the great arteries are switched. 
Importantly, the morphological left ventricle is restored as the systemic ventricle. Long-
term outcome after the arterial switch operation is excellent, including a low incidence 
of arrhythmias.31
Care for patients after atrial switch repair has mostly shifted from the pediatric to the 
adult CHD practice. As these patients are aging, atrial tachyarrhythmias become more 
frequent and problematic, and results of treatment are often unsatisfactory.30,32
Fontan physiology
As the Fontan-type operation applies to many complex forms of CHD, it will be 
discussed here as a separate entity. The Fontan procedure is performed in patients 
with an anatomical or functional single ventricle (e.g. hypoplastic left heart syndrome, 
tricuspid atresia). The first successful Fontan operation was performed in 1971, after 
which many modifications have been made.33,34 In a Fontan circulation, the systemic 
venous return is redirected to the lungs, without passing through the subpulmonary 
ventricle. The single chamber acts as the systemic ventricle, pumping blood into the 
aorta. The atriopulmonary connection – in which the right atrial appendage is directly 
anastomosed to the pulmonary trunk – has been replaced by the total cavopulmonary 
connection as the surgical technique of choice. The total cavopulmonary connection 
consists of a bidirectional anastomosis of the superior vena cava to the right pulmonary 
artery and a conduit (either intra-atrial or extra-atrial) to connect the inferior vena cava 
to the pulmonary artery.
The Fontan physiology may result in many potential complications, including 
arrhythmias, heart failure, thromboembolic events, hepatic dysfunction, protein-losing 
enteropathy, and worsening cyanosis.35 Large areas of scar tissue, suture lines and 
prosthetic materials within the atria of these patients facilitate the development of 
atrial tachyarrhythmias, particularly macroreentrant circuits.36 Although acute success 
rates of ablative therapy for these atrial tachyarrhythmias is relatively high, long-term 
follow-up after ablation is complicated by frequent recurrences, which are most likely 
caused by a progressive atrial cardiomyopathy.37-40
Atrial tachyarrhythmias in congenital heart disease
Atrial tachyarrhythmias frequently complicate long-term follow-up in patients with 
or without prior repair of CHD. As this population ages, the prevalence of atrial 
tachyarrhythmias and its burden continue to increase (Figure 2).6,16,17,31,41-49
These arrhythmias are associated with impaired quality of life, substantial morbidity 
– including heart failure and thromboembolism – and mortality.6,50,51 In a large cohort 
of adult patients with CHD, atrial arrhythmias were the most common indication for 
1
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hospital admission.51 Figure 3 demonstrates mechanisms and corresponding ECG 
rhythm strips from atrial tachyarrhythmias commonly observed in CHD patients, which 
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Age (years)Figure 2. The increasing incidence of atrial tachyarrhythmias in CHD patients associated with age
The plot shows the cumulative incidence of atrial tachyarrhythmias in patients who did not have 
atrial tachyarrhythmias before the age of 18 years.
Modified from Bouchardy et al.6
Macroreentrant atrial tachycardia
Macroreentrant atrial tachycardia (MRAT) is the most common atrial tachyarrhythmia 
in CHD patients, and its prevalence increases with increasing complexity of CHD.1 
By definition, atrial macroreentry requires an area of slow conduction and a zone of 
unidirectional conduction block. The typical variant of MRAT – typical atrial flutter – is 
defined as a (counter)clockwise reentrant circuit, rotating around the tricuspid valve 
and involving the cavotricuspid isthmus (CTI). In the introduction of this thesis, typical 
atrial flutter will be referred to as CTI-dependent MRAT.
Atypical variants of MRAT are referred to in many different ways in the literature, 
including non-CTI dependent MRAT, atypical atrial flutter, scar-related MRAT, or 
incisional MRAT. In the introduction of this thesis, they will be referred to as non-CTI-
dependent MRAT. In essence, the CTI is not involved in these MRAT. Instead, areas of 
slow conduction and zones of unidirectional conduction block are caused by other 
anatomical barriers (e.g. the mitral valve or the orifice of the caval veins), surgical scars or 
prosthetic materials, or areas of fibrosis.52,53 Multiple circuits can occur simultaneously 
in the same patient. Usually, non-CTI-dependent MRAT appears many years after repair 
or palliation of CHD.53
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Figure 3. Mechanisms of atrial tachyarrhythmias and corresponding rhythm strips
Upper left panel: CTI-dependent macroreentrant atrial tachycardia; a (counter)clockwise 
macroreentrant circuit rotating around the tricuspid valve. Upper right panel: non-CTI-
dependent macroreentrant atrial tachycardia; a macroreentrant circuit independent of the CTI, 
rotating around other anatomical or postsurgical structures, e.g. the atriotomy scar (1) or an atrial 
septal defect patch (2). Lower left panel: focal atrial tachycardia; a tachycardia originating from 
a circumscribed area, e.g. the crista terminalis (1), the coronary sinus ostium (2) or the pulmonary 
veins (3), from where it expands centrifugally to the remainder of the atria. Lower right panel: 
atrial fibrillation; rapid and irregular atrial activation.
CTI: cavotricuspid isthmus, MRAT: macroreentrant atrial tachycardia.
Of the two mechanisms, CTI-dependent MRAT is most commonly observed in 
CHD patients. Slow intra-atrial conduction as a result of atrial dilatation favors the 
development of CTI-dependent MRAT, which therefore occurs more often in CHD 
patients than in the general population.6,54 The only solid predictor of the mechanism 
of MRAT (CTI-dependent vs. non-CTI-dependent) identified up till now is complexity of 
the underlying cardiac defect: a higher complexity of the defect is associated with the 
development of non-CTI-dependent MRAT.55,56
Focal atrial tachycardia
Focal atrial tachycardia also occurs in patients with CHD, yet less frequently than 
MRAT.37,57,58 Focal atrial tachycardia originates from a small, circumscribed area from 
where it expands centrifugally to the remainder of the atria.57 Poor cell-to-cell coupling, 
as is the case in scar tissue, is thought to allow a rapidly discharging focus to become 
apparent. It has been postulated that mechanisms underlying this ‘rapidly discharging 
focus’ may include microreentry or triggered activity.57,59
1




AF is characterized by rapid and irregular atrial activation and an irregular ventricular 
response rate. It is widely known that the prevalence of AF in the general population 
increases with age.60 As survival of patients with CHD has improved, AF is now becoming 
a more frequently encountered clinical problem in this population as well. Although in 
the general population, AF is considered to be mainly a left-sided disease, it has been 
shown to occur in a variety of CHD types, including those mainly involving right-sided 
structures.61 It has recently even become clear that in older CHD patients (>50 years), 






































Figure 4. Types of atrial tachyarrhythmia according to age
The plot shows age-related trends of MRAT, FAT and AF as a percentage of presenting atrial 
tachyarrhythmias. Whereas MRAT is by far the most common arrhythmia in younger patients, AF 
surpasses MRAT as the most common arrhythmia beyond 50 years of age.
AF: atrial fibrillation, FAT: focal atrial tachycardia, MRAT: macroreentrant atrial tachycardia. 
Modified from Labombarda et al.1
Studies reporting on the prevalence of AF in CHD patients are relatively scarce. In 3311 
CHD patients (median age 23 years, followed for a median of 11 years), the reported 
prevalence of AF was 4.7%.42 The prevalence of AF in another study in 21982 CHD 
patients (median age 4 years, followed for a median of 27 years) was 2.98%.7 In the 
latter study, CHD patients had a 22 times higher risk of developing AF than age- and 
sex-matched control subjects. Patients with complex CHD (conotruncal defects) had 
the highest risk of developing AF: 84 times higher than control subjects. As expected, 
major complications including heart failure, ischemic stroke and death occurred 
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significantly more often in patients with AF than in those without AF. As patients in 
the abovementioned studies were still relatively young, the absolute risk of AF was 
low. However, the prevalence of AF is expected to continue to rise as these patients 
are aging.6 Only few studies have assessed risk factors for the development of AF in 
CHD patients. In addition to age and number of cardiac surgeries, risk factors include 
unrepaired lesions, left-sided heart disease and increased complexity of the underlying 
defect.7,44,50,61,62 Cardiovascular risk factors associated with AF in the general population 
(e.g. hypertension, diabetes mellitus) also increase the risk of AF in CHD patients.1,62
The pathophysiology of atrial tachyarrhythmias in congenital heart disease
Atrial tachyarrhythmias in CHD patients occur more often and at a younger age than 
in the general population.6,60,61 Moreover, treatment of these arrhythmias is often 
complicated by the emergence of new arrhythmia mechanisms over time.63,64 The fact 
that the course of atrial tachyarrhythmia development in CHD patients strongly differs 
from that in the general population, suggests that the underlying substrate is affected 
by factors that are at least in part specific to the CHD population.
Before introducing factors contributing to the development of atrial tachyarrhythmias 
in CHD patients, basic concepts of the genesis of these tachyarrhythmias and the role 
of triggers and substrate will be discussed.63,64
The role of conduction abnormalities in the development of atrial tachyarrhythmias
Myocardial cells are characterized by anisotropy in conduction, meaning that electrical 
conduction properties depend on the direction of wavefront propagation.65 These 
anisotropic conduction properties are due to the elongated shape of myocardial cells, 
permitting faster conduction in longitudinal than in transverse direction (i.e. uniform 
anisotropy), which is schematically demonstrated in the upper panels of Figure 5.66,67 
Structural remodelling, including interposition of fibrosis between myocardial fibres 
or side-to-side cell uncoupling, may lead to non-uniform anisotropy, which means 
conduction occurs in a discontinuous and asynchronous manner or a ‘zig-zag pattern’: 
this is illustrated in the lower left panel of Figure 5.67 On the other hand, these structural 
changes may also cause inhomogeneity in repolarization, causing local dispersion in 
refractoriness. Subsequently, this may facilitate unidirectional block between adjacent 
regions of tissue.67 Hence, inhomogeneity in conduction may occur.
Conduction abnormalities are crucially involved in the development of atrial 
tachyarrhythmias. Lines of block facilitate micro- and macroreentry. The lower right 
panel of Figure 5 illustrates a schematic example of the initiation of reentry in the 
presence of areas of scar tissue: when a wavefront is forced to rotate around a line of 
block, the distance covered by the wavefront increases and so does the conduction 
time. This increases the likelihood of the wavefront encountering excitable tissue 
after rotating around the line of block, thereby initiating reentry. Atrial extrasystoles 
may initiate such episodes of reentry as a result of decreased conduction velocity 
due to partly refractory myocardial tissue in case of premature atrial extrasystoles.68 
Atrial extrasystoles may also be the cause of lines of conduction block, as previously 
1
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demonstrated in a high-resolution epicardial mapping study in 164 non-CHD patients 
with (n=25) or without (n=139) AF.69 Premature atrial extrasystoles with an aberrant 
conduction pattern provoked considerable abnormalities in conduction, thereby 
increasing the likelihood of reentry to occur.
Uniform anisotropy
Non-uniform anisotropy Macroreentry
Figure 5. The role of conduction abnormalities in the development of atrial tachyarrhythmias
Upper panels: schematic examples of uniform anisotropy, causing faster conduction in 
longitudinal (upper left panel) than in transverse (upper right panel) direction due to the 
elongated shape of myocardial cells. Lower left panel: schematic example of non-uniform 
anisotropy. Interposition of fibrosis and side-to-side cell uncoupling leads to barriers in conduction 
(double red bars), causing discontinuous conduction. Lower right panel: schematic example of 
the initiation of a reentrant circuit (red arrow).
Ortiz et al. performed epicardial mapping of the right atrial free wall in seven dogs with 
sterile pericarditis, and showed that the length of line of functional conduction block 
was critical in the conversion of AF to atrial flutter and vice versa.70 Stable reentrant 
circuits (atrial flutter) required a long line of conduction block combined with areas 
of slow conduction, whereas unstable reentrant circuits occurred when lines of 
conduction block shortened, areas of slow conduction disappeared, and cycle length 
decreased. Migration of such unstable reentrant circuits across the atrial wall gives 
rise to AF. Migration of lines of conduction block was also observed by Alessie et al., 
who performed epicardial mapping of the right and left atrium in 24 patients with long-
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standing persistent AF.71 During AF, lines of conduction block continuously changed on 
a beat-to-beat basis.
Quantification and visualization of atrial electrical abnormalities: cardiac mapping
Cardiac mapping involves the recording of electrograms from the surface of the heart: 
the endocardium (inside) or the epicardium (outside). It is essential for understanding 
mechanisms underlying tachyarrhythmias and for guidance during catheter ablation. 
Box 1 provides background on the characteristics of and differences between unipolar 
and bipolar electrograms.72-75
Box 1. Unipolar and bipolar electrograms
Unipolar electrograms
The morphology of a unipolar electrogram reflects the passage of a depolarization 
wavefront through the tissue surrounding the recording electrode. Propagation 
of the wavefront towards the electrode generates a positive deflection, followed 
by a negative deflection as the wavefront reaches the electrode and moves away. 
Asynchronous activation of the tissue or a change in wavefront direction results 
in multiple positive and negative peaks (fractionation). The maximum negative 
slope (-dV/dt) of a unipolar signal is a good indicator of the depolarization of the 
tissue beneath the electrode (local activation time). Moreover, the morphology 
of unipolar electrograms contains information on the direction of wavefront 
propagation, as well as remote (farfield) activations. However, accurate annotation 
of the local activation time may be complicated by farfield signals (as they may 
obscure relatively small local signals) and noise.
Bipolar electrograms
Bipolar electrograms consist of the difference between two unipolar electrograms. 
As the morphology of farfield electrical activity is generally similar in two adjacent 
unipolar electrograms, most of the farfield activity is eliminated in the bipolar 
electrogram and the local signal remains. The same applies to noise. Consequently, 
annotation of local activation time in regions of scar tissue may be more accurate 
using bipolar electrograms. The timing of the maximum amplitude of the bipolar 
electrogram was shown to correspond with the timing of the maximum negative 
slope of the unipolar electrogram (local activation time). However, unlike the 
morphology of unipolar electrograms, the morphology of bipolar electrograms 
(and thus local activation time) is affected by many non-substrate related factors, 
including the direction of wavefront propagation, interelectrode spacing, and the 
orientation of the recording electrodes relative to the tissue.
Although bipolar electrograms are generally used during clinical mapping studies, 
there is a tendency towards increasing usage of unipolar electrograms, as both 
recording techniques provide complimentary information.
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The endocardium is usually reached by inserting catheters in the femoral vein or artery 
and advancing them to the heart. In the regions of interest, local electrograms are 
recorded by the electrodes integrated in the shaft of the catheter: standard catheters 
usually contain 4 to 20 electrodes, but recently introduced deployable catheters may 
contain up to 64 electrodes. Over two decades ago, electroanatomical mapping was 
introduced, which enables recording of intracardiac electrograms in relation to the 
anatomical location of the catheter in the heart.76 The pattern of wavefront propagation 
along the reconstructed anatomical regions is visualized (activation map). However, the 
limited spatial resolution of these activation maps prevents detailed visualization of the 
conduction abnormalities as described in the previous paragraph. Therefore, bipolar 
voltage amplitude – which is assumed to be a surrogate marker for the presence of 
atrial fibrosis (and thus impaired conduction) – is commonly used during endocardial 
mapping, as it is relatively easy to measure.77 The amplitude of a signal is determined 
by the volume of cardiac tissue activated at the same time. Hence, the amplitude will 
be relatively large when the tissue surrounding the electrode is healthy and large areas 
are activated synchronously. However, in the presence of atrial fibrosis and side-to-side 
cell uncoupling, the tissue is activated asynchronously, resulting in decreased signal 
amplitudes.72,77 These concepts form the basis of voltage mapping and voltage-guided 
ablation, which is aimed at targeting low voltage areas.
Open-heart surgery provides the opportunity to perform cardiac mapping using 
larger electrode arrays (e.g. 128 or 192 electrodes), thereby increasing the spatial 
resolution. Mapping is performed at the epicardium. In contrast to endocardial mapping, 
epicardial mapping allows access to Bachmann’s bundle, which is potentially involved in 
the pathogenesis of AF.78,79 On the other hand, important arrhythmogenic structures 
such as the interatrial septum or the myocardial sleeves of the pulmonary veins cannot 
be reached using epicardial mapping. The high-resolution epicardial mapping approach 
applied in several chapters of this thesis records unipolar electrograms, which are 
used to create activation maps. The high resolution of these maps enables detailed 
visualization of conduction abnormalities and subsequent changes in wavefront 
propagation. Similar to endocardial mapping, unipolar electrograms obtained from 
epicardial mapping may be used to analyze other signal characteristics such as voltage 
amplitude or fractionation.
Triggers and substrate of atrial tachyarrhythmias in congenital heart disease
Atrial tachyarrhythmias require a trigger for initiation and an anatomical and/or 
electrophysiological substrate for maintenance of the tachyarrhythmias. Figure 6 
summarizes the most important factors contributing to the development of atrial 
tachyarrhythmias in patients with CHD, which will be discussed in more detail in the 
following paragraphs.


























Figure 6. The pathophysiology of atrial tachyarrhythmias in patients with CHD
See text for detailed explanation.
IVC: inferior vena cava, SVC: superior vena cava.
Triggers of atrial tachyarrhythmias in congenital heart disease
In their landmark study in 1998, Haïssaguerre et al. demonstrated that episodes of 
paroxysmal AF were frequently initiated by atrial extrasystoles originating from the 
pulmonary veins.80 These triggers responded well to local radiofrequency catheter 
ablation. Based on this observation is the concept of pulmonary vein isolation, where 
the pulmonary veins – being the main source of triggers – are isolated from the rest of 
the atrial tissue using catheter ablation.81 Mechanisms underlying atrial extrasystoles 
include micro-reentry and ectopic activity resulting from enhanced automaticity and 
triggered activity.82 Although ectopic triggers in CHD patients may originate from 
the pulmonary veins, it is likely that other atrial regions are also involved. In these 
patients, it is often the right atrium that is volume or pressure overloaded, leading to the 
deposition of fibrosis.52 As previously described, fibrosis may cause local abnormalities 
in conduction, thereby provoking micro-reentry. Furthermore, ectopic activity is 
enhanced by mechanical stress83, which in this case is caused by stretch of the atrial 
wall due to volume or pressure overload. In addition, the fibroblast itself may induce 
ectopic activity.84 A previous study including 573 patients with CHD demonstrated that 
atrial extrasystoles occurred relatively often in CHD patients.85 A higher frequency of 
atrial extrasystoles per day was associated with a higher risk of developing new-onset 
AF during a median follow-up of 52 months.
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Factors contributing to the substrate of atrial tachyarrhythmias in congenital heart disease
The following circumstances contribute to the substrate of atrial tachyarrhythmias in 
patients with CHD.
1. Previous cardiac surgery
Surgical scars, suture lines and prosthetic material play a major role in the development 
of non-CTI-dependent MRAT. These arrhythmias often circle around surgically created 
central obstacles, including the right atriotomy scar, cannulation sites or atrial septal 
patch.53,86-88 Multiple circuits may occur simultaneously in one patient, and one circuit 
may use multiple central obstacles, causing figure-of-8 reentry.72,87 MRAT requires 
a long line of conduction block together with areas of slow conduction, which was 
previously demonstrated by Ortiz et al.70 For this reason, this type of arrhythmia is 
often found in patients with prior cardiac surgery, as surgical scars generally form long 
lines of transmural conduction block. Surgically injured areas may also give rise to focal 
atrial tachycardia, albeit to a much lesser extent than MRAT.86 As previously described, 
the development of focal atrial tachycardia is enhanced by poor cell-to-cell coupling 
occurring as a result of fibrosis in these areas.57,82,86
2. Longstanding volume or pressure overload
In patients with CHD, hemodynamic conditions are often abnormal during a relatively 
long period of time, resulting in atrial remodelling and increased susceptibility to atrial 
tachyarrhythmias. These abnormal hemodynamic conditions are caused by atrial 
volume overload (e.g. left-to-right shunt, valve regurgitation) or pressure overload (e.g. 
pulmonary hypertension, valve stenosis). Over 20 years ago, long-term follow-up studies 
already demonstrated an association between age at ASD repair and the development 
of AF.16,21 Older age at ASD repair – i.e. a longer duration of atrial volume overload – was 
associated with a higher risk of both pre- and postoperative AF.
Chronic atrial volume or pressure overload leads to atrial wall stretch and 
subsequent significant structural and electrical changes. One of the most important 
structural changes is the interposition of fibrotic tissue between myocardial fibres. Li 
et al. demonstrated significantly more interstitial fibrosis in dogs with heart failure (and 
thus myocardial stretch) which was induced by 5 weeks of rapid ventricular pacing, 
than in control subjects.89 Other features of structural remodelling include myocardial 
cell hypertrophy and apoptotic death of myocytes.90 Two histological studies analysed 
right atrial tissue samples of patients with right atrial volume overload due to ASD and 
found similar structural changes, including atrial fibrosis.52,91 Ueda et al. compared right 
atrial tissue samples from 65 patients with right atrial overload due to unrepaired CHD 
to those of age-matched control subjects, and showed that samples of CHD patients 
had significantly more structural remodelling.52 Hence, these findings suggest that the 
duration of right atrial volume overload plays a significant role in structural remodelling 
in these patients. As a result of these structural changes, increased heterogeneity 
in atrial conduction is expected to occur due to discrete regions of slow conduction 
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associated with atrial fibrosis.92 The effect of chronic atrial stretch on the atrial effective 
refractory period is ambiguous, as various studies reported a decrease, increase or no 
change in atrial effective refractory period in the presence of acute stretch.89,92 Hence, 
structural changes appear to form the basis for the conduction abnormalities that 
predispose to the development of atrial tachyarrhythmias in the presence of chronic 
abnormal hemodynamic conditions.92
3. Early volume or pressure overload
The majority of patients with hemodynamically significant CHD undergo surgical repair 
or palliation at a young age. Despite the relatively short duration of volume or pressure 
overload, these patients still develop atrial tachyarrhythmias during long-term follow-
up.5,19 As these tachyarrhythmias are not always confined to surgically injured areas57,93, 
atrial remodelling as a result of early volume or pressure overload during the first weeks, 
months or years of life may also contribute to the substrate of atrial tachyarrhythmias in 
these patients. A histological study analysing right atrial tissue samples of four patients 
aged 1, 4, 6 and 6 years of age with an ASD found atrial fibrosis and significant other 
degenerative changes in samples of the two older children, indicating that structural 
remodelling already occurs at a relatively young age.91 The role of relatively short-lasting 
volume or pressure overload on the development of electrical abnormalities in CHD 
patients is yet unknown.
4. Interplay of arrhythmias
Another important factor contributing to the substrate of atrial tachyarrhythmias in 
CHD patients is the interrelationship between atrial brady- and tachyarrhythmias, and 
the interplay between regular atrial tachyarrhythmias and AF.
Sinus node dysfunction (SND) and associated chronic bradycardia have been shown 
to predispose to both atrial flutter and AF.32,94,95 SND in CHD patients may be caused 
by direct surgical trauma to the sinus node or its supplying arteries, particularly during 
complex atrial surgery.53,95,96 However, as surgical techniques have been modified 
and improved over the years, surgically induced SND is less likely to occur. SND may 
also be a consequence of the congenital defect itself, due to abnormal anatomy or 
function of the sinus node.53 Several studies demonstrated the presence of impaired 
sinus node function in adult patients before repair of an ASD, indicating that SND 
may also be caused by longstanding right atrial stretch.20,97 Evidence suggests that 
atrial tachyarrhythmias may also cause SND via sinus node remodelling98,99, thereby 
potentially leading to a vicious cycle of arrhythmia interplay.
Two mechanisms support the observation that SND predisposes to atrial 
tachyarrhythmias. The first is based on atrial remodelling induced by chronic 
bradycardia. In 16 non-CHD patients with symptomatic SND and 16 age-matched 
control subjects, Sanders et al. showed that SND was associated with significant 
structural and anatomical abnormalities, including left atrial enlargement and regions 
of low voltage and scarring in the right atrium.100 Furthermore, patients with SND 
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had diffuse conduction abnormalities and prolonged atrial refractoriness in the right 
atrium. The second mechanism involves the occurrence of premature beats initiating a 
reentrant tachycardia.101,102 Potential explanations for increased ectopic activity during 
bradycardia include increased automaticity and early afterdepolarizations.
Regular atrial tachycardia has also been shown to predispose to AF.103 Both regular 
atrial tachycardia and AF were shown to coexist in a considerable amount of patients 
with CHD, in whom regular atrial tachycardia often preceded AF.61 Regular atrial 
tachycardia may increase the susceptibility of AF by electrical remodelling, including 
shortening of atrial refractoriness and inverse rate adaptation.99 Furthermore, regular 
atrial tachycardia may degenerate into AF due to shortening of the line of functional 
conduction block around which the stable reentrant circuit rotates.70
5. Aging
It is generally known that older age is associated with increased incidence of atrial 
tachyarrhythmias, particularly AF.60,104 Beyond the age of 60 years, the incidence of 
AF in the general population rapidly increases.104 Various age-related structural and 
electrophysiological changes may underlie this increased vulnerability for AF.
Age-related changes in myocardial structure have been studied in animal models, 
in which atrial cell hypertrophy and interstitial fibrosis was associated with increasing 
age.105,106 These structural changes may contribute to the age-related electrical changes 
also observed in these studies, including decreased conduction velocity and increased 
arrhythmia inducibility. Anyukhovsky et al. performed endocardial mapping of the right 
atrial wall of adult (1-5 years) and old dogs (>8 years) and found that conduction velocity 
of premature atrial beats was reduced in the old atria; conduction velocity of sinus 
rhythm beats was similar in adult and old atria.105 Furthermore, dispersion of atrial 
repolarization also promotes reentry, although evidence for its relation with aging 
remains ambiguous.107-109
Similar findings have been observed in studies in humans. Matsuyama et al. studied 
the right atrial posterolateral wall in 26 autopsied human hearts and found fibro-fatty 
replacement of musculature of the sinus venosus in the hearts of older patients.110 
Spach et al. correlated age-related structural changes in pectinate muscle tissue to 
the electrical properties of the tissue.66 They showed that with increasing age, the 
distribution of collagenous septa in the intercellular space changed substantially. In 
older subjects, the septa were long and often completely surrounded myocardial 
muscle fibres, whereas in younger subjects, the septa were short and did not completely 
surround muscle fibres. These microstructural changes related to aging resulted in 
progressive electrical uncoupling of side-to-side connections between groups of atrial 
fibres. In turn, this lateral electrical uncoupling resulted in a pronounced zigzag course 
of propagation and hence reduced conduction velocity in transverse direction (but not 
in longitudinal direction). These properties allow reentry to occur within small regions. 
Another more recent study from this group analysed characteristics of conduction 
of premature stimuli in isolated pectinate bundles from patients <20 years and >60 
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years of age.68 Arrhythmogenic conduction abnormalities were only present in the aged 
bundles, which was thought to be due to the presence of fibrosis as a result of aging. 
In a less experimental setting, two endocardial mapping studies in non-CHD patients 
also demonstrated reduced conduction velocity associated with increasing age.111,112
6. Cardiovascular risk factors
Cardiovascular risk factors associated with the development of AF in the general 
population also apply to patients with CHD, especially as they get older. These risk factors 
further contribute to structural remodelling that is already ongoing in these patients. 
These factors include amongst others hypertension, diabetes mellitus, myocardial 
infarction, heart failure, obesity, obstructive sleep apnoea and smoking.1,62,113
7. AF-induced remodelling
Over time, maintenance of AF is also enhanced by atrial electrical and structural 
remodelling as a result of AF itself, a concept commonly known as ‘AF begets AF’.114,115 
Initially, self-limiting episodes of AF are triggered by atrial extrasystoles and atrial 
remodelling as a result of AF is reversible. However, the persistent and progressive 
nature of AF causes a gradual transition from a ‘trigger-driven’ to a ‘substrate-driven’ 
arrhythmia, in which AF itself induces structural alterations in the myocardium, which 
in turn facilitate the perpetuation of AF.
Treatment of atrial tachyarrhythmias
As atrial tachyarrhythmias in CHD patients are associated with significant morbidity 
and mortality, it is essential they are effectively treated, particularly since spontaneous 
conversion to sinus rhythm has been shown to occur in only a minority of adult CHD 
patients (10%).116 Depending on the patient’s clinical presentation and hemodynamic 
stability, acute termination of the arrhythmia may be required. A retrospective study 
by Koyak et al. including 92 patients with new-onset atrial tachyarrhythmias showed 
that electrical cardioversion was most frequently used for acute termination, achieving 
success in 89% of patients.116 However, Kirsh et al. showed in 149 patients with CHD 
that atrial tachyarrhythmias frequently recur after electrical cardioversion: over time, 
the interval between successive cardioversions became shorter, whereas the number 
of cardioversions increased.50
Therefore, additional therapy is required to maintain sinus rhythm after acute 
termination of the arrhythmia. For this purpose, anti-arrhythmic drugs can be used, 
although overall efficacy in this population is disappointing.117 In the study of Koyak et 
al., atrial tachyarrhythmias recurred in 55% of patients using anti-arrhythmic drugs 
during a mean follow-up of 2.5 years: of anti-arrhythmic drugs used, class III drugs 
were most effective in preventing recurrence of atrial tachyarrhythmias.116 Besides 
their inadequate efficacy, anti-arrhythmic drugs have significant side effects, which 
may become especially problematic in CHD patients. Anti-arrhythmic drugs may be 
negative inotropic, proarrhythmogenic, and they may aggravate sinus and AV node 
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dysfunction.117 Amiodarone is well-known for its association with extra-cardiac toxicities 
such as thyroid dysfunction, which occurs particularly often in patients with CHD.118
Antitachycardia pacing (via esophageal or intracardiac catheters or pacemakers with 
antitachycardia pacing features) is another way to terminate reentrant tachycardia. The 
efficacy in patients with CHD is reasonable (54%).119 However, antitachycardia pacing 
carries the risk of acceleration of the atrial tachyarrhythmia and degeneration into AF 
or even induction of a ventricular tachyarrhythmia.120 Moreover, atrial tachyarrhythmias 
may remain undetected as CHD patients often have slow arrhythmias with 1:1 AV 
relation whereas the antitachycardia pacing device requires a ≥2:1 AV relation to trigger 
therapy.119
Surgical ablation of tachyarrhythmias is potentially curative, although currently it 
only plays a small role in the available treatment strategies.121 It is mainly indicated 
in patients requiring cardiac surgery or in those with symptomatic tachyarrhythmias 
refractory to other treatments. It involves the creation of linear lesions in the left, 
right or both atria; lesions are created using the cut-and-sew technique, cryoenergy, 
and/or radiofrequency energy.122,123 The guidelines clearly recommend the addition of 
arrhythmia surgery during a Fontan conversion procedure, which includes conversion of 
the atriopulmonary connection to a total cavopulmonary connection.124 One of the main 
contributors to research in this field is the group from Chicago, which recently reported 
favorable outcomes of Fontan conversion with concomitant arrhythmia surgery in 140 
patients.125 Freedom from recurrence of atrial tachycardia was 77% at 10 years. Atrial 
fibrillation did not recur at all. Concrete evidence-based recommendations for CHD 
patients undergoing cardiac surgery other than Fontan conversion are lacking.
Another commonly applied and potentially curative treatment for atrial 
tachyarrhythmias is catheter ablation. The goal of catheter ablation is to eliminate 
the trigger or substrate of the tachyarrhythmia, by either heating or cooling of the 
tissue in the target area. The target site for ablation depends on the mechanism of 
the arrhythmia. A reentrant circuit is interrupted by placing linear lesions within the 
circuit, connecting two non-conducting barriers (e.g. scar tissue, Figure 7). In case of a 
focal tachycardia, the site of the earliest activation is targeted (Figure 8). Strategies for 
ablation of AF are largely transferred from the general population and most commonly 
include isolation of the pulmonary veins with connecting lesion sets to the left-sided 
atrioventricular annulus, and cavotricuspid isthmus ablation.124,126
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Figure 7. Macroreentrant atrial tachycardia
Three-dimensional electroanatomical activation map of a figure-of-eight macroreentrant atrial 
tachycardia in the right atrium of a 15-year old patient after Fontan palliation. Ablation lesions 
were applied between two areas of scar tissue, which effectively terminated the tachycardia.
LAO: left anterior oblique view, RAO: right anterior oblique view.
Figure 8. Focal atrial tachycardia
Three-dimensional electroanatomical activation map of a focal atrial tachycardia in the left atrium 
of a 17-year old patient with a patent foramen ovale. Ablation lesions were applied at the site of 
earliest activation, which effectively terminated the tachycardia.
AP: anterior-posterior view, IPV: inferior pulmonary vein, PA: posterior-anterior view, SPV: superior 
pulmonary vein.
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In the CHD population, several factors may hamper successful mapping and catheter 
ablation. First, the intrinsic or postsurgical anatomy often complicates access to the 
target site for ablation. Second, several types of CHD are associated with an abnormal 
intrinsic course of the conduction system, which is especially at risk during catheter 
or surgical procedures. Displacement of the conduction tissue occurs as a result of 
malalignment of atrial and ventricular septa, which occurs for example in complete 
atrioventricular septal defect and congenitally corrected transposition of the great 
arteries.127 Damage to the conduction system may result in permanent AV block. Third, 
the often hypertrophied and scarred atrial wall in CHD patients may hamper the 
formation of successful transmural radiofrequency lesions.128 By cooling of the ablation 
electrode, irrigated radiofrequency ablation is able to deliver more radiofrequency 
energy, thereby creating larger and deeper ablation lesions, without the risk of 
thrombus formation.129 Several studies showed that irrigated radiofrequency ablation 
is associated with higher acute success rates in patients with CHD.128,130-132 Finally, venous 
access routes may be limited due to venous occlusion from prior catheterizations or 
surgical interventions, or due to anatomical variations (e.g. interrupted vena cava 
inferior).133,134
Despite the abovementioned challenges and difficulties related to catheter 
ablation in CHD patients, acute success rates of ablation of MRAT and focal atrial 
tachycardia are high. Depending on complexity of the underlying defect and arrhythmia 
mechanism, acute success rates range between 65% and 96% as reported in some of 
the larger studies performed over the past 10 years.58,63,86,135-142 However, recurrence 
rates are considerable; the same studies reported rates up to 56%, mostly around 
40%. Arrhythmia recurrence may in part be due to the abovementioned factors 
complicating catheter ablation in this population. But more importantly, prior studies 
showed that recurrences were often caused by other arrhythmia mechanisms, 
suggesting that ongoing and progressive atrial remodeling over time causes new atrial 
tachyarrhythmias.56,63,64 Table 1 demonstrates the 12-point score devised by Triedman 
et al. assessing clinical activity of arrhythmia, taking into account not only documented 
arrhythmia recurrence, but also severity of symptoms, frequency of cardioversion 
and use of anti-arrhythmic medications.131 Using this clinical arrhythmia score, they 
showed that despite arrhythmia recurrence, catheter ablation provided long-term 
clinical benefit.131,137
With regard to outcomes of AF ablation in CHD patients, most studies published 
up until 2014 were case-series143-145 or consisted mainly of patients with repaired or 
unrepaired ASD146-149 or persistent left superior vena cava.150 Consequently, the 2014 
guidelines on management of arrhythmias in adult CHD patients do not provide any 
specific recommendations for AF ablation in this population.124 In the past few years, 
several larger studies including patients with CHD types of varying complexity were 
published.126,151-153 From these studies, it can be concluded that AF ablation in CHD 
patients is feasible and safe. However, despite the high acute success rates reported 
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in these studies, it appears that repeat procedures for recurrences are more often 
required to achieve long-term success than in the general population.126,152,154
Table 1. Clinical Arrhythmia Severity Score
Category Score Category Score
Documented arrhythmia Cardioversion
None 0 None 0
Nonsustained 1 Single cardioversion 1
Sustained 2 AAIT cardioversion 1
Incessant 3 ≥2 cardioversions 3
Arrhythmia severity Antiarrhythmic medications
Asymptomatic 0 None or digoxin only 0
Palpitations* 1 Class II or Class IV 1
Syncope/CHF/thrombosis 2 Class I or Class III 2
Cardiac arrest 3 Amiodarone toxicity 3
* In infants and younger children not able to indicate the presence of palpitations, alternative 
arrhythmia-related symptoms may include: vomiting, abdominal pain, sweating, pallor, chest 
discomfort. AAIT cardioversion is defined as automatic or manual cardioversion using an 
implanted atrial pacemaker and not requiring any additional intervention.
CHF: congestive heart failure.
Modified from Triedman et al.64
Outline of this thesis
This thesis aims to further characterize factors involved in the pathogenesis of atrial 
tachyarrhythmias in patients with CHD, as this information is essential to be able to 
modify or design treatment strategies and improve treatment outcomes.
The first chapters of this thesis provide an outline of the current treatment 
modalities for atrial tachyarrhythmias in CHD patients. Advances, outcomes and 
shortcomings are discussed. Chapter 2 discusses how advances in mapping and 
catheter technologies have contributed to improved outcomes of ablative therapy in 
CHD patients. Chapter 3 describes the most prevalent atrial tachyarrhythmias in a 
particularly complex subset of CHD patients – those after the Mustard or Senning 
procedure for transposition of the great arteries – and summarizes challenges during 
catheter ablation specifically encountered in this population. Chapter 4 reviews several 
potential treatment strategies in another subset of patients with complex CHD – those 
with Fontan physiology – in response to a case presentation. Chapter 5 presents 
outcomes of catheter ablation of AF and percutaneous ASD closure combined in one 
procedure. Outcomes of catheter ablation for various tachyarrhythmias in pediatric 
patients with CHD are described in Chapter 6. Chapter 7 presents the outcomes of a 
comprehensive literature review summarizing the results of various surgical techniques 
applied during surgical ablation of atrial tachyarrhythmias in CHD patients.
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The next chapters will go into further detail on the role of several factors in the 
pathogenesis of atrial tachyarrhythmias in patients with CHD. Chapter 8 demonstrates 
the immediate effects of open-heart surgery and cardiopulmonary bypass on the 
occurrence of intraoperative and early postoperative arrhythmias in pediatric patients 
with CHD. Long-term consequences of cardiac surgery on arrhythmia development in 
patients with septal defects are discussed in Chapters 9 and 10, including the interplay 
between various arrhythmias. Chapter 12 demonstrates the atrial electrophysiological 
consequences of aging in a large population of patients with ischemic heart disease 
without a history of AF. Chapter 12 describes the consequences of longstanding 
volume overload on intra-atrial conduction during sinus rhythm in adult patients with 
unrepaired ASD. Chapter 13 presents the rationale and study design of a recently 
introduced high-resolution epicardial mapping study in pediatric patients with CHD, 
aimed at determining the early electrophysiological consequences of CHD.
The implications of these findings with regard to current treatment strategies and 
future perspectives will be discussed in Chapter 14. An English and Dutch summary 
of this thesis is provided in Chapters 15 and 16.
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Catheter ablation in congenital heart disease: 
Take a close look at the high-density map 
before you take the next step








Aims: The aim of this review is to discuss how evolvements in mapping and catheter 
technologies contributed to advances in ablative therapy of tachyarrhythmias in patients 
with congenital heart disease (CHD) and to summarize the improved procedural and 
long-term outcomes.
Methods: PubMed was searched for studies reporting on outcomes of mapping and 
ablation procedures of various types of tachyarrhythmias in patients with CHD.
Results: 3-dimensional electroanatomical (ultra-)high-density activation/voltage 
mapping has facilitated ablative therapy of (supra) ventricular tachyarrhythmias by 1) 
providing novel insights into mechanisms underlying tachyarrhythmias, 2) reducing 
fluoroscopy and procedure time, 3) improving catheter navigation, 4) increasing 
procedural and long-term success rates. Catheter navigation in CHD patients is further 
facilitated by remote magnetic navigation, non-fluoroscopic image integration and 
intracardiac echocardiography. Ablation outcomes have improved by usage of irrigated-
tip catheters. ‘Recurrent’ tachyarrhythmias after ablative therapy are common and 
often originate from other sites. Though most tachyarrhythmias are effectively treated 
by either transecting crucial pathways of conduction between two non-conductive 
barriers or isolating areas of ectopic activity, the approach in CHD patients with atrial 
fibrillation is less well established.
Conclusion: Advances in mapping and ablation technologies continue to improve 
outcomes of ablative therapy in CHD patients. Localization of arrhythmogenic 
substrates is difficult due to the distorted cardiac anatomy. Extensive mapping prior 
to ablative therapy to identify appropriate target sites for ablation is essential. Recurrent 
tachyarrhythmias after ablative therapy are indicative of ongoing remodeling. The next 
challenge in CHD patients will be designing effective ablative therapy of AF.
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Patients with congenital heart disease (CHD) have a higher susceptibility for 
tachyarrhythmias than subjects with a normal cardiac anatomy.1 Long-term persisting 
hemodynamic overload causes ectopic activity due to calcium overload triggering 
delayed after depolarizations. In turn, increased ectopic activity triggers episodes of 
tachyarrhythmias such as atrial fibrillation (AF). In a cohort of 573 adult patients with 
CHD, atrial ectopy indeed occurred more frequently in patients who developed de novo 
AF (5%) during a median follow up of 52 months.2
Longstanding hemodynamic overload also causes structural remodeling. Myocardial 
tissue is further damaged by interposition of prosthetic materials and progressive 
scarring along suture lines and prior atrio- or ventriculotomy sites. These structural 
alterations cause localized areas of conduction abnormalities3 (Figure 1) and dispersion 
of atrial refractoriness. Thus, frequent ectopy combined with local conduction 
abnormalities and increased dispersion in refractoriness make CHD patients more 
vulnerable to developing tachyarrhythmias. Hence, tachyarrhythmias in CHD patients 
seem to be an inevitable destiny. The considerable morbidity and mortality associated 
with the occurrence of tachyarrhythmias indicate the need for ablative therapy as a 
potential ‘curative’ treatment modality.
In the past decades, catheter ablation of tachyarrhythmias in patients with CHD has 
emerged as a potential effective treatment modality. The earliest reports on catheter 
ablation in CHD patients date from the mid-90s.4-9 The initial ablation procedures 
were guided by fluoroscopy only and multi-electrode catheters were used to record 
electrograms simultaneously from multiple endocardial sites. Fractionated potentials 
aided in localizing areas of slow conduction, and target sites for ablation were identified 
by entrainment mapping. Comprehension of the underlying mechanism required a 
mental reconstruction of the activation sequence, which could be difficult in case of 
complex intra-atrial reentry circuits such as figure-of-eight reentry. As a consequence, 
these procedures were time-consuming and had moderate success rates.
The introduction of 3-dimensional electroanatomic mapping (3D-EAM, Figure 2) 
guiding ablative therapy is one of the greatest advances in catheter ablation of the 
past decades.10-12 This technology not only provided novel insights into the mechanisms 
underlying tachyarrhythmias, but it also facilitated ablative therapy. Ablative therapy 
in CHD patients guided by 3D-EAM improved procedural outcomes, reduced 
fluoroscopy time, shortened procedure time and even increased long-term success 
rates. 3D-EAM systems enable visualization of anatomical structures, localization of 
prosthetic materials, patterns of activation as well as real-time navigation of mapping 
and ablation catheters. In addition, this technology also contributed substantially to 
our understanding of the arrhythmogenic substrate underlying both supraventricular 
(SVT) and ventricular tachyarrhythmias (VT). Nowadays, 3D-EAM has become an 
indispensable part of the ablation procedure of tachyarrhythmias in CHD patients.
The aim of this review is to discuss how evolvements in mapping and catheter 
technologies contributed to advances in ablative therapy of tachyarrhythmias in CHD 
patients and to summarize the improved procedural and long-term outcomes.
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Figure 1. Spatial distribution of atrial conduction abnormalities
Schematic posterior view of the atria illustrating the spatial distribution of conduction 
abnormalities (red lines) as assessed by high-resolution epicardial mapping in two patients with 
a secundum ASD.
IVC: inferior vena cava, PV: pulmonary vein, SVC: superior vena cava.
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Figure 2. Three-dimensional electroanatomic mapping
Three-dimensional electroanatomic bipolar voltage map of the reconstructed right atrium 
obtained from a patient with a Fontan circulation in anterior (left) and posterior (right) view. 
The grey colored regions indicate areas of scar tissue. IVC: inferior vena cava, SVC: superior vena 
cava.
Overcoming challenges in vascular access
The initial step of ablative therapy – obtaining access to ablation target sites – may 
already pose a major challenge during procedures in patients with CHD. The femoral 
vein approach is not possible in case of an interrupted inferior vena cava or venous 
occlusion, requiring alternative access routes such as a transhepatic approach, superior 
approach via the internal jugular or subclavian vein or an arterial approach.13-16 Access to 
the target chamber may be limited in patients with altered post-surgical atrial anatomy, 
including atrial switches (Mustard or Senning) or total cavopulmonary connections.17 
Also, prosthetic rings or valves, percutaneous closure devices, patches and extensive 
atrial enlargement may impede catheter manipulation and/or access to desired ablation 
sites.18,19
An important improvement in the accessibility of the pulmonary venous atrium (left 
atrium in usual atrial anatomy) was the ability to perform a transseptal puncture in the 
presence of an atrial baffle or patch, which was demonstrated by El-Said et al. more than 
40 years after the introduction of the transseptal puncture.20,21 Several studies have 
since then confirmed the safety and feasibility of the ‘transbaffle’ puncture.22-27 Other 
techniques previously reported in this population include a transthoracic percutaneous 
technique28 or a hybrid approach involving transcatheter ablation via sternotomy.29 
Both techniques carry a significant perioperative risk and should therefore be reserved 
for selected cases.
Remote magnetic navigation (RMN) minimizes the need for such invasive measures, 
as it enables relatively unrestricted catheter movement using retrograde aortic or 
superior venous access in complex anatomies.30 The flexible and compliant design of 
2
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the catheter lowers the risk of cardiac perforation or valvular damage. Results of the 
use of RMN during catheter ablation in CHD patients were first described in 2008 by 
Wu et al. in 4 patients after the Mustard (1) or Senning (3) procedure for transposition 
of the great arteries.31 Successful ablation was achieved in all patients, and the authors 
concluded that the use of RMN was feasible and safe. Subsequent studies including 
larger numbers of patients suggest that procedural and long-term outcomes after 
catheter ablation using RMN are good, although a direct comparison to manual ablation 
is not available.31-39 In 2013, Wu et al. observed higher procedural success rates after 
RMN ablation (100%) than after manual ablations that were performed before the 
introduction of RMN (77%), although this difference did not reach statistical significance 
(p=0.18).38 Ueda et al. compared outcomes of manual ablation in patients with simple 
CHD to those of RMN ablation in patients with more complex CHD, and showed that, 
despite differences in CHD complexity, the procedures were equally safe and successful 
in both groups.37 In terms of safety, no complications resulting from the use of RMN 
were reported in any of these studies apart from a small arteriovenous fistula or 
pseudo-aneurysm related to arterial access in a few individual cases.36-38 Importantly, all 
studies reported relatively short fluoroscopy times using RMN. The limited fluoroscopy 
time underlines the advantage of a retrograde aortic approach using RMN over the use 
of a transbaffle puncture (where possible), which generally requires longer fluoroscopy 
exposure.23,25,37
Non-fluoroscopic image integration
In the course of their lives, CHD patients are exposed to relatively high cumulative 
doses of radiation related to diagnostic and therapeutic cardiac procedures. In a large 
population-based cohort of 16253 CHD patients, Beauséjour Ladouceur et al. observed 
an increase in the number of low-dose ionizing radiation-related cardiac procedures 
per patient between 1990 and 2005, particularly in patients with complex CHD.40 
This increase in radiation exposure raises concerns about the risk of malignancy in 
these patients, especially as their life expectancy nowadays reaches the age at which 
malignancies may become manifest. Indeed, Cohen et al. established an association 
between cumulative exposure to radiation-related cardiac procedures and incident 
cancer in CHD patients that was independent from age, sex, year of birth, CHD 
complexity, and comorbidities.41
The introduction of 3D-EAM led to drastically reduced fluoroscopy times compared 
to conventional fluoroscopy-guided mapping.42,43 Major innovations in 3D-EAM and 
non-fluoroscopic image integration have further reduced the need for fluoroscopy 
guidance during ablation procedures.
The Carto Univu module (module of CARTO 3 system, Biosense Webster Inc, 
Diamond Bar, CA, USA) enables electroanatomical localization of catheters in pre-
recorded X-ray images, thereby eliminating the need for repetitive fluoroscopy imaging. 
Use of the Carto Univu module led to a dramatic reduction in radiation exposure 
compared to the traditional CARTO 3 system in a non-CHD population undergoing 
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catheter ablation of AF or VT.44 Similarly, Cano et al. evaluated the use of the Carto Univu 
module in 55 CHD patients undergoing catheter ablation and concluded that it was safe 
and feasible, resulting in very low radiation exposure.45 The effective radiation dose was 
≤1 mSv in 89% of procedures and tended to be higher in patients with complex CHD.
The effect of intracardiac echocardiography (ICE) on reduction of radiation 
exposure is modest. A randomized study in 74 children with structurally normal hearts 
demonstrated that the use of an integrated EAM/ICE system reduced fluoroscopy times 
by 59% compared to the use of fluoroscopy only; acute success and complication 
rates did not differ.46 Another study in non-CHD patients showed that the use of an 
integrated EAM/ICE system did not reduce radiation exposure compared to EAM alone, 
except in patients requiring a transseptal puncture.47 Besides visualization of anatomical 
structures, advantages of the use of ICE include demonstration of catheter position and 
ablation lesions, safe guidance of transbaffle puncture, and early detection of potential 
complications, including cardiac tamponade.48-50
Computed tomography (CT) or cardiovascular magnetic resonance (CMR) images 
are mostly used for evaluation of cardiac anatomy as a part of preprocedural planning 
or integrated in a 3D-electroanatomical map, rather than specifically aimed at reducing 
radiation exposure. The use of an integrated EAM/CT system reduced fluoroscopy 
times51, although acquisition of the CT images themselves obviously required radiation 
exposure. Integration of CT/CMR images during EAM may be particularly useful in 
patients with complex native or postsurgical cardiac anatomy, as it enables visualization 
of the ablation catheter relative to complex anatomical structures.18,37,52,53 For this 
purpose, CMR imaging is preferred as this does not require exposure to radiation.
From high-density to ultra-high-density mapping
After the introduction of 3D-EAM, 3D color-coded activation maps in CHD patients 
revealed large areas of low voltages scattered throughout the atria which harbored 
complex reentrant circuits with multiple entrances, exits, crucial pathways of conduction 
and dead-end pathways.5,54-57 Within these so-called scar tissue areas, zones of slow 
conduction, characterized by fragmented electrograms and entrainment with concealed 
fusion, were identified as target sites for ablation.
High-density mapping is particularly useful in case of complex scar-related 
tachycardias as it shortens mapping time required for identification of target sites 
for ablation. In addition, acquisition of multiple points likely reduces the chance of 
errors due to too few data points with incorrectly annotated activation times.58 Relative 
fast acquisition of high-resolution maps is feasible due to the combination of two 
innovations: 1) the use of multi-electrode mapping catheters, enabling simultaneous 
acquisition of multiple electrograms, and 2) implementation of accurate algorithms for 
automated annotation of electrograms recorded during regular tachyarrhythmias.59
Most high-density mapping studies in CHD patients were performed with the 
Rhythmia mapping system (Rhythmia HdxTM, Boston Scientific, Marlborough, MA, USA) 
in combination with a 64-electrode basket array. After several case reports showed
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promising results of the use of this system in CHD patients,60-62 seven larger studies 
were published in 2018 and 2019.63-69 Table 1 provides a summary of procedural 
characteristics and outcomes. There was considerable variation in procedural duration, 
fluoroscopy exposure and success rates during the relatively short follow-up periods 
(36%-95%).
In one of these studies, high-resolution maps revealed that 6 tachycardias that were 
initially considered as focal were actually localized reentry circuits.67 In addition, the low 
noise level of the system (usually <0.01 mV) enabled assessment of (very) low voltage 
regions, which are especially relevant in the CHD population.68,70 A more accurate time 
annotation of complex fractionated signals was facilitated by automatic selection of 
activation time based on the timing of the surrounding electrograms.70 However, Ernst 
et al. reported a high number of incomplete maps due to large atrial volumes and a 
high number of accidental terminations or changes in the tachycardia possibly due to 
difficulties with catheter steerability.64 Hence, despite technological progress, impact 
of ultra-high-density mapping still needs to be proven.
Moore et al. compared outcomes of patients treated by the Rhythmia mapping 
system to those of matched control subjects treated by ‘conventional’ mapping with 
CARTO 3.68 The number of tachycardias terminating with the first ablation lesion was 
significantly higher in the ultra-high-density mapping group than in the conventional 
mapping group (32% vs. 5%, p=0.02). The authors also observed slightly prolonged 
procedure durations and fluoroscopy exposure when ultra-high-density mapping was 
performed, which was attributed to the learning curve associated with the use of a 
new mapping system.
Recently, Krause et al. investigated the efficacy of a different multi-electrode 
mapping catheter (16-electrode, grid-style AdvisorTM HD Grid catheter (Abbott, St Paul, 
MN, USA)) for high-density mapping in 24 CHD patients.71 A total of 14814±10140 points 
were collected during mapping of which only 2319±1244 points were used; mapping 
time was not provided. During a median follow-up of 9 months, 87.5% of patients were 
free from tachyarrhythmias.
Although ultra-high-density mapping is a promising new tool, it remains to be 
demonstrated whether it actually improves periprocedural complication rates and 
freedom from arrhythmia recurrence during follow-up in CHD patients.59
Advances in catheter technology: radiofrequency energy
Evolvements in not only mapping technologies but also catheter technologies have 
improved outcomes of ablative therapy. The often hypertrophied and scarred 
myocardium in CHD patients hampers the formation of successful, completely 
transmural ablation lesions.72,73 Apart from tissue characteristics, technical factors 
influencing the size of ablation lesions include power output, duration of energy delivery, 
electrode diameter and catheter-tissue contact.74 A major advance aimed at improving 
lesion size was the introduction of irrigated-tip radiofrequency ablation over two 
decades ago.75 Cooling of the catheter tip prevents thrombus formation and enables an 
2
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increase in maximal power and thus an increase in lesion size. After initial observational 
studies reported favorable outcomes of the use of irrigated-tip radiofrequency 
ablation in CHD patients 72,76,77, a randomized controlled trial by Triedman et al. in 2005 
demonstrated a positive yet modest effect of this approach. These studies have set 
in motion a transition from the recommended use of non-irrigated to predominantly 
irrigated radiofrequency catheter ablation in CHD patients.78
Another important factor in determining lesion size is catheter-tissue contact. 
Excessive catheter-tissue contact, on the other hand, may lead to injury to collateral 
structures, cardiac perforation or thrombosis.79 Indirect markers of ‘good contact’ 
applied by experienced operators (e.g. visual assessment of catheter motion, 
electrogram quality) are poorly predictive of actual catheter-tissue contact.80 Contact 
force sensing technologies enable direct measurement of contact force between the 
catheter tip and tissue. Although initial experimental and observational studies showed 
promising results, randomized controlled trials failed to show superiority of contact 
force sensing over conventional catheters in terms of efficacy.74 Only one study has 
previously investigated the use of a contact force sensing catheter during mapping 
and ablation of intra-atrial reentrant tachycardia (IART) in CHD patients. In their study, 
Krause et al. performed catheter ablation using contact force monitoring in 28 patients; 
32 patients matched according to age, sex and body weight served as a historical 
control group.81 The authors did not find any difference between the groups regarding 
procedural and long-term (188±97 days) success; nor did the amount of radiofrequency 
energy applied to the myocardium differ. Since complications related to excessive 
catheter-tissue contact did not occur, the authors were not able to draw any conclusions 
on the safety of contact versus non-contact force monitoring in this population.
Although contact force sensing does not appear to affect lesion quality and 
procedural success, it does offer procedural safety that is likely equal to the use of 
RMN.82 Hence, in terms of safety, contact force sensing catheters could be a practical 
and economical alternative to RMN, as RMN requires specific structural changes to the 
electrophysiology lab and is relatively costly.82
Advances in catheter technology: cryoenergy
Catheter ablation using cryoenergy is mainly applied in CHD patients with 
atrioventricular nodal reentrant tachycardia (AVNRT). AV conduction block is a potential 
complication related to catheter ablation that obviously should be avoided at all times, 
but particularly in CHD patients. Permanent pacing in this population is associated 
with a relatively high incidence of complications related to device implantation and 
long-term follow-up.83
Particular attention should be paid to the ablation of perinodal substrates in complex 
CHD patients: whereas the location of the AV conduction system in simple CHD is usually 
similar to that in structurally normal hearts, its location may be different or ambiguous 
in more complex forms of CHD.84,85 In patients with a complete atrioventricular septal 
defect, the triangle of Koch does not contain the AV node; instead, it is displaced more 
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posteriorly along the atrial septum and anterior to the coronary sinus.86 In congenitally 
corrected transposition of the great arteries, the AV node and penetrating His bundle 
are anterolaterally displaced at the lateral junction of the pulmonary and mitral valves. 
The presence of a second hypoplastic AV node is not uncommon; it is located in a 
position similar to that in a structurally normal heart and is generally not connected 
to the ventricular musculature, except in the relatively rare case of ‘twin AV nodes’ 
(incidence ~11%).87 In univentricular hearts, the usual landmarks of the triangle of Koch 
are often even completely absent; locations of the AV node may vary considerably, even 
in patients with similar underlying defects.84
The use of cryoenergy for ablation of perinodal substrates was advocated for the 
ability to perform reversible ‘cryomapping’ for selection of safe and effective ablation 
sites. Additionally, adhesion of the catheter tip to tissue during cryoablation enhances 
catheter stability.88 During cryoablation, accelerated junctional rhythm is absent and 
slow pathway conduction during the cryoapplication can still be tested.
In the following paragraphs, procedural and long-term outcomes of ablative therapy of 
various tachyarrhythmias in patients with CHD will be discussed.
Catheter ablation of atrioventricular nodal reentrant tachycardia
Avila et al. demonstrated the safety of cryoablation of 12 perinodal substrates in 10 
patients with displaced or uncertain AV node locations.84 However, cryoablation was 
only moderately successful: 9 of 12 substrates were successfully cryoablated, whereas 
crossover to radiofrequency ablation was required (and successful) at the other 3 
sites. Randomized studies comparing safety and efficacy of the two energy sources 
in CHD patients are not available. In non-CHD patients, radiofrequency ablation of 
AVNRT was more effective than cryoablation, albeit at the cost of a slightly higher 
risk of periprocedural permanent AV block.89 In their multicenter retrospective study 
on catheter ablation of AVNRT in 109 CHD patients, Papagiannis et al. showed that 
cryoablation was equally effective as radiofrequency ablation.85 However, 5 cases of 
AV block requiring permanent pacing occurred, all after radiofrequency ablation in 
patients with complex CHD.
In general, dimensions of cryolesions are positively correlated with catheter tip 
size: compared to 4 mm tip catheters, 6 mm tip catheters are more effective resulting 
in higher procedural success rates and lower recurrence rates.90 Also, repetitive 
freeze-thaw cycles demonstrated an increase in lesion volume compared to single 
cryoapplications.91 However, these benefits have not specifically been demonstrated 
for CHD patients and the selection of cyro- or RF ablation of AVNRT should therefore 
be made on individual basis.
Catheter ablation of atrioventricular reentrant tachycardia
Atrioventricular reentrant tachycardia (AVRT) in patients with CHD have mainly been 
reported in patients with Ebstein’s anomaly. In these patients, AVRT are caused by 
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either accessory atrioventricular pathways (incidence 10%-38%), that are often found 
along the posterior and septal border of the tricuspid valve, or by atriofascicular fibers 
(incidence 5%-8%) along the right anterolateral or lateral free wall.92,93
Ablative therapy of accessory pathways in patients with Ebstein’s anomaly is often 
complicated by the presence of multiple discrete pathways, dilatation of the right atrium/
ventricle and atrialization of the ventricle resulting in extensive areas of fractionated 
electrograms hampering identification of target sites for ablation.92,94 Reported success 
rates of catheter ablation of AVRT in patients with Ebstein’s anomaly range from only 
75% to 88%.95 In addition, recurrence rates in this patient group range from 27% to 40%; 
this is even lower than in patients with other types of CHD (recurrence rates: 19%).96
Catheter ablation of atrial macroreentrant tachycardia
The most frequently reported tachyarrhythmias in patients with both repaired and 
unrepaired CHD are macroreentrant tachycardias including IART or typical (counter) 
clockwise AFL. Reentrant circuits underlying IART reported in literature are highly 
variable, though in many cases the cavotricuspid isthmus is still part of the circuit97, 
in addition to anatomical and surgically created non-conductive barriers. Most IART 
originate from the right atrium98; left atrial IART occur less frequently and have been 
observed in patients with e.g. atrial septal defects, transposition of the great arteries, 
univentricular hearts and tetralogy of Fallot. Ablative therapy targeted at a critical 
isthmus of conduction between two non-conductive barriers (Figure 3) has been 
established as an effective treatment of macroreentrant tachycardias. Procedural 
success rates are variable, ranging from 65% to 94%.97
Despite reasonably successful outcomes of catheter ablation procedures, 
tachyarrhythmias recur frequently; after a follow-up period of 5 years, recurrences rates 
vary from 34% to 54%.99 However, recurrent tachycardias often originated from different 
locations, indicating that these ‘recurrences’ were not caused by arrhythmogenicity of 
prior ablative lesions, e.g. due to insufficient lesion formation in the thickened atrial 
wall.98
It is therefore more likely that ‘recurrent’ tachyarrhythmias after ablative therapy 
may simply reflect a progressive cardiomyopathy caused by the persisting pressure/
volume overload, thereby giving rise to a complex arrhythmogenic substrate containing 
multiple possible reentrant circuits. Indeed, several studies demonstrated the presence 
of multiple discrete reentrant circuits within individual patients. In some patients, 
these different reentrant circuits were maintained by a common critical isthmus.4,7 
Interestingly, successive atrial tachyarrhythmias may also be caused by different 
mechanisms. For example, a FAT may occur after successful ablation of IART.98 However, 
despite the frequent need for repeat ablative therapy in patients of CHD, most patients 
remain in sinus rhythm during long-term follow up. Even in case of recurrences, patients 
have a reduction in the clinical arrhythmia burden.77,100
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Figure 3. Macroreentrant atrial tachycardia
Posterior view of a 3D electroanatomical activation map of the reconstructed right atrium 
obtained from a patient with a Fontan circulation. The reentrant wavelet propagates around a 
large area of scar tissue located in the middle of the posterior wall. This IART (CL 290 ms) was 
terminated by creating a linear lesion between the 2 areas of scar tissue. IVC: inferior vena cava, 
SVC: superior vena cava.
Catheter ablation of focal atrial tachycardia
FAT have been observed in patients with various types of CHD, such as atrial septal 
defects, univentricular hearts and transposition of the great arteries though they are 
less frequently reported. FAT originate from a small, circumscribed area from where the 
wavefront expands to the remainder of the atria.101 When propagation of the expanding 
wavefront is delayed throughout the diastolic interval, flutter-like waves may arise on 
the surface ECG. Hence, differentiation between FAT and IART may be difficult using 
the surface ECG only and invasive mapping studies are required to correctly diagnose 
the underlying mechanism.
Most FAT originate from the borders of areas of scar tissue. Although mapping 
studies have demonstrated that areas of scar tissue in patients with CHD are found 
scattered throughout both atria, FAT – comparable to IART – mainly arise from the 
right atrium.98 Prolonged, fractionated potentials are recorded from the origin of FAT, 
reflecting local dissociation in conduction suggestive of micro-reentry as the underlying 
mechanism.102
2
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Reported success rates of ablative therapy of FAT in patients with a variable 
complexity of CHD are high (86%-100%).101,103 However, comparable with IART, 
‘recurrences’ of atrial tachyarrhythmias after ablation of FAT have been reported.
Catheter ablation of atrial fibrillation
Teuwen et al. demonstrated in 199 patients with 15 different types of CHD that there 
was a fast and frequent progression from paroxysmal to (longstanding) persistent or 
permanent AF; progression occurred in 26% of the population during a mean follow-up 
period of only 3 years.104
Though ablative therapy is nowadays an accepted treatment modality for regular 
atrial tachyarrhythmias in CHD patients, catheter ablation of AF in CHD patients is less 
well established. Sofar, endovascular pulmonary vein isolation in patients with CHD has 
only been reported in case reports, studies with small sample sizes or heterogeneous 
study populations with variable anatomy and history of prior surgical procedures. In 
addition, the ablation approaches are variable, and follow-up is often limited. A recent 
systematic review, including 12 reports on catheter ablation of AF in a total of 393 CHD 
patients, indicated that catheter ablation of AF in CHD patients is a safe procedure 
but has a moderate success rate which could be improved by repetitive ablation 
procedures.105 However, the question remains whether the mechanism underlying AF 
in CHD patients is comparable with patients without CHD.
De Groot et al. found that a surface ECG resembling AF in two CHD patients 
was actually the result of continuous electrical activity within a circumscriptive 
area.101 Endocardial mapping during AF in a 28-year old female patient with a type IB 
tricuspid atresia who had undergone a Fontan procedure revealed that the largest 
part of the right atrium was activated regularly. However, a circumscriptive area at 
the posteroseptal wall exhibited continuous electrical activity. Interestingly, isolation 
of this area terminated AF. A similar observation was made in another 25-year-old 
female patient with a transposition of the great arteries corrected with an arterial switch 
procedure.101 During AF, an area of continuous electrical activation embedded within 
scar tissue was found at the right anterolateral wall (Figure 4). During sinus rhythm 
after electrical cardioversion, total activation time of this region only was already 130 
ms. Again, isolation of this area by ablative therapy terminated AF. In line with these 
observations, Takahashi et al. also demonstrated in a patient with a Fontan circulation 
that AF was caused by continuous fractionated electrical activity in the right atrial free 
wall and lower interatrial septum.106 After ablation of these sites, the patient converted 
to sinus rhythm. Hence, these observations suggest that these patients would not have 
benefitted from a pulmonary vein isolation.
Catheter ablation of ventricular tachycardia
VT in CHD patients occur less frequently than SVT. Although ventricular ectopy and 
non-sustained VT are relatively common, the estimated incidence of sustained VT is 
low (0.1%-0.2% per year).99 VTs are most commonly observed in patients with repaired 
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tetralogy of Fallot, ventricular septal defect and d-transposition of the great arteries, 
and often originate from the right ventricle.
Macro-reentry is frequently the mechanism underlying VT but VTs with a focal 
mechanism have also been reported.107,108 VT in CHD patients generally involve areas of 
scar tissue, aneurysms (Figure 5), suture lines (e.g. infundibulectomy scar) and prosthetic 
materials such as septal patches, comparable to reentrant and focal tachycardias in 
the atria.109
Atrial Fibrillation Sinus Rhythm
150ms
RARA
Figure 4. Continuous electrical activation in an area of scar tissue as a cause of AF
Schematic presentation of areas of scar tissue located at the right atrial free wall of a patient 
with transposition of the great arteries corrected with an arterial switch procedure, depicted on 
a post-mortem heart during AF (left panel) and sinus rhythm (right panel).
See text for detailed analysis. RA: right atrium.
VT ablation is usually performed as an adjunct to ICD implantation to reduce recurrent 
ICD discharges.109 Activation, voltage and/or entrainment mapping may be used to 
identify target sites for ablation. Morwood et al. reported a procedural success rate of 
only 50% in CHD patients undergoing VT ablation, which was due to hemodynamically 
unstable or non-sustained/non-inducible VTs in most cases.110 As a consequence, 
alternative approaches have been introduced. Noncontact mapping using a multi-
electrode basket catheter enables simultaneous acquisition of mapping points and 
fast reconstruction of the activation sequence, requiring only few VT beats.109,111 In the 
absence of inducible VT, pace mapping is a feasible alternative. In 94% of CHD patients, 
ablation guided by pace mapping resulted in non-inducible VT in most cases.112 Ablative 
therapy during sinus rhythm guided by bipolar voltage mapping (‘substrate’ mapping) 
has also been applied in CHD patients. In this approach, ventricular electrograms 
>1.5mV are considered ‘normal’ voltage, whereas high-output pacing at low voltage 
sites <1.5mV is used to identify non-excitable tissue.109,113
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In recent studies reporting on outcomes of VT ablation in CHD patients, procedural 
success rates ranged between 74%-92% and VT recurred in 4% to 14% during follow-up 
ranging from 33 months to 9.5 years.107,108,114,115
Figure 5. Ventricular tachycardia in congenital heart disease
A 19-year-old male with a surgically corrected congenital left ventricular aneurysm in the basal 
posterior wall presented with a monomorphic VT of 218 beats per minute. The CT scan showed 
a remnant of the aneurysm in the basal posterior wall part of the left ventricle. During VT, pacing 
within the left ventricular aneurysm area resulted in entrainment with concealed fusion and 
radiofrequency ablation at this site terminated the VT. LV: left ventricle, RV: right ventricle.
Future perspectives
Advances in mapping and ablation technologies continue to improve outcomes of 
ablative therapy in CHD patients. Localization of the arrhythmogenic substrate may be 
difficult due to the distorted cardiac anatomy, and extensive mapping prior to ablative 
therapy is therefore essential. Recurrences of tachyarrhythmias after ablative therapy 
are common and are indicative of a progressive cardiomyopathy, but despite repetitive 
ablative therapy most patients remain in sinus rhythm. The next challenge in CHD 
patients is ablative therapy of AF, a growing epidemic in this population. However, 
the role of the pulmonary veins in the pathophysiology of AF has yet to be further 
elucidated. As focal activity giving rise to fibrillatory conduction has been demonstrated 
to underly AF in CHD patients, take a close look at the high-density map before you 
take the next step…
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The arterial switch operation has been the procedure of first choice for correction of 
transposition of the great arteries (TGA) for several decades now. However, a large 
number of adult TGA patients nowadays were palliated previously by either a Mustard or 
a Senning procedure. Atrial tachyarrhythmias (AT) are frequently observed during long-
term follow-up of TGA patients after these atrial switch corrections and are associated 
with both morbidity and mortality. Due to the complex postoperative anatomy in 
these patients, ablative therapy of these tachyarrhythmias can be challenging. The 
goal of this review is to discuss the most prevalent AT in patients after the Mustard 
or Senning procedure and to summarize (long-term) outcomes of ablative therapy. In 
addition, recent developments in ablative therapy of AT in this patient population will 
be outlined.
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Introduction
Transposition of the great arteries (TGA) occurs in 2-4 per 10000 newborns and accounts 
for 5 to 7% of all congenital heart defects (CHD).1, 2 Before the introduction of the arterial 
switch operation by Jatene, which is now the surgical procedure of first choice, TGA 
was corrected by either the Mustard or Senning procedure.3 These procedures were 
aimed at switching the flow of blood at the atrial level.4, 5 Because of improved surgical 
techniques and perioperative care, many patients have survived into adulthood. In 
this aging population, atrial tachyarrhythmias (AT) are frequently observed and the 
incidence continues to increase during further follow-up of these patients.6-8 AT may 
become life threatening as they are an important cause of morbidity and mortality.9 
Both atrial flutter (AFL) and atrial fibrillation (AF) are predictors of sudden cardiac death 
in this population.10, 11 Other observed atrial arrhythmias in this population include intra-
atrial reentry tachycardia (IART), atrioventricular nodal reentry tachycardia (AVNRT) and 
focal atrial tachycardia (FAT).
Several strategies have been described to treat these AT. Treatment with 
antiarrhythmic drugs has been unsatisfactory due to inadequate efficacy combined 
with potential side effects. Antiarrhythmic drugs can have negative inotropic effects on 
an already impaired systemic right ventricle and they further affect the often already 
delayed atrioventricular conduction.12-14 Atrial reentry tachycardia can be treated with 
anti-tachycardia pacing, although the efficacy is questionable.15 Furthermore, anti-
tachycardia pacing may increase the risk of acceleration of the AT.16 AT can also be 
successfully terminated with cardioversion.17 Kirsh et al. studied 149 patients with CHD, 
including 10 patients after correction of TGA, who underwent cardioversion for IART or 
AF.9 In this study, intervals between successful cardioversions became shorter as the 
number of required cardioversions increased, suggesting that AT recur more frequently 
over time.
Due to the unsatisfactory outcomes of the aforementioned treatment strategies, 
catheter ablation of AT has become more and more important. Radiofrequency catheter 
ablation of tachyarrhythmias in patients with CHD is a relatively new treatment modality 
with encouraging results and it may be an important asset in the treatment of AT.18 
However in most studies, the number of included patients after atrial switch correction 
for TGA is small, which hampers evaluation of the efficacy of ablative therapy in this 
population. Furthermore, many different techniques regarding access to the atria, 
electro-anatomical mapping and imaging of the atria during ablative therapy have been 
described. The goal of this review is to discuss the most prevalent atrial arrhythmias 
in patients after the Mustard or Senning procedure and to summarize (long-term) 
outcomes of ablative therapy. In addition, recent developments in ablative therapy of 
AT in this patient population will be outlined.
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After atrial switch correction of TGA, the atrial anatomy is extensively changed. Detailed 
knowledge of the anatomy is crucial for successful ablative therapy of arrhythmias. Figure 




baffle region  
Superior 
















Figure 1. Postoperative anatomy in patients after the Mustard or Senning operation
Locations of crucial pathways of conduction in both CTI dependent and non-CTI dependent 
reentry tachycardias are demonstrated. The size of the red and blue dots indicate the relative 
incidences of the various locations. The grey areas indicate flow of deoxygenated blood.
CSO: coronary sinus ostium, CTI: cavotricuspid isthmus, IVC: inferior vena cava, PA: pulmonary 
artery, PVA: pulmonary venous atrium, RA: right atrium, SVA: systemic venous atrium, SVC: 
superior vena cava.
An intra-atrial baffle, constructed from prosthetic material or pericardium (Mustard) 
or from the atrial septum and right atrial free wall (Senning), redirects the systemic 
and pulmonary returns.4, 5 The ‘new right atrium’ is called the systemic venous atrium 
(SVA) and the ‘new left atrium’ becomes the pulmonary venous atrium (PVA). The PVA 
drains in the morphologically right ventricle, that now acts as the systemic ventricle.
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Figure 2 shows the locations of the sinus node, atrioventricular (AV) node, coronary 
sinus ostium and cavotricuspid isthmus (CTI) before and after placement of the intra-
atrial baffle. Since AV connections in patients with TGA are concordant, the AV node is 
usually located in its regular position, comparable to patients with a structurally normal 
heart.19 During the Mustard and Senning procedure, the intra-atrial baffle is routinely 
sutured posterior to the AV node, which means that the AV node is always located in the 
PVA. The location of the coronary sinus ostium varies according to where the suture line 
of the intra-atrial baffle was originally placed. The baffle was routinely placed in such a 
way that the coronary sinus drained into the SVA. Only when adequate baffle placement 
and thus hemodynamics were compromised, the coronary sinus drained into the PVA. 
The coronary sinus can redirect the coronary venous flow into the SVA when the intra-
atrial baffle is sutured anterior to the coronary sinus ostium or when the coronary sinus 
is surgically incised and incorporated in the baffle. The coronary sinus drains into the 
PVA when the intra-atrial baffle is sutured posterior to the coronary sinus ostium.1, 20, 
21 During the atrial switch operations, the atrial baffle was often placed across the CTI, 
which is why the isthmus is most often located partly in both the SVA and the PVA.1, 20 
Figure 3 illustrates the postoperative anatomy in a photograph of a post-mortem heart 
of a Mustard patient.
Atrial tachyarrhythmias
An important risk factor for the occurrence of AT in Mustard and Senning patients is 
the complex atrial (re)operation and reconstruction, with baffle placement and scarring 
of the atrial tissue. The atrial reconstruction results in limited atrial transport function. 
Other potential risk factors include impaired systemic right ventricular function and 
tricuspid regurgitation.22 AT with rapid ventricular response could lead to hemodynamic 
instability and even to sudden cardiac death.11, 23 Atrial reentry tachycardias are the most 
commonly observed type of AT in patients with Mustard or Senning baffles for TGA.1
Cavotricuspid isthmus dependent reentry tachycardia
Typical AFL is defined as a tachycardia resulting from a cavotricuspid isthmus (CTI) 
dependent (counter) clockwise reentry wavefront. However, in the atrial switch 
population, the circuit of an AFL differs from that of patients without CHD due to 
transection of the CTI by the baffle, various scars and/or suture lines. Nonetheless, 
the CTI can still be the critical pathway of conduction of atrial reentry circuits in these 
patients. These CTI dependent reentry tachycardias are commonly observed, with a 
reported cumulative incidence of up to 25% in Mustard patients at 20 years of age.8
Chan et al. showed that the CTI is indeed involved in many atrial reentry tachycardias 
in CHD patients and is therefore an important target for ablation of CTI dependent 
reentry tachycardias.24 In most cases where the mid-cavotricuspid isthmus was 
bisected by the baffle suture line, both portions of the isthmus were involved in the 
atrial reentry circuit.25-27 Successful ablation of a CTI dependent reentry tachycardia 
involves placement of ablative lesions across the CTI in both the SVA and the PVA.20, 
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21, 26, 27 Van Hare et al. proposed that the location of coronary sinus drainage in either 
the SVA or PVA is a predictor for the location of successful ablation of an atrial reentry 
tachycardia.21 In 4/4 successful ablations with coronary sinus drainage in the SVA, 
lesions in the SVA were necessary. When the coronary sinus drained into the PVA, 
lesions in the PVA were required in 3/4 successful ablations. These findings were not 
confirmed by Kanter et al., who also evaluated the location of the coronary sinus ostium 



















Before baffle placement After baffle placement
Figure 2. Anatomical locations of the sinoatrial node, AV node, coronary sinus ostium and CTI
Lateral view from a right atrial incision, illustrating locations of the sinoatrial node, AV node, 
coronary sinus ostium and CTI before (left panel) and after (right panel) placement of the intra-
atrial baffle by the Mustard technique. The sinoatrial and AV node are always located in the PVA. 
In this figure, the coronary sinus ostium is located in the SVA. See text for detailed explanation. 
Dashed lines indicate that the structure is not directly visible from this view.
AV: atrioventricular, Ca: caudal, Cr: cranial, CSO: coronary sinus ostium, CTI: cavotricuspid isthmus, 
IPV: inferior pulmonary veins, IVC: inferior vena cava, L: left, LA: left atrium, PVA: pulmonary venous 
atrium, R: right, RA: right atrium, SPV: superior pulmonary veins, SVA: systemic venous atrium, 
SVC: superior vena cava.
Modified from Kouchoukos et al.68
Initial studies used non-inducibility as the endpoint for acute success of ablation of 
CTI dependent reentry tachycardia, but this method has now been replaced by the 
establishment of bidirectional block over the CTI.20, 21, 27, 28 Schmieder et al. showed 
that lack of bidirectional block was a strong predictor for AFL recurrences in patients 
with normal hearts.29 In addition, Dong et al. demonstrated the necessity of bi-atrial 
ablation of CTI dependent reentry tachycardia to achieve bidirectional block in a Senning 
patient.25 During the short follow-up duration of 3 months, this patient was free from 
tachycardia recurrence.
VolledigbinnenwerkCharlotte.indd   68 18/11/2020   16:08:13
69
Atrial tachyarrhythmias in transposition of the great arteries
Pulmonary 
venous flow




Figure 3. Post-mortem heart of a Mustard patient with pulmonary venous obstruction
The SVC and IVC are redirected into the baffle to the SVA. In this patient, the coronary sinus 
drained into the PVA. This view illustrates the anterior part of the CTI, located in the PVA.
This photograph was provided by professor Yen Ho.
CTI: cavotricuspid isthmus, IVC: inferior vena cava, PVA: pulmonary venous atrium, SVA: systemic 
venous atrium, SVC: superior vena cava.
Bidirectional block can be assessed by a variety of techniques, including 3D mapping 
of the SVA and PVA, requiring a transbaffle puncture to access the latter.1, 25 Balaji et al. 
suggested a simpler method for establishing bidirectional block in Mustard patients 
using 3 electrophysiology catheters, including one catheter high in the SVA, a second 
catheter placed in the low SVA and a third catheter in the low PVA.30 In case of a 
bidirectional block, pacing in the lower SVA results in earlier activation of the high SVA 
compared to the lower PVA and pacing in the lower PVA results in earlier activation 
of the high SVA compared to the lower SVA. Another method to confirm bidirectional 
block was demonstrated in a Senning patient by Kedia et al.31 Guided by intracardiac 
echocardiography, catheters were positioned in the SVA and via a retrograde approach 
in the PVA on either side of the ablation line across the isthmus. Pacing maneuvers 
demonstrated bidirectional block.
Reported acute success rates after ablation of CTI dependent reentry tachycardias in 
TGA patients after the Mustard or Senning correction vary from 67 to 100%.20, 32-37 Four 
out of 5 patients (80%) in the study of Wu et al. underwent successful repeat ablation 
of recurrent CTI dependent reentry tachycardia and in one patient, the arrhythmia had 
to be terminated by intra-procedural cardioversion.36 Long-term arrhythmia recurrence 
is not more often observed in corrected TGA patients compared to patients with other 
CHD, despite the sometimes lower acute success rates in Mustard patients.38 Wu et al. 
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speculated that even without acute tachycardia termination, the reentry circuit might 
be deconstructed enough to prevent recurrences.36
Non-cavotricuspid isthmus dependent reentry tachycardia
In this review, IART refers to an incisional reentry tachycardia in which the CTI is not 
involved. Instead, there is an isthmus between 2 barriers, either anatomic (e.g. the 
orifice of superior or inferior vena cava) or surgically created (e.g. suture lines, scar 
tissue or the atrial baffle).24, 39 Factors predisposing patients to IART include atrial 
scarring caused by multiple atriotomies, long suture lines and pericardial inflammation, 
implanted prosthetic or pericardial patches, abnormal atrial wall stress in disordered 
hemodynamic states, abnormal atrial anatomy and changes in atrial refractoriness 
associated with sinus node dysfunction and concomitant bradycardia.33, 40, 41 Figure 1 
summarizes locations of crucial pathways of conduction in both the SVA and PVA.18, 20, 
21, 24-28, 30, 32-37, 39, 41-53
Kriebel et al. suggested that in Mustard and Senning patients, a significant number 
of IARTs develop in the SVA due to the presence of suture lines and scars combined 
with the orifices of the superior and inferior vena cava that act as natural barriers of 
conduction.33 Therefore, endocardial mapping in this study was first performed in the 
SVA and only if the crucial pathway of conduction of the IART could not be identified 
here, the catheters were redirected into the PVA. In solely 2 of 13 patients in this study 
it was necessary to place ablative lesions in the PVA. Furthermore, this approach may 
have led to a reduction of fluoroscopy time and procedure duration.
Acute success rates of ablation of IART in patients after the Mustard or Senning 
correction ranged from 73 to 100% and recurrences were not often observed.21, 27, 33, 36, 37 
In the study of Zrenner et al., repeat ablation of recurrent IART – all with similar reentry 
circuits as the initial tachycardia – was performed successfully in 3 patients (100%).27
Focal atrial tachycardia
FAT originates from a small circumscribed region from where it expands centrifugally 
to the remainder of the atria.18 There is no wavefront circulating around a macroscopic 
anatomic structure or a functional or structural line of conduction block. De Groot 
et al. suggested micro-reentry as a possible underlying mechanism.18 The presence 
of triggered activity has also been postulated as a potential mechanism of FAT.54
FAT are less frequently observed in patients after atrial switch for TGA compared 
to CTI dependent reentry tachycardias and IART.1 In the study of de Groot et al., a FAT 
originating from the lower intra-atrial septal area in the SVA was observed in a patient 
after a Mustard procedure followed later on by an arterial switch procedure.18 Other 
reported localizations of FAT in Mustard patients include the inferior mitral annulus, 
the left upper pulmonary vein, the region of the sinus node and several locations in the 
PVA and SVA that were not further specified.20, 27, 32, 51 Most ectopic foci are adjacent to 
suture lines and can be ablated successfully.18, 20, 27
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Atrioventricular nodal reentry tachycardia
In most patients with a structurally normal heart, the fast pathway of the AVNRT is 
located near the apex of the Koch’s triangle, whereas the slow pathway is located at 
the level of the coronary sinus.55 AVNRT are infrequently observed in patients after the 
Mustard or Senning procedure.19, 20, 56 During both procedures, surgical manipulation of 
the atrial septum superior and anterior to the AV node could lead to partial disruption 
of either the fast and/or slow pathway.19, 20 Complete disruption of the pathway however, 
would make it impossible for AVNRT to develop, which could be a possible explanation 
for the lower prevalence of this arrhythmia in the atrial switch population.19
In the study of Kanter et al, an AVNRT occurred directly following application of 
radiofrequency lesions to the medial isthmus for an IART in 2 patients.20 It was assumed 
that these AVNRT were iatrogenic, since ablation of an IART in the region of the AV node 
could partially damage the slow pathway, thus resulting in AVNRT. It is likely that ablation 
of the slow pathway minimizes the risk of iatrogenic AV conduction block compared 
to fast pathway ablation.57 Since the coronary sinus ostium is located near the slow 
pathway, detailed knowledge of the initial surgical procedure for the location of the 
coronary sinus ostium is critical for successful AVNRT ablation.19
The acute and long-term outcomes after AVNRT ablation have been reported in 4 
TGA patients after the atrial switch procedure: acute success was achieved in all patients 
and recurrences did not occur during a mean follow-up of nearly 40 months.36
Atrial fibrillation
As the atrial switch population ages, AF will become more and more prevalent. Teuwen 
et al. studied the development of AF in 199 CHD patients with documented AF, including 
17 TGA patients. In this study, TGA patients were relatively young at onset of AF 
compared to patients with several other, less complex CHD.58 It is likely that AF in this 
patient population is not only the result of aging. Other proarrhythmic factors include 
the presence of scars, suture lines and intra-atrial conduction abnormalities and local 
dispersion in refractoriness due to chronic hemodynamic stress.22, 58
Frankel et al. reported outcomes of pulmonary vein isolation in a TGA patient 
after the Mustard operation who presented with recurrent episodes of AF.22 Access 
to the PVA was acquired by transbaffle puncture. Circumferential antral ablation was 
performed around the left and right pulmonary veins; both entrance and exit block 
were demonstrated in all pulmonary vein ostia. This patient had no recurrences of AF 
during 6 months of follow-up.
Technical considerations during ablative therapy
Many different imaging, mapping and ablation techniques during endovascular ablative 
therapy of AT have been used to improve visualization of the difficult anatomy and 
accessibility to target sites and to increase the effectiveness of ablation.
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Access to the pulmonary venous atrium
Due to the complex anatomy in patients after the Mustard or Senning procedure, 
difficulties in the access to the PVA may impede successful ablation of atrial arrhythmias. 
The conventional way to reach the PVA is by the retrograde aortic approach to the 
right ventricle and then posterior to the tricuspid annulus into the PVA. However, 
several studies reported unsuccessful ablations using the retrograde approach due 
to the inability to access the desired ablation site.27, 38, 50 In the study of Yap et al., the 
retrograde approach did not permit adequate catheter stability to complete the lesion, 
due to the large PVA and moderate to severe tricuspid regurgitation in their study 
population.38 It was suggested that the PVA might be more accessible retrogradely in 
a younger population, with smaller atrial size and less severe tricuspid regurgitation. 
Ablation of AVNRT using the retrograde arterial approach might also be challenging, 
due to the relatively sharp angle the ablation catheter must make to reach the AV node. 
However, outcomes of AVNRT ablation using the retrograde approach are good, without 
any reported problems in accessing the AV node.19, 20, 36, 56 To improve the accessibility 
of ablation sites in the PVA by the retrograde approach, Ernst et al. suggested the 
use of remote-controlled magnetic navigation (RMN).48 Magnetic navigation allows all 
sites to be reached, even in patients with the most complex anatomy, since there is no 
limitation to curve radius or reach.
A contra-indication for accessing the PVA in a retrograde way is the presence of a 
mechanical tricuspid or aortic valve.32 Using the retrograde aortic approach could result 
in complications concerning the femoral artery including loss of pulse, excessive post 
catheterization bleeding and thromboembolic events.59 Furthermore, manipulating the 
ablation catheter past the aortic and tricuspid valve could lead to valvular damage.28, 32
Another method to reach the PVA is transseptal puncture, which was first described 
in 1959.60 However, the presence of baffle or patch material was considered to be a 
contra-indication for transseptal puncture for many years. In 2000, El Said et al. showed 
that puncture through intra-atrial patches guided by an angiogram is a safe and simple 
technique, without residual atrial shunts during follow-up. Furthermore, the material of 
the patch did not seem to affect the success of the transseptal procedure.59 Performance 
of a transseptal puncture can be guided by angiogram only or by transesophageal/
intracardiac echocardiography.22, 32, 34, 61, 62 Successful puncture can be confirmed by 
hand injection of radiologic contrast, fluoroscopic examination of tip position, pressure 
recording through the central needle lumen and intracardiac or transesophagal 
echocardiography.22, 28, 32, 34, 49, 61, 62 The transseptal method is particularly useful when 
the retrograde aortic approach is not possible due to technical or anatomical reasons 
or when the desired ablation site cannot be reached. Furthermore, greater catheter 
stability can be achieved compared to the retrograde aortic approach.1 Transseptal 
puncture can be performed using a conventional Brockenbrough or a radiofrequency 
needle. The latter might be more effective in several situations, including 1) thick 
calcification in the septal region evident by fluoroscopy, 2) thick septal dimension at 
the desired puncture site evident by intracardiac echocardiography, 3) the presence 
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of synthetic atrial patch material, a large pericardial baffle or an occlusion device in 
the atrial septum, 4) small left atrial chamber dimensions where forceful needle tip 
advancement is deemed unwise and finally 5) when attempts with a conventional 
needle have failed.49 Krause et al. performed transseptal puncture using a conventional 
Brockenbrough needle in 6 patients after the Mustard procedure for TGA. In all patients, 
mechanical force only was sufficient.61 Due to the frequent presence of calcified baffles 
in these patients, more physical force might be required to puncture the baffle.
Several studies did not report any residual shunts after transseptal puncture during 
follow-up.32, 49, 61 In order to avoid unnecessary transseptal puncture or retrograde aortic 
manipulation, pre-procedural echocardiography can be considered to investigate the 
presence of a pre-existing intra-atrial shunt.25, 34
Imaging techniques during ablative therapy
In patients after the atrial switch operation, insight into the cardiac anatomy and the 
activation pattern of an AT is difficult to understand from only a standard projection of 
the position of catheters, as is usually done in patients with structurally normal hearts.48 
Reconstruction of the atrial anatomy using either 3D contact mapping (CARTO) or non-
contact mapping (Ensite) visualizes the activation pattern in a complex cardiac anatomy. 
Consequently, target sites for ablation can more easily be identified.27, 52, 63 Figure 4 shows 
an anatomical reconstruction visualizing the atrial anatomy in a Mustard patient (left 
panel) and an electro-anatomical activation map of the SVA in another Mustard patient, 
illustrating a macro-reentry tachycardia (right panel).
Several studies reported on the use of intracardiac echocardiography (ICE) in 
addition to 3D electroanatomical or entrainment mapping.26, 31, 34, 46, 64 Advantages of 
using ICE during the electrophysiological study include demonstration of catheter 
position and ablative lesions, monitoring pulmonary venous flows and tissue contact, 
identification of relevant anatomical structures and early detection of potential 
complications including interatrial communications or cardiac tamponade.22, 31, 
34, 46, 64 Reported disadvantages include the relatively large sheath required for ICE 
and a significant part of the procedure time devoted to visualization of the cardiac 
anatomy.64
Integration of 3D computed tomography (CT) or cardiovascular magnetic resonance 
(CMR) images with real-time intraprocedural electranatomical mapping has also been 
reported for ablation of atrial arrhythmias in patients after atrial switch correction.22, 
36, 42, 48 On the resulting images, the ablation catheter can be visualized in relation to 
the complex cardiac anatomy.42
Several limitations of the use of CT imaging include variability in heart rate and 
respiration pattern, differences in atrial volumes (which may limit the fusion process 
of the images) and the exposure to radiation. The latter can be prevented by using ICE 
or CMR.65 The choice of imaging technique depends on several factors, such as the 
presence of an implantable device, personal experience and the available equipment. 
To our knowledge, studies comparing the accuracy and efficacy of ICE, CT or CMR 
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imaging guiding mapping of AT in patients with complex cardiac anatomy have not yet 
been conducted.
Figure 4. Three-dimensional electroanatomic mapping
Left panel: anatomical reconstruction illustrating the anatomy of the PVA and SVA in a Mustard 
patient. Right panel: an electro-anatomical activation map of a macro-reentry tachycardia in a 
patient with TGA corrected by the Mustard procedure. This map shows an activation map of the 
SVA from the left anterior oblique view, with a reentry wavefront circulating around the mitral 
valve.
AP: anterior posterior, CL: cycle length, CS: coronary sinus, IVC: inferior vena cava, LAA: left atrial 
appendage, LAO: left anterior oblique, MV: mitral valve, PV: pulmonary vein, PVA: pulmonary 
venous atrium, SVA: systemic venous atrium, SVC: superior vena cava, TV: tricuspid valve.
Remote-controlled magnetic navigation
RMN ablation combined with 3D mapping has been shown to be a safe and successful 
method to eliminate atrial arrhythmias in Mustard and Senning patients.36, 48 Wu et al. 
studied 15 Mustard and 11 Senning patients who underwent ablation of IART. The acute 
success rate of RMN ablation was higher (100%) compared to manual ablation (77%), 
although this was not significantly different (p=0.18). Furthermore, long-term success 
of initial ablation was higher after RMN ablation (86%) than after manual ablation (59%, 
p=0.22). RMN ablation resulted in reduced fluoroscopy time and therefore a lower 
radiation exposure.36, 48 This is especially important in this relatively young population 
with complex congenital heart disease, who are likely to undergo multiple ablation 
procedures during their life with a high cumulative radiation exposure.
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Minimizing the number of recurrences with irrigated-tip ablation
Recurrence of an atrial tachycardia after an initially successful procedure may occur 
secondary to failure of the initial radiofrequency (RF) lesion. In the study of Collins et al., 
87% of successful RF applications during repeat ablation were located at an anatomic 
site similar to the initial successful ablation procedure.45 A possible explanation could be 
that the hypertrophied and scarred atrial wall in patients after repair of complex CHD 
may limit the formation of successful transmural RF lesions.27, 43 Irrigated-tip ablation 
enables an increase in delivered RF energy without the risk of thrombus formation, a 
complication that can occur with the use of conventional electrodes.48 Triedman et al. 
showed that the use of irrigated-tip ablation of IART in CHD patients was an independent 
predictor of acute procedural success.66 Tanner et al. performed irrigated-tip ablation 
in 36 patients after surgical correction of CHD, of which 5 patients had TGA.35 The 
outcomes of irrigated-tip ablation were compared to the outcomes of conventional 
temperature-controlled RF ablation in a historical group with CHD. This study showed 
that irrigated-tip ablation is safe and provides more effective lesion formation compared 
to conventional RF ablation. When using irrigated-tip catheters, mean power during RF 
application was 33% higher and the number of RF lesions necessary to terminate atrial 
reentry tachycardias was lower compared to conventional catheters.
Future implications
As the atrial switch population ages, AT will become even more prevalent. Ablative 
therapy of these AT will often be challenging due to the extensive atrial surgery and 
abnormal anatomy, but it will often be the therapeutic option of choice. Therefore, it is 
important to optimize the circumstances during the ablative procedure, ranging from 
knowledge of the mechanisms of AT to optimal visualization of activation patterns of 
atrial arrhythmias in patients with complex cardiac anatomy.
The arterial switch operation
After the introduction of the arterial switch operation, the Mustard and Senning 
procedures were no longer performed. The reported incidence of arrhythmias in 
patients after the arterial switch operation is low; Khairy et al. reported an arrhythmia-
free survival rate of 97% after 25 years of follow-up.67 To our knowledge, there are no 
studies on ablative therapy of AT in patients after the arterial switch operation, probably 
because of the low prevalence of AT in this relatively young population. Longer follow-up 
of these patients will indicate whether AT will become more prevalent at older age.
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The case presented in this chapter concerns a patient with complex congenital heart 
disease who underwent multiple palliative surgical procedures and who presented 
with symptomatic postoperative atrial tachyarrhythmias. Several attempts were made 
to treat these atrial tachyarrhythmias. Eventually, patient-activated antitachycardia 
pacing successfully terminated the atrial tachyarrhythmias in this patient. The extensive 
atrial surgery and often dilated atria predispose patients with Fontan physiology to the 
development of atrial tachyarrhythmias – mainly macroreentrant atrial tachycardias – 
at a relatively young age. This chapter reviews the different treatment modalities for 
postoperative atrial tachyarrhythmias in patients after Fontan-type surgery, including 
antiarrhythmic drug therapy, antitachycardia pacing, conversion surgery, arrhythmia 
surgery and catheter ablation.
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Case
This case involves a 33-year female with complex congenital heart disease 
consisting of heterotaxy with a single systemic right ventricle, pulmonary artery 
atresia, and an interrupted inferior vena cava with hemiazygous continuation to 
a persistent left superior vena cava. She is status post pulmonary artery banding, 
creation of bilateral bidirectional cavopulmonary anastomoses (Kawashima 
procedure), creation of a lateral tunnel Fontan, right atrial plication, and tricuspid 
valve repair. She presented to the emergency room multiple times for recurrent 
episodes of tachycardia. She was started on amiodarone but continued to 
have recurrent episodes. She then had an electrophysiologic study where 3 
distinct atrial flutters and a focal atrial tachycardia were induced. Subsequently, 
she underwent a biatrial maze procedure and implantation of a dual chamber 
antitachycardia pacemaker (Medtronic EnRhythm model P1501DR) with epicardial 
lead placement and an abdominal generator; however the initial generator was 
faulty and required replacement.
During normal operation, the pacemaker delivers ATP if the atrial rate is above 
the atrial detection rate. However, the device also assesses the atrioventricular 
(AV) relationship and can only deliver ATP if the atrial rate is faster than the 
ventricular rate. Therefore ATP would not be delivered for atrial arrhythmias with a 
1:1 AV relationship. Because of this software limitation, the pacemaker was loaded 
with custom software from Medtronic (TPARx) under compassionate use allowing 
patient-activated ATP. At the onset of symptoms, the patient presses a button 
on a wireless transmitter that starts a timer (typically 30 minutes). During this 
period, the pacemaker suspends the AV relationship criteria and delivers ATP for 
atrial rhythms above the atrial detection limit. The pacemaker returns to normal 
operation once the atrial arrhythmia ends or the timer expires. Placing a magnet 
over the device will also stop delivery of therapy by TPARx.
Following pacemaker implantation, atrial arrhythmias with a 1:1 atrioventricular 
relationship were documented during pacemaker interrogation. The pacemaker 
did not initially deliver ATP after patient activation because the heart rates were 
below the atrial detection limit. Once the atrial detection limit was lowered, 
ATP was able to be delivered with patient activation. The TPARx software has 
successfully terminated the patient’s subsequent atrial arrhythmias.
This case represents a patient with complex congenital heart disease who underwent 
multiple palliative surgical procedures and who presented with symptomatic 
postoperative atrial tachyarrhythmias. Several attempts were made to treat these 
atrial tachyarrhythmias, including antiarrhythmic drug therapy with amiodarone, a 
biatrial Maze procedure and finally implantation of a dual chamber antitachycardia 
pacemaker. Antitachycardia pacing with patient activation successfully terminated atrial 
tachyarrhythmias in this patient.
4
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Multiple treatment modalities for postoperative atrial tachyarrhythmias have 
been described in patients after Fontan-type surgery, including antiarrhythmic drug 
therapy, antitachycardia pacing, conversion surgery, arrhythmia surgery and catheter 
ablation.
Postoperative atrial tachyarrhythmias in Fontan patients
Atrial tachyarrhythmias are the most commonly observed postoperative arrhythmias 
after Fontan-type surgery, occurring in up to 50% of patients by 20 years of follow-up.1 
Risk factors for development of atrial tachyarrhythmias in Fontan patients include right 
atrial enlargement, elevated atrial pressure, dispersion of atrial refractoriness, sinus 
node dysfunction, older age at the time of cardiac surgery, elevation of pulmonary 
pressure, low oxygen saturation, preoperative arrhythmias, prior palliation with an 
atrial septectomy, atrioventricular valve replacement and aging.2-4
Macroreentrant circuits involving the right atrium are most often observed (Figure 1). 
However, in lateral tunnel-type repairs, a part of the anatomical right atrium (and thus 
the reentrant circuit) may end up in the pulmonary venous (left) atrium after surgery.5 
Slowed conduction with reentry is facilitated by both anatomical and surgical barriers. 
Anatomical barriers include the orifices of the inferior and superior vena cava, the 
ostium of the coronary sinus and an atrial septal defect. Scar tissue, suture lines and 
prosthetic materials form surgically induced barriers. Patients with a Fontan circulation 
often have multiple reentry circuits because of the extensiveness of areas of scar tissue 
that are scattered throughout the dilated atria.6 Follow-up of patients with lateral tunnel 
and extracardiac Fontan modifications show that patients with lateral tunnel repair 
experience more atrial tachyarrhythmias, consistent with the increased placement of 
suture lines in this procedure.7
Focal atrial tachycardias have also been described in Fontan patients, though 
infrequently. A focal atrial tachycardia is defined as an atrial tachycardia originating 
from a circumscribed region from where it expands centrifugally to the remainder of the 
atrium, as demonstrated in Figure 2. Whether these tachycardias are caused by ectopic 
activity or micro-reentry remains questionable.6 Atrial fibrillation also occurs in patients 
with a Fontan circulation and this arrhythmia tended to occur at a much younger age 
(28±9 years) in Fontan patients than in the normal population.8
Drug therapy
Persistent atrial tachyarrhythmias can be treated with chemical or electrical 
cardioversion and, if tachyarrhythmias are recurrent, with antiarrhythmic drug 
therapy. Unfortunately, medical management of atrial tachyarrhythmias in patients 
with congenital heart disease is often difficult, achieving low success rates.9 Moreover, 
antiarrhythmic drugs may be proarrhythmic, negative inotropic and may aggravate 
sinus and atrioventricular node dysfunction.6 In turn, sinus node dysfunction might 
contribute to development of atrial tachyarrhythmias.10 Amiodarone is the most 
effective anti-arrhythmic drug available but severe side-effects like thyroid dysfunction 
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and liver or pulmonary toxicity -which are dose- and time dependent- occur particularly 
in young adults.11 Hence, it is not a preferable therapy for an only 33 years old patient. 
Sotalol may be an alternative, yet meta-analysis have shown that sotalol usage is 
associated with an increased mortality and it has therefore become a class IIb indication 
for patients with congenital heart defects and intra-atrial reentrant tachycardias or 
atrial fibrillation.12-14
Figure 1. Macroreentrant atrial tachycardia
Three-dimensional electro-anatomic activation map of a macroreentrant tachycardia (CL 290 ms) 
involving the right atrial free wall of a patient after the Fontan procedure. The tachycardia was 
caused by a figure of 8 type reentry around 2 scars (grey areas) as indicated by the arrows. The 
dark-red dots indicate the line of ablation that was made between the two scars.
IVC: inferior vena cava, SVC: superior vena cava.
4
VolledigbinnenwerkCharlotte.indd   85 18/11/2020   16:08:29
86
Chapter 4
Figure 2. Focal atrial tachycardia
Three-dimensional electro-anatomic activation map of the right atrium obtained from a patient 
with a Fontan circulation revealing a focal atrial tachycardia originating from the lower part of 
the anterior wall. The tachycardia emerges from a small, circumscribed region nearby an area of 
scar tissue (grey areas). The arrows indicate main propagation directions.
IVC: inferior vena cava, TV: tricuspid valve, SVC: superior vena cava.
Catheter ablation
Catheter ablation is a good alternative in case of failure or adverse effects of medical 
therapy. Although numerous studies have reported ablation outcomes in patients with 
a variety of congenital heart diseases, only a few studies assessed results of catheter 
ablation in Fontan patients specifically. Outcomes of these studies are summarized 
in Table 1. Acute success rates of ablative therapy for atrial tachyarrhythmias are 
variable and follow-up after catheter ablation is complicated by many recurrences. 
Successive atrial tachyarrhythmias developing over time may be caused by different 
mechanisms. It is most likely that recurrences of atrial tachyarrhythmias are caused 
by a progressive atrial cardiomyopathy instead of an unsuccessful ablation procedure 
or arrhythmogenicity of prior ablative lesions.6,15
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Table 1. Results of ablation of atrial tachyarrhythmias in Fontan patients
Study N AT circuits Acute success Follow-up Recurrence
Betts33 5 11 60% 6.4 mo 67%
Weipert1 30 - 83% 1.7 y -*
De Groot15 19 41 78% 53 mo 60%
Yap34 11 - 45% 2.3 y 47%
* Arrhythmia recurrence not specifically stated: Kaplan-Meier estimate for freedom from
tachycardia after initially successful ablation was 81%±10% at 3 years’ follow-up.
AT: atrial tachyarrhythmia, mo: months, N: sample size, y: years.
Difficulties in catheter ablation in patients after Fontan-type surgery include the 
existence of often multiple tachycardia circuits, restricted catheter access, distorted 
anatomy, hemodynamic instability and the inability to deliver lesions of sufficient depth. 
Moreover, extensive ablation results in focal wall thinning, which in itself may produce 
an additional area of slowed conduction, facilitating tachycardia development.5 Catheter 
access is limited due to difficulties in accessing the pulmonary venous atrium from 
the systemic veins. Several approaches have been described, including retrograde 
access via the systemic artery, direct via sternotomy or transthoracic via percutaneous 
access. Disadvantages of retrograde aortic access include poor stability and flexibility 
of the ablation catheter, hemodynamic instability and risk of valve dysfunction or injury 
by manipulation of the catheter past the systemic semilunar and the atrioventricular 
valve.16 Outcomes might improve by using remote-controlled magnetic navigation, 
but this technology is not widely available.17 Transthoracic or via sternotomy access is 
associated with a high incidence of complications and technical limitations.18,19 Another 
method to reach the pulmonary venous atrium is transbaffle puncture, which was 
first described in 1959.20 Several studies showed that puncture through intra-atrial 
baffles or patches is a safe and simple technique, without residual shunts during 
follow-up.16,21 Performance of transbaffle puncture can be guided by angiogram or by 
transesophageal or intracardiac echocardiography. Transbaffle access can be obtained 
by a new puncture with a transseptal needle or addition of radiofrequency energy. In 
order to avoid unnecessary transbaffle puncture, preprocedural echocardiography can 
be considered to investigate the presence of residual baffle leaks or fenestrations.
After access is obtained, electroanatomic activation and/or voltage mapping in 
addition to entrainment techniques contribute to the identification of arrhythmogenic 
substrates and the selection of suitable target sites for ablation. Three-dimensional 
electroanatomic contact or noncontact mapping visualizes the activation wavefront 
throughout the atria, which is especially useful in the presence of areas of scar 
tissue, prior incision sites and prosthetic material, as is generally always the case in 
Fontan patients. Since most atrial tachyarrhythmias in Fontan patients are caused by 
macroreentrant tachycardias related to scar tissue, accurate identification of areas of 
scar tissue is crucial. Prior endovascular voltage mapping studies have demonstrated 
that successful ablative therapy of atrial tachyarrhythmias was often targeted at 
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arrhythmogenic areas from which atrial potentials with small peak-to-peak amplitudes 
were recorded. In a cohort of patients with and without congenital heart disease, 
bipolar voltages of 0.1 mV or less were never recorded in the latter group.22 Based on 
these observations, a cut-off value of 0.1 mV was used to discriminate between healthy 
and diseased (e.g. scarred) myocardium. It was suggested that scar tissue mapping 
using a cut-off value of 0.1 mV in combination with activation and propagation mapping 
facilitated ablation outcomes in patients with congenital heart disease.22
In the electrophysiology study prior to the biatrial maze procedure in our patient, 
there were multiple, different atrial tachyarrhythmias inducible by programmed 
electrical stimulation. It is very likely that after this surgical procedure there are 
still multiple tachyarrhythmias inducible due to the presence of an extensive 
arrhythmogenic substrate. Even when only the clinical tachyarrhythmia is treated, the 
wavefront arising from e.g. an ectopic beat may simply alter its course and give rise 
to another clinically relevant tachycardia. The first decision when scheduling a second 
ablation procedure would thus be either to target only the clinical tachyarrhythmia or 
to target all inducible tachyarrhythmias. In the first case, when the patient is in sinus 
rhythm at the onset of the ablation procedure, inducing the clinical tachyarrhythmia 
can be challenging. In the second case, non-inducibility of all atrial tachyarrhythmias as 
a procedural endpoint could result in an extensive ablation procedure of considerable 
duration and prolonged fluoroscopy times. Due to limited atrial access and the distorted 
cardiovascular anatomy and particularly the interrupted inferior vena cava, creation 
of effective lesions at the desired target site can be difficult, but may be overcome by 
using a remote magnetic navigation system. Because of all these complexities, ablative 
therapy should only be considered when all other therapies, including anti-tachycardia 
pacing and pharmacological rhythm control, fail and the patient has multiple, long 
symptomatic episodes.
Arrhythmia surgery
Atrial tachyarrhythmias can also be treated at the moment of Fontan conversion. 
Recurrence rate of atrial tachyarrhythmias after Fontan conversion without arrhythmia 
surgery is reported in 76%.5 Intraoperative ablation consists of a right-sided Maze 
operation for right atrial reentry tachycardias and a Cox-Maze III procedure for atrial 
fibrillation or left atrial reentry tachycardias.6 Several studies showed that Fontan 
conversion with concomitant arrhythmia surgery is safe and effective, improves clinical 
outcome and has an acceptable recurrence rate (9 – 25%).23-27 The success rate of 
arrhythmia surgery in Fontan patients can be limited by several factors, including 
the type of atrial fibrillation (paroxysmal versus (longstanding) persistent), the size of 
the (remaining) left and right atria or single atrium, the anatomy and function of the 
systemic ventricle, the technique and procedure applied and the presence of clots 
in the left atrial appendage.6 In case of the heterotaxy syndrome, additional ablative 
lesions will be necessary to connect the left-sided superior vena cava to the confluence 
of the pulmonary veins in order to improve outcomes.25 It is of note that focal atrial 
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tachycardia is not addressed by the right-sided Maze procedure and requires direct 
elimination of the tachycardia focus.5
Antitachycardia pacing
Antitachycardia pacing is another treatment modality for atrial tachyarrhythmias. 
The value of antitachycardia pacing is based on the principle of entrainment with 
termination. Termination is only likely to occur if the pacing cycle length is <80% of 
the tachycardia cycle length.28 Results of antitachycardia pacing in the treatment of 
atrial tachyarrhythmias in patients with congenital heart disease are questionable, 
especially in the presence of multiple clinical atrial tachycardia types.28,29 In addition, 
antitachycardia pacing may increase the risk of acceleration of atrial tachycardia 
and degeneration into atrial fibrillation. It has been suggested that antitachycardia 
pacing might be more efficacious when combined with antiarrhythmic drugs or after 
radiofrequency ablation of some of the reentry circuits.28,30
For appropriate therapy, the pacing algorithm requires that the atrial tachyarrhythmia 
has ≥2:1 atrioventricular relation. This algorithm acts as a safety measure to ensure 
that rapid antitachycardia pacing is not conducted 1:1 to the ventricle and to assist in 
arrhythmia identification. However, patients with congenital heart disease often have 
slower atrial tachyarrhythmias that conduct 1:1 to the ventricle. In these cases, the 
algorithm does not recognize the rhythm as atrial tachyarrhythmia.
With TPARx software, the device uses the usual algorithm until the patient feels 
symptomatic and activates antitachycardia pacing. Patients with congenital heart 
disease are often very well able to recognize an atrial tachyarrhythmia. However, several 
disadvantages of the patient-activated device include 1) the need for the patient to be 
conscious or in the presence of someone familiar with the device, 2) the potential risk of 
inducing a ventricular tachyarrhythmia by manipulation of a 1:1 atrial tachyarrhythmia. 
For the latter limitation, concomitant administration of an atrioventricular node-
blocking drug has been suggested when activating the device.31
In addition to the currently presented case, two other cases of congenital heart 
disease and patient-activated antitachycardia pacing have been described in literature. 
One report described an 18 year old female with complex congenital heart disease 
and a Fontan circulation with frequent episodes of atrial tachyarrhythmias with 1:1 
atrioventricular conduction.31 The other case concerned a 28 year old female after 
surgical repair of total anomalous pulmonary venous return with a long history of 
paroxysmal atrial tachyarrhythmias and also 1:1 atrioventricular conduction of 
the tachycardia.32 TPARx software was installed to allow use of patient-activated 
antitachycardia pacing. In both cases, subsequent atrial tachyarrhythmias with 1:1 
atrioventricular conduction could be terminated successfully. No pro-arrhythmic effect 
regarding acceleration of atrial tachycardia or induction of ventricular tachycardia was 
documented. Hence, there is no objection to continue patient-activated antitachycardia 
pacing in our patient.
4




1. Weipert J, Noebauer C, Schreiber C et al. Occurrence and management of atrial arrhythmia 
after long-term Fontan circulation. J Thorac Cardiovasc Surg. 2004;127:457-64.
2. Agnoletti G, Borghi A, Vignati G et al. Fontan conversion to total cavopulmonary connection 
and arrhythmia ablation: clinical and functional results. Heart. 2003;89:193-8.
3. Cecchin F, Johnsrude CL, Perry JC et al. Effect of age and surgical technique on symptomatic 
arrhythmias after the Fontan procedure. Am J Cardiol. 1995;76:386-91.
4. Gelatt M, Hamilton RM, McCrindle BW et al. Risk factors for atrial tachyarrhythmias after 
the Fontan operation. J Am Coll Cardiol. 1994;24:1735-41.
5. Deal BJ, Mavroudis C, Backer CL. Arrhythmia management in the Fontan patient. Pediatr 
Cardiol. 2007;28:448-56.
6. de Groot NMS, Bogers A. Development of Tachyarrhythmias Late After the Fontan Procedure: 
The Role of Ablative Therapy. Card Electrophysiol Clin. 2017;9:273-284.
7. Nurnberg JH, Ovroutski S, Alexi-Meskishvili V et al. New onset arrhythmias after the 
extracardiac conduit Fontan operation compared with the intraatrial lateral tunnel 
procedure: early and midterm results. Ann Thorac Surg. 2004;78:1979-88; discussion 1988.
8. Teuwen CP, Ramdjan TT, Gotte M et al. Time Course of Atrial Fibrillation in Patients With 
Congenital Heart Defects. Circ Arrhythm Electrophysiol. 2015;8:1065-72.
9. Garson A, Jr., Bink-Boelkens M, Hesslein PS et al. Atrial flutter in the young: a collaborative 
study of 380 cases. J Am Coll Cardiol. 1985;6:871-8.
10. de Groot NM, Schalij MJ. The relationship between sinus node dysfunction, bradycardia-
mediated atrial remodelling, and post-operative atrial flutter in patients with congenital 
heart defects. Eur Heart J. 2006;27:2036-7.
11. Thorne SA, Barnes I, Cullinan P et al. Amiodarone-associated thyroid dysfunction: risk factors 
in adults with congenital heart disease. Circulation. 1999;100:149-54.
12. Freemantle N, Lafuente-Lafuente C, Mitchell S et al. Mixed treatment comparison of 
dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of 
atrial fibrillation. Europace. 2011;13:329-45.
13. Khairy P, Van Hare GF, Balaji S et al. PACES/HRS Expert Consensus Statement on the 
Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed 
in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) 
and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, 
the American College of Cardiology (ACC), the American Heart Association (AHA), the 
European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), 
and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 
2014;11:e102-65.
14. Lafuente-Lafuente C, Longas-Tejero MA, Bergmann JF et al. Antiarrhythmics for maintaining 
sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev. 
2012:CD005049.
15. de Groot NM, Lukac P, Blom NA et al. Long-term outcome of ablative therapy of postoperative 
supraventricular tachycardias in patients with univentricular heart: a European multicenter 
study. Circ Arrhythm Electrophysiol. 2009;2:242-8.
16. Correa R, Walsh EP, Alexander ME et al. Transbaffle mapping and ablation for atrial 
tachycardias after mustard, senning, or Fontan operations. J Am Heart Assoc. 2013;2:e000325.
17. Ernst S, Babu-Narayan SV, Keegan J et al. Remote-controlled magnetic navigation and 
ablation with 3D image integration as an alternative approach in patients with intra-atrial 
baffle anatomy. Circ Arrhythm Electrophysiol. 2012;5:131-9.
18. Khairy P, Fournier A, Ruest P et al. Transcatheter ablation via a sternotomy approach as a 
hybrid procedure in a univentricular heart. Pacing Clin Electrophysiol. 2008;31:639-40.
VolledigbinnenwerkCharlotte.indd   90 18/11/2020   16:08:41
91
Antitachycardia pacing in complex congenital heart disease 
19. Nehgme RA, Carboni MP, Care J et al. Transthoracic percutaneous access for electroanatomic 
mapping and catheter ablation of atrial tachycardia in patients with a lateral tunnel Fontan. 
Heart Rhythm. 2006;3:37-43.
20. Ross J, Jr., Braunwald E, Morrow AG. Transseptal left atrial puncture; new technique for the 
measurement of left atrial pressure in man. Am J Cardiol. 1959;3:653-5.
21. El-Said HG, Ing FF, Grifka RG et al. 18-year experience with transseptal procedures through 
baffles, conduits, and other intra-atrial patches. Catheter Cardiovasc Interv. 2000;50:434-9; 
discussion 440.
22. De Groot NM, Kuijper AF, Blom NA et al. Three-dimensional distribution of bipolar atrial 
electrogram voltages in patients with congenital heart disease. Pacing Clin Electrophysiol. 
2001;24:1334-42.
23. Aboulhosn J, Williams R, Shivkumar K et al. Arrhythmia recurrence in adult patients with single 
ventricle physiology following surgical Fontan conversion. Congenit Heart Dis. 2010;5:430-4.
24. Jang WS, Kim WH, Choi K et al. The mid-term surgical results of Fontan conversion with 
antiarrhythmia surgery. Eur J Cardiothorac Surg. 2014;45:922-7.
25. Mavroudis C, Deal BJ, Backer CL et al. J. Maxwell Chamberlain Memorial Paper for congenital 
heart surgery. 111 Fontan conversions with arrhythmia surgery: surgical lessons and 
outcomes. Ann Thorac Surg. 2007;84:1457-65; discussion 1465-6.
26. Sridhar A, Giamberti A, Foresti S et al. Fontan conversion with concomitant arrhythmia 
surgery for the failing atriopulmonary connections: mid-term results from a single centre. 
Cardiol Young. 2011;21:665-9.
27. Terada T, Sakurai H, Nonaka T et al. Surgical outcome of Fontan conversion and arrhythmia 
surgery: Need a pacemaker? Asian Cardiovasc Thorac Ann. 2014;22:682-6.
28. Kanter RJ, Garson A, Jr. Atrial arrhythmias during chronic follow-up of surgery for complex 
congenital heart disease. Pacing Clin Electrophysiol. 1997;20:502-11.
29. Rhodes LA, Walsh EP, Gamble WJ et al. Benefits and potential risks of atrial antitachycardia 
pacing after repair of congenital heart disease. Pacing Clin Electrophysiol. 1995;18:1005-16.
30. Fukushige J, Porter CB, Hayes DL et al. Antitachycardia pacemaker treatment of postoperative 
arrhythmias in pediatric patients. Pacing Clin Electrophysiol. 1991;14:546-56.
31. Batra AS. Patient-activated antitachycardia pacing to terminate atrial tachycardias with 1:1 
atrioventricular conduction in congenital heart disease. Pediatr Cardiol. 2008;29:851-4.
32. Weber S, Jeron A, Schneider HJ et al. Efficacy of patient activated antitachycardia pacing 
therapy using the Medtronic AT500 pacemaker. Europace. 2006;8:413-5.
33. Betts TR, Roberts PR, Allen SA et al. Electrophysiological mapping and ablation of intra-atrial 
reentry tachycardia after Fontan surgery with the use of a noncontact mapping system. 
Circulation. 2000;102:419-25.
34. Yap SC, Harris L, Downar E et al. Evolving electroanatomic substrate and intra-atrial reentrant 
tachycardia late after Fontan surgery. J Cardiovasc Electrophysiol. 2012;23:339-45.
4
VolledigbinnenwerkCharlotte.indd   91 18/11/2020   16:08:41
VolledigbinnenwerkCharlotte.indd   92 18/11/2020   16:08:41
Concomitant pulmonary vein isolation and 









Natasja M.S. de Groot
Published in: Congenital Heart Disease 2019;00:1–7
5




Background: Patients with an atrial septal defect (ASD) are at increased risk of 
developing atrial fibrillation. Currently percutaneous ASD closure is the preferred 
therapeutic strategy and although pulmonary vein isolation (PVI) for atrial fibrillation 
is feasible after ASD closure, the transseptal puncture can be technically challenging 
and may increase the peri-operative risk. A staged approach, with PVI several months 
before ASD closure, has been recommended for patients already scheduled for ASD 
closure, but no data is available on combined procedures.
Purpose: This pilot study evaluates the feasibility of a combined procedure of PVI and 
ASD closure in patients with a hemodynamically important ASD and documented atrial 
fibrillation.
Methods: During one procedure, PVI was performed prior to placement of the ASD 
closure device. Transseptal access for PVI was obtained via wire passage through the 
ASD in all patients. Patients were followed with 5-day-holter monitoring at 3, 6 and 
12 months. Recurrence was defined as a documented episode of atrial fibrillation.
Results: The study population consisted of five patients (4 females, age: 58 ± 3 years). 
Acute PVI was achieved in all patients. Only one patient had a small residual ASD after 
closure. Besides a small groin hematoma in two patients, no complications occurred. 
After 12 months follow-up, three patients were free from atrial fibrillation recurrence 
(60%).
Conclusion: This study shows that a combined PVI with ASD closure is feasible with 
an acceptable success rate of atrial fibrillation-free survival. These preliminary results 
in a small patient group warrant a larger trial.
VolledigbinnenwerkCharlotte.indd   94 18/11/2020   16:08:42
95
Simultaneous pulmonary vein isolation and atrial septal defect repair
INTRODUCTION
Evolving treatment options in patients with congenital heart disease (CHD) resulted in 
an improved survival and a rapidly expanding patient population of grown-ups with 
CHD ASD is one of the most common CHD with a reported birth prevalence of 1 to 
2 per 1000 live births.1-3 As these patients age, atrial tachyarrhythmias are common 
complications, mainly AF.4-6 The prevalence of AF is high in ASD patients (reported 
between 20 and 45%), with the first episode of AF occurring at a younger age than in 
the general population.4,7-12 Both surgical and percutaneous closure of an ASD have 
been proven as an effective treatment of a significant ASD with different procedural 
complication risks and rates of residual shunting.13 Closure of the ASD has been 
associated with a higher risk of developing AF as well as an effective treatment of AF; 
evidence is inconsistent. 9,11,14
In the general population, various treatment options for AF have been extensively 
studied, of which PVI has been accepted as a safe and effective procedure.15,16 Less 
is known about the preferred treatment strategy for AF in patients with an ASD, with 
regard to timing of PVI: before, after or during ASD closure. Although several studies 
have shown that a PVI can be safely performed in patients after ASD closure, transseptal 
puncture can be troublesome and challenging in the presence of a closure device. 
Successful transseptal punctures at native septal sites or directly through the device 
or patch have been described in several studies, often requiring additional tools such 
as intracardiac echo and balloon dilatation through an Amplatzer device.17-21
PVI in patients with an uncorrected ASD is feasible with reasonable success rates 
ranging between 56% and 75% during a follow-up of 20 months in respectively 18 
and 4 patients.22,23 Left atrial access was obtained through the defect and rarely 
required transseptal puncture. In case transseptal puncture is required, it is generally 
not associated with additional risks compared to patients without ASD.22,23 A staged 
procedure of PVI several months before percutaneous closure has been advocated.22 
One of the drawbacks of this approach is that these patients will have to undergo two 
separate procedures, each with the risk of procedural complications. Thus far only one 
patient with concomitant PVI and ASD closure has been described with transseptal 
access through the ASD and successful cryoballoon ablation prior to placement of a 
septal occluder with no residual shunt or atrial arrhythmia at one year follow-up.24 Our 
aim was to the study the feasibility and safety of a combined approach of PVI and ASD 
closure in a small cohort of ASD patients with symptomatic, documented AF and the 
1-year success rate.
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This pilot study was approved by the local ethics committee in the Radboud University 
Medical Center Nijmegen (METC number: 2018-4860).
Inclusion
Patients with an indication for ASD closure, defined according to current clinical 
guidelines; significant left-to-right shunt with echocardiographic signs of right ventricle 
volume overload 25 and documented, symptomatic AF.
Periprocedural management
Prior to the PVI, a computed tomography scan was obtained to examine the 
3-dimensional anatomy of the pulmonary veins. All patients used oral anticoagulation 
therapy prior to the ablation procedure. All patients used a novel oral anticoagulant 
(NOAC), for which we applied an interrupted regimen consisting of a NOAC-free interval 
of 12-24 hours prior to the procedure.
Ablation procedure
All procedures were performed under general anesthesia or conscious sedation, 
with transesophageal echocardiography to exclude the presence of thrombi in the 
left atrium. After gaining right femoral vein access and sheath placement, a steerable 
decapolar diagnostic catheter was positioned in the coronary sinus. Access to the left 
atrium and pulmonary veins was obtained using direct wire passage through the septal 
defect. In case this could not be achieved, transseptal puncture (single or double) under 
fluoroscopic and transesophageal echocardiographic guidance would be performed. 
During the procedure, heparin was administered targeting an activated clotting time 
>300 seconds.
PVI using cryoenergy was performed using the second generation cryoballoon 
(Medtronic, Minneapolis, MN, USA) in combination with the 12-French steerable sheath 
(Medtronic, Minneapolis, MN, USA). All pulmonary veins were mapped with an inner 
lumen mapping catheter. Every vein was treated with at least two applications. The 
freeze cycles were 180 seconds. Balloon size of the cryoballoon was 28 mm in all cases. 
Phrenic nerve palsy was monitored during ablation of the right-sided pulmonary veins. 
PVI using radiofrequency energy was performed guided by a 3-D electroanatomical 
mapping system (Ensite Precision®, Abbott), and a 3.5 mm irrigated open-tip catheter 
was used. Ablative therapy was performed at 25-30W, 43oC and an irrigation rate of 
17 ml/min. A point-by-point series of interconnecting focal ablation lesions was used 
to encircle the left- and right-sided pulmonary vein pairs. PVI was confirmed using 
a steerable multi-electrode lasso catheter. No additional lines or focal lesions were 
made.
After confirming PVI, an over the wire change to an Amplatzer Torque 45° delivery 
system was performed for the ASD closure. After transesophageal echocardiography 
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sizing, the appropriate closure device was delivered using fluoroscopy guidance to 
close the defect. Using contrast injection, residual defects were ruled out and after 
confirmation of a good and stable position, the implantation tool was released and 
retracted.
The day after the procedure, a transthoracic echocardiogram was performed to 
exclude pericardial effusion and confirm a good position of the closure device. The 
patient was discharged hereafter.
Follow-up
Data during follow-up was systematically collected and included a resting ECG and 
physical examination during regular outpatient visits, as well as 5-day holter monitoring 
at 3, 6 and 12 months after ablation, but also symptom-driven consultation. As 
recommended in current guidelines a blanking period of three months after PVI 
was applied.15 Oral anticoagulation was continued for at least three months after the 
procedure, after which life-long treatment was based on the CHA2DS2-VASc score. Anti-
arrhythmic drugs were stopped or continued at the discretion of the treating physician. 
Recurrence of all documented AF episodes, all procedure related complications, 
procedure time and duration of hospital admission were collected.
RESULTS
Between September 2016 and August 2017, five patients (4 female, mean age 58±3 
years) were eligible for the combined procedure of PVI and ASD closure; baseline and 
procedural characteristics are listed in Table 1. All patients had symptomatic paroxysmal 
AF with a median time from onset of symptoms to the procedure of 26 months, ranging 
from 2 to 54 months. The maximal CHA2DS2-VASc score was 2 and all patients used a 
NOAC. Transseptal access for PVI was obtained via wire passage through the ASD in all 
patients and no additional transseptal puncture was needed.
Pulmonary vein isolation was achieved in all patients using cryo- (n=4) or 
radiofrequency (n=1) energy. Either an Amplatzer (n=4) or a Gore Cardioform 
Septal Occluder (n=1) was implanted. Median procedure and fluoroscopy time were 
respectively 183 (153-236) and 24 (23-27) minutes. Figures 1 and 2 show the fluoroscopy 
and transesophageal echocardiography images of one of the procedures.
Immediately after closure, transesophageal echocardiography showed no residual 
ASD. Transthoracic echocardiography performed on the first post-procedural day 
confirmed stable position of the closure device and absence of pericardial effusion in 
all patients. Four patients were discharged on the first post-procedural day and one 
on the second. Every patient continued to use oral anticoagulants. At the end of the 
12-month follow-up period, three patients were free from AF recurrence. One patient 
had a documented recurrence of AF at the three and six month follow-up period. 
Both episodes converted spontaneously to sinus rhythm and additional therapy was 
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not given. Another patient had a recurrence of AF at 12 months follow-up, which was 
treated with an electrical cardioversion. Besides a small groin hematoma at the vascular 
access site in two patients, controlled by means of manual compression, no major 
periprocedural complications occurred.
Table 1. Clinical, procedural and follow-up data
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Age (years) 58 49 59 66 58
Sex F F F F M
Comorbidity M. Graves - HT HCL HT
BMI 25 24 24 29 26
ASD size (mm) 16 15 19 18 4
RVEDD (mm) 47 43 40 43 52
LVF Normal Normal Normal Normal Normal
LVEDD (mm) 46 43 38 35 50
Valve disease - - - - -
LA size (ml/m2) 29 43 32 25 48
AF duration (mo)* 26 2 42 54 25
CHA2DS2-VASc 2 1 2 2 1
Anticoagulation Apixaban Edoxaban Dabigatran Apixaban Apixaban
AAD Propranolol Metoprolol Nebivolol Sotalol Flecainide
PVI technique Cryo Cryo Cryo Cryo RF †
Balloon size (mm) 28 28 28 28 N/A
Acute isolation PVs + + + + +
ASD closure device Amplatzer Amplatzer Amplatzer Amplatzer Gore 
Cardioform
Size device (mm) 28 18 24 20 30
Procedure (min) 153 183 236 153 218
Fluoroscopy (min) 24 N/A 23 24 27
Hospital stay (days) 1 1 1 1 2
Complications Groin 
hematoma
- - Groin 
hematoma
-
Recurrence 3 mo - + - - -
Recurrence 6 mo - + - - -
Recurrence 12 mo - - - - +
* duration between diagnosis of AF and procedure. † point-by-point.
AAD: anti-arrhythmic drugs, AF: atrial fibrillation, ASD: atrial septal defect, BMI: body mass index, 
Cryo: cryoballoon, F: female, HCL: hypercholesterolemia, HT: hypertension, LA: left atrium, LVEDD: 
left ventricular end-diastolic diameter, LVF: left ventricular systolic function, M: male, mo: months, 
PVI: pulmonary vein isolation, PVs: pulmonary veins, RVEDD: right ventricular end-diastolic 
diameter, RF: radiofrequency.
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Figure 1. X-ray images of one of the procedures
A: the wire is passed to the left atrium through the ASD. B: PVI, in this case with a cryoballoon. 
C: the size of the ASD is measured. D: placement of the ASD closure device.
DISCUSSION
This pilot study shows that a combined procedure of PVI and ASD closure in symptomatic 
AF patients and an indication for ASD closure is feasible and safe. During the 12-month 
follow-up period, 3 of 5 patients were free from AF recurrence (60%). Interestingly, both 
patients with AF recurrences had an enlarged left atrium, known as a predictor of AF 
in general and of PVI failure.26,27
Our recurrence rate is comparable to the rate described in patients undergoing 
PVI with an uncorrected ASD (44%).23 Another study showed a comparable recurrence 
rate after PVI in patients with a previously closed ASD (44%).20 Lakkireddy et al. 
compared outcomes of PVI during a mean follow-up of 15 months between patients 
with a corrected ASD (51% percutaneous closure device and 49% surgical repaired 
ASD) and a matched control group with AF and found no significant difference in 
recurrence rate (18% versus 24%, p=0.6).18 Our recurrence rates were similar to those 
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reported for PVI in the general population, which ranged between 45 and 89%.15 Also, 
major complications did not occur. The median procedure time of 183 minutes in the 
present study seems reasonable, particularly when considering that this is a combined 
procedure. Our procedure time is only slightly longer than the mean PVI procedure time 
of 124 (cryoballoon) and 141 minutes (radiofrequency) in the FIRE and ICE study and the 
162 (cryoballoon) and 166 minutes (radiofrequency) reported in a recent meta-analysis 
on ablative therapy in PAF.28,29
Figure 2. Transesophageal echocardiography images of one of the procedures
A: the ASD (arrow). B: left-to-right shunt through the defect. C: the size of the defect is measured. 
D: the ASD closure device in situ.
The consideration to perform PVI several months before closure seems reasonable 
but has a clear downside of performing two procedures and subsequent exposure to 
twice the procedural complication risks. The disadvantage of performing a PVI and ASD 
closure in one single procedure is that in case of an AF recurrence, a redo PVI may be 
more challenging. Nevertheless, previous studies showed the feasibility of transseptal 
access, although extra imaging modalities or other tools were often required. These 
studies reported no residual defects, regardless of the transseptal access site (the 
native septum or the closure device itself).17-21
Considering an average recurrence rate of 40% after a combined procedure of PVI 
and ASD closure, every 4 out of 10 patients will be a potential candidate for a redo PVI. 
The decision to perform the redo procedure will depend on the severity of symptoms 
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and will be a joint decision of the patient and physician. Nevertheless, if all patients with 
AF recurrences would opt for a redo procedure, up to 40% of patients will be subjected 
to the complication risks of a redo procedures. However, in the stepwise approach 
every patient will by definition at least have two procedures. If a redo PVI is required, 
it should be performed either before or concomitant with the closure procedure. With 
a presumed recurrence rate of 40% and all patients with AF recurrences undergoing 
a redo procedure, at least 6 out of 10 patients will have had two procedures and 4 
patients might even have undergone three procedures, in the case redo PVI and ASD 
closure are performed in two separate procedures. Another issue to be resolved in 
this approach is the advised waiting times between procedures.
Although the available data are positive on the feasibility of performing PVI in 
patients with a closure device, we do recognize that a redo PVI does logically introduce 
a slightly higher complication risk. This is, to our opinion, insufficient reason to expose 
all patients to at least two procedures and thereby doubling the complication risk in all 
patients. Moreover, our limited data showed AF recurrences in patients with a dilated 
left atrium, in which case it could even be reasonable to consider a surgical approach 
(e.g. epicardial or hybrid) when AF recurs. This will overcome the additional challenge 
of puncturing through or passed a closure device and additional complications, such 
as device dislodgement and septal laceration. On the other hand, left atrial dilatation 
is probably a marker of disease progression and it would be interesting to be able 
to treat these patients earlier, possibly through improved screening tools yet to be 
developed.
CONCLUSION
In conclusion, the preferred strategy for symptomatic patients with AF accepted for ASD 
closure could potentially be a concomitant procedure of a PVI followed by ASD closure. 
However, larger studies are needed to provide further evidence that this could indeed 
be the preferred strategy and to better define patient characteristics and risk factors 
associated with procedural outcomes.
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Background: In contrast to the adult population with congenital heart disease (CHD), 
arrhythmia mechanisms and outcomes of ablation in pediatric CHD patients in recent 
era have not been studied in detail. Aims of this study were to determine arrhythmia 
mechanisms and to evaluate procedural and long-term outcomes in pediatric CHD 
patients undergoing catheter ablation.
Methods: Consecutive patients <18 years of age with CHD undergoing catheter 
ablation over an 11-year period (2007-2018) were included. Procedural outcome 
included complete or partial success, failure or empiric ablation. Long-term outcome 
included arrhythmia recurrence and burden according to a 12-point clinical arrhythmia 
severity score.
Results: The study population consisted of 232 patients (11.7 years (0.01-17.8), 
33.5kg (2.2-130.1)). The most common diagnoses were Ebstein’s anomaly (n=44), 
septal defects (n=39) and single ventricle (n=36). Arrhythmia mechanisms included 
atrioventricular reentry tachycardia (n=104, 90 patients), atrioventricular nodal reentry 
tachycardia (n=33, 29 patients), twin atrioventricular nodal tachycardia (n=3, 2 patients), 
macroreentrant atrial tachycardia (n=59, 56 patients), focal atrial tachycardia (n=33, 
25 patients), ventricular ectopy (n=10, 8 patients) and ventricular tachycardia (n=15, 
13 patients). Fifty-six arrhythmias (39 patients) were undefined. Outcomes included 
complete success (n=189, 81%), partial success (n=7, 3%), failure (n=16, 7%) or empiric 
ablation (n=20, 9%). Over 3.6 years (0.3-10.7) arrhythmia recurred in 49%. Independent 
of arrhythmia recurrence, arrhythmia scores decreased from 4 (0-10) at baseline to 
0.5 (0-8) at 4 years follow-up (p<0.001). In 23/51 repeat procedures (45%), a different 
arrhythmia substrate was found. Overall adverse event rate was 9.4%, although only 
1.6% (n=4) were of major severity and 0.8% (n=2) of moderate severity.
Conclusions: Pediatric CHD patients demonstrate a broad spectrum of arrhythmia 
mechanisms. Despite recurrence and emergence of novel mechanisms following a 
successful procedure, ablation can be performed safely and successfully resulting in 
decreased arrhythmia burden.
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INTRODUCTION
Macroreentrant atrial tachycardia (MAT) is the most common arrhythmia observed in 
adults with congenital heart disease (CHD).1 Although procedural success rates after 
catheter ablation are considerable, numerous studies have demonstrated recurrence 
rates of approximately 40% by 5 years follow-up.2-7 Long-term outcomes vary according 
to the complexity of the underlying CHD, and have been reported to improve after 
repeat ablation.3,5-7 Recurrences are often caused by different arrhythmia mechanisms 
from those previously ablated, suggesting progressive atrial remodelling.4,6,8 Well-known 
factors contributing to the arrhythmogenic substrate in these patients include atrial 
hypertrophy and dilatation due to longstanding volume and pressure overload, fibrosis, 
surgical scars and suture lines, and ventricular dysfunction.9
Arrhythmia mechanisms in pediatric CHD patients may be more variable 
compared to the adult population, although information is limited. Younger age and 
shorter duration of hemodynamic overload and structural remodeling may limit the 
substrate for MAT and perhaps also recurrences after catheter ablation. Common 
arrhythmias such as atrioventricular reentry tachycardia (AVRT) and atrioventricular 
nodal reentry tachycardia (AVNRT) also occur in CHD patients.9,10 These arrhythmias 
often present during childhood or adolescence,11 and may be associated with more 
significant hemodynamic consequences in CHD patients. Additionally, successful 
mapping and ablation may be impeded by limited access to the desired ablation site, 
complex anatomy or abnormal location of the atrioventricular (AV) node.12 The risk of 
procedural complications may be higher in children of younger age and smaller size, 
although evidence is inconclusive.12-14 In contrast to the adult CHD population, outcomes 
of ablative therapy in pediatric CHD patients in recent era have not been studied in 
detail.10,12
Therefore, the aims of this study were to determine arrhythmia mechanisms, 




The data that support the findings of this study are available from the corresponding 
author upon reasonable request. With approval from the local ethic committees, 
case records of all patients aged <18 years with CHD undergoing catheter ablation 
of supraventricular or ventricular tachyarrhythmia between January 2007 and April 
2018 at the participating centers were retrospectively reviewed. CHD types eligible 
for inclusion were those listed in the classification of CHD complexity proposed by the 
ACC/AHA task force on practice guidelines for adults with CHD.15 According to these 
guidelines, CHD was classified into defects of simple, moderate and severe complexity. 
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A total of 283 electrophysiology studies (EPS) were included (Boston Children’s Hospital: 
n=256, Erasmus Medical Center: n=27). Complexity of CHD did not differ between the 
populations of the participating hospitals (p=0.720).
Electrophysiology study
Procedures were performed under general anesthesia (95%) or conscious sedation 
(5%). Vascular access was via the femoral vein(s) (n=243, 85.9%), with additional (n=39, 
13.7%) or alternative (n=1, 0.4%) access through the subclavian or internal jugular 
veins in case of femoral vein occlusion (n=9), interrupted inferior caval vein (n=4) or 
unknown reasons (n=27). Based on operator’s preference, the procedure was guided 
by fluoroscopic or 3D electroanatomic mapping (CARTO [Biosense-Webster, Diamond 
Bar, CA, USA] or EnSite NavX [St. Jude Medical, St Paul, MN, USA]).
Standard diagnostic maneuvers were applied at the operator’s discretion to 
determine the underlying arrhythmia mechanism and included atrial and ventricular 
programmed stimulation techniques and diagnostic use of isoproterenol and adenosine. 
Arrhythmias were defined according to recognized diagnostic criteria.16
In patients who had undergone Fontan palliation or double switch procedure the 
atria were referred to as systemic venous atrium (SVA) and pulmonary venous atrium 
(PVA). For patients with usual atrial arrangement standard nomenclature was used.
Ablation was performed using conventional temperature-controlled or irrigated-tip 
radiofrequency energy or cryotherapy, at the discretion of the operator.
Procedural and long-term outcome
Ablation of MAT or ventricular tachycardia (VT) was considered successful if acute 
termination was observed during lesion application with subsequent noninducibility 
of the targeted arrhythmia and/or bidirectional conduction block. Ablation of atrial or 
ventricular ectopy was considered successful with complete elimination of ectopic beats, 
partially successful with significant reduction and empiric when P-wave morphology 
or pace mapping was used in the absence of spontaneous or inducible ectopy. 
Successful ablation of AVNRT was defined as noninducibility of AVNRT and consisted 
of slow pathway ablation (no residual slow pathway conduction) or modification (AH 
jump and/or single atrial echo beat). Ablation of an accessory pathway was considered 
successful when antegrade and/or retrograde conduction block over the pathway was 
demonstrated in the absence of inducible AVRT. Procedural success was complete 
with successful ablation of all targeted arrhythmias and partial when not all targeted 
arrhythmias were successfully ablated.
Adverse events were defined as any (un)anticipated event for which injury occurred 
as a consequence of the EPS and were classified according to previously established 
definitions for severity (trivial, minor, moderate, major, catastrophic).17
Recurrence was defined as documentation of arrhythmia on ECG, 24h-Holter or 
pacemaker telemetry. For analysis of long-term outcome, only patients with follow-up 
>3 months were included.
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Clinical arrhythmia severity score
A 12-point score employed in prior outcome studies for adult CHD patients was used 
to compare arrhythmia burden before ablation and during follow-up (Supplemental 
Table 1).2,18 An arrhythmia score was calculated at baseline and during follow-up on 
each clinical visit where sufficient information was available. Follow-up scores were 
categorized according to time after ablation (3-12, 12-24, 24-48 and >48 months) 
and in case of multiple scores per patient per follow-up category, a mean score was 
calculated.
Statistical analysis
Continuous variables were expressed as mean±standard deviation and compared with 
the independent T-test (parametric distribution) or as median (range) and compared 
with the Mann-Whitney U test (non-parametric distribution). Categorical data were 
denoted by numbers and percentages and compared with the chi-square or Fisher’s 
exact test. Predictors of the first recurrence of arrhythmia after catheter ablation 
were determined using multivariable Cox regression analysis, entering variables with 
a p-value <0.2 derived from univariable Cox regression analysis. Patients were censored 
after the first event and therefore only the time until the first recurrence of arrhythmia 
after catheter ablation was taken into account. Clinical arrhythmia severity scores 
during follow-up were compared to baseline using the Wilcoxon signed rank test. A 
p-value <0.05 was considered statistically significant. Statistical analysis was performed 
with SPSS version 24 (IBM Corporation, Armonk, New York).
RESULTS
Patient and procedural characteristics
The study population consisted of 232 patients (60% male) with a median age of 11.7 
years (4 days-17.8 years) (Figure 1). Twenty patients after Fontan palliation have been 
described previously.2
Associated anatomical lesions are displayed in Table 1. Most patients had CHD 
of moderate (n=109, 47%) or severe complexity (n=92, 40%) and had undergone 
prior corrective or palliative cardiac surgery (66%). Primary indications for EPS and 
ablation were documented tachycardia (n=87, 38%), failed drug therapy (n=67, 29%), 
ventricular preexcitation (n=39, 17%), pre-surgery work-up (n=34, 15%), patient or 
family preference (n=4, 2%) or syncope (n=1, 0.5%). Most patients were symptomatic 
(n=157, 68%). The patients with failed drug therapy had used at least 1 anti-arrhythmic 
drug aimed at either control of rhythm (n=23), rate (n=18) or both (n=26). Clinical and 
procedural characteristics are listed in Table 2. Procedural time was longer with use of 
3D-electronatomic mapping (n=152, 66%) compared to fluoroscopy alone (n=81, 34%; 
median 271 vs. 229 minutes, p<0.001) but fluoroscopy time was shorter (median 17 
vs. 28 minutes, p<0.001).
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In the 232 patients, 313 distinct arrhythmia mechanisms were observed during the 
initial procedure. Four patients had no inducible arrhythmias and underwent empiric 






























Figure 1. Patient age during the initial ablation procedure
Congenital substrates
Accessory pathway
Ninety patients (39%), including 32 with Ebstein’s anomaly (36%), had a total of 104 
accessory pathways. Figure 2A demonstrates surgical status of these patients. The 
majority of patients had a single pathway (87%), the remainder had either 2 (11%) or 3 
(2%) pathways. Most pathways had bidirectional conduction properties (52%; Figure 2B) 
and were right-sided (70%; Figure 2C ). A Mahaim pathway was present in 4 patients, all 
with Ebstein’s anomaly. Sixty-one orthodromic and 3 antidromic AVRTs were induced 
(cycle length (CL) 320ms, 220-480) and Mahaim automaticity was documented in one 
patient. AVRT was non-inducible in 21 cases: 12 patients with ventricular preexcitation 
and documented supraventricular tachycardia (SVT), 5 patients with a concealed 
pathway and documented SVT and 4 patients with ventricular preexcitation without 
documented SVT. Arrhythmia induction was not attempted for the remaining 18 
pathways.
Most pathways were successfully ablated (n=98, 94%; left-sided: 97%, right-sided: 
93%). Ablation was aborted in the remaining 6 pathways in 5 patients (of which 4 with 
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Ebstein’s anomaly), due to potential risks of perforation, coronary injury, transient 
mechanical AV node dysfunction, close proximity to the AV node or a left atrial (LA) 
appendage to left ventricle connection.19











Ebstein’s anomaly (n=44) 6 (7) 1 (3) - 2 (13) 35 (45)
Septal defect (n=39) 24 (26) - - - 15 (19)
Single ventricle (n=36) 1 (1) 28 (72) - 7 (47) -
TOF + variants (n=27) 21 (23) 5 (13) - 1 (7) -
VHD (n=21) 4 (4) 1 (3) - 1 (7) 15 (19)
ccTGA + variants (n=21) 2 (2) 1 (3) 8 (100) 3 (20) 7 (9)
TGA + variants (n=14) 11 (12) 2 (5) - - 1 (1)
AVSD (n=10) 7 (8) 1 (3) - 1 (7) 1 (1)
CoA (n=6) 6 (7) - - - -
Other (n=14) 10 (11) - - - 4 (5)
Values are presented as n (%).
Other anatomic diagnoses: Shone’s complex (n=5), total abnormal pulmonary venous return (n=2), 
partial abnormal pulmonary venous return (n=2), cor triatriatum (n=2), truncus arteriosus (n=1), 
patent ductus arteriosus (n=1), cor triatriatum/sinus venosus defect/partial abnormal pulmonary 
venous return (n=1).
Other surgical status: bidirectional Glenn (n=12), pulmonary artery band (n=2), Damus-Kaye-
Stansel and right modified Blalock-Taussig shunt (n=1).
* n=34 intracardiac Fontan, n=4 extracardiac Fontan, n=1 atriopulmonary connection.
AVSD: atrioventricular septal defect, BiV: biventricular, ccTGA: congenitally corrected transposition 
of the great arteries, CoA: coarctation of the aorta, TGA: transposition of the great arteries, TOF: 
tetralogy of Fallot, VHD: valvular heart disease.
Atrioventricular nodal reentrant tachycardia
Thirty-three variants of AVNRT were observed in 29 patients (12%), including 25 typical 
(CL 340ms, 230-440; VA-interval 36ms, -14-73) and 6 atypical AVNRT (CL 320ms, 
290-375; VA-interval 220ms, 176-255). The type of AVNRT could not be determined 
in 2 patients, including one with suspected twin AV nodes. Treatment of AVNRT was 
successful in 28 patients (97%) with slow pathway ablation in 22 patients and slow 
pathway modification in 6. AVNRT remained inducible in 1 patient with both typical 
and atypical AVNRT and an extracardiac Fontan circulation despite extensive ablation 
attempts.
Two patients with atrial isomerism, atrioventricular septal defect and ventriculo-
arterial concordance (1) or discordance (1) had twin AV nodal tachycardias with three 
different types of activation directions. Both patients underwent successful ablation 
of one AV node.
6
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Table 2. Clinical and procedural characteristics (N=232)
Male gender 140 (60)
Age 11.7 years (4 days-17.8 years)
   Age <18 months 18 (8)
Weight (kg) 33.4 (2.2-130.1)
   Weight <15 kg 44 (19)
Complexity of CHD
   Simple 31 (13)
   Moderate 109 (47)
   Severe 92 (4)
Pacemaker 20 (9)
Subaortic ventricular dysfunction, ≥ moderate 11 (5)
Subpulmonary ventricular dysfunction, ≥ moderate 6 (3)
Access to left atrium, PVA or systemic ventricle 91 (39)
   Baffle fenestration, ASD or PFO 34 (37)
   Conventional transseptal puncture 35 (38) 
   Radiofrequency transseptal puncture 7 (8)
   Retrograde aortic approach 12 (13) 
   Retrograde + transseptal puncture 3 (3)
3D-electroanatomic mapping 152 (66)
Procedural time (min) 260 (120-608)
Fluoroscopy time (min) 23.8 (0.2-115)
Arrhythmia mechanism(s) 
   Noninducible 4 (2)
   1 166 (72)
   2 44 (19)
   3 13 (6)
   4 5 (2)
Ablation energy source
   Nonirrigated-tip radiofrequency 150 (65) 
   Irrigated-tip radiofrequency 50 (22)
   Cryoablation 14 (6) 
   Combination 18 (8)
Values are presented as n (%) or median (range). 
ASD: atrial septal defect, PFO: patent foramen ovale, PVA: pulmonary venous atrium. 
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Figure 2. Characteristics of accessory pathways
A: surgical status of patients with an accessory pathway. B: conduction properties of accessory 
pathways. Conduction properties of two pathways were unknown. C: locations of accessory 
pathways; most pathways were right-sided (70%).
* Dimple of atretic tricuspid valve. † Midposterior in common atrium. BiV: biventricular.
Acquired substrates
Macroreentrant atrial tachycardia
Fifty-nine MATs (CL 250ms (170-460)) were identified in 56 patients (24%). MATs occurred 
after double switch surgery (63%), Fontan palliation (46%), biventricular repair (32%), 
palliative shunt or pulmonary artery banding (‘other’) (7%) and no previous surgery 
(2%).
Most circuits (n=46) were CTI (n=38) or cavomitral isthmus (CMI, n=6) dependent, or 
circled around both AV valves (n=2: 1 Fontan and 1 repaired complete atrioventricular 
septal defect). Two of these circuits were dual loop MAT, using both CTI and scar tissue. 
Ablation of all circuits was successful by blocking the CTI or CMI in the right atrium (RA, 
28), SVA and PVA (13), PVA only (4) or SVA only (1).
The remaining 13 MATs in 11 patients were located in the RA (7), SVA (4) or PVA (2). 
All circuits in the SVA and 6 of 7 in the RA involved scar tissue. Twelve circuits (92%) 
were successfully ablated. Two patients underwent additional empiric CTI ablation.
6




Of 33 focal atrial tachycardias (FATs; CL 335ms, 200-490) identified in 25 patients (11%), 
ablation was successful in 24 (72%), partially successful in 2 (6%) and unsuccessful in 7 
(21%). FATs were located in the RA (18), SVA (7), LA (5) or PVA (3).
Ventricular tachyarrhythmias
Ventricular tachyarrhythmias were observed in 21 patients (9%). Indication for EPS was 
(non-sustained) VT (n=14), premature ventricular contractions (PVC, n=4), pre-surgery 
work-up (n=2) or syncope (n=1).
Eight patients underwent ablation of 10 PVC foci, which was successful in 3 (38%), 
unsuccessful in 1 (13%) and empiric in 4 patients (50%). Ablation was performed in the 
right (9) or left ventricle (1).
Fifteen VTs were induced (CL 290ms, 200-330) in 13 patients (6%), most with 
Ebstein’s anomaly (n=8; 62%). Of 12 targeted VTs, 9 (75%) were successfully eliminated 
in the right (6) or left ventricle (3), 1 was targeted empirically in both ventricles (8%) and 
2 ablations failed (17%). Three non-sustained VTs were not targeted because they did 
not represent the clinical tachycardia.
Undefined supraventricular tachycardia
Underlying mechanisms of 56 SVTs in 39 patients (17%) could not be defined. SVT were 
non-sustained (40), degenerated into atrial fibrillation (7), did not represent the clinical 
arrhythmia (3), led to hemodynamic instability (1) or were incompletely mapped (5).
Ablation of 10 SVT was attempted, of which 3 (30%) were successfully eliminated. 
Empiric ablation was performed in another 15 patients, including CTI/CMI ablation 
(8), CTI ablation with additional lesions in the RA (2), slow pathway modification (4) or 
substrate modification (1).
Procedural outcome
As illustrated in Figure 3A, procedural success was complete in 81% (n=189) and partial 
in 3% (n=7) of patients, whereas ablation failed in 7% (n=16) and was empiric in 9% 
(n=20).
Long-term outcome
Overall, 174 patients (75%) had a median follow-up of 3.6 years (3.1 months-10.7 years) 
and a total of 1276 clinical encounters (mean: 7.3 per patient). Recurrence of arrhythmia 
(75) or ventricular preexcitation (10) was observed in 85 patients (49%; Figure 3B), after 
a double switch procedure (n=5, 100%), Fontan palliation (n=17, 61%), palliative shunt or 
pulmonary artery banding (‘other’; n=6, 46%), biventricular repair (n=35, 44%) or without 
previous cardiac surgery (n=22, 42%; p=0.077). Recurrence was relatively more often 
observed after slow pathway modification (50%) compared to ablation (14%) for AVNRT 
(p=0.091). Arrhythmia recurred less frequently after empiric ablation in symptomatic 
patients than in asymptomatic patients (4/11, 36% vs. 2/3, 67%), although statistical 
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significance was not reached (p=0.538). Median time-to-recurrence was 2.5 months 
(1 day-6.7 years) and overall, 36% occurred within 1 month and 68% within 1 year. 
Arrhythmia recurrence was independently associated with the presence of an acquired 
arrhythmia substrate during EPS (Table 3).
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Figure 3. Outcomes of initial and repeat ablation procedures
A: procedural outcomes after the initial ablation procedure, indicating complete success in 81%. 
B: arrhythmia recurred in 49%; the panel shows recurrence according to procedural outcome. 
C: procedural outcomes after repeat ablation, indicating complete success in 76%. D: arrhythmias 
during repeat procedures compared to those from previous procedures, categorized as acquired 
or congenital substrate. Most novel substrates encountered during repeat procedures were 
acquired substrates (17/20).
‘Multiple’ indicates both recurrences and different substrates. ‘N/A’ indicates that comparison 
between procedures was not possible due to noninducibility or undefined arrhythmias.
Outcomes of ablation in children <15kg
Table 4 summarizes characteristics of the initial ablation procedure in patients weighing 
<15kg (n=44) and >15kg (n=187). In 1 patient, weight could not be retrieved from the 
medical records. Although the complexity of CHD tended to be more severe in patients 
<15kg (55% vs. 36%, p=0.053), the type of underlying substrate (congenital or acquired) 
and rates of complete procedural success, complications and arrhythmia recurrence 
did not differ.
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Table 3. Predictors of arrhythmia recurrence (n=85)
Univariate analysis Multivariate analysis
HR 95% CI p HR 95% CI p
Patient factors
Age 0.991 0.951-1.031 0.644
Male gender 0.891 0.579-1.371 0.599
Weight <15 kg 1.375 0.831-2.273 0.215
Severe CHD 1.433 0.935-2.194 0.098 1.464 0.945-2.268 0.088
Fontan circulation 1.258 0.739-2.142 0.398
Prior ablative therapy 1.095 0.566-2.120 0.788
Procedural factors
3D-EAM 1.446 0.908-2.303 0.121 1.205 0.725-2.004 0.472
Acquired substrate 2.090 1.353-3.228 0.001 2.013 1.243-3.261 0.004
>1 arrhythmia* 1.834 1.184-2.842 0.007 1.477 0.931-2.341 0.097
≥1 undefined SVT 1.282 0.744-2.210 0.371
Irrigated-tip RF 1.363 0.849-2.187 0.200 0.774 0.450-1.333 0.356
Procedural success§ 0.690 0.418-1.140 0.147 0.611 0.359-1.041 0.070
* >1 arrhythmia mechanism. § Complete success.
CHD: congenital heart disease, CI: confidence interval, EAM: electroanatomic mapping, HR: hazard 
ratio, p: p-value, RF: radiofrequency, SVT: supraventricular tachycardia.
Repeat ablation and mechanisms of recurrences
Forty-six patients (26%) underwent 51 repeat procedures. Indications included 
documented arrhythmia recurrence in 43 patients, arrhythmia-related symptoms 
without documented arrhythmia in 2 and pre-surgery work-up in 1. Complete 
procedural success was achieved in the majority of repeat procedures (76%; Figure 
3C ). As illustrated in Figure 3D, different arrhythmias were encountered in 20 repeat 
procedures, including 17 ‘new’ acquired substrates, mostly FATs. Recurrences were 
found in 18 repeat procedures, including 9 accessory pathways and 2 AVNRT. Three 
patients had both recurrences and novel substrates. After the last repeat procedure, 
arrhythmia recurrence was observed in 15/28 patients (54%) with a completely or 
partially successful procedure and >3 months follow-up.
Clinical arrhythmia severity score
Two patients were excluded because of in-hospital death unrelated to the ablation 
procedure. Median arrhythmia score before the initial ablation procedure was 4 (0-10) 
(Figure 4). Arrhythmia scores significantly decreased compared to baseline in both 
groups (p<0.001) and remained low during follow-up over 48 months.
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Table 4. Procedural characteristics according to weight <15kg (n=44) and >15kg (n=187)
Weight <15kg* Weight >15kg p-value
Complexity of CHD 0.053
    Simple 6 (14) 25 (13)
    Moderate 14 (32) 95 (51)
    Severe 24 (55) 67 (36)
Procedural time (min) 227 (157-534) 264 (120-608) 0.018
Fluoroscopy time (min) 27 (0.6-70) 22 (0.2-115) 0.053
Congenital substrate 22 (50) 97 (52) 0.823
Acquired substrate 19 (43) 79 (42) 0.910
>1 arrhythmia mechanism 7 (16) 54 (29) 0.079
Complete procedural success 38 (86) 151 (81) 0.385
Procedural complications 9 (22) 31 (19) 0.610
Arrhythmia recurrence 20 (59) 65 (46) 0.195
Values are presented as n (%) or median (range).
* Including the 18 patients aged <18 months. 43/44 patients (98%) underwent ablation at Boston 
Children’s Hospital, and 1/44 (2%) at Erasmus Medical Center.
CHD: congenital heart disease.
Complications and mortality
Forty-eight adverse events were encountered in 47 of 254 procedures for which 
sufficient information was available (18.5%) and were classified as major (n=4, 1.6%), 
moderate (n=2, 0.8%), minor (n=18, 7.1%) or trivial (n=24, 9.4%). A detailed list of all 
adverse events is provided in Supplemental Table 2. Overall complication rate was 
comparable between patients < and >18 months of age (26% vs. 18%, p=0.361) and 
patients < and >15kg (21% vs. 18%, p=0.581).
Fourteen patients (6%) died, with a median time to death of 26 months after the last 
procedure (23 days-52 months), during a total of 736 patient years (1.9%/patient-year). 
Supplemental Table 3 summarizes causes of death. None of the deaths were directly 
related to the EPS or ablation. One patient underwent cardiac transplantation for a 
failing Fontan circulation 9 years after ablation.
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Figure 4. Clinical arrhythmia severity score at baseline and during follow-up in patients with and 
without arrhythmia recurrence
In both groups, arrhythmia scores decreased significantly compared to baseline and remained 
low during follow-up over 48 months. *p<0.001 compared to score at baseline.
VolledigbinnenwerkCharlotte.indd   118 18/11/2020   16:08:49
119
Catheter ablation in pediatric congenital heart disease
DISCUSSION
Main findings
This study describes arrhythmia mechanisms and reports procedural and long-term 
outcomes after catheter ablation in the largest pediatric cohort analyzed in recent 
era.12-14,20 The main findings are as follows:
1. These patients demonstrated a broad spectrum of arrhythmia mechanisms. 
Although congenital substrates – predominantly accessory pathways – 
outnumbered acquired substrates, MAT was the second most common arrhythmia 
observed, followed by FAT.
2. Complete or partial procedural success was achieved in the majority of cases 
(84%), although arrhythmia recurrences were observed in 49% of patients during 
median follow-up of 3.6 years.
3. Arrhythmia recurrence was independently associated with the presence of an 
acquired arrhythmia substrate during EPS.
4. The arrhythmia burden as defined by a clinical arrhythmia severity score was 
persistently low during long-term follow-up, even in patients with arrhythmia 
recurrence, suggesting catheter ablation provides long-term benefit despite 
arrhythmia recurrence.
Congenital substrates
The high prevalence of AVRT seen in the structurally normal heart is mirrored in CHD 
patients, and although proportionally less due to the presence of other arrhythmia 
mechanisms, AVRT was the most common mechanism in this experience.13,14,20 Several 
CHD types are associated with the presence of accessory pathways, predominantly 
Ebstein’s anomaly and L-looped ventricles.1 CHD patients more often have multiple 
pathways, which may negatively impact procedural outcome and/or recurrence rate.13,21 
In the present study, 13% of patients had multiple pathways, which is somewhat lower 
than reported in other cohorts with structural heart disease (20-29%).10,21,22 Acute and 
long-term outcomes after ablation were not significantly different between patients 
with single or multiple pathways.
Given the potential for hemodynamically intolerant AVRT in the perioperative period 
and the increased risk of rapid anterograde conduction of atrial tachyarrhythmia (AT) 
via accessory pathways in CHD patients, we have adopted an aggressive approach to 
early elimination of these pathways.12,22 Procedural success for ablation of accessory 
pathways (94%) in our study was comparable to that of studies in pediatric patients 
with and without CHD (88-96%), as was the higher success rate of ablation of left-
sided pathways.13,14,20,23 Four of 32 patients with Ebstein’s anomaly in our study had 
unsuccessful ablation of one or more accessory pathways, resulting in a procedural 
success rate (88%) similar to that reported in older ablation studies in patients with 
Ebstein’s anomaly (81-87%).10,22
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The incidence of atypical AVNRT (fast-slow or slow-slow) in our study (21%) is in line 
with previous studies in pediatric and adult CHD patients.24,25 The presence of atypical 
AVNRT has been associated with procedural failure both in patients with and without 
CHD.24,26 The only procedural failure in our study was in a Fontan patient with both typical 
and atypical AVNRT. The abnormal anatomy in CHD may lead to challenges in ablation of 
AVNRT due to an abnormal location of the AV node (e.g. complete atrioventricular septal 
defect) and difficult access to the slow pathway (e.g. baffle).24,25 Our overall procedural 
success rate (97%) is comparable to previously reported rates in pediatric patients with 
structurally normal hearts or CHD (96-100%)13,14,20,23, but somewhat higher than in mixed 
pediatric/adult patients with more complex CHD (82-92%)24,25, although success rate 
in our subgroup of patients with CHD of severe complexity was 91% (10/11). Several 
factors may contribute to favorable outcomes of AVNRT ablation in CHD patients, which 
include the use of 3D-electroanatomic mapping, careful patient selection (benefits vs. 
risk of AV block), and operator experience, particularly in cases with complex native or 
post-surgical anatomy.7,18,25,27
Acquired substrates
The incidence of MAT in CHD patients increases with advancing age as a result of 
progressive atrial remodeling, believed to be an ongoing process in the face of chronic 
abnormal hemodynamic loading. As seen in this series and numerous studies of older 
patients, the most prevalent mechanism of MAT is peri-tricuspid reentry via the CTI (or 
CMI in L-looped transposition). Patients after extensive atrial surgery develop CTI/CMI 
dependent MAT more often and at a younger age compared to patients after simpler 
or no cardiac surgery.1,28 In line with these observations, MAT in our study was more 
common after Fontan palliation or double switch operation, which is potentially due 
to surgically constructed obstacles providing the posterior site of conduction block 
within the right atrium. Perhaps earlier or more severe atrial remodeling also occurs 
in these patients, as a result of prior surgery and/or the underlying heart defect. Our 
procedural success rates of ablation of CTI/CMI dependent MAT (100%) and non-CTI/
CMI dependent MAT (92%) are in line with those reported in recently published studies 
in adult patients with CHD (97% and 92%).3,5
Comparable to AT, mechanisms for development of ventricular tachyarrhythmias 
in CHD patients include surgically induced fixed obstacles to conduction such as 
ventriculotomy or patches, and chamber dilatation resulting from chronic volume and 
pressure loading.1,9,12 Although tetralogy of Fallot is notorious for its association with 
ventricular tachyarrhythmias, most patients with VT in our study had Ebstein’s anomaly. 
Reports on the outcomes of VT ablation in CHD patients are limited, particularly in 
pediatric CHD patients. We achieved complete procedural success in 75% of targeted 
VTs, which is in line with reported procedural success rates in mixed pediatric/adult 
(83%) or adult CHD studies (81%).29,30
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Outcomes of ablation
Although procedural success was high, arrhythmia recurrence was observed in nearly 
half of patients, which despite differences in underlying substrates is comparable to 
reported outcomes after ablation in adult CHD patients, as is the emergence of novel 
mechanisms after an initially successful procedure.2,4,8 This suggests that progressive 
atrial remodeling starts at a young age, although it remains unclear whether this earlier 
presentation and arrhythmia recurrence is an expression of more severe myocardial 
disease as surgical techniques and perioperative survival continue to improve. This 
ongoing process of atrial remodeling may explain the predominance of FATs presenting 
as ‘new’ substrates during repeat procedures in our study, as FATs are thought to 
originate from sites with poor cell-to-cell coupling, as is the case in scar tissue.31,32
However, in concordance with previous studies, our study demonstrates clinical 
improvement did not solely depend on freedom from arrhythmia. The arrhythmia 
burden also depends on severity of symptoms and need for therapy.2,18 For instance, 
recurring palpitations without documented arrhythmia or chronic use of anti-
arrhythmic drugs could be considered to constitute a higher burden compared to a 
one-time occurrence of asymptomatic, non-sustained SVT, although the latter would 
be classified as recurrence and thus ‘failure’ of ablation. Our findings and those from 
previous ablation studies highlight the importance of taking into account the clinical 
picture rather than arrhythmia elimination only when evaluating clinical improvement 
after ablation.2,18
Complications and mortality
Complications were observed in 18.5% of cases. When excluding trivial complications, 
the complication rate was 9.4%, which is similar to previously reported rates after 
ablation in children with or without CHD.10,12,13,17,20 Of this 9.4%, only 4 (1.6%) were major 
adverse events.
Although our population included patients with complex native and postoperative 
anatomy often with abnormal course of the intrinsic conduction system, there were 
no cases of permanent AV block. To avoid potential injury to the conduction system or 
coronary arteries, cryoablation was used in 26 cases. Only one patient experienced 
‘prolonged transient’ complete AV block secondary to catheter manipulation. Despite 
adequate periprocedural anticoagulation, two thromboembolic complications occurred 
(0.8%), which is in line with previously reported rates in adult patients after catheter 
ablation.33 Although reported risk of serious injury to the cardiac valves is low, the mitral 
valve was damaged during ablation of a left lateral accessory pathway in an 11-day old 
neonate.34 Although such complications likely relate to patient size (2.7kg in this case), 
overall complication rate in experienced centers is not higher in children <18 months 
of age compared to older and larger patients.13
Mortality in our study population (6%) was comparable to a mixed pediatric/adult 
CHD population, but higher than mortality rates from the Pediatric Radiofrequency 
Ablation Registry (0.12%-0.89%).18,35 Interestingly, deaths in the Registry occurred 
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markedly earlier after catheter ablation (median 8 days, <1 day-105 days), compared 
to our study (median 26 months, 23 days-52 months). Procedures in the Registry were 
performed years before procedures in our study (1991-1996 versus 2007-2018). The 
shift from early to predominantly late mortality may be caused by increased knowledge 
and experience in EPS and ablation in this population and ongoing improvements 
in periprocedural care over the past decades. Late mortality in our study likely also 
reflects natural history in these patients and highlights the vulnerable well-being of CHD 
patients. As life expectancy of CHD patients is increasing, this population faces new 
issues with advancing age, which include ventricular dysfunction, recurrent arrhythmias 
and risk of sudden death.1
Study limitations
Since data for this study was acquired retrospectively without a predetermined study 
protocol, frequency and documentation of follow-up encounters differed between 
patients. Maneuvers during EPS were performed at the operator’s discretion. There 
is a possibility of referral bias towards patients with more complex CHD. However, 
patients with more complex CHD tend to present with arrhythmias more often and at 
a younger age than patients with simpler CHD types, which could also explain the high 
proportion of moderate and complex CHD types in this cohort. Given the structure 
of the arrhythmia score, recurrence by definition resulted in ≥1 point increase of the 
score. However, rather than comparing patients with and without recurrences, the 
score was used to illustrate the course of the arrhythmia burden during follow-up in 
both groups separately.
CONCLUSIONS
Pediatric CHD patients presenting for ablation demonstrated a broad spectrum of 
arrhythmia mechanisms, that were both typical for their age (congenital substrates) 
and also related to their underlying heart disease (acquired substrates). Our findings 
showed that ablation of these arrhythmias can be performed safely and successfully. 
However, arrhythmia “recurrence” occurred in nearly half of patients, often with 
a different mechanism from that previously observed, suggesting that progressive 
myocardial remodeling is already present at a young age in CHD patients. Nonetheless, 
the arrhythmia burden following catheter ablation was persistently low during long-
term follow-up, supporting the use of this treatment as a valid mechanism to improve 
clinical symptoms and quality of life.
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SUPPLEMENTAL MATERIAL
Supplemental Table 1. Clinical Arrhythmia Severity Score
Category Score Category Score
Documented arrhythmia Cardioversion
None 0 None 0
Nonsustained 1 One cardioversion 1
Sustained 2 AAIT cardioversion 1
Incessant 3 ≥2 cardioversions 3
Arrhythmia severity Antiarrhythmic medications
Asymptomatic 0 None or digoxin only 0
Palpitations* 1 Class II or Class IV 1
Syncope/CHF/thrombosis 2 Class I or Class III 2
Cardiac arrest 3 Amiodarone toxicity 3
* In infants and younger children not able to indicate the presence of palpitations, alternative 
arrhythmia-related symptoms may include: vomiting, abdominal pain, sweating, pallor, chest 
discomfort. AAIT cardioversion is defined as automatic or manual cardioversion using an 
implanted atrial pacemaker and not requiring any additional intervention. CHF: congestive heart 
failure.
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Background: The improved life expectancy of patients with congenital heart disease 
(CHD) is often accompanied by the development of atrial tachyarrhythmias. Similarly, 
the number of patients requiring redo operations, either for their primary defect or for 
acquired heart disease, is expected to continue to rise as these patients are aging. As 
a result, the role of arrhythmia surgery in the treatment of atrial arrhythmias is likely 
to become more important in this population. Although atrial arrhythmia surgery is 
a well-established part of Fontan conversion procedures, concrete evidence-based 
recommendations for arrhythmia surgery in other CHD patients are still lacking. 
Therefore, this systematic review aimed to summarize outcomes of arrhythmia surgery 
for macroreentrant atrial tachycardia (MRAT) and atrial fibrillation (AF) in patients with 
CHD undergoing cardiac surgery other than Fontan conversion.
Methods and Results: A comprehensive literature review resulted in 28 studies 
meeting the inclusion criteria, which were published over a time span of 25 years. 
Overall, the median reported arrhythmia recurrence was 13% (interquartile range: 
4%-26%) during follow-up ranging from 3 months to 15.2 years. A large variation in 
surgical techniques was observed. Based on the acquired data, biatrial lesions are 
more effective in the treatment of AF than exclusive right-sided lesions. Right-sided 
lesions may be more appropriate in the treatment of MRAT; evidence for the superiority 
of additional left-sided lesions is lacking. There is not enough data to support the use 
of exclusive left-sided lesions in patients with CHD. Theoretically, prophylactic atrial 
arrhythmia surgery may be beneficial in this population, but evidence is currently 
limited.
Conclusions: In order to be able to provide specific recommendations for arrhythmia 
surgery in CHD patients, future studies should report outcomes according to the type 
of preoperative arrhythmia, underlying CHD, lesion set and energy source. This is 
essential for determining which surgical techniques should ideally be applied under 
which circumstances.
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INTRODUCTION
Congenital heart disease (CHD) is the most common cause of congenital anomalies, with 
an estimated prevalence of 9 per 1000 live births and 4 per 1000 adults.1,2 Although 
surgical correction or palliation is often performed in childhood, a considerable 
number of patients (20%) require primary or redo surgery in adulthood.3,4 As a result 
of improved life expectancy in these patients, the number of redo operations is 
expected to continue to rise. Patients may not only require redo operations for their 
primary defect, but also for acquired coronary or valvular heart disease.5,6 Moreover, 
the improved life expectancy in CHD patients is often accompanied by the development 
of atrial tachyarrhythmias (ATA), including macroreentrant atrial tachycardia (MRAT) and 
atrial fibrillation (AF).7,8 ATA in this population occur at a relatively young age and show 
rapid progression, resulting in impaired quality of life, morbidity and mortality.8-10
Therefore, the role of arrhythmia surgery in the treatment of atrial arrhythmias may 
become more important in this specific population. For patients undergoing Fontan 
conversion, class I recommendations were provided by the 2014 PACES/HRS guidelines 
in favour of performing concomitant atrial arrhythmia surgery, which is supported 
by a large body of evidence.11 However, regarding atrial arrhythmia surgery in other 
CHD patients, recommendations provided by multiple guidelines are either largely 
extrapolated from studies on patients without CHD11, patients undergoing Fontan 
conversion12, or they are based on only a small number of published studies in this 
population.12,13 In addition, the Society of Thoracic Surgeons 2017 guidelines for surgical 
treatment of AF do not yet provide specific recommendations for CHD patients at 
all.14
Therefore, this systematic review aimed to evaluate and summarize outcomes of 
atrial arrhythmia surgery for MRAT and AF in patients with CHD undergoing cardiac 
surgery other than Fontan conversion.
METHODS
The systematic review was performed in accordance with the PRISMA (Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.15 The data that 
support the findings of this study are available from the corresponding author upon 
reasonable request.
Search strategy and selection criteria
We searched Embase, MEDLINE, Web-of-Science Core Collection, Cochrane Library 
and Google Scholar for relevant articles using terms associated with congenital heart 
disease and atrial arrhythmia surgery up to November 20, 2019, with no start date 
restriction. The complete search strategy is provided in the Supplemental Material. 
7
VolledigbinnenwerkCharlotte.indd   131 18/11/2020   16:08:51
132
Chapter 7
Additionally, we manually searched reference lists of identified articles and relevant 
reviews.
Eligibility assessment of identified articles was performed independently by two 
reviewers (CH, EM); disagreements were resolved by consensus. Studies were first 
screened based on title and abstract. If potentially relevant, the full text was assessed. 
Studies were included if they reported outcomes of arrhythmia surgery for AF or 
MRAT in patients with CHD undergoing surgery other than Fontan conversion. Studies 
were excluded if they only reported outcomes of arrhythmia surgery for focal atrial 
tachycardia, accessory pathways or atrioventricular nodal reentry tachycardia; if 
duration of follow-up was <3 months; or if >25% of the study population consisted of 
patients undergoing Fontan conversion surgery. We excluded review articles, book 
chapters, conference abstracts, editorials, case reports and studies written in languages 
other than English. If double reporting of the same patient populations was suspected, 
the most recent publication was included. Both publications were included if it was 
possible to exclude duplicate data from one of the publications, or if both publications 
also included a substantial amount of unique data.
Data extraction and data appraisal
Data extraction was performed by one reviewer (CH) into a predetermined template 
and the extracted data was subsequently checked for accuracy by the second reviewer 
(EM). Disagreements were resolved by discussion and where necessary, a third reviewer 
with expertise in the field (AB) was consulted.
Available data on study characteristics (study period, study design), patient 
characteristics (age, sex, CHD type, preoperative arrhythmias), procedural characteristics 
(location of lesions, energy source) and follow-up (duration, arrhythmia recurrence, 
new-onset ATA, permanent pacemaker implantation) were collected. The number of 
arrhythmia recurrences was derived from Kaplan-Meier curves, where possible, if it was 
not explicitly described. If a distinction was made between early (generally <3 months) 
and late recurrences, the number of late recurrences was selected.
Quality assessment of the included articles was performed using the Newcastle-
Ottawa Scale (nonrandomized studies) or the Cochrane Risk of Bias 2 tool (randomized 
controlled trials).16,17 The Newcastle Ottawa Scale assesses risk of bias and ranges 
from 0 points (high risk) to 9 points (low risk). The following items were assessed: 1) 
representativeness of the exposed cohort (1 point), 2) selection of the non-exposed 
cohort (1 point), 3) ascertainment of exposure (i.e. arrhythmia surgery) (1 point), 4) 
demonstration that the outcome of interest was not present at the start of the study 
(1 point), 5) comparability of cohorts on the basis of the design or analysis (2 points), 
6) assessment of outcome (1 point), 7) follow-up being long enough (i.e. mean/median 
>6 months) for outcomes to occur (1 point), and 8) adequacy of follow-up of cohorts (1 
point). The Risk of Bias 2 tool assesses risk of bias in 5 domains: randomization process, 
deviations from the intended intervention, missing outcome data, measurement of the 
outcome, and selection of the reported result.
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Data analysis
Outcomes of arrhythmia surgery were presented for relevant subcategories (type 
of arrhythmia surgery or CHD). When calculating the proportion of patients with a 
recurrence, the preferred denominator was the number of patients that had long-term 
follow-up available (excluding early deaths and those lost to follow-up); otherwise, the 
number of patients at the start of the study was used. The 95% confidence interval 
was calculated using the normal approximation method; when conditions were not 
appropriate for approximation of the binomial distribution by the normal distribution, 
a Clopper-Pearson interval was calculated.18 Pronounced heterogeneity within and 
between studies (e.g. large variation in follow-up duration) precluded meaningful meta-
analyses, even after dividing the studies into relevant subcategories.19 In order to provide 
an overall indication of the outcomes of the studies anyhow, the median (interquartile 
range (IQR)) was provided for the following parameters: duration of inclusion period, 
quality score, and the number of arrhythmia recurrences or permanent pacemaker 
implantations.
RESULTS
As illustrated in Figure 1, our initial search identified 2175 records after removal of 
duplicates and addition of 1 article identified by searching reference lists. After exclusion 
of records based on screening of title and abstract, 132 full-text articles were assessed 
for eligibility, resulting in 28 studies included in this review.
A summary of the included studies is provided in Table 1. Of the included studies, 
27 were cohort studies and 1 was a randomized controlled trial. First of all, quality 
of the included studies as assessed by the Newcastle-Ottawa Scale was relatively 
good. As we only included data from patients (cases) and not from controls (where 
applicable), items (2) and (5) of the scale were not assessed, resulting in a maximum 
score of 6 points. The median score was 5 (IQR 5-6). Most scores <6 were due to the 
lack of information with regard to follow-up duration or loss to follow-up if the study 
population of interest was a subset of a larger group of patients.20-28 In some cases, 
follow-up was short29, loss to follow-up was relatively high30, or the authors did not 
provide specific information regarding patient acquisition31 or the objective assessment 
of rhythm outcomes.25,32,33 The randomized controlled trial was judged to be at low risk 
for bias in all five domains.
Year of publication ranged from 1994 to 2019 (median 2010) and patients were 
included over a median span of 10 years (IQR 4-17). Overall, the reported number of ATA 
recurrences during variable follow-up periods ranged between 0% and 78% (median 
13%, IQR 4%-26%; Table 1). Potentially duplicate data was presented in four studies22,34-36; 
the decision to include these studies was based on the presence of a significant amount 
of unique data in each study according to the inclusion period and inclusion criteria.
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Additional records identified 
through other sources
N=1














- Outcomes CHD patients unavailable, n=34
- Surgery outcomes unavailable, n=23
- No arrhythmia surgery or no CHD, n=16
- No follow-up available, n=13
- Double reporting of same populations, n=9
- Fontan conversion, n=5






















Figure 1. The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 
flow-chart of the study selection
CHD: congenital heart disease.
Types of arrhythmia surgery
Most studies provided a comprehensive description of their methods for arrhythmia 
surgery (n=18, 64%)20,24-26,29-33,36-44, which was accompanied by a detailed figure of lesion 
sets and/or references in 14 studies.24-26,29-32,36-38,40,42-44 Six studies described their 
method only by referring to a previously published study providing a comprehensive 
description22,23,27,28,35,45, and in four studies, the method applied was referred to only 
by name.21,34,46,47 The studies demonstrated a large variation in methods used for 
arrhythmia surgery, including the locations of lesions within the atria and the use of 
different energy sources. Not only did these methods vary between studies, but also 
between patients within studies.
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Biatrial arrhythmia surgery, consisting of lesions in both the right and left atrium, was 
performed in 19 studies (68%) (Table 1), including 10 studies in which biatrial lesions 
were applied in >20 patients. Lesions were generally applied according to the Cox 
maze III/IV lesion set, sometimes with modifications.48,49 Four studies only performed 
isolation of the pulmonary veins instead of the full left atrial lesion set in a subset of 
patients. Specific outcomes for these variations were only provided in the study of 
Sakamoto et al., who showed similar outcomes for the full left atrial lesion set versus 
exclusive isolation of the pulmonary veins in the context of biatrial arrhythmia surgery 
(p=0.70).34,37,46,47 In most studies (n=16), biatrial arrhythmia surgery was performed 
in patients with AF; the three other studies did not specify the type of preoperative 
arrhythmia.34,45,46
Fourteen of the 19 studies provided separate outcomes of biatrial arrhythmia 
surgery, which are summarized in the upper panel of Figure 2. The number of arrhythmia 
recurrences reported in these studies varied between 0% and 78% (median 13%, IQR 
0%-27%), during follow-up ranging from 0.4 to 7.4 years. Even though sample sizes of 
studies published from 2013 onwards were larger than those of earlier studies, 95% 
confidence intervals were still relatively wide, spanning a range of ≈20%. When only 
taking into account the 8 studies with sample size >20, the median reported amount 
of arrhythmia recurrences was 20% (IQR 11%-39%) during follow-up ranging from 1 to 
7.4 years.
Interestingly, one study reported outcomes of biatrial arrhythmia surgery according 
to type of preoperative AF and found no difference in the number of recurrences 
between patients with paroxysmal AF and those with non-paroxysmal AF (45% vs. 
44%; p-values not provided).37 Also, the presence of CHD did not appear to influence 
the results of biatrial arrhythmia surgery in the study of Engelsgaard et al. In their 
study, they reported outcomes of the Cox maze IV procedure for AF in 144 patients, 
including 41 CHD patients, during a median follow-up of 7.4 years (IQR 2.7).20 Despite 
their strict definition of recurrent arrhythmias (>3 months after the procedure, lasting 
≥30 seconds, documented on ECG, Holter monitoring, or device interrogations), a 
relatively high number of recurrences was observed in both non-CHD patients (79%) 
and CHD patients (78%; p-value not provided).
Right-sided arrhythmia surgery
Exclusive right-sided arrhythmia surgery was performed in 19 studies (68%) (Table 1). 
In the majority of these studies (n=11), lesions were generally applied according to 
the right-sided maze procedure21,22,28,30,34,35,38,40,42,45,46, which is a modification of the 
traditional Cox maze III procedure. This modification was proposed and published 
in 1998 and was specifically intended for patients with CHD affecting the right side 
of the heart.50 Several older studies used the right atrial compartment or isolation 
technique, which generally consisted of a single incision parallel to the sulcus terminalis, 
extending posteriorly and anteriorly towards the tricuspid valve annulus, including 
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cryolesions between the incision and the tricuspid valve.25,31,33 Solely cryoablation of 
the cavotricuspid isthmus was performed in three studies.23,25,36 The indication for right-
sided arrhythmia surgery was AF (n=621,22,31,33,40,42), MRAT (n=128) or both (n=923,25,30,34-
36,38,45,46). Three studies performed prophylactic right-sided arrhythmia surgery.29,43,44
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0 20 40 60 80 100
0 20 40 60 80 100
Overall median (IQR)
Overall median (IQR)
Figure 2. Outcomes of biatrial and right-sided arrhythmia surgery
Forest plot of the proportions of patients with arrhythmia recurrence and corresponding 95% 
confidence intervals. The overall median and interquartile range of proportions are displayed in 
red. AF/MRAT indicates that both arrhythmias were regarded as indication: outcomes of arrhythmia 
surgery were not further specified according to the type of preoperative arrhythmia.
a Outcome measure: recurrence of preoperative arrhythmia or other atrial tachyarrhythmias 
(not specified).
b Outcome measure: recurrence or on anti-arrhythmic drugs.
c Partially duplicate data but studies also contain a significant amount of unique data.
d Including n=22 patients with exclusive isthmus ablation; outcomes not specified.
e Including n=9 patients with exclusive isthmus ablation; outcomes specified in text.
f Right atrial compartment or isolation techniques applied.
g Number of patients at start study.
h Separate outcomes only available in sub-analysis at 1 year follow-up.
i Follow-up not specified for subgroup.
7
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Twelve of the 19 studies provided separate results of right-sided arrhythmia surgery 
in patients with AF or MRAT (lower panel Figure 2). The proportion of arrhythmia 
recurrences was below 30% in most studies (median 19%, IQR 7%-29%) during follow-
up ranging from 1 to 13.2 years. Studies performed before 2004 had smaller sample 
sizes resulting in more imprecise estimates of true arrhythmia recurrence. The two 
studies reporting the highest proportion of arrhythmia recurrence (50% and 100%) 
had only small study populations (respectively n=231 and n=342).
Separate outcomes of the right-sided maze procedure versus exclusive cyroablation 
of the isthmus were provided in the study of Khositseth et al. In patients undergoing 
surgery for Ebstein’s anomaly, they found no significant difference in the recurrence rate 
between the two procedures (10/35 (29%) vs. 1/9 (11%), p=0.50), although the type of 
preoperative arrhythmia (AF or MRAT) was not specified.36 Outcomes of the right-sided 
maze procedure according to the type of preoperative arrhythmia were reported in the 
study of Stulak et al. (2006): though not statistically significant, arrhythmias appeared 
to recur more often when the indication was AF (6/62 (10%)) rather than MRAT (0/21 
(0%), p-value not provided) and when the indication was non-paroxysmal AF (3/11 (27%)) 
rather than paroxysmal AF (3/51 (6%), p=0.15).35
Biatrial versus right-sided arrhythmia surgery
Three studies performed both biatrial and right-sided arrhythmia surgery for similar 
indications in their study population and reported separate outcomes for each 
procedure.34,40,42 When comparing biatrial and exclusive right-sided lesions for the 
treatment of AF in patients with an atrial septal defect (ASD), two studies showed 
that exclusive right-sided lesions appeared to be less effective than biatrial lesions 
(recurrence right vs. biatrial: 7/23 (30%) vs. 3/33 (9%)40 and 3/3 (100%) vs. 0/23 (0%)).42 In 
addition, exclusive right-sided lesions appeared to be less effective than biatrial lesions 
in the treatment of non-paroxysmal AF/MRAT (recurrence right vs. biatrial: 7/19 (37%) 
vs. 3/29 (10%)40 and 29% vs. 14% (p=0.053)34, whereas the number of recurrences in 
patients with paroxysmal AF/MRAT was fairly similar for both lesion sets (recurrence 
right vs. biatrial: 0/4 (0%) vs. 0/4 (0%)40 and 12% vs. 23% (p=0.08)34. In line with these 
observations, authors of several studies explicitly state that their current policy – which 
is in contrast to that during the study period in some cases – is to perform biatrial 
arrhythmia surgery in patients with AF (regardless of duration) or longstanding ATA, 
also in patients with predominantly right-sided CHD.34,38,40,47
Left-sided arrhythmia surgery
Only 5 studies (18%) performed exclusive left-sided arrhythmia surgery in a relatively 
small subset of their study populations (median 5%, IQR 4%-40%; Table 1). None of 
these studies provided solid indications for performing exclusively left-sided rather 
than biatrial arrhythmia surgery and none provided separate results on the outcomes 
of exclusively left-sided arrhythmia surgery. Two studies performed isolated PVI in 
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only a small subset of patients (2/1047 and 5/6646), but they did not report outcomes 
in these patients.
Energy sources
The original Cox maze III procedure consists of a set of atrial incisions (also called ‘the 
cut-and-sew technique’) which makes it a technically complex and long procedure, 
with a relatively high incidence of postoperative bleeding.48,49,51 Over the years, various 
alternative energy sources have been used in an attempt to simplify the technique, 
which also applies to the studies included in this review. Most studies published up 
until 2007 (9 of 12) used a combination of incisions and cryolesions.23,25-27,31-33,35,42 The 
other 3 studies only used cryoablation.24,29,36 The first study included in this review to 
report the use of radiofrequency energy is that of Lai et al. in 2008.41 Nine of the 15 
studies published thereafter used radiofrequency energy.20-22,34,37-39,46,47 None of the 
studies compared outcomes of different types of energy sources.
Prophylactic arrhythmia surgery
As shown in Table 2, four studies described outcomes of prophylactic arrhythmia 
surgery in CHD patients undergoing surgery other than Fontan conversion.29,30,43,44 
One study only provided the general location of the lesions (right-sided or biatrial), 
whereas the other three applied a standardized lesion or lesion set, which included a 
lesion between the right atriotomy and the right atrioventricular valve annulus in all. The 
randomized controlled trial of Atallah et al. was not able to detect differences in terms 
of efficacy or safety between the intervention and control group, although sample size 
was small, and follow-up may not have been long enough to detect late occurrence of 
MRAT. Prophylactic arrhythmia surgery in the study of Lim et al. included two additional 
lesions and modifications of suture lines; 4 cases of spontaneous (1) and inducible 
non-sustained MRAT (3) were observed during long-term follow-up. 29,44Interestingly, 
the four cases of atrial flutter (either spontaneous or induced) in the study of Lukac et 
al. occurred in the four patients in whom bidirectional block was not obtained due to 
incomplete cryolesions, thereby creating an isthmus between the atriotomy scar and 
the tricuspid annulus and facilitating the development of reentry tachycardias. This led 
the authors to conclude that, although effective when bidirectional block is achieved, 
this prophylactic lesion may be proarrhythmogenic in the absence of bidirectional 
block.
Anti-arrhythmic drugs
Table 3 provides an overview of available data on perioperative use of anti-arrhythmic 
drugs (AAD). Twelve studies (39%) provided information on their policy regarding 
postoperative AAD use. These policies were more or less in accordance with the 2017 
guidelines for surgical treatment of AF, which advise the use of a class III AAD, e.g. 
amiodarone, for at least 2-3 months after surgery until stable sinus rhythm is achieved.14 
However, several studies only prescribed AAD in case of early postoperative AF. Thirteen 
7
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studies (46%) specified the number of patients using perioperative AAD, which varied 
considerably: preoperative AAD use ranged from 35% to 100% and postoperative AAD 
use from 0% to 83%. Two studies reported a substantial decrease in the number of 
patients using AAD after arrhythmia surgery35,38, whereas use of AAD remained stable 
or showed only a minimal decrease in three studies.30,45,46 Data comparing the use of 
AAD in patients with or without arrhythmia recurrence was reported in two studies 
(54% vs 30%, p=0.0445 and 81% vs. 79%, p-value not available46).
Table 2. Prophylactic arrhythmia surgery
Author, year N CHD Lesions Outcome 




Freedom from ATA at 1, 3, 
5 yrs: 97%, 97%, 80%
Lim 2017 27 Initial LT 
Fontan
1) Atrial incision right 
atriotomy – CS 
2) Cryolesion right 
atriotomy – RAVV 
3) Sandwich closure right 
atriotomy 
Spontaneous MRAT: 1/27 
(3.7%) at 12.6 yrs
Inducible non-sustained 
MRAT: 3/19 (11.1%) at 5.2-
11.8 yrs
Atallah 2012 15 Initial LT 
Fontan
Atrial incision right 
atriotomy – RAVV
Spontaneous MRAT: 0/15 
(0%) at 9 yrs
Inducible MRAT: 0/2 (0%) 
at 9 yrs
14 Initial LT 
Fontan
Control group (no 
prophylactic lesion)
Spontaneous MRAT: 0/14 
(0%) at 9.3 yrs
Inducible MRAT: 0/5 (0%) 
at 9.3 yrs




Spontaneous MRAT: 2/17 
(12%) at 3 mo
Inducible MRAT: 2/17 
(12%) at 3 mo 
a Lesion locations and energy sources not further specified. 
ASD: atrial septal defect, ATA: atrial tachyarrhythmias, CS: coronary sinus, LT: lateral tunnel, MRAT: 
macroreentrant atrial tachycardia, N: number of patients, RAVV: right atrioventricular valve.
Outcomes according to type of congenital heart disease
As summarized in Table 1, a considerable number of studies reported outcomes of 
arrhythmia surgery in a cohort of patients with a variety of CHD. CHD-specific outcomes 
were provided in 12 studies for patients with an atrial septal defect (ASD), in 4 studies for 
patients with Ebstein’s anomaly and in 1 study for patients with tetralogy of Fallot.
Atrial septal defect
Most studies (n=8) performed biatrial arrhythmia surgery in patients with an ASD, 
four studies performed right-sided arrhythmia surgery and two did not specify 
outcomes according to the location of lesions (Figure 3). As described before, two 
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studies compared outcomes after biatrial versus right-sided arrhythmia surgery for 
AF in ASD patients, and showed that biatrial lesions were more effective.40,42 Overall, as 
illustrated in Figure 3, the reported proportion of arrhythmia recurrence after biatrial 
arrhythmia surgery (median 5%, IQR 0%-30%, follow-up range: 0.4-7 years) appeared 
to be somewhat smaller than after right-sided arrhythmia surgery (median 40%, IQR 
17%-88%, follow-up range: 2-4.1 years). However, this should be interpreted with great 
caution as 95% confidence intervals of the proportions in a considerable number of 
studies were wide.
Two studies demonstrated the positive effect of concomitant arrhythmia surgery 
on the occurrence of postoperative AF when compared to ASD repair only. In the 
study of Kobayashi et al., 26 patients with a history of AF underwent ASD repair and 
concomitant arrhythmia surgery; AF persisted after surgery in 3 patients (12%). However, 
postoperative AF occurred less often in the 23 patients who regained sinus rhythm 
after arrhythmia surgery (0/23, 0%) than in patients without a history of AF who only 
underwent ASD repair (8/45, 18%).42 In patients with preoperative non-paroxysmal AF, 
Wi et al. showed that the prevalence of postoperative AF was higher in those undergoing 
ASD repair only (14/17, 82%) than in those undergoing concomitant arrhythmia surgery 
(3/12, 25%, p=0.006).21
Table 3. Anti-arrhythmic drugs



































All patients, at least early 
postoperative, AAD class N/A
- -
Lim 2017 - - Class II: 2/27 
Giamberti 2017 All patients, at least 3 months, 
AAD class III (amiodarone) 
AAD class N/A 
51/80
AAD class N/A  
12/75
Stulak 2015 AF, 3 months, AAD Class III - -
Wi 2013 - - Class I/III:
PAF: 0/3 
PeAF: 5/12 without 
recurrence
7










Shim 2013 AF, duration N/A
AAD class III (amiodarone)
- -
Nitta 2013 - - -
Im 2013 AF, AAD class I/III 3 months, 
digoxin >3 months
- -
Gutierrez 2013 - Class I, III: 8/19 
Class II, digoxin: 
16/19
Class I, III: 4/19
Class II, digoxin: 
13/19 
Stulak 2012 - - -
Atallah 2012 - - -
Mavroudis 2008 - - -
Lai 2008 All patients, max. 3 months, AAD 
class III (amiodarone) 
- 0/7
Lukac 2007
- - Class I, III: 0/17
Class II, digoxin: 1/17







Class I: 1/87 





Karamlou 2006 - - -
Ohtsuka 2005 All patients, duration N/A, 
digoxin 
- -
Khositseth 2004 - - RSM: 4/35 AAD 
class N/A
CTI: 1/9 AAD class III 
(amiodarone)
Huang 2000 - - -
Kobayashi 1998 - - -
Kamata 1997 - - -
Vigano 1996 All patients, duration N/A, AAD 
class III (amiodarone) 
- Class III 
(amiodarone): 1/7 
Lin 1996 - Class I, digoxin: 
1/2
0/2
Kosakai 1995 All patients, until stable SR, AAD 
class N/A
- -
Suwalski 1994 All patients, 3 months, AAD 
class II
Class I-IV, digoxin: 
3/3
-
a Outcomes from sub-analysis at 1 year follow-up. 
AAD: anti-arrhythmic drugs, AF: atrial fibrillation, CTI: exclusive cavotricuspid isthmus ablation, 
MRAT: macroreentrant atrial tachycardia. PAF: paroxysmal atrial fibrillation, PeAF: persistent atrial 
fibrillation, RSM: right-sided maze, SR: sinus rhythm.
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Ebstein’s anomaly
As displayed in Table 1, four studies provided separate outcomes of atrial arrhythmia 
surgery in patients with Ebstein’s anomaly, who are particularly at risk of developing ATA 
due to their often severely enlarged right atrium.25,26,34,36 Of note, the two largest studies 
of these four were performed in the same centre and their inclusion period showed 
an overlap of 6 years (1995-2001); hence, duplicate data may be present in these 
studies.34,36 However, both studies also provide unique data for parts of their inclusion 
periods that lasted 5 years (1990-199536) and 11 years (2001-201234) respectively. In the 
initial study, 48 patients underwent right-sided arrhythmia surgery (right-sided maze 
procedure: 38, isthmus ablation: 10), resulting in an overall freedom from recurrent 
ATA of 74.6%±7.1% during a mean follow-up of 2.8 years. In the more recent study, 
86 patients underwent either right-sided (n=62) or biatrial arrhythmia surgery (n=24), 
resulting in an overall freedom from recurrent ATA of 91% during a median follow-up 
of 4.5 years. As described before, biatrial lesions were more effective than right-sided 
lesions in the treatment of non-paroxysmal ATA in these patients. In the two smaller 
studies, either right-sided or biatrial arrhythmia surgery was performed. Both studies 
reported no recurrence of ATA in any of the patients (0/3 at mean follow-up of 13.2 
years25 and 0/1 at mean follow-up of 1.9 years26).













































Suwalski 1994 3 0.4 (0.3-1.2)d0
Biatrial
Unspecified
Im 2013 23c 4.1 (0.4-12.4)7
Kobayashi 1998 3 2.7±1.73
Right-sided
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Overall median (IQR)
Overall median (IQR)
Figure 3. Outcomes of arrhythmia surgery in patients with an atrial septal defect
Forest plot of the proportions of patients with arrhythmia recurrence and corresponding 95% 
confidence intervals. The overall median and interquartile range of proportions are displayed 
in red.
a Outcome measure: recurrence of preoperative arrhythmia or other atrial tachyarrhythmias 
(not specified).
b Right atrial compartment or isolation techniques applied.
c Number of patients at start study.
d Follow-up not specified for subgroup.
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Only one study documented the prevalence of arrhythmias in 249 patients with 
tetralogy of Fallot undergoing reoperation and evaluated the outcomes of arrhythmia 
surgery in a subset of these patients.23 Their results showed great advantage of 
performing arrhythmia surgery in those with documented preoperative arrhythmias. 
ATA were present prior to surgery in 41/249 (16%) patients, and 34 of these patients 
underwent concomitant right-sided arrhythmia surgery (isthmus ablation: 22, right-
sided maze procedure: 12). The 7.5-year survival free of recurrent ATA was 75% in 
patients undergoing arrhythmia surgery, as opposed to 34% of the 7 patients without 
concomitant arrhythmia intervention (p<0.001).
Factors associated with atrial arrhythmia recurrence
As shown in Table 4, several studies analysed the effect of clinical and surgical 
characteristics on the outcomes of atrial arrhythmia surgery. Independent predictors of 
arrhythmia recurrence included older age at the time of surgery30,37,46 and preoperative 
atrial arrhythmia duration ≥3 years.38 One study analysed factors associated with time 
to event (event being the first episode of AF recurrence, new-onset ATA, or permanent 
pacemaker implantation), which was decreased in patients undergoing right-sided maze 
procedure (versus biatrial arrhythmia surgery) and those with significant preoperative 
tricuspid regurgitation.40
Table 4. Factors associated with arrhythmia recurrence
Author, year Variable Outcome HR (95% CI)
Sakamoto 2019 Age at surgery Recurrence 1.067 (1.001-1.137)
p=0.04
Gonzalez Corcia 2019 Age at surgery Recurrence N/A
p=0.0018
Ramdjan & Mouws 2018 Age at surgery Recurrence 1.05 (1.015-1.092)a
p=0.0006
Giamberti 2017 Duration ATA ≥3 years Recurrence 11.95 (2.6-52)
p=0.001
Im 2013 1. Right-sided mazeb
2. Significant TR





b Versus biatrial maze
c Event: recurrence, new-onset ATA, permanent pacemaker implantation
ATA: atrial tachyarrhythmia, CI: confidence interval, HR: hazard ratio, N/A: not available, TR: 
tricuspid regurgitation.
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New-onset atrial tachyarrhythmia after arrhythmia surgery
Three studies reported on the development of new-onset regular ATA after arrhythmia 
surgery, which may arise as a result of incomplete lesions. Two studies reported a 
relatively high prevalence of new-onset regular ATA of respectively 20% and 24% after 
3.8 and 2 years of follow-up in patients who had AF prior to arrhythmia surgery.21,46 
One of these studies even demonstrated that the prevalence of new-onset ATA was 
higher in patients with arrhythmia surgery (20%) than in those without (8%; p-value 
not provided).21 In addition, Lukac et al. investigated the outcome of prophylactic 
cryolesions between the right atriotomy and the tricuspid annulus. In their study, 
new-onset spontaneous or inducible atrial flutter was observed in patients without 
bidirectional block within 3 months after arrhythmia surgery.29 Hence, this study 
supports the hypothesis of incomplete lesions as a potential cause of the development 
of new-onset regular ATA after arrhythmia surgery.
Permanent pacemaker implantation
As displayed in Figure 4, 20 studies (71%) reported the number of patients requiring 
permanent pacemaker implantation, which varied between 0% and 42% (median 9.6%, 
IQR 0%-20%) during follow-up ranging from 0.3 to 15.2 years. When only taking into 
account the 13 studies with sample size >20 patients, the median reported number 
of pacemaker implantations increased to 15% (IQR 3%-28%) during follow-up ranging 
from 1 to 15.2 years.
Only 9 studies provided indications for pacemaker implantation, which was sinus 
node dysfunction (SND) in most cases. In six studies, the number of permanent 
pacemakers implanted included those implanted intra-operatively. Indications for intra-
operative pacemaker implantation were atrioventricular conduction block or sinus node 
dysfunction35,43,45, or implantation as part of the Fontan conversion procedure (<25% of 
the population).30,35,38,45 In three studies, the indications of some or all intra-operative 
pacemaker implantations were not provided (23/2328, 2/2238, unknown proportion of 
3430).
7























































Kobayashi 1998 26 2.7±1.70
Vigano 1996 8 0.3-4.30
Lin 1996 2 1.3, 2.70





























Author, year Follow-up (y) Permanent pacemaker implantation (%)Total (n)Event (n) SNDa (n)
0 20 40 60 80 100
Overall median (IQR)
Figure 4. Permanent pacemaker implantation
Forest plot of the proportions of patients with permanent pacemaker implantation and 
corresponding 95% confidence intervals. The overall median and interquartile range of 
proportions are displayed in red.
a Indication for permanent pacemaker implantation.
b Including intra-operatively implanted pacemakers.
c Indication only provided for the 8 early pacemaker implantations.
d Separate outcomes only available in sub-analysis at 1 year follow-up.
e Follow-up not specified for subgroup.
SND: sinus node dysfunction.
DISCUSSION
Summary of evidence
In this systematic review, we aimed to evaluate the outcomes of arrhythmia surgery 
for MRAT and AF in patients with CHD undergoing cardiac surgery other than Fontan 
conversion. The variation in lesion sets and energy sources used was striking, an 
observation that was appropriately captured by Gonzalez Corcia et al.: “Over time, 
‘maze’ has become synonymous with just about any lesion that is applied to the atria as 
therapy for arrhythmias.”30 Not only did surgical techniques vary between studies, but 
the indications for which specific procedures were performed also differed. Even though 
these significant variations precluded any meaningful meta-analyses, the following 
conclusions can be drawn from the qualitative synthesis of the data.
Based on the available data included in this review, we can conclude that the 
creation of biatrial lesions (rather than exclusive right-sided lesions) is the preferred 
strategy in the surgical treatment of paroxysmal or non-paroxysmal AF in this 
population. More specifically, patients with an ASD and a history of AF (paroxysmal or 
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non-paroxysmal) appear to benefit from concomitant biatrial arrhythmia surgery during 
ASD repair. Although evidence is limited, the right-sided maze procedure is likely the 
most appropriate treatment of MRAT without documented AF, also because there is no 
evidence for superiority of biatrial lesions in this situation. As of yet, there is not enough 
data to support the use of exclusive left-sided lesions in patients with CHD. CHD-specific 
outcomes were not only provided for ASD, but also for Ebstein’s anomaly and tetralogy 
of Fallot, although the amount of data was limited. It may however be reasonable to 
assume that the conclusions stated above also apply to these lesions, as they are 
associated with predominantly right-sided disease and outcomes of arrhythmia surgery 
were not vastly different from those in ASD patients. As none of the studies compared 
outcomes of different energy sources, we cannot provide specific recommendations 
on the type of energy sources to be used for creation of lesions in this population.
Arrhythmia surgery techniques
In 1998, the right-sided maze procedure was proposed for patients with right-sided 
CHD, after several reports had published their experience with exclusive left-sided 
lesions.50 It was assumed that the left atrium was relatively unaffected in patients with 
right-sided CHD. Limiting the creation of lesions to the supposedly affected atrium 
resulted in a significant simplification and shortening of the original procedure, with 
a lower risk of complications.35,50 However, also in 1998, Kobayashi et al. disputed the 
efficacy of exclusive right-sided lesions compared to biatrial lesions in the treatment of 
AF in ASD patients.42 Years later, Im et al. confirmed in a larger cohort of ASD patients 
that exclusive right-sided lesions were less effective in the treatment of AF than biatrial 
lesions.40 These results indicate that the left atrium may contribute at least in part to 
the substrate of AF in these patients, even if their CHD is predominantly right-sided.
In line with these observations, most studies in this review performed biatrial 
arrhythmia surgery for paroxysmal or non-paroxysmal AF. The median reported 
number of arrhythmia recurrences after biatrial arrhythmia surgery was 13% (IQR 0%-
27%) in all studies and 20% (IQR 11%-39%) in studies with sample size >20. The type of 
preoperative AF did not appear to affect late success, although this was only reported 
by one study in this review.37 Extensive variations in follow-up durations and surgical 
techniques limit the ability to comment on the efficacy of this procedure in the CHD 
population relative to that in a general AF population without CHD (7% after 1 year, 
22% after 5 years; no difference between types of AF).52
Although the right-sided maze is not as effective as the biatrial maze for treatment 
of AF, it is likely the most appropriate treatment strategy in patients with MRAT (without 
prior documented AF). From a mechanistic point of view, this can be explained by the 
fact that most MRATs are located in the right atrium, which is subject to longstanding 
pressure or volume overload and, often, surgical scarring.53 One study included in 
this review reported no recurrences during a median follow-up of 2 years after right-
sided arrhythmia surgery for MRAT.35 Importantly, not one study provided evidence 
in favour of performing biatrial arrhythmia surgery for MRAT. There were no studies 
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specifically investigating the effect of duration of preoperative MRAT (paroxysmal vs. 
non-paroxysmal) on the outcomes of arrhythmia surgery. Stulak et al. (2015) indicate 
that they would favour biatrial lesions over right-sided lesions in case of ‘longer-
standing arrhythmias’, although they did not differentiate between AF and MRAT in 
this recommendation nor in their results.34
Since only few studies included in this review (5/28) performed exclusive left-sided 
arrhythmia surgery in a small subset of patients without providing separate outcomes, 
we cannot form a solid conclusion on this matter. However, prior studies concerning 
a more general surgical population demonstrated the superiority of biatrial lesions 
over left atrial lesions only, particularly in case of persistent AF.54,55 In turn, a complete 
left atrial lesion set – generally consisting of pulmonary vein isolation (PVI), connecting 
lesions to the mitral valve annulus and the left atrial appendage, and excision of the 
left atrial appendage – has also been shown to be more effective than PVI alone.56,57
Energy sources
The complexity of arrhythmia surgery has decreased somewhat due to the emergence 
of alternative energy sources replacing the cut-and-sew lesions of the original Cox 
maze III procedure.40 However, in contrast to the cut-and-sew technique, continuity and 
transmurality of lesions created by alternative energy sources may be incomplete.58 
Various energy sources have been applied in the studies in this review, although none 
provided separate outcomes. Radiofrequency ablation was the most commonly applied 
method in the more recent studies (>2008). A large systematic review by Khargi et al. 
including 48 studies and 3832 patients compared outcomes of surgical AF ablation 
using either the cut-and-sew technique or alternative energy sources.58 There was no 
difference in freedom from AF between the two groups. As patients with CHD often 
have thickened and scarred myocardium, the risk of incomplete lesions when using 
alternative sources may still be relevant in this specific population. In order to minimize 
this risk, irrigated radiofrequency may be used. Cooling of the catheter tip allows for 
higher power levels and hence the ability to create larger and deeper lesions.59 A 
recent study of Ad et al. demonstrated the superiority of cryothermal energy over 
radiofrequency energy, particularly in patients with larger left atrial size and longer 
AF duration.60 Of note, the successful use of cryothermal energy is dependent on 
tissue thickness, requiring multiple freezes to obtain complete lesions in thicker target 
tissue.
Prophylactic arrhythmia surgery
The 2014 PACES/HRS guideline and a 2018 position paper by the EHRA/AEPC/ESC 
recommend that prophylactic arrhythmia surgery may be considered in certain 
situations (patients with Ebstein’s anomaly or atrial dilatation undergoing surgery, CHD 
patients undergoing re-operation).11,12 However, these recommendations were based 
on expert opinion or extrapolated from studies on therapeutic arrhythmia surgery in 
CHD patients or prophylactic arrhythmia surgery in patients with non-congenital mitral 
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valve disease. Our extensive literature search only identified four studies describing 
outcomes of prophylactic arrhythmia surgery in only a small number of patients. The 
only randomized controlled trial included in this review was not able to draw conclusions 
on the efficacy of a prophylactic lesion during the lateral tunnel Fontan procedure, 
given the lack of occurrence of the primary endpoint in both the intervention and 
the control group. Another study applied prophylactic right-sided lesions in most 
patients, which were not standardized and may have varied from patient to patient.30 
Postoperative occurrences of MRAT (either spontaneous or induced) were observed 
in two studies, in which a prophylactic lesion between the right atriotomy and the 
right atrioventricular valve annulus was applied using cryoenergy.29,43 In one of these 
studies, the authors confirmed that these arrhythmias were caused by incomplete 
cryolesions.29 Similar observations were described in a study reporting characteristics 
of new-onset ATA after catheter ablation of AF in a mixed population.61 In this study, 
nearly all ATA were related to gaps in prior ablation lines. As prophylactic arrhythmia 
surgery is performed without knowing if the patient will ever develop atrial arrhythmias, 
the development of arrhythmias due to incomplete lesions is an extremely undesirable 
outcome. Although prophylactic arrhythmia surgery may be beneficial for CHD patients 
with specific anatomic substrates predisposing them to the development of ATA, it is 
yet unknown which lesion sets should be applied and which energy sources should 
be used. Based on the four studies that we identified in our literature search, we are 
unable to provide recommendations on specific surgical techniques for this matter. This 
indicates the need for studies investigating the outcomes of prophylactic arrhythmia 
in CHD patients; ideally these are randomized studies with a sufficient sample size and 
follow-up duration following a standardized approach. This was also acknowledged 
by Mavroudis et al. in 2015, who suggested prophylactic lesion sets to be used in 
standardized experimental protocols.62
Permanent pacemaker implantation
Twenty of the studies included in this review reported numbers of patients requiring 
permanent pacemaker implantation varying between 0% and 42%. Apart from 
those implanted in the context of Fontan conversion, the most common indication 
for pacemaker implantation was SND. It is widely recognized that permanent 
pacemaker implantation for SND is a potential adverse outcome of atrial arrhythmia 
surgery.63 Underlying SND may be unmasked once the ATA is successfully abolished.64 
Furthermore, injury to the sinoatrial node or its arteries may cause postoperative 
SND, although this is less likely to occur due to technical improvements and increased 
experience over the years.63,65
The wide range in reported numbers of pacemaker implantations may be due to 
the fact that policies differ between centres, for example regarding the indications for 
intra-operative pacemaker implantation. Furthermore, policies may have changed over 
the years as experience with arrhythmia surgery has evolved. Whereas in earlier years, 
early postoperative junctional rhythm may have been an indication for pacemaker 
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implantation, experience has shown that stable sinus rhythm returns in many of these 
patients.63,65 In addition, the number of pacemaker implantations in some studies 
included those implanted as a part of the Fontan conversion procedure. For these 
reasons, and given the large heterogeneity in follow-up durations, study populations 
and arrhythmia surgery techniques, it is not possible to draw conclusions on whether 
pacemaker implantation in CHD patients is more often required than in the general 
population (around 10%).65
Strengths and limitations at study and outcome level
Except for some of the more recent studies, sample sizes were relatively small, as 
is often the case in studies involving CHD patients. Similar to studies evaluating the 
outcomes of endovascular AF ablation in CHD patients66, ASD was the predominant CHD 
type in most studies. Study designs were non-randomized and mostly retrospective 
in nature. Despite limitations generally associated with these designs, overall quality 
of the studies was acceptable. In some studies, CHD patients were a subset of a larger 
group of patients not included in this review. As a result, more detailed information 
beyond the number of patients with an arrhythmia recurrence was often not provided 
(e.g. outcomes according to lesion set or CHD type, pacemaker implantation). Although 
most studies reported the number of arrhythmia recurrences, a considerable number 
of studies (n=10) did not differentiate between recurrence vs. new-onset ATA, and 1 
study reported outcomes as recurrence or use of anti-arrhythmic drugs. Data on the 
use of perioperative AAD was relatively scarce and heterogeneous, thereby limiting 
the ability to provide solid conclusions on the possible influence of AAD on outcomes 
of arrhythmia surgery in this population. Furthermore, indications for permanent 
pacemaker implantation were not always provided. The number of pacemaker 
implantations in some studies included those implanted intra-operatively, which 
may be due to a variety of indications other than those directly related to arrhythmia 
surgery.
The large variation in follow-up durations among the included studies complicates 
the interpretation of outcomes, particularly since most studies did not report yearly 
event rates or the number of recurrences at fixed time points (e.g. 1 year, 5 years). It 
may be reasonable to expect that the duration of follow-up is related to the number 
of arrhythmia recurrences. We chose not to calculate yearly event rates, because 
we did not have individual study data at our disposal. Also, since the distribution of 
follow-up duration appeared skewed in many studies, extrapolation to rates merely 
based on presented number of recurrences and mean or median follow-up duration 
may potentially have led to incorrect results. This limited our options for performing 
a meaningful meta-analysis. In addition, the proportion of arrhythmia recurrence in a 
considerable number of studies was 0 or 1; small sample size contributed to this. For 
inclusion in a meta-analysis, corrections that account for such proportions would have 
to be made, with arguable consequences for the results. Finally, even after dividing 
results into relevant subcategories, significant heterogeneity remained regarding study 
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populations, definitions of outcome measures and variations in lesion sets and energy 
sources. For these reasons, we deemed a meta-analysis unable to provide meaningful 
results here and chose to refrain from it.
Strengths and limitations at review level
This review was conducted according to the PRISMA guidelines, thereby providing 
transparency of the methods and a systematic and uniform approach to answering 
our primary research question.15 We included studies from many different countries 
and centers, which broadens the perspective on the one hand, but is accompanied by 
various levels of expertise, patients volumes, and center-specific policies on the other 
hand, which should be taken into account when interpreting the results. We did not set a 
start date restriction for the literature search, as there was no concrete evidence on the 
basis of which a specific year or time period should have been selected. Furthermore, 
this approach resulted in a complete overview of the evolution of atrial arrhythmia 
surgery in patients with CHD. Inevitably, this decision in itself causes heterogeneity 
among studies, given the changes in surgical techniques over the years. Only studies 
written in the English language were included, which may have led to the exclusion 
of potentially relevant studies. We decided not to exclude studies including also 
patients undergoing Fontan conversion, as this would often have led to the exclusion 
of a substantial number of other patients relevant to the primary research question. 
Instead, by setting specific inclusion criteria (i.e. <25% of patients undergoing Fontan 
conversion) we limited the influence of these patients on the outcomes.
CONCLUSION
This systematic review summarized outcomes of atrial arrhythmia surgery in CHD 
patients published over a time span of 25 years. Regardless of the many variations 
in indications, surgical techniques and follow-up durations, this review reports a 
median arrhythmia recurrence of 13% (IQR 4%-26%). More specifically, based on the 
acquired data, biatrial lesions are preferred in the treatment of AF, whereas exclusive 
right-sided lesions may be more appropriate in the treatment of MRAT. As of yet, it is 
unclear whether addition of left-sided lesions would be beneficial to the treatment of 
MRAT. Theoretically, prophylactic atrial arrhythmia surgery may be beneficial in this 
population, but evidence is currently limited. In order to be able to provide more specific 
recommendations, future studies should specifically report outcomes according to 
the type of preoperative arrhythmia, underlying CHD, lesion set and energy source, 
as this is essential for determining which surgical technique should ideally be applied 
under which circumstances. Additionally, differentiation between recurrence and new-
onset regular ATA should be made and indications for pacemaker implantation clearly 
described, in order to be able to assess potential adverse outcomes.
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SUPPLEMENTAL MATERIAL
Complete search strategy
Date of search: 20-11-2019
Outcomes of atrial arrhythmia surgery in patients with congenital heart disease.




Embase Embase.com 1971 - Present 1594 1573
Medline ALL Ovid 1946 - Present 1454 326




1975 - Present 842 121
Cochrane Central Register 
of Controlled Trials
Wiley 1992 - Present 90 61
Other sources: Google Scholar 200 93
Total 4180 2174
Embase, 1594
(‘congenital heart disease’/de OR ‘congenital heart malformation’/exp OR (fontan* OR 
((triatr* OR dextro*) NEAR/3 (cor* OR heart* OR cardiac*)) OR dextrocard* OR ebstein* 
OR fallot* OR ((congen* Or anomal* OR malform* OR defect*) NEAR/12 (heart* OR 
septa* OR septum* OR ventricle*)) OR ((heart*) NEAR/6 (shunt* OR hypoplastic*) 
NEAR/6 (left OR right))):ab,ti,kw) AND (‘maze procedure’/de OR ‘maze surgery’/de OR 
‘cox maze procedure’/de OR ((‘supraventricular tachycardia’ OR ‘reentry tachycardia’/
exp OR ‘atrial fibrillation’/exp OR ‘reentry arrhythmia’/de OR ‘heart atrium arrhythmia’/
exp) AND (‘ablation therapy’/exp) AND (‘Fontan procedure’/exp OR ‘surgery’/de OR 
‘heart surgery’/exp OR ‘cryosurgery’/de)) OR (((surger* OR surgi* OR fontan) NEAR/8 
(tachyarrhythm* OR dysrhythm* OR disrhythm* OR flutter* OR tachycardi* OR 
fibrillation* OR arrhythm*)) OR maze*):ab,ti,kw) NOT ([Conference Abstract]/lim) NOT 
([animals]/lim NOT [humans]/lim)
Medline(Ovid), 1454
(exp “Heart Defects, Congenital”/ OR (fontan* OR ((triatr* OR dextro*) ADJ3 (cor* OR 
heart* OR cardiac*)) OR dextrocard* OR ebstein* OR fallot* OR ((congen* Or anomal* 
OR malform* OR defect*) ADJ12 (heart* OR septa* OR septum* OR ventricle*)) OR 
((heart*) ADJ6 (shunt* OR hypoplastic*) ADJ6 (left OR right))).ab,ti,kw.) AND (((exp 
“Tachycardia, Supraventricular”/ OR “Atrial Fibrillation”/ OR “Atrial Flutter”/) AND 
(“Ablation Techniques”/) AND (“Fontan Procedure”/ OR exp “Surgical Procedures, 
Operative”/ OR “Thoracic Surgery”/ OR “Cryosurgery”/)) OR (((surger* OR surgi* 
OR fontan) ADJ8 (tachyarrhythm* OR dysrhythm* OR disrhythm* OR flutter* OR 
tachycardi* OR fibrillation* OR arrhythm*)) OR maze*).ab,ti,kw.) NOT (news OR 
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congres* OR abstract* OR book* OR chapter* OR dissertation abstract*).pt. NOT 
(exp animals/ NOT humans/)
Web-of-Science Core Collection, 842
TS=(((fontan* OR ((triatr* OR dextro*) NEAR/2 (cor* OR heart* OR cardiac*)) OR 
dextrocard* OR ebstein* OR fallot* OR ((congen* Or anomal* OR malform* OR 
defect*) NEAR/12 (heart* OR septa* OR septum* OR ventricle*)) OR ((heart*) NEAR/5 
(shunt* OR hypoplastic*) NEAR/5 (left OR right)))) AND (((surger* OR surgi* OR fontan) 
NEAR/8 (tachyarrhythm* OR dysrhythm* OR disrhythm* OR flutter* OR tachycardi* 
OR fibrillation* OR arrhythm*)) OR maze*) NOT ((animal* OR rat OR rats OR mouse OR 
mice OR murine OR dog OR dogs OR canine OR cat OR cats OR feline OR rabbit OR 
cow OR cows OR bovine OR rodent* OR sheep OR ovine OR pig OR swine OR porcine 
OR veterinar* OR chick* OR zebrafish* OR baboon* OR nonhuman* OR primate* OR 
cattle* OR goose OR geese OR duck OR macaque* OR avian* OR bird* OR fish*) NOT 
(human* OR patient* OR women OR woman OR men OR man))) AND DT=(article OR 
review)
Cochrane, 90 (1 cochrane review, trials 89)
((fontan* OR ((triatr* OR dextro*) NEAR/3 (cor* OR heart* OR cardiac*)) OR dextrocard* 
OR ebstein* OR fallot* OR ((congen* Or anomal* OR malform* OR defect*) NEAR/12 
(heart* OR septa* OR septum* OR ventricle*)) OR ((heart*) NEAR/6 (shunt* OR 
hypoplastic*) NEAR/6 (left OR right))):ab,ti,kw) AND ((((surger* OR surgi* OR fontan) 
NEAR/8 (tachyarrhythm* OR dysrhythm* OR disrhythm* OR flutter* OR tachycardi* 
OR fibrillation* OR arrhythm*)) OR maze*):ab,ti,kw)
Google Scholar, 200
“congenital heart disease” arrhythmia|arrhythmias surgery|surgical
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Aims: The significance and incidences of intraoperative arrhythmias occurring in the 
operating room in children with congenital heart disease (CHD) are unknown. Aims of 
this study were to determine incidences of intraoperative arrhythmias in children with 
CHD and to examine whether they are associated with persistent arrhythmias during 
follow-up.
Methods: Continuous ECG recordings obtained from 134 consecutive pediatric CHD 
patients were manually examined from the moment the aortic cross-clamp (ACC) was 
removed (use of ACC and cardiopulmonary bypass (CPB)), when CPB was stopped (use 
of only CPB) or when the sternum was closed (no use of ACC and CPB) until departure 
from the operating room.
Results: In the operating room, 2nd(60%) and 3rd(34%) degree atrioventricular 
conduction block (AVB), ectopic atrial rhythm(30%) and junctional rhythm(32%) were 
most often observed in patients who underwent surgery with both ACC and CPB. 
Incidences of these arrhythmias decreased after cessation of CPB (p<0.01). (Supra)
ventricular premature beats were mostly observed between end of ACC time and 
sternum closure (64-84%), but decreased before departure from the operating room (6-
16%, p<0.01). During a median follow-up of 37 months, 17 patients (13%) had new onset, 
late postoperative arrhythmias. Of these patients, 88% had intraoperative arrhythmias 
compared to 85% of patients without late postoperative arrhythmias (p=1).
Conclusion: Intraoperative arrhythmias, mainly 2nd degree AVB and (supra)ventricular 
premature beats, were frequently observed in children with CHD undergoing cardiac 
surgery with use of CPB and ACC. Most arrhythmias were short-lasting and transient 
and appeared not to be related to late postoperative arrhythmias.
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INTRODUCTION
Congenital heart disease (CHD) occurs in 9 per 1000 live births.1 A well-known 
complication of surgical correction of CHD is development of late postoperative 
brady- and tachyarrhythmias.2-5 Reported incidences of early postoperative brady- 
and tachyarrhythmias, occurring between admission to the (pediatric) intensive care 
unit (ICU) until intensive care or hospital discharge, vary between 15 and 79%.6-9
In the intraoperative period, the child is vulnerable to development of arrhythmias 
due to multiple factors including cooling and rewarming, surgical manipulation, 
electrolyte imbalance, hypovolemia and diffuse myocardial damage.8,10 However, 
incidences of intraoperative arrhythmias in CHD patients occurring in the operating 
room have so far never been reported. Furthermore, it is unknown whether the 
occurrence and type of intraoperative arrhythmias might predispose to development 
of late postoperative arrhythmias or mortality during follow-up.
The aims of this study were 1) to determine incidences of intraoperative arrhythmias 
in children during and after surgery for CHD using continuous ECG recordings, 2) to 
identify procedural characteristics of patients with intraoperative arrhythmias and 3) 




This retrospective study is part of the rotterdAm rhythM mOnitoring pRoject (AMOR), 
which was approved by the institutional medical ethical committee (MEC 2012-481). 
Perioperative data were retrieved from patients’ medical records. Patients visited the 
pediatric cardiology outpatient clinic at regular intervals postoperatively: at t≈1 month, 
t≈3 months, t≈9 months and hereafter at least once every 1 to 1.5 years. If necessary, 
patients visited the outpatient clinic at shorter time intervals. All postoperative letters, 
ECGs and 24h-Holter recordings during follow-up were reviewed for the occurrence 
of arrhythmias.
All patients ≤18 years of age who underwent cardiac surgery for CHD between 
April 2011 and June 2012 at our hospital were included. Patients with a paced rhythm 
preoperatively or with incomplete continuous ECG recordings were excluded. Seven 
patients underwent more than one operation during the study period. In these cases, 
the operation on the main CHD was included. Diagnoses of CHD and performed surgical 
procedures were classified according to the International Nomenclature for Congenital 
Heart Surgery (INCHS).11 In contrast to the INCHS, we classified patients who were 
diagnosed with hypoplastic left heart syndrome in the single ventricle category instead 
of left heart lesions.
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Intra- and postoperative continuous ECG recordings
Intra- and postoperative continuous ECG recordings were obtained from bedside 
Infinity® monitors (Draeger, Lubeck, Germany). Data were stored on hard disk as CPZ-
files (compressed monitoring data) collected using a custom-made program (Taperec, 
Rotterdam, the Netherlands) with sampling rate of 200Hz.12 CPZ-files were converted 
into International Society for Holter and Noninvasive Electrocardiology (ISHNE) files, 
a standard Holter output file format.13 ECG recordings were semi-automatically 
analyzed in multichannel Holter scanning software SynescopeTM (Sorin Group, Ela 
Medical, Clamart, France) using standardized algorithms. Two electrocardiogram (ECG) 
leads were selected from lead I, II and III, since the precordial leads are not available 
during cardiac surgery. Hereafter, QRS-complexes were automatically classified and 
grouped into one of three templates, including normal, ventricular and supraventricular 
beats. After manual correction of all templates and marking the start and end time 
of arrhythmias on the rhythm strips, an event list was automatically generated and 
verified or adjusted by one of the investigators, with final confirmation from one of 
the staff electrophysiologists. After analysis of ECG recordings, data were exported as 
ASCII text files from SynescopeTM into a custom-made program to convert ASCII files 
into database format.
Continuous ECG recordings obtained by cardiac telemetry were analyzed either 
from the moment the aortic cross-clamp (ACC) was removed (in case of use of both ACC 
and cardiopulmonary bypass (CPB)), when CPB was stopped (in case of use of only CPB) 
or when the sternum was closed (in case of no use of ACC and CPB). ECG recordings 
during the first postoperative hours were analyzed from the moment the child arrived 
at the cardiothoracic ICU until discharge to the pediatric ICU.
Classification of arrhythmias
For the occurrence of arrhythmias, this article defines the intraoperative period (in 
the operating room), early postoperative period (at the ICU) and late postoperative 
period (from hospital discharge until last visit to outpatient clinic, also referred to as 
‘follow-up’).
Intraoperative arrhythmias were diagnosed according to the following definitions. 
Supraventricular (SV-)ectopy included supraventricular premature beat (SVPB), SV-
couplet and SV-run. An SVPB was defined as a supraventricular beat with cycle length 
≤25% of the average cycle length of the 2 preceding beats and SV-couplets consisted of 
two consecutive SVPBs. Three or more consecutive SVPBs above the maximum heart 
rate according to age were classified as SV-run (≤29 seconds) or atrial tachycardia (≥30 
seconds).14 Ventricular (V-)ectopy included ventricular premature beat (VPB), V-couplet 
and V-run. A VPB was defined as a premature contraction originating from one of 
the ventricles with a different and prolonged QRS complex compared to the patients’ 
usual QRS morphology.7 Two consecutive VPBs formed a V-couplet and 3 to 10 VPBs 
were defined as a V-run. Ten or more ventricular beats above the maximum heart 
rate according to age were classified as non-sustained ventricular tachycardia (VT, ≤29 
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seconds) or sustained VT (≥30 seconds).14 Ectopic atrial rhythm was defined as a series 
of supraventricular beats with abnormal P-wave morphology under the maximum heart 
rate according to age and junctional rhythm as a narrow complex rhythm in the absence 
of P-waves or in the presence of retrograde P-wave activation. Junctional ectopic 
tachycardia was defined as junctional rhythm above the maximum heart rate according 
to age.14 Second degree atrioventricular conduction block (AVB) was defined as missed 
ventricular beats with consistent PR-durations (e.g. 2:1) or with progressive prolongation 
of PR-duration. Third degree AVB was defined as atrioventricular dissociation with a 
junctional or ventricular escape rhythm.
Statistical analysis
Continuous variables were expressed as mean ± standard deviation or median 
(minimum – maximum). The ANOVA or Mann-Whitney U test was used to compare 
procedural characteristics. Categorical variables, including the incidence of arrhythmias 
and procedural characteristics, were denoted by numbers and percentages, and 
compared with Chi-square, Fisher’s exact or McNemar’s tests. Spearman’s correlation 
coefficient was used to calculate measures of association between (S)V-ectopy and 
procedural characteristics. A p-value <0.05 was considered statistically significant. 
Statistical analysis was performed with SPSS, version 21 (IBM, Armonk, New York).
RESULTS
Study population
We included 134 consecutive patients with a median age at the moment of cardiac 
surgery of 10 months (0.2 months–17 years). Table 1 provides an overview of the 
underlying CHDs; most patients had a septal defect (37%), right sided heart lesion 
(22%) or single ventricle (12%).
Surgical procedures included procedures for septal defects (N=46, 34%), right sided 
heart lesions (N=25, 19%), palliative procedures (N=22, 16%, thoracic arteries and veins 
(N=12, 9%), left sided heart lesions (N=11, 8%), pulmonary venous anomalies (N=6, 
4%), single ventricle (N=6, 4%) or transposition of the great arteries (N=6, 4%). Most 
patients underwent surgery with use of both ACC and CPB (N=99, 74%); 13 patients 
(10%) had only CPB and 22 (16%) had no CPB. Ninety-six patients (72%) were exposed 
to hypothermia <35°C. ACC duration ranged from 6 to 267 minutes and CPB duration 
from 15 to 360 minutes. Duration from end of ACC time until end of CPB ranged from 4 
to 188 minutes, from end of CPB time until sternum closure from 9 to 164 minutes and 
from sternum closure until departure from the operating room from 6 to 115 minutes. 
Preoperative ECGs were available in 126 patients (94%) at an average of 14 days (1-194 
days) prior to the surgical procedure. Sinus rhythm was present in 124 patients (98%) 
and two patients (2%) had an atrial tachycardia.
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Double outlet right ventricle 9 (7) 5 (56) 3 (0.5-46)
Left sided heart lesions 11 (8) 7 (64) 53 (6-168)
Aortic valve disease 11
Shone’s syndrome 1
Pulmonary venous anomalies 4 (3) 2 (50) 6 (2-201)
TAPVC 2
PAPVC 2
Right sided heart lesions 29 (22) 13 (45) 12 (0.3-188)
Pulmonary atresia 12
RVOT obstruction 7
Tetralogy of Fallot 10
Septal defects 49 (37) 25 (51) 10 (2-170)
Atrial septal defect 17




Single ventricle 16 (12) 14 (88) 3 (0.2-39)
Hypoplastic left heart syndrome 4
Left ventricular hypoplasia 2
Double inlet left ventricle 3
Atresia AV valve 6
cAVSD and straddling AV valves 1
Thoracic arteries and veins 11 (8) 6 (55) 33 (0.5-182)
Coronary artery anomalies 1
CoA, aortic arch hypoplasia 9
Vascular rings and slings 1
Transposition of the great arteries 5 (4) 3 (60) 0.5 (0.2-16)
Patients and gender: N (%), age: months (minimum-maximum).
AV: atrioventricular, cAVSD: complete atrioventricular septal defect, CHD: congenital heart disease, 
CoA: coarctation of the aorta, INCHS: International Nomenclature for Congenital Heart Surgery, 
P/TAPVC: partial/total abnormal pulmonary venous connection, RVOT: right ventricular outflow 
tract, TAPVC: total abnormal pulmonary venous connection.
VolledigbinnenwerkCharlotte.indd   166 18/11/2020   16:08:58
167
Intraoperative arrhythmias in pediatric congenital heart disease
Intraoperative arrhythmias
In total, 114 patients (85%) had one or more intraoperative arrhythmias. Arrhythmias 
were observed in 100% of patients who underwent surgery with use of ACC and CPB 
or CPB only compared to only 9% of patients without use of CPB (p<0.01). Figure 1 





Figure 1. Examples of arrhythmias that occurred in the intraoperative period
A: Second degree AVB during the first 5 minutes after removal of the ACC in a 4 month old 
patient who underwent correction of a VSD and patent foramen ovale. B: Alternating junctional 
rhythm and ectopic atrial rhythm in a 4 month old patient who underwent correction of a large 
VSD and an atrial septal defect type 2. C: Episode of ventricular fibrillation in a 1 year old patient 
with an interrupted aortic arch type B, a VSD and a relatively small left ventricle who underwent 
repair of the aortic arch, banding of the arteria pulmonalis and an atrioseptectomy. D: Episode of 
supraventricular tachycardia up to 300 beats per minute in a 1 month old patient with tricuspid and 
pulmonary atresia who underwent an atrioseptectomy and construction of a central shunt.
Episodes of intraoperative 2nd degree AVB had a median duration of 79 seconds (5 
seconds-21 minutes), whereas the median duration of 3rd degree AVB episodes was 25 
seconds (4 seconds-17 minutes). Median durations of episodes of ectopic atrial rhythm 
and junctional rhythm were respectively 44 seconds (2 seconds-63 minutes) and 20 
seconds (1 second-62 minutes).
Figure 2 shows time-dependent prevalence of the aforementioned arrhythmias in 
a subset of 96 patients who underwent a surgical procedure with both ACC and CPB. 
Three patients were excluded from this sub analysis because of missing data concerning 
8
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time points of end of CPB (N=2) or sternum closure (N=1). All arrhythmias were most 
often observed during CPB (T1, 30-60%) but decreased significantly after cessation of 
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Figure 2. Intraoperative arrhythmias in patients with use of both ACC and CPB
Prevalence of 2nd degree AVB, 3rd degree AVB, ectopic atrial rhythm and junctional rhythm are 
shown for each part of the surgical procedure in a subset of 96 patients who underwent surgery 
with use of both ACC and CPB.
ACC: aortic cross-clamp, AVB: atrioventricular conduction block, CPB: cardiopulmonary bypass, OR: 
operating room. * p<0.01 compared to T1. † p <0.01 compared to T2. ǂ p=0.04 compared to T2.
The number of (S)V-ectopy and their time-dependent occurrence in the subset of 96 
patients with ACC and CPB is shown in Figure 3 and Figure 4, respectively. The number of 
patients with SVPBs and SV-couplets was higher between the end of CPB and sternum 
closure (T2) compared to during CPB (T1; respectively p<0.01 and p=0.03). A relatively 
large number of patients developed VPBs, V-couplets and V-runs in the intraoperative 
period before sternum closure (41-84%) but this number decreased significantly after 
closure of the sternum (0–6%), p<0.01). All episodes of non-sustained VT and ventricular 
fibrillation occurred during CPB (not shown in Figure 4).
Three patients underwent one or more cardioversions for atrial tachycardia, AF or 
ventricular fibrillation. Temporary pacemaker leads were inserted in 3 patients with 
persistent junctional rhythm (N=2) and 2nd degree AVB (N=1).
Procedural characteristics of patients with intraoperative arrhythmias
Patients with intraoperative AVB, junctional rhythm or (S)V-ectopy more often had 
septal defect surgery compared to patients without these arrhythmias (AVB: 43% vs. 
24%, p=0.02; junctional rhythm: 49% vs. 29%, p=0.04; (S)V-ectopy: 40% vs. 0%, p<0.01). 
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Patients with atrial (88%) or combined atrioventricular (100%) septal defect surgery 
more often had V-ectopy compared to patients with only ventricular septal defect 
surgery (67%, p=0.02). Other types of surgery did not differ between patients with and 
without these arrhythmias; neither did they differ between patients with and without 
ectopic atrial rhythm.




































Figure 3. Time-dependent frequency of intraoperative SVPBs, SV-couplets and SV-runs
The number of SVPBs, SV-couplets and SV-runs in a subset of 96 patients who underwent surgery 
with use of ACC and CPB during each part of the surgical procedure. Percentages indicate the 
number of patients with the arrhythmia and the bars depict the median number of SV-ectopy.
* p<0.01 compared to T1. † p=0.03 compared to T1. §p=0.02 compared to T1. ǂ p<0.01 compared 
to T2.
ACC: aortic cross-clamp, CPB: cardiopulmonary bypass, OR: operating room, SV: supraventricular, 
SVPB: supraventricular premature beat.
Hypothermia was significantly more often used in patients with AVB (92% vs. 48%), 
ectopic atrial rhythm (90% vs. 65%), junctional rhythm (92% vs. 65%) or (S)V-ectopy 
(85% vs. 0%) compared to patients without these arrhythmias (all p<0.01).
Patients with AVB or (S)V-ectopy had longer median duration of ACC time (AVB: 
58 minutes, 14–175 vs. 45, 6–189; p=0.03 and (S)V-ectopy: 57 minutes, 6–189 vs. 26, 
17–36; p<0.01) compared to patients without these arrhythmias. Duration of CPB was 
comparable in patients with versus without AVB (p=0.06) and none of the patients 
without (S)V-ectopy had CPB. ACC and CPB duration did not differ between patients 
with and without ectopic atrial rhythm or junctional rhythm and it was not correlated 
with the number of (S)V-ectopy/hour.
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Figure 4. Time-dependent frequency of intraoperative VPBs, V-couplets and V-runs
The number of VPBs, V-couplets and V-runs in a subset of 96 patients who underwent surgery 
with use of ACC and CPB during each part of the surgical procedure. Percentages indicate the 
number of patients with the arrhythmia the bars depict the median number of V-ectopy.
* 1 patient had 67 VPBs. † p<0.01 compared to T1. § p<0.01 compared to T2.
ACC: aortic cross-clamp, CPB: cardiopulmonary bypass, OR: operating room, V: ventricular, VPB: 
ventricular premature beat.
Early postoperative period
Median duration of continuous ECG recordings during the first postoperative hours 
in the cardiothoracic ICU was 2.3 hours (0.7–20.9 hours). The number of patients 
with persistent and de novo arrhythmias in the ICU is shown in Figure 5. One patient 
developed de novo 2nd degree AVB, which resolved before transfer to the pediatric ICU. 
SVPBs occurred at a median of 1.3 per hour (0.2–22) in 72 patients (54%) and VPBs at 
a median of 0.6 per hour (0.2–35) in 29 patients (22%). Three patients developed one 
or more V-runs; one of them developed a non-sustained VT. Of 114 patients with an 
intraoperative arrhythmia, 79 (69%) still had an arrhythmia in the ICU, whereas of 20 
patients without intraoperative arrhythmias only 4 (20%) developed an arrhythmia in 
the ICU (p<0.01).
Follow-up
Median follow-up duration was 37 months (1 day–54 months): 2 patients had only 1 day 
of follow-up as they died on the first postoperative day. The 2 patients with preoperative 
paroxysmal atrial tachycardia did not develop any postoperative arrhythmias. Seventeen 
patients (13%) with preoperative sinus rhythm had late postoperative arrhythmias, 
including ectopic atrial rhythm (N=7), junctional rhythm (N=2, one of which also had 
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paroxysmal atrial tachycardia), sinus bradycardia (N=2), paroxysmal atrial tachycardia 
(N=2), sinus rhythm with SVPB bigeminy (N=2) or VPB bigeminy (N=1) and sick sinus 
syndrome (N=1). In only 2 patients, the intraoperative arrhythmia persisted during 
follow-up (1 ectopic atrial rhythm, 1 junctional rhythm). The other patients had late 
postoperative arrhythmias that differed from their intraoperative arrhythmia(s) (Figure 
5). Comparing patients with new onset, late postoperative arrhythmias to patients who 
did not develop postoperative arrhythmias, there was no difference in the number of 
patients with intraoperative arrhythmias or early postoperative arrhythmias in the 
ICU (Table 2).
Seven patients died during follow-up at a median age of 0.4 years (0–5); 
characteristics of these patients are shown in Table 3. The number of patients with 
intraoperative arrhythmias, early postoperative arrhythmias or late postoperative 

































Figure 5. Persistence of intraoperative arrhythmias
The number of patients with persistent or de novo intraoperative (= OR), early postoperative 
(= ICU) and late postoperative (= follow-up) arrhythmias. Nn indicates patients with de novo 
arrhythmias.
* this patient also had paroxysmal atrial tachycardia. † sinus bradycardia (n=2), paroxysmal 
atrial tachycardia (n=2), sinus rhythm with SVPB bigeminy (n=2) or VPB bigeminy (n=1), sick sinus 
syndrome (n=1).
AVB: atrioventricular conduction block, EAR: ectopic atrial rhythm, ICU: intensive care unit, JR: 
junctional rhythm, NA: not applicable, OR: operating room, SV: supraventricular, V: ventricular.
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With our study, we intended to provide insight into the incidence of different types 
of intraoperative arrhythmias in CHD patients and to determine whether these 
arrhythmias are of any clinical significance during follow-up. Intraoperative arrhythmias 
were observed in 85% of children undergoing cardiac surgery for CHD and were related 
to use of CPB, either with or without ACC. Although 2nd and 3rd degree AVB, ectopic 
atrial rhythm and junctional rhythm were often observed, these arrhythmias were 
generally short-lasting and often resolved after cessation of CPB. (S)V-ectopy was also 
relatively often observed in patients with use of CPB but the number of patients with 
these arrhythmias strongly decreased in the last intraoperative period.
To the best of our knowledge, we only found one other study that mentioned the 
incidence of intraoperative arrhythmias in pediatric patients. Cohen et al. studied 
the occurrence of intraoperative adverse events in 29.220 pediatric patients – most 
without cardiovascular disease – undergoing various types of surgery under general 
anesthesia.15 The incidence of intraoperative arrhythmias (defined as (supra)ventricular 
arrhythmias and heart block) varied between 0.86% and 9.33% depending on patient 
age. Arrhythmia definitions and methods of arrhythmia detection were not further 
specified; therefore, an adequate comparison to our results is not possible.







Intraoperative 15 (88) 98 (85) 1
2nd degree AVB 7 (41) 56 (48) 0.58
3rd degree AVB 2 (12) 31 (27) 0.24
EAR 5 (29) 32 (28) 1
JR 4 (24) 30 (26) 1
SV-ectopy 13 (77) 90 (78) 1
V-ectopy 14 (82) 89 (77) 0.76
Early postoperative 9 (53) 74 (64) 0.39
2nd degree AVB 1 (6) 1 (1) 0.24
3rd degree AVB 0 0
EAR 2 (12) 7 (6) 0.32
JR 2 (12) 4 (3) 0.17
SV-ectopy 8 (50) 63 (54) 0.75
V-ectopy 1 (6) 29 (25) 0.12
N (%).
AVB: atrioventricular conduction block, EAR: ectopic atrial rhythm, ICU: intensive
care unit, JR: junctional rhythm, SV: supraventricular, V: ventricular.
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Table 3. Postoperative mortality
# CHD type Main surgery OR* ICU† Cause of death (time 
postoperatively)
1 TOF Central shunt 2nd AVB, V-ectopy SV-ectopy Circulatory failure (1d)
2 PA, VSD Central shunt (S)V-ectopy EAR, JR, (S)
V-ectopy
Circulatory failure (1d)
3 HLHS PA banding SV-ectopy - Circulatory failure (2m) 
4 DORV, AVSD PA banding - - Circulatory failure (4m)
5 Tricuspid atresia, 
pulmonary atresia
Central shunt 2nd/3rd AVB, EAR, JR, 
AT, VF, (S)V-ectopy
SV-ectopy Circulatory failure (3y)
6 AVSD, straddling 
AV valves
Atrioseptectomy JR, (S)V-ectopy SV-ectopy Circulatory failure (4y)




(S)V-ectopy - Cerebral infarction (4y)
* intraoperative arrhythmias in the OR. † early postoperative arrhythmias in the ICU. 
AT: atrial tachycardia, AV: atrioventricular, AVB: atrioventricular conduction block, AVSD: 
atrioventricular septal defect, CHD: congenital heart disease, DORV: double outlet right ventricle, 
EAR: ectopic atrial rhythm, HLHS: hypoplastic left heart syndrome, ICU: intensive care unit, JR: 
junctional rhythm, OR: operating room, PA: pulmonary artery, SV: supraventricular, TAPVC: total 
abnormal pulmonary venous connection, TGA: transposition of the great arteries, TOF: tetralogy 
of fallot, V: ventricular, VF: ventricular fibrillation. 
Intraoperative arrhythmias: transient events?
Our results show that by the time the sternum was closed, the number of patients 
with AVB, ectopic atrial rhythm or junctional rhythm had decreased significantly. 
Diffuse myocardial damage due to hypoxia and ischemia during CPB and reperfusion 
after cessation of CPB has been suggested to contribute to development of early 
postoperative arrhythmias.7,9,16,17 Several studies assessing the incidence of early 
postoperative arrhythmias in children after surgery for CHD identified longer 
duration of CPB as an independent risk factor for postoperative arrhythmias.6,8,9,17,18 
Hypothermia during CPB results in slowing of impulse conduction, which may lead 
to various degrees of AVB.19 Reversal of nearly all AVBs after CPB with ACC (and thus 
during normothermia) in our study strongly suggests that transient intraoperative 
AVBs were caused by hypothermia rather than by injury to the conduction system 
itself. Hypothermia additionally reduces automaticity of cardiac pacemaker cells.20 The 
relatively high prevalence of ectopic atrial rhythm and junctional rhythm during CPB 
might be explained by reduced automaticity of the sinoatrial node, which may lead to 
increased competition between activity from the sinoatrial node, ectopic atrial foci and 
the atrioventricular node. After cessation of CPB, 10% of patients still had ectopic atrial 
rhythm or junctional rhythm. Persistence of these arrhythmias after cessation of CPB 
might be a result of diffuse myocardial damage that occurred during CPB or from atrial 
manipulation during surgery.17
8
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The number of patients with (S)VPBs and (S)V-couplets increased after cessation 
of CPB. This finding is in line with the study of Mallet et al., who suggested that 
ventricular ectopy is often suppressed by mild degrees of hypothermia but reappears 
with rewarming.21 Furthermore, the increased number of patients with (S)VPBs and (S)
V-couplets after cessation of CPB might be the result of longer duration of the time 
period between end of CPB and sternum closure compared to end of ACC and end of 
CPB. The number of patients with (S)V-ectopy decreased significantly after the sternum 
was closed. It is likely that mechanical manipulation of the heart by the surgeon for 
decanulation, hemostasis and drainage, which can occur until the sternum is closed, 
provokes (S)V-ectopy.
During the early postoperative hours at the cardiothoracic ICU, incidences of all 
arrhythmias were low. The number of patients with intraoperative arrhythmias did not 
differ between patients with and without late postoperative arrhythmias. Furthermore, 
intraoperative arrhythmias persisted in only 2 patients during follow-up. Our results 
indicate that intraoperative arrhythmias, similar to early postoperative arrhythmias, 
are mainly transient.7-9
Intraoperative arrhythmias: innocent events?
Active termination of arrhythmias by cardioversion was necessary in 3 patients 
and temporary pacemaker wires were implanted in 4 patients. In other patients, 
intraoperative arrhythmias were generally self-limiting. During the intra- and early 
postoperative period, death or other major complications did not occur due to 
arrhythmias, which is in line with outcomes of studies assessing the incidence of early 
postoperative arrhythmias in CHD children.6,8,9
Significance of intraoperative arrhythmias
The etiology of early postoperative arrhythmias differs from that of late postoperative 
arrhythmias. Late postoperative arrhythmias mostly develop as a complication of 
scarring or longstanding volume/pressure overload leading to conduction disorders or 
ventricular failure.22,23 Several studies found an association between early postoperative 
arrhythmias, defined as any arrhythmia within 30 days, and late postoperative 
arrhythmias in patients who underwent surgical correction of a CHD at young age.2-
5 The association between early and late postoperative arrhythmias may also apply 
to intraoperative arrhythmias. While short and subtle intraoperative arrhythmias 
often appeared to be benign, occurrence of these arrhythmias indicates electrical 
instability of the myocytes.7 A longer follow-up duration is necessary to further study 
the relation between intraoperative electrical instability and the propensity to develop 
late postoperative arrhythmias.
Limitations
Due to the retrospective nature of this study, several data regarding patient 
characteristics and intraoperative details were missing. However, the number of patients 
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with missing data was limited and these patients were excluded from sub analyses. 
Furthermore, since patients were transferred to the pediatric ICU in the children’s 
hospital after several hours postoperatively and subsequently to the pediatric ward, 
we only analyzed postoperative ECG recordings during the stay at the cardiothoracic 
ICU; ‘longer-term’ rhythm observations are missing. However, we analyzed follow-up 
letters, ECGs and 24h-Holter recordings in order to assess the occurrence of de novo 
or persistent arrhythmias. Due to the various types of intraoperative arrhythmias, 
heterogeneous patient population and relatively low incidence of late postoperative 
arrhythmias, it was not possible to perform predictive analyses with intraoperative 
arrhythmias and patient and procedural characteristics.
CONCLUSIONS
We conclude that intraoperative arrhythmias were frequently observed in children 
undergoing surgery for CHD with use of CPB, both with and without use of ACC. However, 
these arrhythmias were generally short-lasting, transient and clinically insignificant. 
Even though 13% of patients had new onset, late postoperative arrhythmias during 
follow-up, development of these postoperative arrhythmias appeared not to be related 
to arrhythmias in the operating room or at the ICU.
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Objective: Outcomes after surgical repair of complete atrioventricular septal defect 
(cAVSD) have improved. With advancing age, the risk of development of dysrhythmias 
may increase. The aims of this study were to 1) examine development of sinus node 
dysfunction (SND), atrial and ventricular tachyarrhythmias, and 2) study progression 
of atrioventricular conduction abnormalities in young adult patients with repaired 
cAVSD.
Methods: In this retrospective multicenter study, 74 patients (68% female) with a 
cAVSD repaired in childhood were included. Patients’ medical files were evaluated 
for occurrence of SND, atrioventricular conduction block (AVB), atrial and ventricular 
tachyarrhythmias.
Results: Median age at repair was 6 months (interquartile range 3–10) and median 
age at last follow-up was 24 years (interquartile range 21–28). SND occurred after a 
median of 17 years (interquartile range 11–19) after repair in 23% of patients, requiring 
pacemaker implantation in 2 patients (12%). Regular supraventricular tachycardia was 
observed in 3 patients (4%). Atrial fibrillation and ventricular tachyarrhythmias were 
not observed. Twenty-seven patients (36%) had 1st degree AVB, which was self-limiting 
in 16 (59%) and persistent in 10 (37%) patients. One patient developed 3rd degree AVB 
7 days after mitral valve replacement. Spontaneous type II 2nd degree AVB occurred in 
a 28-year old patient. Both patients underwent pacemaker implantation.
Conclusions: Clinically significant dysrhythmias were uncommon in young adult 
patients after cAVSD repair. However, three patients required pacemaker implantation 
for either progression of SND or spontaneous type II 2nd degree AVB. Longer follow-up 
should point out whether dysrhythmias will progress or become more prevalent with 
increasing age.
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INTRODUCTION
The first report of successful repair of complete atrioventricular septal defect (cAVSD) 
dates from 1955 by C.W. Lillehei.1 In the following decades, alterations in surgical 
techniques, increased knowledge of the anatomy of the conduction system and 
improved perioperative care led to improved outcomes after cAVSD repair.2 New 
problems may arise in this aging population, including brady- and tachyarrhythmias. 
Previous studies have shown that the incidence of dysrhythmias in patients with 
congenital heart disease (CHD) steadily increases with increasing age.3,4 In patients 
with an atrial septal defect (ASD), age at repair – and thus duration of volume overload 
and subsequent arrhythmogenic atrial stretch5 – is associated with development of 
atrial tachyarrhythmias (AT).5-7 The reported incidence of AT was lower when ASD repair 
was performed at a younger age.6,7 Since the majority of patients with cAVSD undergo 
surgical repair at young age, the duration of volume overload and its consequences is 
relatively short. Nonetheless, these patients not only develop AT – which may also result 
from surgical scars and suture lines – but also bradyarrhythmias, including sinus node 
dysfunction (SND) and late atrioventricular conduction block during follow-up.8-11
However, the number of studies explicitly focusing on dysrhythmias in patients with 
cAVSD repaired in childhood in a recent surgical era is scarce.9 Additionally, the timeline 
of dysrhythmias, including age and relation to (redo) surgery, has less well been studied. 
When patients with a surgically repaired cAVSD grow older and reach (early) adulthood, 
it is likely that the risk of development of various dysrhythmias may increase.
Therefore, the aims of this study were to 1) examine the occurrence of SND, 
atrial and ventricular tachyarrhythmias and 2) study time course and progression of 
atrioventricular (AV) conduction abnormalities in a cohort of young adult patients after 
surgical repair of cAVSD in childhood.
METHODS
Study population
This retrospective multicenter study was part of the Dysrhythmias in pAtients with 
congeNitAl heaRt diseAse (DANARA) project, which was approved by the local ethics 
committee in the Erasmus University Medical Center Rotterdam (MEC-2012-482). 
Informed consent was not required.
Seventy-four patients who underwent surgical repair of cAVSD <18 years of age 
between 1986 and 1999 were collected from databases of the participating academic 
hospitals (Erasmus University Medical Center: N=52, Radboud University Medical Center: 
N=22). This study period was based on stable operator and institutional experience in 
cAVSD repair and perioperative management, as well as consistent availability of patient 
data. Patients <18 years of age at last follow-up and patients with cAVSD unsuitable for 
biventricular repair or other types of major CHD were excluded.
9
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Data were collected from patients’ medical records, starting from the moment of first 
diagnosis of cAVSD. Intervals between clinical evaluations depended on the presence 
of relevant sequelae or residual lesions according to the guidelines.12 Clinical evaluation 
of patients included history, physical examination, electrocardiography (ECG) and, 
when available, 24-hour Holter recording, echocardiography and exercise testing. 
Echocardiographic characteristics at last follow-up were available in 63 patients; in 
the other 11 patients, latest echocardiographic characteristics dated from follow-up 
encounters at a median of 16 months (range 4 months–4.5 years) before last follow-
up. The following interpretations of echocardiographic parameters were included: 
left or right ventricular function, moderate/severe left or right atrioventricular valve 
insufficiency; severe left or right atrial dilatation, and residual ASD and/or ventricular 
septal defect (VSD). Echocardiographic definitions were based on guidelines.13,14
Dysrhythmias
All available rhythm registrations and correspondence between first diagnosis of 
cAVSD and last follow-up were included and evaluated for occurrence of the following 
dysrhythmias: 1) SND, 2) 1st, 2nd and 3rd degree AVB, 3) atrial fibrillation (AF), 4) regular 
supraventricular tachycardia (SVT; including atrial flutter, intra-atrial reentrant 
tachycardia, ectopic atrial tachycardia, atrioventricular nodal reentrant tachycardia, and 
atrioventricular reciprocating tachycardia) and 5) ventricular tachyarrhythmia (including 
sustained ventricular tachycardia and ventricular fibrillation).
Dysrhythmias were defined according to the guidelines.15,16 SND included sinus 
bradycardia or chronotropic incompetence without identifiable causes, paroxysmal 
or persistent sinus arrest with replacement by subsidiary escape rhythms in the atrium, 
AV junction or ventricular myocardium, or tachy-brady syndrome.15 We subsequently 
defined sinus bradycardia in patients >16 years of age as sinus rhythm <50 beats/min 
without use of β-blockers.17 In patients <16 years of age, heart rate <2nd percentile 
and PR-duration >98th percentile according to age as recommended by Rijnbeek et 
al. were applied for retrospective diagnosis of respectively sinus bradycardia and 1st 
degree AVB.18 Sinus bradycardia was diagnosed on an ECG made by day or a 24-hour 
Holter recording. In case of the latter, SND did not include 1) strictly nocturnal sinus 
rates under the lower limit appropriate for age and 2) an overall average heart rate 
under the lower limit over 24 hours. First degree AVB was diagnosed in the absence 
of use of drugs potentially causing PR-prolongation. We did not differentiate between 
typical (counter) clockwise atrial flutter, intra-atrial reentrant tachycardia or ectopic 
atrial tachycardia.
Statistical analysis
Normally distributed continuous variables were expressed as mean ± standard deviation 
and skewed continuous variables as median (interquartile range (IQR)). Categorical 
variables were expressed as numbers and percentages. Cumulative freedom from SND 
was estimated using a right-censored Kaplan-Meier curve, constructed with age as time 
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scale.3 A P-value <0.05 was considered statistically significant. Statistical analysis was 
performed with SPSS version 24 (IBM Corporation, Armonk, New York).
RESULTS
Study population
Clinical characteristics of 74 patients (female: N=50, 68%) with a repaired cAVSD are 
listed in Table 1. Fifty patients (68%) were additionally diagnosed with Down syndrome 
and 3 (4%) had impaired mental functioning with (1) or without (2) a known underlying 
chromosomal abnormality. Given similar difficulties in reporting of symptoms, these 
patients will be combined in 1 group (‘syndromic’) for the sake of this study. These 
patients did not differ from non-syndromic patients regarding characteristics listed in 
Table 1 (all p>0.05).
Repair of cAVSD was performed at a median age of 6 months (3–10). Typically, a 
two-patch technique was applied throughout the series.19,20 In one patient, the atrial 
component was closed with a patch and the ventricular component was directly closed. 
Another patient underwent additional infundibulectomy for infundibular pulmonary 
stenosis. A preparatory pulmonary banding had been performed in one patient and in 
another patient an aortic coarctation had been repaired before cAVSD repair. Median 
age at last follow-up was 24 years (IQR: 21–28, range: 18–37).
During follow-up, 17 patients (23%) underwent one or more additional surgical 
procedure(s) including AV valve surgery (N=13), AV valve surgery and resection of 
subaortic stenosis (N=3), resection of subaortic stenosis (N=3), and AV valve surgery and 
repair of residual ASD/VSD (N=2). Latest echocardiography interpretations described 
moderately impaired left ventricular function in 4 of 73 available reports (5%) and 
moderately impaired right ventricular function in 4 of 69 reports (6%). Moderate to 
severe left atrioventricular valve insufficiency was present in 32% of patients.
Sinus node dysfunction
As demonstrated in Figure 1, SND was identified in 17 patients at a median age of 18 
years (12–24), corresponding to 23% of syndromic patients and 24% of non-syndromic 
patients (p=1). Types of SND at presentation included sinus bradycardia (N=15) and 
sinus arrest (N=2); all were initially documented on a routine ECG. The two patients 
with sinus arrest underwent 24-hour Holter monitoring to confirm the diagnosis.
As illustrated in the upper panel of Figure 2, SND occurred (relatively) late after 
repair of cAVSD in all 17 patients (median: 17 years (IQR 11–19, range: 1.5–27)). Three 
of these patients underwent redo surgical procedures during follow-up: SND occurred 
long (respectively 18 and 20 years) after redo AV valve surgery in 2 patients and 6 years 
before redo AV valve surgery in 1 patient. Two patients (12%) received a pacemaker for 
symptomatic SND at the age of respectively 18 and 24 years. Characteristics of these 
patients are listed in Table 2. Both patients initially had asymptomatic sinus bradycardia 
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for several years before they developed progressive symptoms that were correlated 
to SND on respectively implantable loop recorder and 24-hour Holter monitoring. The 
lower panel of Figure 2 shows that at the age of 35 years, an estimated 65% of cAVSD 
patients remained free from SND.
Table 1. Patient characteristics (N=74)
Female gender 50 (68)
Down syndrome 50 (68)
Age at cAVSD repair (months) 6 (3-10)










LAVV replacement 3 (3)
Echocardiographic characteristics
Left ventricular function
Normal/mildly impaired 69/73 (95)
Moderately impaired 4/73 (5)
Right ventricular function
Normal/mildly impaired 65/69 (94)
Moderately impaired 4/69 (6)
Severe left atrial dilatation 4/56 (7)
Severe right atrial dilatation 1/34 (3)
Moderate/severe LAVV insufficiency 24/74 (32)
Moderate/severe RAVV insufficiency 6/73 (8)
Residual shunt 0/41
Values are presented as N (%) or as median (interquartile range).
For each echocardiographic parameter, the number of patients with available data is shown.
cAVSD: complete atrioventricular septal defect, LAVV: left
atrioventricular valve, RAVV: right atrioventricular valve.
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Atrioventricular conduction block
AVB was observed in 28 patients (38%) at a median age of 3 years (9 months–9 years; 
Figure 1). The incidence did not differ between syndromic and non-syndromic patients 
(both 38%, p=1). The majority of patients with AVB presented with 1st degree AVB on 
a routine ECG (N=27; upper left panel Figure 3). In 4 patients 1st degree AVB presented 
before cAVSD repair. As illustrated in the upper right panel of Figure 3, 1st degree AVB 
was self-limiting in 16 (59%) and persistent in 10 (37%) of 27 patients. Self-limiting 1st 
degree AVB was present for a median duration of 5 years (11 months–7 years) before 




































Figure 1. Dysrhythmias in patients with cAVSD
Upper panel: occurrence of dysrhythmias in syndromic and non-syndromic patients. Lower 
panel: age at development of dysrhythmias. Bars indicate median age.
AF: atrial fibrillation, AVB: atrioventricular conduction block, cAVSD: complete atrioventricular 
septal defect, SND: sinus node dysfunction, SVT: supraventricular tachycardia, VTA: ventricular 
tachyarrhythmia.
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Figure 2. SND in patients with cAVSD
Upper panel: time course of diagnosis of SND, redo surgical procedures and pacemaker 
implantation in relation to cAVSD repair. Lower panel: SND-free survival curve.
SND: sinus node dysfunction.
Pacemaker implantation was required in 2 patients with AVB (Table 2). One patient 
underwent mitral valve replacement and developed postoperative 3rd degree AVB, 
18 years after initial presentation of 1st degree AVB. This patient had normal sinus 
rhythm with 1st degree AVB for the first 7 postoperative days, before development of 
3rd degree AVB. Another patient presented with symptomatic type II 2nd degree AVB 
without apparent cause at the age of 28 years, which was diagnosed on 24-hour Holter 
monitoring. ECG at this time showed pre-existent bifascicular block and new onset 1st 
degree AVB. Both patients received a pacemaker at respectively 28 (2nd degree) and 
18 years (3rd degree) of age.
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Figure 3. AVB in patients with cAVSD
Upper left panel: type of AVB at presentation. Upper right panel: course of 1st degree AVB. 
Lower panel: time course of AVB in relation to cAVSD repair.
AVB(-I, -II, -III): (1st, 2nd, 3rd degree) atrioventricular conduction block, MVR: mitral valve 
replacement.
Atrial and ventricular tachyarrhythmias
Only 3 patients (4%; all with Down syndrome) had regular SVT, which was diagnosed 
based on postoperative rhythm monitoring early after cAVSD repair (1) or left 
atrioventricular valvuloplasty (1) and did not recur after the early postoperative period 
in both patients. Another patient developed SVT 9 months after initial repair in the 
setting of severe residual left atrioventricular valve insufficiency and residual ASD and 
VSD. This patient underwent redo surgery, after which SVT did not recur. Median age 
at occurrence of SVT was 16 months (range 15 months–10 years). AF and ventricular 
tachyarrhythmias were not observed in this study population.
9
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Table 2. Characteristics of patients requiring pacemaker implantation
# M/F DS Age Indication Symptoms Diagnosis Surgery*
1 F Yes 17.5 SND Syncope Symptomatic SND (ILR) 17y after repair
2 F No 18.5 AVB-III None ECG, telemetry 7d after MVR
3 F Yes 24.4 SND Pre-syncope Progressively symptomatic SND 24y after repair
4 M Yes 28.7 AVB-II Pre-syncope Symptomatic AVB (Holter) 28y after repair
* temporal relation of pacemaker implantation to (redo) surgery.
AVB(-II, -III): (2nd, 3rd degree) atrioventricular conduction block, DS: Down syndrome, ILR: 
implantable loop recorder, M/F: male/female, MVR: mitral valve replacement, SND: sinus node 
dysfunction.
DISCUSSION
This study demonstrated development of late postoperative SND in 23% of patients 
with cAVSD repaired at a median age of 6 months and a median postoperative follow-
up duration of 23 years. Most patients remained asymptomatic, but pacemaker 
implantation was required in 12% of these patients. One patient developed spontaneous 
symptomatic type II 2nd degree AVB 28 years after cAVSD repair, requiring pacemaker 
implantation. Fortunately, regular SVT were less common (4%) and AF and ventricular 
tachyarrhythmias were not observed, as may be expected in this relatively young study 
population.
Prior studies including arrhythmic outcomes during long-term follow-up after 
surgical repair of cAVSD in childhood are scarce. Either surgery was performed decades 
ago – thus with considerable differences in surgical techniques and perioperative 
care2,8,21 –, patients were older at the time of repair10, long-term follow-up until 
adulthood was missing11, or outcomes for complete and partial AVSD were only partially 
separated.9,10 One of these studies included 238 patients with repaired cAVSD and 177 
with repaired partial AVSD and a mean postoperative follow-up duration of 9 years.9 SND 
was observed in 6.7% and late complete AVB in 0.7%, although these outcomes were 
not further specified according to AVSD type. First degree AVB was identified in 19% of 
patients, as opposed to 36% in our study. Use of age-specific criteria18 for retrospective 
diagnosis of 1st degree AVB in the present study may explain the difference in these 
findings. Soufflet et al. evaluated long-term outcomes in 71 patients after surgical repair 
of cAVSD at a median age of 3.8 years (0.2–61.3).10 AT occurred more often compared 
to our study (respectively 11% vs. 4%), which might be explained by the difference in 
age at repair. Suzuki et al. included 116 patients undergoing surgical cAVSD repair at a 
median age of 4.8 months (9 days–5.4 years), who were followed for a median duration 
of 27 months.11 Permanent pacemaker implantation was performed in 2/116 patients 
(2%), although the indication was not provided. The somewhat higher percentage of 
patients requiring pacemaker implantation in our study (5%) may be explained by the 
considerable difference in follow-up duration.
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Sinus node dysfunction
In the present study, SND occurred late after cAVSD repair and was not related to 
redo surgical procedures. These findings are comparable to those of a previous 
study including 34 patients with a surgically repaired ASD and SND.17 Median interval 
between ASD repair and SND was 16 years and late SND was not related to redo surgical 
procedures. Similar findings were reported by Roos-Hesselink et al., who studied 
outcomes of surgical repair of VSD at young age after 22–34 years of follow-up.22 A 
pacemaker was implanted in 4/95 patients because of sick sinus syndrome more than 
15 years after surgery. The progressive nature of the disease in these patients was 
illustrated by the presence of minor indicators of SND after 10–22 years of follow-up.23 
Development of (late) SND in CHD patients was also previously studied by Goldman 
et al., who reviewed indications for permanent pacing in 132 patients after surgery for 
CHD.24 Specific results for patients with cAVSD (N=4) were not provided, but overall, late 
SND was the indication for permanent pacing in 14% of patients. In the present study, 
two patients requiring pacemaker implantation for symptomatic SND had pre-existent 
asymptomatic sinus bradycardia for over a decade before they became progressively 
symptomatic. It was previously demonstrated that the incidence of SND in the general 
population increased with age: from 0–1.2% at 45–54 years of age to 6–23% in subjects 
75–84 years of age.25 Thus, it should be taken into account that SND in cAVSD patients 
may also be a progressive disease and may become more severe as these patients are 
aging. The cause of SND in cAVSD patients is unknown, but is probably multifactorial. 
A congenital origin, direct surgical damage, late fibrosis after surgery, sinus node 
abnormalities due to atrial stretch, persistence of electrophysiological abnormalities 
beyond surgical repair and aging may all contribute to development of SND in patients 
with septal defects.24-27
Atrioventricular conduction block
In line with previous findings, first degree AVB was relatively often observed.28 The 
anatomy of the conduction system in patients with cAVSD is abnormal, with a more 
posterior position of the atrioventricular node (AV) and His bundle compared to patients 
with a structurally normal heart.2 First degree AVB in these patients is most commonly 
caused by intra-atrial conduction delay28, which is probably due to the altered course 
of the atrial conduction system and thus atrial activation in the presence of the atrial 
component of cAVSD. In the present study, a large atrial component of the defect was 
found in 2 of 4 patients with preoperative 1st degree AVB. Regression of 1st degree 
AVB occurred in 59% of patients. We assume that in some patients, regression may 
be caused by inversed atrial remodeling after cAVSD repair. Furthermore, the relative 
difference in PR-duration initially caused by intra-atrial conduction delay as described 
above may become less outspoken with increasing age compared to healthy peers.
Increased knowledge of the course of the conduction system in cAVSD patients 
and improved surgical techniques resulted in a dramatic decrease of surgically 
induced 3rd degree AVB.2 In the present study, not one patient developed immediate 
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postoperative 3rd degree AVB. One patient did develop 3rd degree AVB 7 days after 
mitral valve replacement, necessitating pacemaker implantation. A prior study 
demonstrated a relatively high incidence of early postoperative 3rd degree AVB after 
mitral valve replacement compared to mitral valvuloplasty in cAVSD patients, which – 
the authors suggested – may be explained by mechanical compression of the prosthesis 
on the conduction system.29 However, our patient had normal sinus rhythm with a 
previously known 1st degree AVB for 7 days before development of 3rd degree AVB. 
This course implicates that AVB in this patient was not caused by direct surgical injury 
or compression of the prosthesis to the AV conduction system. We assume that 3rd 
degree AVB in this patient was caused by development of scar tissue after mitral valve 
replacement.
One 28-year old patient developed spontaneous symptomatic type II 2nd degree 
AVB without apparent cause. Concomitant documentation of pre-existent bifascicular 
block and de novo 1st degree AVB might imply a progressive deterioration of the AV 
conduction system. A previous study on dysrhythmias in patients with a surgically 
repaired ASD showed that development of AVB was not related to a redo surgical 
procedure in 6 of 10 patients with late 3rd degree AVB.17 Development of AV conduction 
abnormalities in patients with septal defects may be a progressive disease22 influenced 
by (a combination of) several factors including abnormal anatomy, a genetic origin, 
direct surgical damage, late fibrosis after cardiac surgery and aging.24,30 Given the overall 
young age at cAVSD repair, fibrosis near the AV node caused by hemodynamic effects 
of the shunt seems less likely but cannot be ruled out as contributing cause.
Aging and atrial tachyarrhythmias
It was previously demonstrated that aging is associated with an increased incidence 
of AT.31 However, the incidence of AT in aging patients with CHD is strikingly higher 
compared to the general population.4 The underlying mechanism of AT in CHD patients 
is variable: ‘incisional’ AT are directly related to prior surgical lesions, whereas AT may 
also occur as a result of longstanding volume and/or pressure overload leading to atrial 
stretch.5,32 Our data did not allow us to differentiate between these types of AT.
As expected, given the young age of our study population, the number of patients 
with AT was relatively low. These findings are in line with previously reported incidences 
of AT in adult cAVSD patients (~2%–10%).8,10 In addition, it can be postulated that AT are 
also less common in patients with cAVSD due to generally early closure of the defect. 
Prior studies including patients with an ASD demonstrated that young age at repair 
resulted in significantly lower incidences of AT.5,6 This observation is most likely based 
on earlier termination of the left-right shunt, thereby preventing further right atrial 
dilatation and consequent vulnerability to development of AT.5 Longer follow-up of 
surgically repaired cAVSD patients should point out whether AT become more frequent 
as these patients become older.
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Study limitations
Our selection of the study period (1986 – 1999) obviously resulted in a young study 
population at follow-up. This may explain the relatively low incidence of dysrhythmias, 
which may be expected to increase with increasing age, as seen with other CHD types.3,4 
However, in our opinion, this time period represents stable surgical experience – 
about 10 years after introduction of the two-patch technique2 – and encompasses 
patients currently entering (early) adulthood, who may be at risk of development of 
dysrhythmias.
Due to the retrospective nature of this study, patients did not receive the exact 
same diagnostic tests at the same time points during follow-up. In accordance with the 
guidelines, frequency of follow-up depended on the presence and severity of residual 
lesions.12 Although the majority of patients was seen at follow-up intervals up to 5 years, 
some patients had a gap >6 years in follow-up: 12% of patients with SND and/or AVB had 
a gap as opposed to 30% of patients without. Furthermore, 24-hour Holter recordings 
were performed at the discretion of the treating physician. Our results showed that 
dysrhythmias were not documented on 24-hour Holter recordings that were performed 
for screening purposes only, without a specific indication. These differences in follow-
up intervals and rhythm monitoring methods may result in an underestimation of the 
number of patients with (asymptomatic) dysrhythmias. Furthermore, asymptomatic 
events may have occurred before the first actual documentation of dysrhythmia. 
The number of dysrhythmias in patients with impaired mental functioning or Down 
syndrome may be underestimated due to potential underreporting of symptoms.
CONCLUSION
Incidence of clinically significant dysrhythmias in young adult patients after surgical 
repair of cAVSD in childhood was low, as indicated by the absence of atrial fibrillation and 
ventricular tachyarrhythmias. In addition, there was a low incidence of regular SVT, most 
of which only occurred in the immediate postoperative period. Although SND was not 
uncommon, most patients remained asymptomatic. However, pacemaker implantation 
was required in 12% of these patients. One patient developed spontaneous type II 2nd 
degree AVB requiring pacemaker implantation. SND and AV conduction abnormalities 
in cAVSD patients are probably caused by multiple factors and might have a progressive 
course in some patients. Longer follow-up of these young adult patients should point 
out whether dysrhythmias will progress or become more prevalent with increasing 
age.
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Background: Atrial fibrillation (AF) and other supraventricular tachycardias (SVT) are 
known complications after surgical repair of an atrial septal defect (ASD), but sinus 
node dysfunction (SND) and complete atrioventricular conduction block (cAVB) may 
also occur.
Objectives: The aims of this study were to examine time course and interrelationship 
of various dysrhythmias in patients with an ASD.
Methods: Adult patients (N=95) with a surgically repaired secundum ASD (N=40), partial 
atrioventricular septal defect (N=37) or sinus venosus defect (N=18) and documented 
SND, cAVB, AF and/or other SVT were included. Median age at repair was 13 years 
(interquartile range 6-45) and patients were followed for 26 years (interquartile range 
15-37) after ASD repair.
Results: SND was observed in 34 patients (36%), cAVB in 14 (14%), AF in 48 (49%) and 
SVT in 44 (45%); 37 (39%) patients had ≥2 dysrhythmias. All dysrhythmias presented 
most often after ASD repair (p<0.01) with a median duration of 12 to 16 years between 
repair and onset. Development of SND and cAVB late after ASD repair was not related 
to a redo procedure in respectively 100% and 60% of patients. SND preceded atrial 
tachyarrhythmias in 50% (p=0.31) and SVT preceded AF in 68% (p=0.09) of patients 
with both dysrhythmias.
Conclusions: A substantial number of dysrhythmias presented (very) late after ASD 
repair. In most patients, development of late SND and cAVB was not related to redo 
procedures. In patients with multiple dysrhythmias, a specific order of appearance 
was not observed.
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INTRODUCTION
One of the long-term sequelae of an atrial septal defect (ASD) is the occurrence of 
dysrhythmias, mainly atrial tachyarrhythmias.1,2 The incidence of atrial tachyarrhythmias 
is associated with age at surgical ASD repair and is reported to be lower when 
surgical repair is performed at young age.2,3 Other dysrhythmias include sinus node 
dysfunction (SND) and atrioventricular conduction block (AVB), which may be observed 
postoperatively due to damage caused by surgical manipulation.4 Several studies also 
reported abnormalities in sinus node and atrioventricular (AV) node function during 
electrophysiology testing in patients before ASD repair.5,6
It has been suggested that bradycardia predisposes to atrial tachyarrhythmias by 
1) bradycardia-mediated atrial remodeling4,7,8 or 2) occurrence of ectopic atrial activity 
during sinus bradycardia.9,10 In addition, electrical remodeling of the atria caused by 
regular SVT facilitates development of AF.11 Teuwen et al. studied 199 patients with 
congenital heart disease (CHD) and atrial fibrillation (AF) and demonstrated that AF 
and regular supraventricular tachycardia (SVT) coexisted in a considerable number of 
patients (33%), most of which initially presented with regular SVT.12 Thus, development 
of different types of dysrhythmias may be interrelated. Based on these observations, 
we hypothesized that the time course of various dysrhythmias in patients with an ASD 
will follow a general pattern, in which bradyarrhythmias precede atrial tachyarrhythmias 
and regular atrial tachyarrhythmias precede AF.
The aim of the present study was therefore 1) to examine the time course of 
development of SND, compete AVB (cAVB), AF and other SVT in patients with an 
isolated ASD, including secundum ASD, partial atrioventricular septal defect (pAVSD) 
or sinus venosus defect (SVD) and 2) to study the interrelationship between various 
dysrhythmias.
METHODS
This retrospective multicenter study was designed as part of the ‘Dysrhythmias in 
pAtients with congeNitAl heaRt diseAse’ (DANARA) project, which was approved by 
the local ethics committee in the Erasmus University Medical Center Rotterdam (MEC-
2012-482). Informed consent was not obliged.
Study population
We extracted 245 adult patients with a surgically repaired secundum ASD, pAVSD or SVD 
and ≥1 year of follow-up after ASD repair from databases of the participating hospitals. 
From these patients, 95 patients with at least one of the following dysrhythmias were 
included in the present study: SND, cAVB, AF and/or other SVT (definitions in next 
section). Patients with other types of major CHD were excluded.
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Data on clinical characteristics were collected from patients’ medical records. 
Follow-up intervals differed between patients based on age at repair and presence 
of relevant sequelae or residua, in accordance with the guidelines.13 Evaluation before 
ASD repair and during the follow-up period included history, physical examination, 
ECG and, if indicated, 24h-Holter recording, echocardiography and exercise testing.
Classification of dysrhythmias
First episodes of each type of dysrhythmia were collected from surface ECG, 24h-Holter 
recordings or exercise testing. All available documentations between birth and last 
follow-up visit were included and evaluated.
Dysrhythmias were classified as 1) SND, 2) cAVB, 3) AF and 4) SVT (including atrial 
flutter (AFL), intra-atrial re-entrant tachycardia (IART), ectopic atrial tachycardia, 
atrioventricular nodal re-entrant tachycardia (AVNRT), atrioventricular reciprocating 
tachycardia (AVRT)).
All dysrhythmias were diagnosed according to the guidelines.14-17 The guidelines14 
identify ‘sinus bradycardia without identifiable causes’ as one of the criteria for SND; 
we subsequently defined sinus bradycardia as sinus rhythm <50 beats per minute or 
symptomatic sinus rhythm between 50 and 60 beats per minute, without use of beta 
blockers. We did not differentiate between a typical (counter) clockwise AFL, IART or 
ectopic atrial tachycardia, as differentiation between these types arrhythmias cannot 
always be made based on the surface ECG only.18
Statistical analysis
Continuous variables were expressed as mean±standard deviation or median 
(interquartile range (IQR)) depending on skewness and compared with the independent 
T-test, one-way ANOVA, Mann-Whitney U or Kruskal-Wallis H test, where appropriate. 
Categorical data were denoted by percentages and compared with the chi-square 
or Fisher’s exact test. Distribution of cases within a single categorical variable was 
assessed with the chi-square goodness-of-fit test. Bonferroni correction was applied 
to adjust for inflation of type I error for comparison of the ASD types with 3 tests; a 
p-value <0.017 (i.e. 0.05/3) was considered statistically significant. Overall, a p-value of 
<0.05 was considered statistically significant. Statistical analysis was performed with 
SPSS, version 21 (IBM, Armonk, New York).
RESULTS
Study population
Of 95 included patients, 40 (42%) had a secundum ASD, 37 (39%) a pAVSD and 18 (19%) 
a SVD. Patient characteristics are shown in Table 1. Median age of patients at repair was 
13 years (6-45); repair of pAVSD was performed at a significantly younger age compared 
to SVD (p=0.016). Median duration of follow-up after ASD repair was 26 years (15-37). 
VolledigbinnenwerkCharlotte.indd   198 18/11/2020   16:09:04
199
Dysrhythmias in patients with atrial septal defect 
Twenty-nine patients (31%) underwent >1 surgical procedure – other than ASD repair 
– including AV valve surgery (N=25), AV valve surgery and repair of residual ASD (N=10), 
repair of residual ASD (N=1), replacement of infected ASD patch (N=2) and non-ASD 
related cardiac surgery (N=4). One additional patient underwent percutaneous closure 
of a residual ASD.
Table 1. Patient characteristics
ASD 2 pAVSD SVD p-value
Patients 40 (42) 37 (39) 18 (19) -
Female 27 (68) 22 (60) 9 (50) 0.42
PAPVR 2 (5) 1 (3) 15 (83) <0.01
Age ASD repair (yrs) 17 (8-47) 9 (5-20) 37 (6-63) 0.016
Duration postoperative FU (yrs) 24 (7-37) 28 (20-35) 20 (6-35) 0.25
Residual ASD repair 2 (5) 10 (27) 0 <0.01
Mitral valve plasty 2 (5) 31 (84) 1 (6) <0.01
Mitral valve replacement 1 (3) 10 (27) 0 <0.01
Tricuspid valve plasty 4 (10) 9 (24) 4 (22) 0.23
Tricuspid valve replacement 0 1 (3) 0 0.58
>1 surgical procedure 4 (10) 22 (60) 3 (17) <0.01
Values are presented as N (%) or as median (interquartile range).
ASD: atrial septal defect, ASD 2: secundum atrial septal defect, FU: follow-up, PAPVR:
partial abnormal pulmonary venous return, pAVSD: partial atrioventricular septal defect,
SVD: sinus venosus defect.
Sinus node dysfunction
Thirty-four patients (36%) had SND. As shown in the upper left panel of Figure 1, there 
was no impact of the ASD type on occurrence of SND (p=0.11). Types of SND included 
sinus bradycardia (N=16, 47%), sick sinus syndrome (N=10, 29%), sinus arrest (N=7, 21%) 
and chronotropic incompetence (N=1, 3%). Only 2 patients developed SND before ASD 
repair in contrast to 32 patients after ASD repair (p<0.01; upper right panel Figure 1). 
Median age at development of SND was 28 years (19-45; lower panel Figure 1) and did 
not differ between ASD types (p=0.98).
Figure 2 illustrates duration between ASD repair and onset of dysrhythmias. SND 
generally occurred late after ASD repair (median 16 years (5-25)), except in 1 patient, 
who developed SND within 1 month. The upper panel of Figure 3 shows the relation 
between redo procedures and development of late SND. The majority of patients with 
late SND did not have surgical procedures other than ASD repair (26/31). In the other 
5 patients, redo procedures were performed long before development of SND (2 to 
25 years). A pacemaker was implanted in 32% of patients with SND (N=11), including 5 
patients with secundum ASD, 5 with pAVSD and 1 with SVD.
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Figure 1. Characteristics of dysrhythmias
Upper left panel: proportion of ASD types within each dysrhythmia. Upper right panel: 
development of dysrhythmias before or after ASD repair. Lower panel: age at development 
of each dysrhythmia. Bars indicate median age. There were no significant differences between 
ASD types.
AF: atrial fibrillation, ASD: atrial septal defect, ASD 2: secundum atrial septal defect, cAVB: 
complete atrioventricular conduction block, pAVSD: partial atrioventricular septal defect, SND: 
sinus node dysfunction, SVD: sinus venosus defect, SVT: supraventricular tachyarrhythmia.
Complete atrioventricular conduction block
Complete AVB was observed in 14 patients (14%); none of these patients had SVD 
(upper left panel Figure 1). Four patients (29%) showed 1st degree AVB before they 
developed cAVB. Complete AVB was perioperative and transient in only 2 patients. 
As shown in the upper right panel of Figure 1, cAVB occurred significantly more often 
after compared to before ASD repair (N=12, 86% vs. N=2 14%; p=0.008). Median age 
at development of cAVB was 19 years (9-37; lower panel Figure 1), which did not differ 
between ASD types (p=0.64).
Figure 2 illustrates development of cAVB during follow-up after ASD repair; most 
patients (10/12) developed late cAVB (>6 months). Half of these patients did not 
undergo surgical procedures other than ASD repair (lower panel Figure 3). Complete 
AVB occurred immediately after a redo procedure in 4 patients; all these patients 
underwent mitral valve replacement. One patient had multiple surgical procedures 
>2 years before development of late cAVB. As expected, all patients with persistent 
cAVB received a pacemaker (N=12, 86%), including 8 patients with pAVSD and 4 with 
secundum ASD.
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Figure 2. Duration between ASD repair and onset of dysrhythmias
Dysrhythmias were divided according to early (<1 month), intermediate (1–6 months) or late (>6 
months) occurrence after ASD repair. The bars indicate median duration between repair and 
onset of dysrhythmias.
AF: atrial fibrillation, SVT: supraventricular tachycardia, cAVB: complete atrioventricular conduction 
block, SND: sinus node dysfunction.
Atrial tachyarrhythmias
As shown in the upper left panel of Figure 1, AF was observed in 48 patients (49%). There 
was a trend towards a higher proportion of patients with secundum ASD (p=0.068). 
Twenty-nine patients (61%) had paroxysmal AF, 5 (10%) persistent AF and 14 (29%) 
permanent AF. Most patients developed AF after ASD repair (83%, p<0.01; upper right 
panel Figure 1). AF presented at a median age of 47 years (40-62; lower panel Figure 1). 
Age at AF development did not differ between ASD types (p=0.31). The median interval 
between ASD repair and development of AF was 12 years (17 days-32 years; Figure 2). 
AF occurred within 1 month after ASD repair in 11 patients (28%) and between 1 and 
6 months in 2 patients (5%).
Other SVT occurred in 44 patients (45%), without a difference in ASD types (p=0.19; 
upper left panel Figure 1). Most patients developed SVT after ASD repair (95%, p<0.01; 
upper right panel Figure 1). Median age at development of SVT was 39 years (20-52). 
There was a trend towards older age at development of SVT in patients with SVD 
compared to secundum ASD (p=0.021) which was not significant after correction for 
multiple testing (required p-value: <0.017). Patients developed SVT after a median of 
16 years (4-28) after ASD repair (Figure 2). The majority of patients developed late SVT 
(36/42).
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Figure 3. Redo procedures and late SND and cAVB
Redo procedures before late SND (upper panel) and late cAVB (lower panel). Twenty-six 
patients with late SND and 5 with late cAVB did not undergo surgical procedures other than 
ASD repair. Time intervals (minimum-maximum) between ASD repair, redo procedures and late 
SND/cAVB are shown. Patients are ranked according to interval between redo procedure and 
occurrence of late SND/cAVB. Due to the large variation in time intervals between ASD repair, 
redo procedures and development of late SND/cAVB, intervals are not scaled.
* replacement of infected patch. ǂ 1 patient with transient postoperative cAVB.
ASD: atrial septal defect, m: months, MVP: mitral valve plasty, MVR: mitral valve replacement, 
PVR: pulmonary valve replacement, rASD: residual atrial septal defect, TVP: tricuspid valve plasty, 
y: years.
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Interrelationship between dysrhythmias
In 37 patients (39%), multiple dysrhythmias were present (2: N=28, 3: N=8, 4: N=1). Figure 
4 illustrates order of appearance of SND and atrial tachyarrhythmias (AF and/or SVT; 
upper panels) and AF and SVT (lower panels). Sixteen patients had both SND and AF 
and/or SVT; there was no predominant order of appearance (p=0.31). SVT preceded 
AF in 68% of patients with both SVT and AF (15/22, p=0.09). A large variation in time 
intervals between subsequent dysrhythmias without apparent pattern was observed 






























































Figure 4. Interrelationship between dysrhythmias
Upper left panel: order of appearance in 16 patients with SND and atrial tachyarrhythmias (AF 
and/or SVT), p=0.31. Lower left panel: order of appearance in 22 patients with AF and SVT, 
p=0.09. Right panels: time intervals between subsequent dysrhythmias. Bars indicate median 
interval.
AF: atrial fibrillation, ATA: atrial tachyarrhythmia, SND: sinus node dysfunction, SVT: 
supraventricular tachycardia.
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This study evaluated time course and interrelationship of SND, cAVB, AF and other SVT in 
patients with a surgically repaired secundum ASD, pAVSD or SVD and a median duration 
of follow-up after ASD repair of 26 years (15–37). A substantial number of dysrhythmias, 
including SND and cAVB, presented only years after ASD repair. Late development of 
SND or cAVB in our study could not fully be explained by redo surgical procedures for 
significant residual lesions. This is in line with previous findings of Goldman et al., who 
studied characteristics of 132 CHD patients who required permanent cardiac pacing 
for early AVB, late AVB or sick sinus syndrome after surgical repair, including 27 patients 
with an ASD.19 Overall, late AVB and sick sinus syndrome occurred respectively 4.7±4.8 
years and 4.8±5.4 years after cardiac surgery. The authors suggested development of 
late fibrosis in the area of repair and cannulation as a potential underlying pathogenic 
mechanism. In patients with multiple dysrhythmias, bradyarrhythmias did not precede 
atrial tachyarrhythmias. Although not statistically significant, there was a trend towards 
SVT preceding AF.
Sinus node dysfunction
In the present study, 75% of patients with SND already developed SND before the age 
of 45 years. This is in contrast with the general population, in which the peak incidence 
of SND occurs within the elderly population (≥65 years).20 SND in patients with CHD 
can be caused by direct damage to the sinus node or its blood vessels during cardiac 
surgery.4,21 Even though most patients in the present study developed SND after ASD 
repair, SND presented only (very) late after ASD repair and/or redo procedures. A direct 
association between surgically induced damage to the sinus node and postoperative 
SND thus appears less likely. Morton et al. studied electrophysiological effects of chronic 
atrial stretch in ASD patients and demonstrated that sinus node function was impaired 
in the presence of chronic stretch compared to age-matched controls.22 In patients 
with unrepaired secundum ASD, abnormalities in sinus node function were observed 
during electrophysiology studies in previous literature, which the authors defined as 
possibly ‘congenital in origin’, apart from the hemodynamic effects of the shunt.5,6
It could be hypothesized that in ASD patients, ‘normal’ age-related deterioration 
of the sinus node20,23 combined with a higher level of ‘baseline’ damage to and around 
the sinus node – from a congenital origin, atrial stretch, cardiac surgery19 – results in 
earlier development of SND.
Complete atrioventricular conduction block
An interesting finding was the relatively high number of patients with (very) late 
development of cAVB after ASD repair, which was directly related to a redo procedure 
in only 4 of 10 patients. Postoperative cAVB may be caused by surgical damage to the 
AV node, even though the incidence of surgically induced AVB has decreased due to 
improved knowledge of the course of the conduction system.24 However, mitral valve 
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replacement in patients with complete atrioventricular septal defect was reported to 
be associated with a high risk of postoperative cAVB.25 This is in line with our findings: 
4 patients (all with secundum ASD) developed immediate postoperative cAVB after a 
redo procedure for mitral valve replacement.
Complete AVB in ASD patients may also have a congenital origin. Several studies 
observed electrophysiological abnormalities of the AV node in 12%6 and 33%5 of 
unrepaired secundum ASD patients. Embryonic development of the heart and the 
cardiac conduction system are narrowly related.26 Patients with a pAVSD have an 
abnormal anatomy of the AV canal, which may predispose to cAVB development. It 
has also been suggested that turbulence and trauma at the site of a pAVSD causes 
a fibrous tissue reaction around the defect, which may consequently invade the His 
bundle, leading to AV conduction abnormalities.27
Based on previous literature and our findings, we assume that development of (late) 
cAVB in ASD patients might be mediated by multiple factors, including a congenital 
origin, hemodynamic effects of the shunt, damage to the conduction system after 
(repeated) surgical procedure(s) and/or late fibrosis after cardiac surgery.19
Atrial tachyarrhythmias
One of the mechanisms for occurrence of atrial tachyarrhythmias in ASD patients is 
right atrial stretch in response to longstanding volume or pressure overload, present 
at respectively older age at repair or increased pulmonary artery pressure.1,28,29 In case 
of scar-related atrial macro-reentrant tachycardia, the arrhythmogenic substrate after 
repair consists of surgical lines of conduction block. Furthermore, Morton et al. showed 
that conduction delay at the crista terminalis was present in unrepaired ASD patients 
and persisted beyond surgical repair. Impaired conduction at the crista terminalis might 
contribute to development of late postoperative atrial tachyarrhythmias and perhaps 
also AF.22
Interrelationship between dysrhythmias
Occurrence of multiple dysrhythmias was observed in 39% of patients. Most patients 
had alternating SVT and AF episodes, with a trend towards more patients developing 
SVT before AF than vice versa. These findings are in line with those of Teuwen et al., 
who demonstrated coexistence of SVT and AF in 33% of CHD patients with atrial 
tachyarrhythmias, in whom SVT most often occurred before AF.12 The underlying 
mechanism for this observation might be that regular SVT causes electrical remodeling, 
thereby facilitating AF.11,30
It has been suggested that SND is associated with development of atrial 
tachyarrhythmias, either by 1) bradycardia-mediated atrial remodeling4,7,8 or 2) 
increased automaticity and early after-depolarizations leading to ectopic atrial 
activity9,10. In our study, no significant difference was observed in the number of patients 
first developing SND followed by atrial tachyarrhythmia(s) and vice versa. Development 
of atrial tachyarrhythmias involves multiple factors, of which SND might be only one. 
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Another possible factor includes prolongation of the atrial effective refractory period 
and corrected sinus node recovery time induced by episodes of AF or atrial flutter, 
leading to (reversible) SND.11,31,32
Limitations
In general, retrospective studies carry the risk of incomplete data. The first 
documentation of a dysrhythmia might not be the actual first occurrence of the 
dysrhythmia, since patients may have had asymptomatic events before. Patients in 
this study underwent surgical ASD repair at a relatively older age compared to newborn 
ASD patients nowadays.
CONCLUSIONS
The majority of dysrhythmias in surgically repaired ASD patients presented (very) late 
after ASD repair. In most patients, occurrence of late SND and cAVB was not related to 
redo procedures. Development of late dysrhythmias in surgically repaired ASD patients 
is probably related to multiple factors including increased susceptibility, cardiac surgery, 
electrical remodeling due to chronic right atrial stretch and a complex interplay between 
various dysrhythmias.
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Background: Older age is a known risk factor for developing atrial fibrillation (AF), 
yet it is unknown which electrophysiological changes contribute to this increased 
susceptibility. The goal of this study was to investigate heterogeneity in conduction 
and unipolar voltages related to aging.
Methods: We included 216 patients (182 male, age 36-83 years) without a history of 
AF undergoing elective coronary artery bypass grafting. Five seconds of sinus rhythm 
were recorded intraoperatively at the right atrium (RA), Bachmann’s bundle (BB), the 
left atrium and the pulmonary vein area. Conduction delay, conduction block (CB), 
conduction velocity and unipolar voltage was assessed in all locations, as well as the 
length of longest CB lines.
Results: With aging, increasing conduction heterogeneity was found, particularly in the 
RA and at BB (RA: longest CB line rs 0.158, p=0.021; BB: CB prevalence rs 0.206, p=0.003 
and conduction velocity rs -0.239, p<0.0005). Prevalence of low unipolar voltage areas 
(unipolar voltage <5th percentile) increased with aging at BB and in the pulmonary 
vein area (BB: rs 0.237, p<0.0005 and pulmonary vein area: rs 0.228, p=0.001). Median 
unipolar voltage in the RA and at BB were both inversely correlated with age (BB: rs 
-0.328, p<0.005; RA: -0.291, p<0.005).
Conclusions: Aging was accompanied by an increase in heterogeneity in conduction 
and low unipolar voltage areas, particularly at BB and in the RA. As expected, variability 
in these electrophysiological parameters among patients with similar age was large. 
Nevertheless, a trend towards increased electropathology with aging was found. These 
electrophysiological changes may at least in part explain the rising prevalence of AF 
with aging.
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INTRODUCTION
Older age is a known risk factor for developing atrial fibrillation (AF).1,2 Prevalence of 
AF is low before the age of 60 but rises steeply afterwards.3 Even though the relation 
between age and AF is clear, there is limited data on the electrophysiological changes 
that underlie this relation.4-6
Electrogram morphology in relation to age has been investigated by endocardial 
mapping of the right atrium (RA) during sinus rhythm in 111 patients (mean age 57.0 ± 
14.1 years) with paroxysmal AF. Patients ≥ 60 years had more abnormal electrograms, 
defined as electrograms with a duration of ≥ 100 ms and/or containing eight or 
more negative deflections.4 In 23 patients (age 17-75 years) with left-sided accessory 
pathways, Kojodjojo et al. found that endocardial wave propagation velocity in both 
the left (LA) and RA declines with increasing age.6 These previous studies were limited 
to either the RA or LA, included a relatively low number of recording sites or examined 
only one electrophysiological parameter.
Additionally, Bachmann’s Bundle (BB) is presumed to be involved in the 
pathophysiology of AF.7 However, so far it is unknown whether Bachmann’s Bundle (BB) 
undergoes electrophysiological changes with aging. Furthermore, it is unknown to what 
degree comorbidities influence the electrophysiological changes found during aging.
The goal of this study was to examine conduction heterogeneity and unipolar 
voltages in relation to age using a high-resolution epicardial mapping approach of the 
RA, LA and BB in a large cohort of patients without a history of AF, in order to find an 
explanation for the increased susceptibility to AF associated with aging.
METHODS
Study population
Patients (age ≥ 18 years) without a history of AF undergoing elective open chest cardiac 
surgery for coronary bypass grafting were included. Echocardiographic images were 
used to identify left atrial dilatation (left atrial diameter of >45 mm). This study was 
approved by the Medical Ethical Committee in the Erasmus Medical Center (MEC 2010-
054 and MEC 2014-393) and follows the declaration of Helsinki principles. Written 
informed consent was obtained from all patients.
Mapping procedure
Before commencement of extracorporeal circulation, high-resolution epicardial mapping 
was performed as described previously.8 A bipolar wire was attached to the crista 
terminalis, serving as a reference electrode, and a steel wire was fixed to subcutaneous 
tissue in the thorax and used as an indifferent electrode. Recordings were made during 
sinus rhythm using either a 128-unipolar electrode (electrode diameter: 0.65 mm) or a 
192-unipolar electrode (electrode diameter: 0.45 mm) array. Inter-electrode distances 
11
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of both arrays were 2 mm. The mapping array was shifted over predefined sites to cover 
both atria (Figure 1). Five seconds of sinus rhythm were recorded at each mapping site. 
This recording included a bipolar reference electrograms, all unipolar electrograms, 
a surface electrocardiogram and a calibration signal with an amplitude of 2 mV and 
a duration of 1000ms. Sampling rate was 1kHz and the signals were amplified (gain 
1000), filtered (bandwidth 0.5 – 400 Hz), analogue-to-digital converted (16-bits) and 
stored on a hard disk.
Analysis of mapping data
Electrograms were visualized and annotated using dedicated mapping software. The 
steepest negative atrial deflection was marked if the amplitude exceeded the noise 
level of the electrogram at least twice. For every sinus beat, local activation times 
were used to construct activation maps. Electrogram files were excluded when less 
than 40% of the atrial deflections in the mapping array were annotated due to poor 
quality recordings. Atrial extra systolic beats were excluded. If data from more than 
one location (RA, BB, LA, pulmonary vein area (PVA)) was unavailable for any reason, 
the patient was excluded.
Analysis of conduction abnormalities and electrogram amplitude
Peak-to-peak amplitude of the steepest atrial deflection was measured to create voltage 
maps. As the cutoff point for low voltage, the 5th percentile of all unipolar peak-to-peak 
amplitudes was taken. Continuous areas of low voltages were defined as connecting 
electrodes from which peak-to-peak amplitudes below the 5th percentile were recorded. 
Similar to previous studies, conduction delay (CD) was determined as a difference in 
local activation time (conduction time) of 7-11 ms between two adjacent electrodes 
and conduction block (CB) as a conduction time of ≥12 ms between two electrodes.9 
If a CD area was connected to a CB area it was labeled as a continuous CDCB area. 
Overall, CD and CB combined (regardless of whether they are connected or not) was 
indicated as CDCB. Conduction velocity (CV) was computed by the method of discrete 
velocity vectors as described by van Schie et al. (Identification of local atrial conduction 
heterogeneities using high density conduction velocity estimation. Submitted).
All locations (except BB when using the 192-array) had multiple mapping sites 
(Figure 1). All voltage and conduction parameters were calculated per mapping site 
and expressed as either an average or summation for each location or for all locations 
together (biatrial). Additionally, from the mapping sites per atrial location, we identified 
the one mapping site with the highest degree of heterogeneity in conduction which 
was defined as the ‘maximum prevalence of CB/CDCB’ or the ‘lowest CV’. As the main 
direction of myocardial fibers at BB is known7, we used this location to investigate 
differences between transverse and longitudinal conduction slowing. For this purpose 
we included only conduction times ≥4 ms; conduction times of 1-3 ms were considered 
‘normal’ conduction. We calculated the ratio of the prevalence of conduction times ≥4 
ms in the transverse direction to the longitudinal direction (TL4 ratio) in patients in 
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whom BB was activated from the RA to the LA, as in this case wavefront propagation 




































Figure 1. High-resolution epicardial mapping
Upper panel: overview of the mapping locations on a posterior view of the heart. Middle panel: 
two electrograms of three sinus beats, showing atrial potentials followed by a ventricular far-field 
signal. Lower panel: wavefront entry sites at BB (see text for detailed explanation). Isochrones 
are drawn at 10ms. Arrows indicate the main direction of wavefront propagation. Thick black 
lines indicate conduction block.
A: atrial signal, BB: Bachmann’s bundle, CT: crista terminalis, IVC: inferior vena cava, LA: left 
atrium, PVA: pulmonary vein area, RA: right atrium, SVC: superior vena cava, V: ventricular far-
field signal.
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Wave entry sites at Bachmann’s bundle
A prior study demonstrated that patients with a history of AF more often had a 
wavefront entering in the middle of BB.9 Therefore, at BB, the site of wavefront entry 
was examined for all patients as depicted in Figure 1. Entry sites were classified as right 
atrial entry (RA entry), central entry, breakthrough or multiple entry sites. RA entry site 
was defined as a wavefront entering BB from the right atrial side. A wavefront entering 
from the lateral side of the array and propagating radially to the left and right was 
defined as a central entry. A wavefront entering in the middle of the array was defined 
as breakthrough. When more than one wavefront activated BB (almost) simultaneously, 
it was labeled as multiple entry.
Statistical analysis
Normally distributed data was described as mean ± standard deviation, skewed data as 
median [interquartile range] and categorical data as number (percentage). Continuous 
data was tested with an independent samples t-test or ANOVA; a Mann-Whitney U or 
Kruskal-Wallis test was used when data was skewed. Categorical data was tested using 
chi-square test or a Fisher’s exact test where appropriate. The measure of correlation 
between age and baseline characteristics, and age and electrophysiological parameters 
was determined by Spearman’s rank correlation. Linear regression was performed to 
determine associations between electrophysiological parameters and age; multivariate 
regression included the following additional independent variables: gender, BMI, 
myocardial infarction, hypertension, hypercholesteremia, diabetes mellitus, thyroid 
disease, left ventricular function. A β coefficient value from multiple linear regression 
was described as β [95% confidence interval]. Log transformation was performed for 
TL-ratio, continuous area of low voltage (at RA and BB) and prevalence of low voltage (at 
RA, BB and PVA) as the criteria for linear regression were not met. We included various 
cardiovascular risk factors and electrode array set-up (128- or 192-electrode array) in 
the regression model as independent variables to eliminate a possible confounding 
effect. All statistical analyses were performed with IBM SPSS statistics for Windows, 
version 25 (IBM Corp., Armonk, N.Y., USA).
RESULTS
Baseline characteristics
A total of 216 patients (182 male (84.3%)) aged between 36 and 83 years (median 
66.7 years [58.9-72.5]) were included. The relative frequency distribution of age in 
our population is demonstrated in the upper panel of Figure 2. Detailed baseline 
characteristics are listed in Table 1. Except for BMI, (rs -0.23, p=0.001), none of the 
baseline characteristics were associated with age. Mapping data consisted of a total of 
413,606 electrograms (1882.5 [1701-2125] electrograms per patient).
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Relation between heterogeneity in conduction and aging
The middle and lower panel of Figure 2 demonstrate examples of regional differences 
in the prevalence of CB and local CV in a 52- and an 81-years old patient. CB prevalence 
was higher in the older patient and differences between the two patients were most 
pronounced at BB and the RA. Similarly, CV was substantially lower in these locations 
in the older patient.
With aging, the prevalence of biatrial CB increased (rs 0.158, p=0.020). Maximum 
prevalence of CB and CDCB (rs 0.218, p=0.001, rs 0.143, p=0.035), regardless of 
location, increased with advancing age. The scatterplot in the upper panel of Figure 
3 demonstrates the relation between age and maximum prevalence of CB. This 
scatterplot also illustrates the large variability found among patients of a similar 
age, which accounts for the low correlation coefficient as well as the low β in linear 
regression (Supplemental Table 1 and Supplemental Table 2). Maximum prevalence of CB 
and CDCB was found at the RA in most patients: in 132 (61.1%) and 122 (56.5%) patients, 
respectively. Age of patients did not differ according to the location of the maximum 
prevalence of CB or CDCB (p=0.529 and p=0.146, respectively).
Significant correlations between conduction parameters and age were found at BB 
and RA; outcomes are summarized in Supplemental Table 1. At BB, prevalence of CD, 
CB and continuous CDCB as well as several properties of conduction disorders (e.g. 
length of lines) increased with aging. At the RA, the longest CB line (rs 0.158, p=0.021) 
and maximum CB prevalence significantly increased with age (rs 0.196, p=0.004). 
Interestingly, at the RA, only the amount of CB was affected, whereas at BB the amount 
of CD also increased with aging.
In the entire study population, biatrial CV was 86.9 [81.8-91.8] cm/s. Lowest CV 
decreased with aging (rs -0.210, p=0.002) (Figure 3); the lowest CV was most often found 
in the RA (n=83 patients, 38%). Age of patients did not differ according to the location of 
the lowest CV (p=0.240). In both the RA and at BB, a decline in CV with aging was seen 
(RA: lowest CV rs -0.231, p=0.001 and BB: CV rs -0.239, p<0.0005).
After multivariate analysis for correction of a confounding effect of various 
cardiovascular risk factors, most conduction disturbances were independently related 
to aging, as summarized in Supplemental Table 2 .
Sinus rhythm wavefront entry site at Bachmann’s Bundle
Age did not differ among patients with different wave entry sites (RA entry: 64.7 years 
[57.0–71.5], central entry: 67.2 years [60.8-72.3], breakthrough: 69.2 years [66.6-74.7], 
multiple entry: 68.4 years [61.1-73.7], p=0.249). Additionally, patients with a ‘regular’ 
wave entry (RA entry) at BB were not significantly younger than patients with another 
entry site, although a trend towards significance was observed (64.7 years [57.0-71.5] 
versus 67.7 years [61.8-72.7], p=0.062).
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Figure 2. Age and conduction disorders
Upper panel: the relative distribution of age in the study population. Lower panel: examples of 
the distribution of CB prevalence and CV in a younger (left) and older (right) patient.
CB: conduction block, CV: conduction velocity, IVC: inferior vena cava, SVC: superior vena cava.
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Table 1. Baseline characteristics (N=216)
Age (years) 66.7 (58.9-72.5)
Female gender 34 (15.7)
Body Mass Index (kg/m2)* 28.4 ± 4.1
Hypertension 139 (64.4)
Diabetes mellitus 75 (34.7)
Dyslipidemia 98 (45.4)
Thyroid disease 9 (4.2)
Myocardial infarction 105 (48.6)
Left ventricular function
Normal 162 (75.0)
Mild impairment 47 (21.8)
Moderate impairment 6 (2.8)
Severe impairment 1 (0.5)
Left atrial enlargement † 25/123(20.3)
Missing 93
Left atrial diameter (mm) 39.0 (37-43)
Missing 125
Values are expressed as n (%), median (IQR), or mean ± SD.
* significant correlation with age. † left atrial enlargement = left atrial diameter > 45 mm.
Differences between transverse and longitudinal conduction slowing
Examples of TL4 ratios in a 51- and a 70-year old patient are depicted in the upper panel 
of Figure 4. Both patients had a similar prevalence of longitudinal conduction times 
≥4 ms (both 6.1%). However, the older patient had a higher prevalence of transversal 
conduction times ≥4 ms (6.9% versus 2.9%) resulting in a higher TL4 ratio (1.14 versus 
0.46).
In the 116 patients with an RA entry site, aging was associated with an increased 
TL4 ratio (β 0.004 [0.001-0.006])/year, p=0.011 and rs 0.221, p=0.017), indicating 
slowing of transverse conduction to a greater extent than longitudinal conduction 
with advancing age (lower panel of Figure 4). After correction for cardiovascular risk 
factors, age remained an independent predictor for a higher TL4 ratio (β 0.003 [0.000-
0.006]/year, p=0.046).
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Location RA (n = 83, 38%)
BB 
(n = 28, 13%)
PV 
(n = 56, 26%)
LA 
(n = 49, 23%)
Age (yrs) 67.2 [58.6-72.5] 70.0 [59.6-77.4] 66.0 [57.8-71.6] 66.2 [58.8-70.6]
Maximum prevalence of CB 
Location RA 
(n = 132, 61%)
BB 
(n = 35, 16%)
PV 
(n = 32, 15%)
LA 
(n = 17, 8%)





Figure 3. Correlation between age and conduction disorders
The correlation between age and maximum CB prevalence (upper panel) and age and lowest CV 
(lower panel) in each atrial location. Lines indicate 95% confidence intervals.
* Max %CB: p = 0.001 / Min CV: p = 0.004
BB: Bachmann’s bundle, CB: conduction block, CV: conduction velocity, LA: left atrium, PVA: 
pulmonary vein area, RA: right atrium.
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transversal % CTs ≥ 4
longitudinal % CTs ≥ 4TL4 ratio =
TL4 ratio 0.46
2.8% / 6.1% 6.9% / 6.1%
Figure 4. Transverse versus longitudinal conduction slowing
Upper panel: examples of a low TL4 ratio in a young patient (left) and a high TL4 ratio in an older 
patient (right). Arrows indicate the main direction of wavefront propagation. Thick blue and black 
lines show conduction times ≥4 ms, in transversal (blue) and longitudinal (black) direction. Lower 
panel: the correlation between age and TL4 ratio in patients with an RA entry site (n=116). Lines 
indicate 95% confidence intervals. * p=0.022
CT: conduction time.
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Low voltage zones and aging
Figure 5 shows scatterplots of median amplitudes per location and age; again, large 
variability is seen among patients of a similar age. The cutoff for low voltage was based 
on the 5th percentile of the amplitudes of all atrial deflections and was 0.7339 mV. 
With advancing age, in the RA and BB, median amplitude was lower (RA: rs -0.291, 
p<0.0005, BB: rs -0.328, p<0.0005) and the largest continuous area of low voltage 
increased (RA: rs 0.175, p=0.010, BB: rs 0.136, p=0.045). At BB, the prevalence of low 
voltage areas was higher (BB: rs 0.237, p<0.0005). At the PVA, the prevalence of low 
voltage areas, but not the size of continuous areas, increased with advancing age (rs 
0.228, p=0.001). After multivariate testing to correct for a confounding effect of various 
cardiovascular risk factors, all parameters except prevalence of low voltage at the RA 
remained independently related to age. Supplemental Table 3 and Supplemental Table 


















Age (years) Age (years)
Amplitude = 7.79 - 0.049 * Age
Rho: -0.291
Amplitude = 12.93 - 0.112 * Age
Rho: -0.328
Amplitude = 5.54 - 0.001 * Age
Rho: -0.013 
Amplitude = 7.22 - 0.031 * Age
Rho: -0.074
Figure 5. Age and voltage distribution
The relation between signal voltage and age for each location separately. Lines indicate
95% confidence intervals.
* RA: p <0.0005 , BB: p <0.0005
BB: Bachmann’s bundle, LA: left atrium, PVA: pulmonary vein area, RA: right atrium.
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DISCUSSION
Key findings
Using a high-resolution epicardial mapping approach, we found that advancing age 
was associated with increasing heterogeneity in conduction and decreasing unipolar 
voltages. With increasing age, CB occurred more frequently, and conduction slowed. 
More specifically, conduction abnormalities at BB and in the RA were more prevalent 
in older patients. This is the first study suggesting enhanced lateral uncoupling in the 
aging intact human heart. Low voltage areas were more pronounced at BB, RA and PVA 
in older patients. Conduction disorders and low voltage areas remained significantly 
related to age after multivariate analysis with cardiovascular risk factors.
Electrophysiological changes related to aging
Several endocardial mapping studies also found a relation between age and slowing of 
conduction and low voltage areas. A decrease in wavefront propagation velocity in the 
RA and LA with aging was found in an electro-anatomic mapping study by Kodjojo et al. 
in 23 patients.6 Additionally, two studies focusing on electrophysiological parameters in 
relation to age in the RA divided patients into 3 age groups (≤ 30 years, 31-59 years and 
≥ 60 years). They found an increase in low voltage areas and fractionated electrograms 
along the crista terminalis with aging.5,10 Kistler et al. found conduction slowing in the 
RA by calculating CV in six locations throughout the RA.5 Interestingly, in our study, the 
average CV for the entire RA area did not change with aging. Yet, the lowest CV for the 
RA area was lower in older patients, indicating regional differences in CV.
The abovementioned studies contained relatively small study populations and 
patients were divided into groups based on age. In addition, these studies did not 
correct for cardiovascular risk factors. Our study used age as a continuous parameter 
to find true correlations between electrophysiological parameters and age. Also, we 
were able to take other cardiovascular risk factors into account due to our large study 
population. Large interindividual variability was expected as sinus rhythm activation 
pathways differ from patient to patient.11,12 Nevertheless, a trend of increasing 
electropathology with age during sinus rhythm was observed.
Structural changes related to aging
Various studies have investigated structural changes in the atria occurring during aging. 
Compensatory cellular hypertrophy due to loss of cardiomyocytes by apoptosis and 
necrosis in advancing age is seen as well as increased fibrosis content which impairs cell-
to-cell interactions.13,14 The relation between age and atrial fibrosis has been extensively 
studied. Almost all studies found a positive relation between fibrosis and aging in 
patients with and without a history of AF.15,16 Structural remodeling accompanied by 
age could explain the lower voltage areas, conduction disturbances including (local) 
conduction slowing seen in our study at BB and is likely to contribute to development 
of AF.
11
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In 1988, Spach et al. found progressive electrical uncoupling of side-to-side 
connections with increasing age and development of collagenous septa between 
fibers impairing conduction even more. This uncoupling resulted in a slower transverse 
propagation at a long (800 ms) cycle length in older atrial muscle bundles.17 Similarly, 
Koura et al. found connexin modification in the RA free wall of canine atria with aging. 
In infant dogs the gap junction Cx43 was distributed over the entire cell surface, while 
in older dogs Cx43 was more localized to the cell termini causing lateral uncoupling. 
Consequentially, wavefront curvature differed in the older dogs already at a cycle 
length of 500 ms. In younger dogs, an elliptical pattern of propagation was seen, while 
older dogs with slower transverse propagation showed a more ‘square’ wavefront by 
crowding of transverse isochrones.18 This side-to-side uncoupling gives rise to micro 
re-entry circuits, facilitating AF domestication.17,19 Interestingly, a study in mice by Jansen 
et al. found that reduced ventricular connexin43 (Cx43) expression results in excessive 
collagen deposition.20 In our study, we measured transverse to longitudinal conduction 
times ≥4 ms prevalence ratio in patients with a similar conduction direction. Of course, 
we measure at a more macroscopic level than Spach et al. in their study, and we can 
only determine the effective conduction times between measured areas of tissue. 
Furthermore, the fiber direction in relation to our mapping array might vary from 
patient to patient resulting in a slight variation in direction of conduction delays. Still, 
in 116 patients we found that with increasing age transverse conduction deteriorates 
relatively more than longitudinal conduction, implying lateral uncoupling with aging.
Sinus rhythm wave entry at BB
In previous studies, it was shown that different activation patterns at BB have a 
possible arrhythmogenic connotation. Teuwen et al. found that patients with a history 
of AF more often had a wavefront entering in the middle of BB compared to patient 
without a history of AF.9 Mouws et al. found that patients with (ischemic and) valvular 
heart disease more often had a wavefront entering in the middle of BB compared to 
patients with only ischemic heart disease.12 In an anatomical study by Knol et al. in 19 
postmortem dissected hearts, the relation of the interatrial septum to BB was shown 
which could be the origin of breakthrough waves. Furthermore, a posterosuperior 
bundle was found in all hearts that coincides with a central entry site at BB.21 As all 
patients have this posterosuperior bundle, it is interesting that differences were found 
in the previous studies by Teuwen et al. and Mouws et al. Hypothetically, development 
of conduction disturbances could lead to a change in preferential activation route from 
a “normal” RA entry site to an entry site in the middle of BB using the posterosuperior 
bundle or the interatrial septum, which would make wave entry site at BB an indirect 
indicator for these disturbances. This is supported by the findings in our study, where 
patients with a “normal” RA entry were younger compared to other entry sites, although 
this did not reach significance. However, as the the exact location of the mapping array 
as well as anatomical structures might shift patient to patient, an entry site might 
sometimes be misclassified.
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Limitations
As we only included patients without a history of AF, the older patients in our group 
could represent patients with a less severe arrhythmogenic substrate as a result of 
aging than patients of the same age with AF. Additionally, the younger patients probably 
do not represent an average person at their age, as they already required coronary 
artery bypass grafting. However, this implies that the changes in relation to aging 
observed in our study may be even more outspoken in the general population.
CONCLUSION
Aging was accompanied by an increase in conduction abnormalities, general 
conduction slowing and low voltage areas during sinus rhythm, particularly at BB and 
RA. Additionally, lateral uncoupling at BB increased with advancing age. As expected, 
variability in these electrophysiological parameters among patients with similar age 
was large. Nevertheless, a trend towards increased electropathology with aging was 
found. These changes may at least in part explain the rising prevalence of AF with aging. 
Future studies during pacing and (induced) AF may provide additional information on 
the development of the arrhythmogenic substrate related to aging.
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SUPPLEMENTAL MATERIAL
Supplemental Table 1. Correlations between conduction parameters and age
Location Dependent variable Correlation with age
Spearman’s rho P
Biatrial %CB 0.158 0.020
Max %CB 0.218 0.001
Max %CDCB 0.143 0.035
Min CV -0.210 0.002
RA Longest CB line 0.158 0.021
Max %CB 0.196 0.004
Min CV -0.231 0.001




Median cCDCB line 0.120 0.079
Longest CB line 0.151 0.028
Longest cCDCB line 0.155 0.023
No. of CD lines 0.179 0.009
No. of CB lines 0.183 0.007
CV -0.239 <0.0005
LA - - -
PVA No. of CB lines 0.132 0.054
CV in cm/s, lines in mm.
BB: Bachmann’s bundle, CB: conduction block, CD: conduction delay, cCDCB: continuous area of 
conduction delay and conduction block, CV: conduction velocity, LA: left atrium, med: median, 
PVA: pulmonary vein area, RA: right atrium.
11
VolledigbinnenwerkCharlotte.indd   227 18/11/2020   16:09:10
228
Chapter 11
Supplemental Table 2. Significant associations between conduction parameters and age
Location Dependent 
variable
Univariate analysis Multivariate analysis
β [95% CI] P β [95% CI] P
Biatrial %CB 0.020 [0.002-0.039] 0.034 0.019 [-0.001-0.039] 0.057
Max %CB 0.111 [0.046-0.175] 0.001 0.093 [0.032-0.155]* 0.003
Max % CDCB 0.097 [0.019-0.175] 0.015 0.077 [0.006-0.149]* 0.035
Min CV -0.262 [-0.425 - -0.099] 0.001 -0.274 [-0.442 - -0.107]* 0.001
RA Max CB line 0.279 [0.031-0.526] 0.028 0.211 [-0.045-0.468] 0.105
Max %CB 0.118 [0.039-0.197] 0.004 0.103 [0.020-0.186]* 0.016
Min CV -0.251 [-0.405 - -0.097] 0.002 -0.230 [-0.379 - -0.082]* 0.003
BB %CD 0.053 [0.018-0.087] 0.003 0.052 [0.016-0.087] 0.005
%CB 0.072 [0.033-0.111] <0.0005 0.074 [0.032-0.115] 0.001
%CDCB 0.124 [0.063-0.185] <0.0005 0.125 [0.061-0.189] <0.0005
%cCDCB 0.095 [0.041-0.149] 0.001 0.098 [0.040-0.155] 0.001
Med cCDCB line 0.203 [0.056-0.349] 0.007 0.208 [0.053-0.363] 0.009
Max CB line 0.233 [0.050-0.417] 0.013 0.242 [0.046-0.437] 0.016
Max cCDCB line 0.394 [0.113-0.674] 0.006 0.411 [0.113-0.708] 0.007
No. of CD lines 0.073 [0.020-0.126] 0.007 0.058 [0.003-0.113] 0.037
No. of CB lines 0.046 [0.012-0.079] 0.008 0.042 [0.007-0.077] 0.020
CV -0.310 [-0.489 - -0.132] 0.001 -0.332 [-0.556 - -0.148] <0.0005
LA - - - - -
PVA No. of CB lines 0.043 [0.0-0.086] 0.049 0.038 [-0.008-0.084] 0.103
CV in cm/s, lines in mm.
Multivariate analyses included the following independent variables: age, gender, BMI, myocardial 
infarction, hypertension, hypercholesteremia, diabetes mellitus, thyroid disease, left ventricular 
function
* Additional independent variable: electrode set-up (128 or 192 electrodes). Since the maximum 
CB prevalence or lowest CV may be influenced by the size of the area covered by the mapping 
array, electrode set-up was added as an independent variable in the multivariate analysis of 
these dependent variables.
BB: Bachmann’s bundle, CB: conduction block, CD: conduction delay, CI: confidence interval, CV: 
conduction velocity, LA: left atrium, med: median, PVA: pulmonary vein area, RA: right atrium.
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Supplemental Table 3. Correlations between unipolar voltage parameters and age
Location Dependent variable Correlation with age
Spearman’s rho P
RA Median voltage -0.291 <0.0005
Continuous area of low voltage* 0.175 0.010
% low voltage 0.107 0.116
BB Median voltage -0.328 <0.0005
Continuous area of low voltage* 0.136 0.045
% low voltage 0.237 <0.0005
LA - - -
PVA % low voltage 0.228 0.001
Voltage in mV. * number of electrodes.
BB: Bachmann’s bundle, CB: conduction block, CD: conduction delay, CI: confidence interval, CV: 
conduction velocity, LA: left atrium, med: median, PVA: pulmonary vein area, RA: right atrium.
Supplemental Table 4. Significant associations between unipolar voltage parameters and age
Location Dependent 
variable
Univariate analysis Multivariate analysis
β [95% CI] P β [95% CI] P
RA Median voltage -0.049 [-0.070 - -0.029] <0.0005 -0.047 [-0.069 - -0.026] <0.0005
Continuous 
area of low 
voltage*†
0.010 [0.003-0.018] 0.005  0.010 [0.002-0.017] 0.013
% low voltage†  0.011 [0.001-0.021] 0.029 0.010 [0.000-0.021] 0.054
BB Median voltage -0.112 [ -0.152 - - 0.071] <0.0005 -0.117 [-0.159 - -0.074] <0.0005
Continuous 
area of low 
voltage*†
0.007 [0.000-0.014] 0.049 0.008 [0.000-0.015] 0.042
% low voltage† 0.027 [0.012-0.042] 0.001 0.030 [0.014-0.045] <0.0005
LA - - - - -
PVA % low voltage† 0.004 [0.002-0.005] <0.0005 0.004 [0.002-0.006] <0.0005
Voltage in mV. * number of electrodes.
Multivariate analyses included the following independent variables: age, gender, BMI, myocardial 
infarction, hypertension, hypercholesteremia, diabetes mellitus, thyroid disease, left ventricular 
function
† Log transformation of the dependent variable was performed to meet the criteria for linear 
regression. Therefore, for each unit change in X (age), Y (e.g. prevalence of low voltage) changes 
10 ^ β.
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Objectives: The aim of this study was to quantify characteristics of atrial conduction 
disorders in patients with right atrial (RA) volume overload.
Background: Patients with an interatrial shunt are prone to developing atrial fibrillation 
(AF), which may be related to conduction disorders occurring due to atrial stretch.
Methods: Thirty-one patients undergoing surgery for an interatrial shunt (49±14 years) 
underwent epicardial sinus rhythm mapping of the RA, Bachmann’s bundle (BB) and left 
atrium (LA). Conduction delay (CD) was defined as inter-electrode conduction time (CT) 
of 7-11ms and conduction block (CB) as CT ≥12ms. Prevalence of CD/CB (percentage 
of mapped region), length of lines, and severity of CB (75th percentile of CTs ≥12ms) 
were analyzed.
Results: All patients had some degree of CD and CB. Prevalence of CD and CB was 
higher in the RA and BB than in the LA (p<0.0083 after Bonferroni correction). The 
longest CB line within each patient was found in the RA in most patients (52%). Inter-
individual variation in prevalence and lengths of lines was considerable. CB was more 
severe in the RA than in the LA (p<0.0083). Within the RA, conduction disorders were 
more prevalent and more severe in the intercaval region than in the RA free wall 
(p<0.05).
Conclusions: In patients with an interatrial shunt, conduction disorders during sinus 
rhythm are most pronounced in the RA – particularly the intercaval region – and 
BB. Knowledge of the conduction during sinus rhythm is essential to determine the 
relevance of conduction disorders for initiation and perpetuation of AF.
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INTRODUCTION
Atrial septal defect (ASD) is one of the more common congenital heart defects 
which often remains undiagnosed until adulthood. The interatrial left-to-right shunt 
causes volume overload, dilatation and stretch of the right atrium (RA). A long-term 
consequence of ASD is the development of atrial fibrillation (AF), which is associated 
with substantial morbidity.1 AF prevalence is considerably higher in ASD patients than in 
the general population1,2, which suggests the substrate underlying AF in these patients 
is either different or more severe.
A key factor determining risk of AF is age at ASD repair, as this will determine the 
duration of right atrial volume overload and stretch.1 The consequences of atrial 
stretch have been described extensively in humans with atrial volume overload.3-6 
A prime consequence is the presence of atrial conduction abnormalities, which 
may be aggravated by a longer stretch duration. It is assumed that atrial conduction 
abnormalities are crucially involved in initiation and perpetuation of AF.7
In ASD patients, conduction abnormalities have been found in both the right and 
left atrium. Morton et al. reported that conduction delay at the crista terminalis was 
significantly more pronounced in ASD patients than in control subjects.3 Roberts-
Thomson et al. also compared ASD patients with control subjects and demonstrated 
the presence of conduction abnormalities in the LA, as well as low voltage regions, 
increased inducibility of AF and echocardiographic LA dilatation in ASD patients.4
However, the spatial distribution of conduction disorders across both atria, including 
Bachmann’s bundle (BB), in patients with longstanding RA volume overload has so far 
not been studied. In order to be able to interpret the relevance of conduction disorders 
for initiation and perpetuation of AF in this specific patient population, it is essential to 
understand their characteristics and spatial distribution within the atria during sinus 
rhythm.
The aim of this study was therefore to quantify the characteristics of atrial 
conduction disorders during sinus rhythm in adult patients with an interatrial left-to-
right shunt, and to establish whether predilection sites exist. To this end, we performed 
intra-operative, high-resolution epicardial mapping of the RA, BB and LA in patients 
undergoing surgical correction of the defect.
METHODS
Study population
The study population consisted of 31 adult patients with a congenital interatrial left-
to-right shunt, scheduled for the first surgical correction of the defect. This study was 
approved by the institutional medical ethical committee (MEC-2010-054, MEC-2014-393). 
All patients provided written informed consent. Patient characteristics were obtained 
12
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from electronic files. LA and RA dimensions were assessed on 2D echocardiography 
and dilatation was defined according to the guidelines.8
Mapping procedure
Epicardial mapping during sinus rhythm was performed prior to commencement of 
extra-corporeal circulation, as previously described in detail.9 A bipolar epicardial 
pacemaker wire was temporarily attached to the right atrial free wall and served 
as temporal reference signal. The indifferent electrode was a steel wire fixed to 
subcutaneous tissue of the thoracic cavity.
The mapping procedure was performed with an electrode array consisting of either 
128 or 192 unipolar electrodes with diameters of respectively 0.65 or 0.45 mm and an 
inter-electrode distance of 2 mm. Mapping sites were defined according to anatomical 
landmarks and borders (upper panel Figure 1). The electrode array was placed on 
each mapping site in a systematic and consecutive order, including the RA (from cavo-
tricuspid isthmus towards the RA appendage, perpendicular to the caval veins), BB 
(between the border of the LA appendage and the superior cavo-atrial junction), left 
atrioventricular groove (LAVG; from the lower border of the left inferior pulmonary 
vein towards the LA appendage), and the pulmonary vein area (PVA; from the sinus 
transversus along the borders of the pulmonary veins towards the atrioventricular 
groove).
At each mapping site, 5 seconds of sinus rhythm were recorded, including a 
simultaneously recorded surface ECG, a bipolar reference electrogram, a calibration 
signal (2mV, 1000ms) and unipolar epicardial electrograms. Recordings were sampled 
with a rate of 1kHz, amplified (gain: 1000), filtered (bandwidth: 0.5–400 Hz), converted 
from analog to digital (16 bits) and stored on a hard disk.
Mapping data analysis
Local activation maps were constructed by annotating the steepest negative deflection 
of atrial potentials on every electrode, provided that the amplitude exceeded twice the 
baseline noise level. Atrial extrasystolic beats were excluded. Signals were manually 
checked by two investigators and false annotations (e.g. artifacts) were corrected.
Difference in local activation time was calculated between each electrode and the 
adjacent right and lower electrode, resulting in two inter-electrode conduction times 
(lower panel Figure 1). Consistent with prior mapping studies, conduction delay (CD) 
and conduction block (CB) were defined as conduction times of respectively 7-11ms 
and ≥12ms between two adjacent electrodes, corresponding to effective conduction 
velocities of respectively 18 to 29 cm/s and <18 cm/s.10,11
Prevalence of CD/CB was defined as the number of inter-electrode conduction 
times satisfying the definitions for CD/CB as a percentage of the total number of inter-
electrode conduction times measured in a sampled region. Prevalence of CD/CB was 
calculated for all mapping regions combined as well as for each region separately (RA, 
BB, LAVG, PVA). Lines of CD, CB and continuous CDCB were defined as uninterrupted 
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series of inter-electrode CD, CB or a combination of CD and CB and length was 
measured on a 2mm resolution scale. Severity of CB was defined as the 75th percentile 
of CTs ≥12ms. To further analyze the spatial distribution of conduction disorders within 
the RA, the RA surface was subdivided into 2 areas: the intercaval region and the RA 



























Figure 1. High-resolution epicardial mapping
Upper panel: mapping sites on a schematic posterior view of the atria. Lower panel: color-
coded activation map recorded on BB with isochrones drawn at 10ms (left) and conduction 
delay/block map (right).
BB: Bachmann’s bundle, CB: conduction block, CD: conduction delay, CT: conduction time, ICR: 
intercaval region, IVC: inferior vena cava, LAVG: left atrioventricular groove, LAT: local activation 
time, PVA: pulmonary vein area, PV: pulmonary vein, RA: right atrium, RAFW: right atrial free wall, 
SVC: superior vena cava.
12




Normally distributed continuous variables were expressed as mean ± standard 
deviation (minimum-maximum) and skewed variables as median (minimum-maximum). 
A paired samples t-test or Wilcoxon signed-rank test was used to compare continuous 
parameters between the four atrial regions and between the intercaval region and 
RA free wall. Bonferroni correction was applied for comparison of the four regions; 
a p-value of <0.0083 (0.05/6) was considered statistically significant. Categorical data 
was presented as numbers and percentages and compared with the chi-squared 
test. Univariate linear regression was performed with dependent variables including 
prevalence, median length of lines and length of the longest line of CB and continuous 
CDCB and independent variables including age, indexed RA volume (ml/m2) and 
indexed LA diameter (cm/m2). If the model did not conform to the assumptions of 
linear regression, log-transformation of the dependent variable was performed and 
subsequently, if necessary, of the independent variable or of both variables. A p-value 




Clinical characteristics of the study population are summarized in Table 1. Most patients 
had a secundum ASD (n=18, 58%), followed by a sinus venosus defect with partial 
abnormal pulmonary venous return in 11 patients (36%) and isolated partial abnormal 
pulmonary venous return in 2(7%). The RA was dilated in 26 patients (84%) and LA 
dilatation was present in 10 patients (32%). Five patients had a history of paroxysmal 
AF; clinical characteristics did not differ significantly between patients with and without 
a history of AF. One patient had a history of atrial flutter. Median (minimum-maximum) 
cycle length during sinus rhythm was 833ms (638-1326) and did not differ between the 
atrial regions (p>0.0083).
Regional differences in heterogeneity in conduction
The upper panel of Figure 2 illustrates examples of distribution of CD and CB within the 
atria of 3 patients, showing considerable intra-atrial and inter-individual variation.
All patients had some degree of CD in each atrial region; median prevalence of 
CD within all regions combined was 2.9% (1.7-5.4). The lower left panel of Figure 2 
demonstrates prevalence of CD for each atrial region. The highest prevalence of CD was 
measured in BB (3.9% (0.7-8.1)), followed by RA (3.2%, 0.4-7.6). CD was less prevalent 
in the PVA (2.5%, 0.2-6.5, BB vs. PVA: p=0.001) and LAVG (2.2%, 0.2-5, RA vs. LAVG: 
p=0.003, BB vs. LAVG: p<0.001).
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Table 1. Patient characteristics
Total
N=31




Age (years) 49±14 (18-70) 47±14 (18-70) 55±13 (37-69)
Female 18 (58) 16 (62) 2 (40)
Type of congenital heart defect
Secundum ASD 18 (58) 14 (54) 4 (80)
SVD with PAPVR 11 (36) 10 (39) 1 (20)
PAPVR 2 (7) 2 (8) 0
Body Mass Index 27.6±4.6 28±4.7 25.5±3.6
Right atrial volume (ml/m2) 49 (20-99) 50 (20-76) 41 (38-99)
Right atrial dilatation 26 (84) 23 (89) 3 (60)
Left atrial dimension (cm/m2) 2.2±0.4 2.2±0.4 2.3±0.4
Left atrial dilatation 10 (32) 8 (31) 2 (40)
Left ventricular function
Normal 26 (84) 21 (81) 5 (100)
Mild dysfunction 4 (13) 4 (15) 0
Moderate dysfunction 1 (3) 1 (4) 0
Right ventricular function*
Normal 25 (81) 20 (83) 5 (100)
Mild dysfunction 2 (7) 2 (8) 0
Moderate dysfunction 2 (7) 2 (8) 0
Antiarrhythmic drugs
Class II 10 (32) 7 (27) 3 (60)
Class III 2 (6) 0 2 (40)
Values are expressed as n (%), median (minimum-maximum), or mean ± SD (minimum-
maximum).
* Not available in 2 patients.
There were no statistically significant differences between patients with and without a history 
of AF.
AF: atrial fibrillation, ASD: atrial septal defect, PAPVR: partial abnormal pulmonary venous return, 
SVD: sinus venosus defect.
Compared to CD, median prevalence of CB within all regions combined was lower (1.9%, 
0.6-7). All patients had some degree of CB in at least 2 atrial regions, including the RA 
(n=30, 97%), BB (n=30, 97%), LAVG (n=26, 87%) or PVA (n=26, 87%). Prevalence of CB 
for every atrial region is displayed in the lower right panel of Figure 2; inter-individual 
variation was high, particularly in BB. Median prevalence of CB was lower in the LAVG 
(0.8%, 0-4.4) than in BB (2.1%, 0-10.9, p=0.001) and RA (2.1%, 0-12.3, p=0.004). The 
upper left panel of Figure 3 demonstrates that in most patients, the highest prevalence 
of CB within each patient was found in BB (n=15, 48%), followed by the RA (n=9, 29%). 
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The lower left panel of Figure 3 visualizes for each patient the prevalence of CB in 
every atrial region; patients are ranked according to prevalence of CB in BB. Again, this 
graph illustrates the inter-individual variation in CB. There was no relation between the 

























































RA BB LAVG PVA RA BB LAVG PVA
Figure 2. Prevalence of CD and CB
Upper panel: spatial distribution of CD and CB in 3 patients. Lower left panel: prevalence of CD. 
Lower right panel: prevalence of CB. Bars indicate median. Dashed lines indicate p<0.0083.
BB: Bachmann’s bundle, CB: conduction block, CD: conduction delay, LAVG: left atrioventricular 
groove, PVA: pulmonary vein area, RA: right atrium.
Characteristics of areas of conduction disorders
Examples in the upper panel of Figure 4 show that areas of CD and CB formed either 
long, continuous CDCB lines (left panel) or shorter, diffusely scattered lines (right panel). 
As demonstrated in the lower left panel of Figure 4, CD lines were short and varied only 
between 2 and 8mm across all regions; they were the shortest in the RA (p<0.0083). 
Median lengths of CB and continuous CDCB lines did not differ between the various 
atrial regions.
Length of the longest line of CD in all patients was 14mm (4-50), of CB 18mm (2-172) 
and of continuous CDCB 29mm (4-190). These CB lines were longer in the RA than LAVG 
(24mm, 16-38 vs. 12mm, 6-24, p=0.008) (lower right panel Figure 4).
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The longest CB line within each patient was most often located in the RA (n=16, 52%), 
followed by BB (n=8, 26%; upper right panel Figure 3). Similar to the prevalence of CB, 
both length and distribution of the longest CB lines also varied considerably between 
individuals, as demonstrated in the lower right panel of Figure 3. There was no relation 






























































































Figure 3. Intra-atrial and inter-individual variation in distribution of CB
Upper left panel: location of the highest prevalence of CB within every patient. Lower left 
panel: prevalence of CB in the atrial regions; patients are ranked according to prevalence of 
CB in BB. Upper right panel: location of the longest CB line within every patient. Lower right 
panel: lengths of the longest CB lines in the atrial regions; patients are ranked according to 
length of lines in the RA.
* length of this line was 172mm.
BB: Bachmann’s bundle, CB: conduction block, LAVG: left atrioventricular groove, PVA: pulmonary 
vein area, RA: right atrium.
When comparing patients with a secundum ASD (n=18) and sinus venosus defect 
(n=11), patients with a secundum ASD had more CB in BB (mean ± standard deviation 
(minimum-maximum): 4.6±3.2% (0-10.9) vs. 1.5±0.8% (0.4-3.1), p=0.001) and longer CB 
lines in BB (longest line: 26.6±12.2mm (2-54) vs. 8.9±4.8mm (4-20), p<0.001); similar 
findings were observed for continuous CDCB. There were no differences in the other 
atrial regions. Older age was associated with higher prevalence of CB and continuous 
CDCB in the RA (respectively b=0.006 log(%)/year, p=0.042 and b=0.008 log(%)/year, 
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p=0.016) and with length of the longest continuous CDCB line in the RA (b=0.711 mm/
year, p=0.018). LA dimension was associated with both prevalence of continuous CDCB 
in BB (b=2.743 %/(cm/m2), p=0.046) and length of the longest continuous CDCB line in 
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Figure 4. Characteristics of areas of conduction disorders
Upper panels: examples of interconnected CD and CB lines creating long, continuous CDCB lines 
(left panel, recorded on the PVA) or shorter, diffusely scattered lines (right panel, recorded 
on the RA). Isochrones are drawn at 5ms. Arrows indicate main trajectories of activation. Lower 
left panel: median length of lines. Lower right panel: length of the longest lines. Bars indicate 
median. Dashed lines indicate p<0.0083.
BB: Bachmann’s bundle, CB: conduction block, CD: conduction delay, LA*: left atrioventricular 
groove, PVA: pulmonary vein area, RA: right atrium.
Severity of conduction disorders
The upper panel of Figure 5 shows an example of the relative distribution of all CTs 
measured within the atria in one patient. The middle right panel demonstrates 
corresponding distribution of CD and CB lines. Most CTs were short (73% ≤2ms), 
indicating absence of conduction disorders. Similarly, in the entire study population, 
most CTs were ≤2ms (median: 78%, 67-83). Though the 90th percentiles of all CTs were 
short, they were longer in both RA and BB than LAVG and PVA (RA: 5ms, 3-16, BB: 5ms, 
3-13, LAVG: 3ms, 2-6, PVA: 4ms, 2-27, p<0.0083).
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12 20 30 >35ms
Figure 5. Severity of conduction disorders
Upper panel: relative distribution of CTs within the atria in one patient. Distribution of CD and 
CB lines (middle right panel) and relative distribution of CTs ≥12ms for each atrial region (lower 
left panel) in the same patient. Lower right panel: severity of CB. Bars and numbers indicate 
median. Horizontal dashed lines indicate p<0.0083.
BB: Bachmann’s bundle, CD: conduction delay, CB: conduction block, CT: conduction time, LAVG: 
left atrioventricular groove, PVA: pulmonary vein area, RA: right atrium.
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Histograms in the lower left panel of Figure 5 illustrate relative distribution of CTs ≥12ms 
(i.e. CB) for each atrial region in this same patient. CB appeared to be most severe in the 
RA and, to a lesser extent, the LAVG. In the entire study population, however, CB was 
more severe in the RA than the LAVG and PVA (p<0.0083; lower right panel Figure 5).
Heterogeneity in right intra-atrial conduction
The upper left panel of Figure 6 shows a typical example of the distribution of areas 
of CD, CB and continuous CDCB within the RA. As demonstrated in the upper right 
panel, prevalence of both CD and CB was higher in the intercaval region than in the RA 
free wall. In addition, lines of CB and continuous CDCB in the intercaval region were 





























































ICR RAFW ICR RAFW
Figure 6. Heterogeneity in right intra-atrial conduction
Upper left panel: example of distribution of CD (blue) and CB (red) lines in the intercaval region 
and RA free wall. Upper right panel: prevalence of CD and CB. Lower left panel: median length 
of CD, CB and continuous CDCB (purple) lines. Lower right panel: severity of CB.
Bars indicate median. Dashed lines indicate p<0.05.
CB: conduction block, CD: conduction delay, ICR: intercaval region, IVC: inferior vena cava, RAFW: 
right atrial free wall, RIPV: right inferior pulmonary vein, RSPV: right superior pulmonary vein, 
SVC: superior vena cava.
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History of atrial fibrillation
When comparing patients with and without a history of AF, prevalence and 
characteristics of conduction disorders only differed in BB, yet only 5 patients (16%) 
had a history of AF. Patients with AF had a higher prevalence of CB (6.3%, 1.3-8.5 vs. 
2.0%, 0-10.9, p=0.047) and longer lines of CB (longest line: 34mm, 12-40 vs. 12mm, 
2-54, p=0.041), although severity of CB was similar. Prevalence and lines of continuous 
CDCB did not differ.
DISCUSSION
This high-resolution, epicardial mapping study is the first to report the prevalence, 
spatial distribution and severity of conduction disorders in the RA, BB and LA in patients 
with RA volume overload resulting from an interatrial shunt. Although these patients 
have longstanding volume overload and stretch of the RA, conduction disorders were 
not exclusively located in the RA, but also in BB and – to a lesser extent – the LA. Overall, 
conduction disorders were most prevalent in the RA and BB and most severe in the 
RA, although considerable inter-individual variation was observed. Further analysis of 
the RA revealed a predilection site for conduction disorders in the intercaval region.
Consequences of chronic right atrial stretch
The concept of electrical remodeling in response to atrial stretch has been studied 
extensively in humans with cardiovascular disease causing atrial stretch, including 
congestive heart failure, mitral regurgitation, and ASD.3-6 Acute atrial dilatation increases 
spatial heterogeneity in conduction, which can result in a reduction in conduction 
velocity and the formation of lines of intra-atrial conduction block.12 These conduction 
abnormalities may become aggravated during chronic atrial stretch, as is the case in 
adult patients with unrepaired ASD. The presence of lines of CB makes it more likely 
for reentrant circuits to develop, which, when combined with atrial enlargement, may 
increase the likelihood of AF development.7
Atrial stretch has also been associated with structural myocardial remodeling.13,14 
These structural changes are thought to contribute to increased heterogeneity in 
atrial conduction. Macchiarelli et al. analyzed RA tissue samples from four children 
aged 1, 4, 6 and 6 years undergoing surgery for ASD and found atrial fibrosis and 
other significant myocardial degenerative changes in the two older children.13 Another 
study that examined RA tissue samples from 65 adult patients with RA overload due 
to unrepaired CHD showed that, compared with similar samples from healthy age-
matched controls, these samples had more structural remodeling including fibrosis.14 
The age of these patients – which determines the duration of overload and stretch – was 
associated with various histological markers of structural RA remodeling. In line with 
this observation was our finding that with increasing age, conduction disorders in the 
RA became more prevalent and created longer lines of CB.
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Electrical and structural remodeling in ASD patients also occur in the LA. Roberts-
Thomson et al. have shown that ASD patients have significant LA enlargement as well 
as LA electrophysiological abnormalities that include conduction disorders, low voltage 
regions and increased inducibility of AF.4 Comparative measurements in the RA have 
not been reported. Although we found conduction disorders to be present in the LAVG 
and the PVA, the extent and severity of these conduction disorders were considerably 
lower than those in the RA.
Bachmann’s bundle
Our study is the first to demonstrate a high prevalence of conduction disorders in 
BB in patients with RA volume overload. The presence of conduction disorders in 
BB was associated with LA dimension rather than RA dimension or age. A possible 
explanation for this association lies in the embryonic development of the atria. BB 
is a muscular bundle on the atrial septal roof connecting the RA and LA. Jongbloed 
et al. demonstrated in mouse embryos that on the right side, BB is connected to the 
septum spurium, which is continuous with the left and right venous valves guarding the 
sinus venosus. On the left side, BB is connected to the left atrioventricular ring bundle, 
which continues into the dorsal wall of the LA and pulmonary veins.15 This suggests 
that, anatomically, BB may be connected more to LA tissue rather than RA tissue. An 
enlarged LA may therefore confer more stretch and thus stress on BB than an enlarged 
RA, thereby giving rise to conduction disorders in BB.
Previous studies have suggested a potential role for BB in the pathophysiology of 
AF. Indeed, despite the small number of patients in our study who had a history of AF, 
these patients were more likely to have more extensive CB in BB than patients without 
a history of AF. The mechanism by which conduction disorders in BB may contribute to 
the initiation and perpetuation of AF is still under investigation. One theory proposes an 
association between interatrial conduction block and the development of AF.16 However, 
Teuwen et al. performed epicardial mapping in patients with ischemic heart disease 
and showed that long lines of conduction block in BB did not result in delayed LA 
activation, because wavefronts emerging from the central or left part of BB activated 
the areas behind lines of conduction block.17 This implies that conduction abnormalities 
in BB do not necessarily cause interatrial conduction block. The most likely theory is 
that conduction abnormalities in BB facilitate the formation of reentrant circuits and 
hence development of AF.17,18
Conduction disorders in the right atrium
Studies in patients with chronic atrial volume overload3,6 and in patients without 
structural heart disease causing atrial volume overload19 have demonstrated the 
presence of functional conduction delay in the region of the crista terminalis. Conduction 
disorders in this region are involved in the development of both typical and atypical 
atrial flutter and AF.19,20 The crista terminalis is a relatively thick muscle band, from 
which the pectinate muscles arise anterolaterally towards the RA appendage. The areas 
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containing pectinate muscles act as RA volume reserve during increased preloading 
conditions. This anatomical and functional distinction might explain the predisposition 
for conduction disorders in the intercaval region – which roughly corresponds to 
the region of the crista terminalis – in the presence of RA volume overload, as also 
observed in our study and that of Morton et al.3 However, the presence of conduction 
abnormalities in this region may also be related to anatomical barriers rather than a 
specific disease process.19 Due to the invasive nature of our mapping approach, it was 
not possible to study healthy control subjects. Lanters et al. performed epicardial sinus 
rhythm mapping in 209 patients without a history of AF undergoing coronary artery 
bypass grafting, and found a predilection site for conduction disorders in the superior 
intercaval region.21 Although these patients do not qualify as a suitable control group 
due to the potential effects of ischemia on atrial conduction, these findings do suggest 
that conduction abnormalities in this region may not be specific to patients with RA 
volume overload.
The crista terminalis is a highly anisotropic region due to directional differences in 
gap junction distribution which result in impaired transverse conduction as opposed to 
preserved longitudinal conduction.19,22 The sinus rhythm wave generally originates from 
the superior intercaval region, traveling along the crista terminalis in a more longitudinal 
rather than transverse direction. It is therefore possible that mapping during sinus 
rhythm has left additional conduction disorders caused by tissue anisotropy in this 
region undetected. Given that our study found extensive conduction disorders in the 
intercaval region – with marked differences within the RA and between the RA and LA – 
we propose that mapping during pacing maneuvers will uncover even more conduction 
disorders in this region.
Conduction disorders in the RA may be involved in the development of both AF and 
atrial flutter. In 7 dogs with sterile pericarditis, Ortiz et al. demonstrated by epicardial 
mapping of the RA free wall that a certain length of a line of CB was required for either 
stable (atrial flutter) or unstable reentry (AF) to occur. Atrial flutter required a long line 
of CB together with areas of slow conduction, whereas AF occurred when areas of slow 
conduction disappeared, the cycle length decreased and lines of CB shortened. On 
the one hand, our findings of prominent conduction disorders in the RA may relate to 
the development of postoperative atrial flutter by serving as areas of slow conduction 
supporting a stable reentrant circuit around the atriotomy scar. On the other hand, 
these conduction disorders may also result in unstable reentrant circuits mitigating 
across the atrial wall, giving rise to AF.
Reverse electrical and structural remodeling
It remains unknown whether electrical and structural changes resulting from RA volume 
overload can be reversed after repair of the defect. While ASD repair during childhood 
is known to reduce the chances of AF during long-term follow-up, in adults, repair does 
not seem to lower the risk for AF.1 It is therefore likely that in adults, the damage has 
already been done and the resultant RA remodeling is – at least in part – irreversible.3 
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In their study in adults undergoing ASD closure, Morton et al. showed incomplete 
normalization of RA and LA size and persistence of conduction disorders at the crista 
terminalis after percutaneous ASD closure, although late electrophysiological evaluation 
was only performed in 4 of 12 patients.3 However, another study in 21 adult patients 
with severe mitral stenosis undergoing mitral commissurotomy demonstrated both 
immediate and late reversal of structural and conduction abnormalities, although the 
late measurements were only performed in the RA.23
Limitations
Only a limited number of patients with a history of AF were included in this study, partly 
due to the relative rarity of these patients and partly because sinus rhythm could not 
always be obtained in patients with AF. Therefore, our comparison of patients with and 
without a history of AF should be interpreted with caution. This study was primarily 
designed to quantify the distribution of conduction disorders within the atria in patients 
with RA volume overload, rather than to find abnormalities specifically associated with 
AF. Mapping of the interatrial septum was not possible due to our closed-heart mapping 
approach.
CONCLUSIONS
In order to improve treatment strategies aimed at eliminating AF, it is essential to 
understand the underlying substrate, which may be different or more severe in patients 
with RA volume overload than in the general population. Conduction disorders during 
sinus rhythm in these patients are most prevalent in the RA and BB and most severe 
in the RA. A predilection site for conduction disorders within the RA is present in 
the intercaval region, which is likely related to the conduction properties of the crista 
terminalis and the pectinate muscles. The next step will be to determine the relevance 
of these conduction disorders for initiation and perpetuation of AF. The considerable 
inter-individual variation observed in this study emphasizes the need for a patient-
tailored approach to further unravel the substrate of AF in these patients.
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Patients with congenital heart disease (CHD) are prone to developing cardiac 
tachyarrhythmias and heart failure. In these patients, structural remodeling of myocardial 
tissue is caused by longstanding volume/pressure overload or prior cardiac surgery, 
which in turn leads to complex conduction disorders (i.e. electropathology). Conduction 
disorders predispose to development of atrial and ventricular tachyarrhythmias. 
However, whether CHD also causes electrophysiological changes early in life is yet 
unknown. The present study therefore aims to quantify and characterize the early 
effects of CHD on atrial and ventricular electropathology. To this end, intra-operative, 
high-resolution epicardial mapping of the atria and ventricles will be performed in 30 
pediatric patients with CHD undergoing initial surgical correction or palliation of the 
defect. Using a 192-electrode array, unipolar electrograms are recorded from the atrial 
and ventricular surface during sinus rhythm. Local activation times are converted into 
activation maps, which are used to study wavefront propagation and heterogeneities 
in conduction. Characteristics of signal morphology are analyzed, including voltage 
and signal fractionation. We hypothesize that even short-lasting volume or pressure 
overload at young age causes electropathology that might persist beyond CHD repair 
and into adulthood. Over time, these electropathological changes aggravate by other 
contributing factors such as cardiac surgery, aging or volume/pressure overload from 
e.g. residual lesions, until the severity of electropathology is high enough to induce 
tachyarrhythmias or heart failure.
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INTRODUCTION
Congenital heart disease (CHD) is the most common cause of major congenital 
anomalies with an incidence of approximately 9 per 1000 live births.1 Because of 
improved surgical techniques and perioperative care, more and more patients 
survive into adulthood.2,3 As a consequence of aging, these patients face long-term 
complications, of which atrial tachyarrhythmias and heart failure are among the most 
common.4,5 Both conditions are associated with impaired quality of life, substantial 
morbidity and mortality.6-9 Pathophysiological mechanisms underlying these long-term 
sequelae are yet incompletely understood. A relatively well-known factor predisposing 
to both tachyarrhythmias and heart failure is remodeling due to longstanding abnormal 
hemodynamic conditions resulting from unrepaired or residual defects.10-14
The consequences of longstanding abnormal hemodynamic conditions on the 
development of atrial tachyarrhythmias are illustrated by the relevance of age at repair 
of an atrial septal defect (ASD). Several studies showed that older age at the time of ASD 
repair was associated with a higher prevalence of both pre- and postoperative atrial 
tachyarrhythmias.15-17 An ASD causes right atrial volume overload by an interatrial left-
to-right shunt. Hence, the age at repair of the defect more or less equals the duration 
of right atrial volume overload. Volume overload leads to stretch on the atrial wall. As a 
result, separation of myocardial fibers by interposition of fibrous tissue occurs, leading 
to conduction disorders and thereby making the atria vulnerable to the development of 
atrial tachyarrhythmias.18-20 A recent study evaluating the outcomes of ASD repair before 
the age of 18 years (median 7 years) demonstrated that the risk of atrial fibrillation (AF) 
was increased compared to the general population despite early repair.21 Although 
the existing literature on this topic generally refers to consequences of ‘longstanding ’ 
abnormal hemodynamic conditions in CHD patients, this observation actually raises 
the question to what extent conduction abnormalities already occur at a young age. 
As atrial conduction disorders have been shown to persist beyond ASD repair in adult 
patients12, this might also apply to pediatric patients.
Longstanding abnormal hemodynamic loading conditions may also cause heart 
failure, which in CHD patients is often caused by failure of the right ventricle. Abnormal 
conditions straining the right ventricle include volume overload from e.g. pulmonary 
valve regurgitation or left-to-right shunting, or pressure overload from e.g. pulmonary 
hypertension or right outflow tract obstruction.10 A specific situation of abnormal 
loading conditions occurs in patients with a systemic right ventricle, for example in 
congenitally corrected transposition of the great arteries or hypoplastic left heart 
syndrome palliated with the Norwood and Fontan operations.22 In terms of morphology 
and function, the right ventricle differs considerably from the left ventricle23, which 
has important implications for understanding the pathophysiology of right ventricular 
dysfunction in the presence of these abnormal hemodynamic conditions.11 Animal 
models have provided new insights into the pathophysiology of right ventricular 
dysfunction with regard to genetic and epigenetic changes and various processes on 
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tissue and cellular level.11 However, the role of electrophysiological abnormalities as one 
of the aspects underlying right ventricular dysfunction is relatively understudied.24-27 
Given the electrical consequences of wall stretch in the atria, it is likely that similar 
electrophysiological changes might also occur in the ventricles, although this has never 
been explored.
Knowledge of the various contributors to development of electropathology – i.e. 
complex electrical conduction disorders caused by structural tissue damage – in 
CHD patients is important as it may be the first step towards the development of 
novel therapies aimed at prevention, treatment or reversal of atrial and ventricular 
electropathology. The contribution of relatively short-lasting volume or pressure 
overload to development of cardiac electropathology has never before been studied.
This study was therefore designed to quantify and characterize the early effects of 
CHD on atrial and ventricular electropathology. To this end, high-resolution epicardial 
mapping of the atria and ventricles will be performed during sinus rhythm in pediatric 
patients with CHD undergoing initial surgical correction or palliation of the defect. 
As this has never been examined before in a pediatric population, this study will 
primarily be observational and hypothesis generating. The present paper describes 
the methodology of epicardial mapping in this population and provides a detailed 
approach to mapping data analysis.
METHODS
The FANTASIA study is a prospective, observational study. The study protocol was 
approved by the Medical Ethics Committee of the Erasmus Medical Center, Rotterdam, 
the Netherlands, in January 2020 (MEC-2019-0543). This project will be carried out 
according to the Declaration of Helsinki and the law on medical research involving 
human subjects.
Study population
All patients aged <18 years scheduled for elective open chest cardiac surgery for CHD 
at the Erasmus Medical Center, Rotterdam, the Netherlands, are eligible for inclusion, 
except those receiving inotropic agents. Furthermore, patients with prior cardiac surgery 
involving pericardiotomy are excluded due to the likelihood of adhesions between 
epicardium and pericardium, thereby hampering reliable epicardial mapping.
Each eligible patient and/or his/her parents or guardian will be provided with an oral 
and written explanation of the study procedure and potential risks of participating in 
the study. Patients will be enrolled after written informed consent is obtained. According 
to the Dutch law on research in minors, informed consent is required from patient and/
or parents or guardian, depending on the age of the patient.
Upon inclusion, patients will be classified into one of three categories according to 
CHD complexity (simple, moderate, complex), a classification that was proposed by the 
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ACC/AHA task force on practice guidelines for adults with CHD.28 Figure 1 summarizes 
the inclusion and exclusion of patients and provides examples of the more common 
types of CHD per complexity category. In addition, the study procedures for patients 
participating in the study are shown.
Patient selection
• CHD patients <18 years
• Elective cardiac surgery
Enrollment
Written informed consent +
Exclusion criteria
• Use of inotropic agents
• Redo cardiac surgery
Simple
• Isolated ventricular septal defect
• Isolated atrial septal defect 






• Tetralogy of Fallot
• Ventricular septal defect*
• Complete/partial AVSD
Complex





Part of standard care
Figure 1. Flowchart of patient inclusion and study procedures
* ventricular septal defect with associated lesion(s): absent valve(s), aortic regurgitation, 
coarctation of the aorta, mitral valve disease, right ventricular outflow tract obstruction, straddling 
tricuspid/mitral valve, subaortic stenosis.
AVSD: atrioventricular septal defect CHD: congenital heart disease.
Study procedures
Epicardial mapping is performed during open chest cardiac surgery. Patients are 
under full anesthesia and vital signs are monitored continuously throughout the 
procedure. Methods of epicardial mapping in adult (CHD) patients have been described 
before.29,30 However, several modifications have been made in the present study. 
Epicardial mapping will only be performed during sinus rhythm. Before institution of 
cardiopulmonary bypass, wires serving as the indifferent electrode and the temporal 
reference electrode are placed (Figure 2A). The indifferent electrode consists of a surgical 
clamp that is fixed to the subcutaneous tissue. The temporal reference electrode 
consists of a unipolar pacemaker wire that is stitched to the area of the terminal crest. In 
our mapping setup, the reference channel is configured as a bipolar channel; therefore, 
the positive pole is connected to the temporal reference electrode and the negative 
13
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pole is connected to the indifferent electrode. A custom-made electrode array (192 
electrodes, electrode diameter 0.6 mm, interelectrode distance 2.12 mm) is used to 
record unipolar electrograms during sinus rhythm from the atria and ventricles (Figure 
2B-D). A surface electrocardiogram (lead I) is recorded simultaneously. All electrograms 
are stored on a hard disk after amplification (gain 1000), filtering (bandwidth 0.5–400 
Hz), sampling (1 KHz) and analogue to digital conversion (16 bits). Provided that access 
is feasible, the following regions will be mapped: right atrium, Bachmann’s bundle, 
left atrioventricular groove, pulmonary vein area, right ventricle and left ventricle. The 
electrode array will be shifted from site to site in a predefined order; recordings will be 
made for 5 seconds per site. The number of sites mapped per region depends on the 
size of the atria and ventricles; the lower panels of Figure 2 show examples of mapping 
sites in a larger (left) and a smaller patient (right). Omission of areas is avoided at the 
expense of possible overlap between successive sites. The expected duration of the 
entire mapping procedure including preparations is approximately 10 minutes.29
Postoperative continuous rhythm recordings (bedside telemetry) are performed 
as part of standard care. These recordings will be analyzed using the rhythm scanning 
software SyneScopeTM (Sorin Group S.p.A., Milano, Italy) for the occurrence of early 
postoperative atrial and ventricular tachyarrhythmias.
Analysis of mapping data
Figure 3 summarizes the initial analysis of raw mapping data: from the acquisition of 
the electrograms during epicardial mapping to the annotation of local activation times, 
consistent with previous mapping studies.30,31 Local activation times of the recorded 
signals are determined by annotating the steepest negative deflection with a maximum 
slope of -0.05 V/s and a minimum peak-to-peak amplitude exceeding the noise level. 
Additional deflections are annotated by the same slope and amplitude criteria and 
a minimum of 2 ms between successive deflections. Negative deflections with a 
slope between -0.05 and 0 V/s are regarded as farfield signal and are therefore not 
annotated. The annotated electrograms are manually checked and false annotations 
are removed.
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Figure 2. High-resolution epicardial mapping
Intra-operative, high-resolution epicardial mapping of the atria and ventricles in a 4-month old 
child undergoing repair of a secundum atrial septal defect and a ventricular septal defect.
A: The indifferent electrode (surgical clamp) is attached to subcutaneous tissue (*). The temporal 
reference electrode (unipolar pacemaker wire) is attached to the area of the terminal crest (not 
visible, indicated by arrow). B: The custom-made 192-electrode array (electrode diameter 0.6 mm, 
interelectrode distance 2.12 mm, total area 15.4 mm by 49.4 mm). C: Epicardial mapping of the 
right atrium. D: Epicardial mapping of the right ventricle. Lower panels: atrial and ventricular 
mapping positions in a larger (left) and smaller (right) patient.
AVN: atrioventricular node, BB: Bachmann’s bundle, IVC: inferior vena cava, LA: left atrioventricular 
groove, LAD: left arterial descending artery, LV: left ventricle, PV: pulmonary vein, PVL/R: 
pulmonary vein area left/right, RA: right atrium, RV: right ventricle, SVC: superior vena cava.
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Figure 3. Mapping data analysis
Mapping data obtained from the right atrium (upper panels) and right ventricle (lower panels) 
of the same patient as in Figure 2. The mapping array records up to 189 unipolar electrograms, of 
which 3 examples per mapping location are shown. Grey shaded areas contain the farfield atrial 
and ventricular signal. Local activation time is determined by annotating the steepest negative 
deflection (red cross). The first local activation time of the mapping array is set to T=0 ms; all other 
local activation times are measured relative to this time. Based on these local activation times, 
an activation map is reconstructed.
A: atrial signal, LAT: local activation time, RA: right atrium, RV: right ventricle, V: ventricular 
signal.
Figure 4 illustrates analysis of conduction and signal morphology parameters. Local 
activation maps are used to assess atrial and ventricular activation patterns. Differences 
in local activation times between two adjacent electrodes are used to calculate local 
conduction delay (7-11 ms, corresponding to 19-30 cm/s) and conduction block (≥12 ms, 
corresponding to <19 cm/s), consistent with prior mapping studies in adult patients.32,33 
Conduction velocity is calculated using the discrete velocity vectors technique [van Schie 
et al. Submitted]. Signal voltage is defined as the peak-to-peak amplitude of the steepest 
deflection. The 5th percentile of all voltage amplitudes from the entire population is 
calculated and used as a cutoff for the identification of low voltage signals, as validated 
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cutoff values for low voltage are not available for our mapping data. Signals are classified 
as single potentials (one deflection), short double potentials (<15 ms between two 
deflections), long double potentials (≥15 ms between two deflections), and complex 
fractionated potentials (≥3 deflections).34 Fractionation delay is defined as the duration 
between the first and last deflection of a fractionated potential (i.e. short double, long 
double, and complex fractionated potentials).
Statistical analysis
Mapping data are described per region and not per mapping site, as the number of 
mapped sites per region may differ between patients according to the size of the atria 
and ventricles. Mapping data are tested for normality using the Shapiro-Wilk test and 
expressed as mean ± standard deviation (minimum-maximum) or median (minimum-
maximum), depending on the distribution of the data. Primary presentation of the 
mapping data is according to complexity of the underlying CHD: simple, moderate 
or complex. The association between clinical variables (independent variables: age, 
gender, body surface area, echocardiographic left and right atrial dimensions and left 
and right ventricular function) and mapping data (dependent variables) will be tested 
in the entire study population (N=30) using linear regression. If the model does not 
conform to the assumptions of linear regression, log-transformation of the dependent 
variable will be performed and subsequently, if necessary, of the independent variable 
or of both variables.
Sample size
Ten patients will be included in each category of CHD complexity, hence resulting in the 
following study population: simple: n=10, moderate: n=10, complex: n=10 (Figure 1). In 
determining this sample size and sub classification, several considerations were taken 
into account. First, the sample size is preferably kept as limited as possible due to the 
age of the study patients (<18 years). Second, both a sample size of 10 (per complexity 
category) and 30 (total) is enough to provide means and standard deviations. Finally, 
including 10 patients per complexity category is likely to result in a sufficient variation in 
age and CHD types in the entire study population, as age at first surgery is often related 
to complexity of the defect. In addition, presentation of the amount of electropathology 
according to CHD complexity is deemed relevant as previous studies showed that both 
atrial tachyarrhythmias and heart failure occurred more often in patients with more 
complex CHD.9,35 13


















































Figure 4. Analysis of parameters derived from epicardial mapping
Conduction: activation maps are used to study activation patterns and local heterogeneities in 
conduction. Isochrones are drawn at 10ms intervals; the arrows indicate the main trajectories 
of the wavefront. The prevalence of conduction delay and block is calculated as a percentage 
of the total number of interelectrode conduction times measured in a sampled region. Signal 
morphology: voltage maps are reconstructed from the peak-to-peak amplitude of the steepest 
deflection. Mean signal voltage in the example is 6.9 mV. Signals are classified based on the 
number of additional deflections. Fractionation delay is the time between the first and last 
deflection of a fractionated potential, which is also used to further classify double potentials 
into short (<15 ms) or long (≥15 ms) double potentials. Maps were recorded at the right atrium 
(upper maps) and right ventricle (lower map) of the same patient as in Figure 2.
CB: conduction block, CD: conduction delay, LAT: local activation time.
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DISCUSSION
Study design
This is the first study ever to perform intra-operative, high-resolution epicardial 
mapping of the atria and ventricles in pediatric patients with CHD. Consequently, 
several decisions with regard to the study design were related to the fact that this is 
primarily a hypothesis generating study. In this initial study in 30 patients, mapping 
will only be performed during sinus rhythm. Hence, in contrast to the adult epicardial 
mapping studies, programmed electrical stimulation or induction of tachyarrhythmias 
will not be performed. Mapping of not only the atria but also the ventricles will be 
performed. This will provide unique insights into the ventricular conduction properties 
of young hearts that are often affected by abnormal hemodynamic conditions. In 
addition, ‘traditional’ cardiovascular risk factors (such as hypertension, smoking and 
hypercholesterolemia) are generally not (yet) present in these young patients. This limits 
the potentially confounding effect of these factors on the degree of electropathology. 
Based on the findings from this study, specific hypotheses and subsequent research 
questions may be composed, which will improve the yield of future mapping studies 
during pacing or tachyarrhythmia in this population. At that point, it should also be 
reevaluated whether additional follow-up procedures are required to answer additional 
research questions.
Electropathology in adult congenital heart disease
Apart from age-associated changes in the myocardium, previous cardiac surgery and 
longstanding volume/pressure overload play an important role in the development of 
electropathology in patients with CHD. Surgical scars or patch material are particularly 
involved in the occurrence of macroreentrant circuits. However, previous studies 
showed that locations of successful ablative therapy were not solely confined to sites 
with surgical scars.36,37 Longstanding volume/pressure overload in CHD patients leads to 
left and/or right atrial stretch and subsequent structural changes. Ueda et al. analyzed 
RA tissue samples in 65 adult patients with an unrepaired ASD, and showed that the 
samples of these patients showed more structural remodeling, including fibrosis, than 
those of healthy age-matched control subjects.20
Several studies have quantified the amount of electropathology in adult patients 
with longstanding volume overload.12,13,30 These studies were all performed in adult 
patients with an ASD undergoing either transcatheter or surgical repair of the 
ASD. ASD is among the more common congenital heart defects that often remain 
undiagnosed until adulthood, requiring repair at adult age. Morton et al. performed 
electrophysiology studies in 13 patients without a history of atrial tachyarrhythmias 
undergoing transcatheter ASD closure, and found that conduction delay at the crista 
terminalis was significantly more pronounced in these patients than in control subjects.12 
Importantly, after ASD closure, there was incomplete normalization of atrial dimensions. 
In addition, in four of the thirteen patients who underwent electrophysiology studies 8 
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months after ASD closure, persistent conduction abnormalities at the crista terminalis 
were observed. Roberts-Thomson et al. showed that atrial structural and electrical 
remodeling also occurred in the left atrium in patients with an unrepaired ASD.13 In their 
study, they compared 11 patients with hemodynamically significant ASDs undergoing 
transcatheter closure to 12 patients without structural heart disease or a history of 
atrial tachyarrhythmias. Compared to the control subjects, the patients with an ASD had 
echocardiographic left atrial enlargement and areas of conduction slowing and signal 
fractionation, as well as low voltage regions suggesting scarring in the left atrium. Our 
group performed intra-operative epicardial mapping in 31 adult patients with an ASD 
undergoing surgical repair, which showed that conduction abnormalities were present 
throughout both left and right atrium, although they were most prevalent in the RA 
and Bachmann’s bundle.30 A predilection site for conduction disorders was found in 
the intercaval region, which is likely due to the conduction properties of the underlying 
tissue (i.e. crista terminalis). Conduction disorders in the RA were more pronounced 
with increasing age.
Electropathology in pediatric congenital heart disease
To our knowledge, there is only one small study that investigated structural myocardial 
changes in atrial tissue in pediatric patients with CHD. Macchiarelli et al. analyzed tissue 
samples from the right atrial wall from four children with an ASD.38 In their study, the 
authors found intercellular fibrosis and other significant myocardial ultrastructural 
changes in specimens taken from two children aged 6 years with an ASD; however, 
specimens taken from the other two children aged 1 and 4 years with an ASD did not 
show significant myocardial damage. Despite the limited sample size and lack of control 
subjects, these findings suggest that structural remodeling may already occur at a 
young age in patients with CHD. As structural remodeling underlies the development 
of electrical abnormalities, the present study aims to investigate whether electrical 
abnormalities can already be found in pediatric CHD patients. If so, are they related 
to age (similar to the findings in adult CHD patients) or other clinical characteristics, 
such as atrial or ventricular dimensions, severity of CHD (simple, moderate, complex), 
gender, and body surface area? Do electrophysiological characteristics differ between 
patients with increased preload and those with increased afterload or a mixture? Do 
young children have ‘superfast’ conduction, e.g. on Bachmann’s bundle, and does the 
conduction velocity decrease with age? Are conduction properties of the right ventricle 
in patients with a single or systemic right ventricle different from those in patients with 
two functional ventricles? This study in 30 pediatric patients with CHD will hopefully 
provide answers to these questions thereby creating the basis for future hypotheses 
on this topic.
Study limitations
Mapping of the endocardium , including the atrial and ventricular septum, is not possible 
using our epicardial mapping approach. It is unknown whether our mapping parameters 
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are influenced by general anesthesia and intra-operative drugs. However, as a standard 
anesthetic protocol is generally applied, possible effects of anesthesia are expected 
to be equally dispersed among the study population. A subset of patients included in 
this study may require additional cardiac surgery in the future. Although it would be 
interesting to compare the degree of atrial and ventricular electropathology between 
subsequent procedures, it is not possible to perform reliable epicardial mapping due 
to the likelihood of adhesions between epicardium and pericardium.
Clinical relevance
CHD patients comprise a unique, rapidly growing and aging population, posing many 
challenges in terms of prevention and treatment of long-term complications, including 
tachyarrhythmias and heart failure. Among the various contributors to the development 
of electropathology in CHD patients, the early electrophysiological consequences of 
CHD are yet unknown. As prior studies have demonstrated that acute atrial stretch also 
causes electrophysiological changes39,40, we hypothesize that even relatively short-lasting 
volume/pressure overload at young age causes electropathology that might persist 
beyond CHD repair and into adulthood. Over time, these electropathological changes 
aggravate by other contributing factors such as cardiac surgery, aging or volume/
pressure overload (from e.g. residual lesions), until the severity of electropathology 
is high enough to induce atrial or ventricular tachyarrhythmias and/or heart failure. 
Knowledge of the origin of electropathology in CHD patients is essential to be able 
to modify current anti-arrhythmic treatment strategies or to develop novel therapies 
aimed at prevention or reversal of atrial and ventricular electropathology.
Project Status
Patient inclusion started in March 2020. Data is expected to become available in 
2021.
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Patients with congenital heart disease (CHD) constitute a unique population due to 
the combination of an anatomical defect, volume or pressure overload, and (in many 
cases) prior cardiac interventions. Improved surgical techniques and perioperative 
care have led to increased survival of these patients, resulting in a rapidly growing and 
aging population.1-3 As a result, these patients face many long-term complications, of 
which atrial tachyarrhythmias are among the most common.4,5 Compared to the general 
population, the prevalence of atrial tachyarrhythmias is higher in patients with CHD, 
particularly those with more complex forms of CHD.4,6,7 A previous study showed that 
the prevalence of macroreentrant atrial tachycardia (MRAT) increased with increasing 
complexity of the underlying defect.8 In addition, patients with complex CHD tend to 
be younger when developing atrial fibrillation (AF) than the general population as well 
as patients with simple CHD.6,9 It is yet unknown whether the mechanism underlying 
AF in patients with CHD is similar to that in patients without CHD.
Atrial fibrillation in congenital heart disease: a question of reaching the threshold?
As outlined in Chapter 1, AF requires a trigger for initiation and a substrate for 
maintenance of the arrhythmia. Triggers of AF consist of atrial extrasystoles that often 
originate from the pulmonary veins but may also arise from fibrotic areas elsewhere 
in the atria.10,11 However, in many instances, atrial extrasystoles do not initiate a 
tachyarrhythmia. In general, atrial extrasystoles are common and innocent interruptions 
of sinus rhythm, not only in patients with underlying heart disease but also in the 
general population.12,13 For an atrial extrasystole to initiate a tachyarrhythmia, there 
must be a sufficient amount of substrate to subsequently maintain this arrhythmia.
It is expected that the accumulation of the arrhythmogenic substrate over time 
differs among patients with various forms of CHD, as the complexity of the defects, 
extent of hemodynamic overload and number of prior cardiac operations are variable. 
We hypothesized that the arrhythmogenic substrate in patients with CHD accumulates 
over time until it reaches a certain threshold where it is able to sustain an arrhythmia 
induced by atrial extrasystoles. The moment this threshold is reached varies from CHD 
patient to CHD patient and is dependent on various factors. Figure 1 illustrates the 
theoretical accumulation of arrhythmogenic substrate in four patients with different 
types of CHD and their clinical course until 50 years of age. These examples show that 
the substrate in these cases is affected by various factors at different points in time. 
The following paragraph will further elaborate on each of these factors.
Arrhythmogenesis in congenital heart disease: a lifelong story
In contrast to patients with ‘normal’ hearts, patients with CHD may already have a 
certain amount of ‘congenital’ arrhythmogenic substrate present at birth, although 
this has never been quantified (dashed red lines Figure 1). Several genes are involved 
in both cardiac morphogenesis as well as the development of the cardiac conduction 
system.14-16 Mutations in ion channel genes or genes encoding for cardiac connexin 
proteins may cause increased non-uniform anisotropy17, which promotes micro-reentry 
and subsequent perpetuation of tachyarrhythmias.














































Figure 1. The arrhythmogenic substrate in patients with CHD
Theoretical accumulation of the arrhythmogenic substrate between birth and 50 years of age in 
four patients with CHD. The ‘threshold’ (dashed black line) represents a fictive amount of substrate 
which is able to maintain atrial fibrillation. The dashed red line indicates the potential amount of 
congenital arrhythmogenic substrate (see text for explanation).
Example 1: a patient with a complete atrioventricular septal defect, who underwent early repair 
without any residual lesions.
Example 2: a patient with a ventricular septal defect, who underwent early repair without any 
residual lesions and who developed sinus node dysfunction decades after surgery.
Example 3: a patient with hypoplastic left heart syndrome, who underwent 3 cardiac procedures 
(Norwood, partial and total cavopulmonary connection) and who developed MRAT and sinus 
node dysfunction late after surgery.
Example 4: a patient with a secundum atrial septal defect, which was diagnosed at 50 years of 
age when the patient presented with symptoms of atrial fibrillation.
MRAT: macroreentrant atrial tachycardia, SND: sinus node dysfunction.
Early effects of CHD on myocardial structure have been investigated in right atrial 
tissue samples of 4 subjects aged 1, 4, 6 and 6 years with an atrial septal defect 
(ASD).18 The samples of the two oldest children (6 years) showed significant myocardial 
changes, including myocardial hypertrophy and intercellular fibrosis. Despite the 
small sample size and lack of a control group, these findings suggest that structural 
remodeling as a result of CHD already occurs at a young age. Whether CHD also causes 
electrophysiological changes early in life is the main question of the research project 
introduced in Chapter 13. Using high-resolution epicardial mapping, this project aims 
to quantify electrophysiological abnormalities in pediatric patients with CHD. As acute 
atrial dilatation has been shown to result in conduction disorders19, it may be expected 
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that electrophysiological abnormalities will be present in pediatric patients with CHD, 
despite the relatively short duration of hemodynamic overload (Figure 1). Although this 
project is not designed to determine whether or not these changes are reversible, a 
study in adult patients with an ASD demonstrated that conduction disorders resulting 
from volume overload – albeit longstanding – persisted beyond ASD repair.20
Whereas the early electrophysiological consequences of CHD are yet unknown, 
longstanding volume or pressure overload is known to cause structural and electrical 
changes. Right atrial tissue samples of 65 CHD patients with right atrial volume overload 
aged 4 to 43 years (median 18) showed signs of structural remodeling, which were nearly 
absent in control samples.21 This led the authors to conclude that structural remodeling 
in ASD patients depends on overload duration rather than age alone. Two endocardial 
mapping studies in ASD patients showed that abnormalities in conduction occurred 
in both the right20 and left22 atrium. As the relatively low mapping resolution in these 
studies prevented quantification of local conduction disorders, the high-resolution 
epicardial mapping study presented in Chapter 12 was carried out to realize this 
task. This study in patients with right atrial volume overload showed that conduction 
disorders were not only located in the right atrium, but also at Bachmann’s bundle and 
– to a lesser extent – the left atrium. Importantly, age was positively associated with 
conduction disorders in the right atrium, which is in line with the histological findings 
in this population described by Ueda et al.21 The association between longstanding 
volume overload and arrhythmogenic substrate is illustrated in the 4th example of 
Figure 1.
The first three examples of Figure 1 illustrate the increase in arrhythmogenic 
substrate related to cardiac surgery. Whereas Chapter 8 showed that the immediate 
arrhythmogenic effects of cardiac surgery were generally mild and transient, surgical 
sequelae (e.g. suture lines, patches) are crucially involved in the development of MRAT in 
the long term (3rd example Figure 1). Indeed, a comprehensive literature review outlined 
in Chapter 3 showed that MRAT were the most common atrial tachyarrhythmia in a 
sub selection of CHD patients with extensive atrial surgery (those after the atrial switch 
operation), which is in line with findings from other studies.7,8
In the 2nd and 3rd example of Figure 1, sinus node dysfunction occurs years after 
a surgical procedure, a phenomenon that was described in Chapters 9 and 10. The 
findings reported in these chapters build further on similar observations in a cohort 
of ventricular septal defect patients23 and a cohort of mixed CHD patients undergoing 
pacemaker implantation.24 Fortunately in the current era, cardiac surgery rarely results 
in immediate damage to the sinus node and subsequent sinus node dysfunction. 
Hemodynamic consequences of CHD before repair may cause damage to the sinus 
node, which may persist beyond repair.20,25,26 As aging was shown to be associated with 
sinus node dysfunction in the general population27, a combination of these factors may 
result in the relatively early development of spontaneous sinus node dysfunction in 
CHD patients.
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Aging not only affects sinus node function – thereby indirectly contributing to the 
arrhythmogenic substrate – but it also directly affects myocardial conduction properties 
and subsequent vulnerability to atrial tachyarrhythmias, as demonstrated in Chapter 
11. It may be reasonably expected that all structural and electrical consequences of 
aging that apply to the general population, also apply to patients with CHD. In CHD 
patients however, these age-related changes occur in addition to pre-existing changes 
related to the underlying defect and/or cardiac surgery, as described above. This 
also applies to cardiovascular risk factors, which often arise with advancing age and 
which are also related to atrial tachyarrhythmias, such as AF.8,28,29 Altogether, it may be 
hypothesized that the presence of an increased level of ‘baseline’ myocardial damage 
in CHD patients might expedite the occurrence of age-related cardiac arrhythmias.
Current treatment strategies: room for improvement
Currently, prophylactic treatment for atrial tachyarrhythmias is not routinely 
applied, neither in patients with CHD nor in the general population. As many of the 
factors contributing to the arrhythmogenic substrate in CHD patients are not or 
barely modifiable (e.g. aging, cardiac surgery), adequate therapeutic treatment of 
atrial tachyarrhythmias is essential. Theoretically, catheter or surgical ablation of 
tachyarrhythmias may be curative. However, as outlined in Chapters 2 and 7, these 
treatments are associated with only moderate long-term success rates. The following 
paragraphs will further elaborate on several aspects of current ablation strategies that 
may explain these moderate results.
Ablation of atrial fibrillation in congenital heart disease: what to target?
Table 1 summarizes outcomes of catheter ablation of AF in CHD patients reported in 
some of the larger studies (sample size >30) published on this topic. Success rates at 12 
months follow-up are only moderate, and several studies noted that repeat procedures 
for recurrent AF appeared to be required more often than in the general population.30-32 
Moreover, a large variation in lesion sets is observed: pulmonary vein isolation was 
not always performed, and other or additional lesions were often applied. The large 
variation in lesion sets was also observed in Chapter 7, which summarized published 
literature on surgical ablation of AF/MRAT in CHD patients.
With regard to both catheter and surgical AF ablation, clear ‘how-to’ guidelines 
for this unique population are lacking. In order to be able to define specific target 
sites for AF ablation, it is essential to understand the underlying mechanism of AF in 
these patients. However, to this day, the mechanism of AF is yet unresolved – not only 
in CHD patients but also in the general population – and remains a matter of great 
controversy.33-36 In the general population, AF is considered a mainly left-sided heart 
disease. In CHD patients however, the right atrium often faces longstanding abnormal 
hemodynamic loading conditions, which likely results in different locations of AF triggers 
and substrates.
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Table 1. Atrial fibrillation ablation in congenital heart disease: approaches and outcomes
Author, 
year




84 Various 35.7% Non-PV triggers, CTI, mitral 






58 Various #1: 97%
Redo: 47%







57 Various #1: 36.8
Redo: 20%
CTI, mitral isthmus/roof 
line, CFAE, posterior wall 






36 Mainly ASD 100% - 42% (300 days)
Santangeli 
2011





45 ASD/PFO 100% CTI, atriotomy scar 76% (15±4 mo)
#1/2/3: 1st/2nd/3rd procedure. AAD (–, +/–): (off, on/off) anti-arrhythmic drugs, ASD: atrial septal 
defect, CFAE: complex fractionated atrial electrogram, CTI: cavotricuspid isthmus, N: sample size, 
PFO: patent foramen ovale, PV: pulmonary vein, PVI: pulmonary vein isolation.
A previous epicardial mapping study by Nitta et al. examined activation patterns during 
AF in 10 adult patients undergoing ASD repair.37 The authors showed that the complexity 
of atrial activation patterns during AF correlated with the type of preoperative AF 
(paroxysmal (n=4) vs. longstanding persistent (n=6)). In patients with paroxysmal AF, 
activation patterns mimicked those of (counter)clockwise atrial flutter, albeit with 
irregular cycle lengths varying from beat to beat. Reentrant or focal activations were 
mainly confined to the right atrium, whereas the left atrium was passively activated 
via Bachmann’s bundle. Activation patterns in patients with longstanding AF however 
were more complex, showing reentrant and focal activations arising mainly from the left 
atrium. ‘Foci’ were mainly distributed near the pulmonary veins and posterior left atrial 
wall. The shift from a mainly right-sided to a mainly left-sided origin of fibrillation waves 
in this study was attributed to age (patients with longstanding AF were older) and longer 
duration of left atrial remodeling due to the ASD. What the authors did not mention 
as a potential explanation for these observations, is that structural remodeling of the 
left atrium in patients with longstanding persistent AF may have occurred secondary 
to AF. 38,39
Altogether, these observations raise the hypothesis that paroxysmal AF in patients 
with longstanding right atrial volume overload (e.g. ASD) initially starts as a mainly right-
sided heart disease, secondary to CHD-related structural myocardial changes in the 
right atrium. Over time, as paroxysmal AF progresses to (longstanding) persistent AF9, 
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the substrate involved in the initiation and perpetuation of AF may gradually shift from 
the right to the left atrium, secondary to AF-induced left atrial structural remodeling.
An outline of all potential mechanisms underlying AF is beyond the scope of this 
thesis. Instead, two potential mechanisms that are closely associated with structural 
myocardial remodeling will be highlighted, as this is an important feature of CHD.
1. Increased non-uniform anisotropy leading to reentry
As outlined in Chapter 1, non-uniform anisotropy is caused by changes in cell-to-cell 
connections – either by interposition of fibrosis or side-to-side cell uncoupling – and 
gives rise to discontinuous and asynchronous conduction, which in turn may lead 
to reentry and AF. A previous endocardial mapping study in 24 patients with mitral 
stenosis demonstrated that in these patients with chronic left atrial stretch, direction-
dependent conduction was more pronounced than in control subjects without 
chronic atrial stretch.40 In this study, direction-dependent conduction was assessed 
by comparing conduction parameters (velocity, biatrial activation time, complex 
fractionated electrograms) during sinus rhythm and coronary sinus pacing. Although 
these results most certainly support the association between direction-dependent 
conduction and chronic atrial stretch, the relatively low mapping resolution precludes 
a closer look at local conduction properties during differing wavefront directions.
We therefore performed high-resolution epicardial mapping at the right atrium 
of a patient with CHD during pacing from four directions. This patient, a 54-year old 
male, had a secundum ASD and paroxysmal AF since 2017. His right atrium was mildly 
dilated and left atrial dimensions were normal. Figure 2 shows activation maps of the 
right atrium of this patient during sinus rhythm (cycle length 850 ms) and during pacing 
at a cycle length of 400 ms from four different directions. The activation patterns 
during pacing clearly show differences in the distribution of lines of conduction 
disorders resulting from changing wavefront directions. When comparing activation 
patterns during sinus rhythm and pacing, conduction disorders during pacing may 
also arise as a result of the shorter cycle length, similar to the effects of premature 
atrial extrasystoles on conduction.41 After epicardial mapping, the patient underwent 
primary ASD repair and the Cox maze IV procedure. Rate- and direction-dependent 
conduction abnormalities may cause small reentry circuits to occur, which may on the 
one hand initiate AF, and on the other hand maintain AF.33
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Figure 2. Rate- and direction dependent conduction disorders
High-resolution epicardial mapping of the right atrium in a patient with a secundum ASD during 
sinus rhythm and pacing from four directions. Thick black lines indicate conduction abnormalities. 
Arrows indicate the main trajectories of activation.
CL: cycle length, LAT: local activation time.
2. Endo-epicardial dissociation
Focal activation patterns during AF have been suggested to occur as a result of 
rapid pulse formation at specific sites, thereby acting as a ‘driver’ maintaining AF.42,43 
However, de Groot et al. performed high-resolution epicardial mapping in 24 patients 
with longstanding persistent AF, and showed that the large majority of focal activation 
patterns occurred as single events (90.5%).34 Only 0.8% showed a high degree of 
repetitive focal activity (i.e. focal waves occurring >3 times in a row). Moreover, focal 
waves did not originate from specific predilection sites, nor was the median coupling 
interval of these waves evidently shortened (only 11 ms). Finally, unipolar electrograms 
at the origin of these focal waves showed a small yet clear R wave. These findings 
support the theory of transmurally propagating fibrillation waves emerging as focal 
waves during epicardial mapping. Asynchronous electrical activation of the endo- 
and epicardial layer is a prerequisite for these endo-epicardial breakthrough waves 
to occur. The first evidence for endo-epicardial asynchrony during AF in humans was 
provided by de Groot and van der Does et al., who performed simultaneous mapping 
of the endocardium and epicardium in 10 patients with AF.44 The incidence of endo-
epicardial asynchrony ranged up to 55.9% and focal waves occurred equally often at 
the endo- and epicardial side. Importantly, 65% of all focal fibrillation waves could be 
explained by breakthrough waves occurring between endocardium and epicardium. 
Endo-epicardial asynchrony may play a major role in the pathophysiology of AF, as it 
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provides the opportunity for fibrillation waves to continuously replace each other as 
soon as other waves die out.44 The authors of this study hypothesized that structural 
atrial remodeling – induced by AF in these patients – transforms the atrial wall into 
dissociated layers, thereby causing asynchronous electrical activation.
Following this hypothesis, it is expected that endo-epicardial asynchrony may also 
be an important mechanism underlying AF in CHD patients, as structural remodeling 
is generally an inevitable consequence of CHD. The often thickened and hypertrophied 
atrial wall in patients with CHD may further increase the likelihood of endo-epicardial 
asynchrony to occur.45 The degree of endo-epicardial asynchrony in CHD patients is 
yet unknown; future endo-epicardial mapping studies should point out to what extent 
asynchronous activation of the two layers occurs during AF, and how this relates to 
patients without lifelong structural heart disease. Furthermore, similar to epicardial 
conduction disorders, an association between endo-epicardial asynchrony in ASD 
patients and age is expected, as age indicates the duration of overload and subsequent 
remodeling. As AF itself also induces structural remodeling, electrical asynchrony is 
likely to be more pronounced in patients with a longer duration of AF.
Until data from simultaneous endo- and epicardial mapping is available, focal 
activation patterns identified during epicardial mapping of AF may be studied to further 
characterize their origin. Figure 3 demonstrates an example of a focal wave occurring 
during induced AF in a 26-year old patient with a sinus venosus defect and partial 
abnormal pulmonary venous return. Future studies should determine whether focal 
waves in CHD are repetitive or bound to certain predilection sites. Furthermore, it 
remains in question whether clinical characteristics (e.g. age, right atrial dilatation, left 
atrial dilatation) influence the prevalence of focal waves during AF.
Overcoming challenges in vascular access
Obtaining vascular access and accessing the target chamber is often the first practical 
challenge to be undertaken during catheter ablation in patients with CHD. The femoral 
vein approach is not possible in case of an interrupted inferior vena cava or venous 
occlusion, requiring alternative access routes such as a transhepatic approach, superior 
approach via the internal jugular or subclavian vein or an arterial approach.46-49 Access 
to the target chamber may be limited in patients with altered post-surgical atrial 
anatomy.50 Prosthetic rings or valves, percutaneous closure devices, patches and 
extensive atrial enlargement may also impede catheter manipulation and/or access to 
desired ablation sites.51,52 Chapters 3 and 4 described approaches to obtain access 
in specific subpopulations of CHD patients, namely those with extensively distorted 
post-surgical atrial anatomy resulting in a systemic and pulmonary venous atrium 
(instead of right and left atrium in usual atrial anatomy). The pulmonary venous atrium 
is particularly difficult to reach and may be accessed via transbaffle puncture (venous 
approach) or retrograde via the aorta (arterial approach). Remote magnetic navigation 
is especially useful in these complex anatomies and enables precise and relatively 
unrestricted catheter movement, even via the retrograde approach.53
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Figure 3. Focal activation patterns during AF
Example of a focal wave (white star) occurring at the right atrium during induced AF in a patient 
with a sinus venosus defect and partial abnormal pulmonary venous return. Thick black lines 
indicate conduction abnormalities. Arrows indicate the main trajectories of activation.
LAT: local activation time.
Access to the target chamber may also be troublesome in patients with simpler forms 
of CHD. Ablation of left-sided substrates in patients after percutaneous ASD closure 
may require transseptal puncture, which is feasible yet potentially difficult in the 
presence of an ASD closure device.54-57 Theoretically, combining percutaneous ASD 
closure and pulmonary vein isolation in one procedure may reduce standard risks 
related to catheterization procedures. However, as of yet, there is scant literature on the 
combination of these two procedures. Chapter 5 therefore described the outcomes of 
a pilot study in which this combined procedure was performed in 5 ASD patients with 
AF. This study showed that percutaneous ASD closure and concomitant pulmonary vein 
isolation was feasible with an acceptable rate of AF-free survival (60%). Given the small 
sample size, a larger study is needed to confirm these results.
The quest for the optimal candidate site for ablation
Once the target chamber is reached, mapping of the clinical tachycardia – either 
spontaneous or induced – is performed. Activation, entrainment and/or voltage 
mapping during tachycardia may be used to determine the underlying mechanism 
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and target site for ablation. In case of an MRAT, successful ablation is achieved by 
transecting a crucial pathway of conduction between two non-conductive barriers 
(e.g. valve annuli, areas of scar tissue).58 Elimination of focal atrial tachycardia requires 
isolation or destruction of the ectopic focus. However, as demonstrated in Chapter 6, 
it is not uncommon that the clinical tachyarrhythmia terminates or degenerates into AF, 
or that only non-clinical tachyarrhythmias are inducible. Moreover, a tachyarrhythmia 
may not be inducible at all. In the study of Klehs et al., arrhythmia was non-inducible 
in 27 of 144 CHD patients (19%) undergoing catheter ablation of atrial tachycardias, 
whereas 9 patients (6%) only had multiple unstable MRATs induced.59 In these situations, 
the approach to successful mapping and ablation is less straightforward.
A relatively common strategy is the application of an empiric ablation line at the 
cavotricuspid isthmus. The rationale behind this approach is that the majority of MRATs 
in patients with CHD involve the cavotricuspid isthmus.59-62 Recently, Sawhney et al. 
compared MRAT-free survival after cavotricuspid isthmus ablation in CHD patients 
without inducible MRAT (i.e. empiric, n=28) to those in which the cavotricuspid isthmus 
was confirmed to be involved in the tachycardia circuit (n=59).63 At 21 months follow-up, 
arrhythmia-free survival in the two groups was similar (empiric: 64.3%, non-empiric: 
72.8%; p=0.44).
Another strategy commonly applied in CHD patients is ablation during sinus rhythm 
guided by bipolar voltage mapping (‘substrate’ modification). It is generally assumed 
that low voltage is a surrogate marker for diseased atrial tissue and scar. Whereas 
synchronous activation of a large area will result in a relatively large voltage amplitude, 
asynchronous activation of smaller areas (due to e.g. fibrosis) will result in decreased 
signal amplitudes. A previous endocardial mapping study compared bipolar voltage 
distribution in CHD patients with atrial tachyarrhythmias to that in patients with a 
structurally normal heart and e.g. atrioventricular nodal reentry tachycardias.64 In this 
study, signals ≤0.1 mV were only identified in CHD patients, which led the authors 
to conclude that 0.1 mV is a valid cut-off value to delineate scar tissue. Several other 
definitions of ‘scar’ have been used throughout the literature, varying from <0.05 mV 
to 0.5 mV, none of which has ever been validated by histology.65 Although mapping 
and ablation using bipolar voltage cut-off values to identify scar is widely applied in 
patients with CHD, this approach is not without limitations and its efficacy may be 
further improved.
First, it is yet unknown whether different cut-off values should be applied to the 
different atrial regions to accommodate for differences in wall thickness.65-67 Normal 
voltage distribution may even vary from patient to patient. Second, as atrial rhythm is 
an important determinant of voltage, it remains a matter of debate which rhythm is 
most appropriate for substrate mapping.65,68,69 In addition, bipolar voltage is dependent 
on many non-substrate related factors, such as the direction of wavefront propagation 
and electrode orientation relative to the tissue. To account for these non-substrate 
related factors, omnipolar mapping was recently introduced.65 This technique compares 
voltages of different orientations of bipolar electrograms and selects the largest 
14
VolledigbinnenwerkCharlotte.indd   277 18/11/2020   16:09:18
278
Chapter 14
bipolar electrogram, thereby reducing the risk of overestimating ‘low voltage’ due to 
technical reasons. Finally, Wong et al. showed that the left atrial substrate identified 
by mapping is dynamic, as it was critically dependent on pacing cycle length or wave 
front direction.70 Although this may be reasonably inferred from the principle of (non-)
uniform anisotropic conduction of myocardial cells, these findings do imply that a single 
static bipolar atrial voltage map may not be sufficient for identifying atrial scar tissue.
Given the above, it remains in question whether a single binary threshold for 
characterization of atrial fibrosis actually exists and how (voltage) mapping of the 
substrate should be carried out. Perhaps mapping of unipolar signal morphology (i.e. 
voltage and signal fractionation) may provide complementary information. Future 
studies on this topic are warranted.
Ablation of atrial tachyarrhythmias: a curative or palliative treatment?
After an initially successful ablation of MRAT or focal atrial tachycardia, a considerable 
number of patients with CHD suffer from arrhythmia recurrence. Several studies in 
adult CHD patients showed that these ‘recurrences’ often originated from different 
locations or were caused by entirely different mechanisms.71-73 Similarly, Chapter 6 
demonstrated that this was also the case in a considerable number of ‘recurrences’ 
in pediatric patients with CHD undergoing catheter ablation. New-onset regular atrial 
tachyarrhythmias may also occur after surgical ablation of AF, as described in Chapter 
7. The clinical case description in Box 1 captures and illustrates these observations.
A relatively simple explanation for arrhythmia recurrence would be 
arrhythmogenicity of the ablation lesions themselves. Lukac et al. applied a prophylactic 
cryolesion between the tricuspid valve annulus and the atriotomy scar during open 
chest cardiac surgery in patients with CHD (mainly ASD).74 Within three months after 
surgery, four patients developed atrial flutter (either spontaneous or induced), which 
was related to an incomplete lesion in all. Similarly, another study in non-CHD patients 
established that the majority of regular atrial tachycardias occurring after pulmonary 
vein isolation for AF were related to gaps in prior ablation lines.75
However, the frequent emergence of tachyarrhythmias originating from locations 
other than those targeted during previous ablations in CHD patients suggests that 
these arrhythmias are often not caused by arrhythmogenic prior ablation lesions.71 
Instead, it is more likely that progressive and diffuse remodeling of atrial tissue 
is responsible for a considerable number of ‘recurrences’ in these patients. This 
raises the question of whether ablation of atrial tachyarrhythmias in CHD patients 
actually is a palliative rather than a curative treatment. Nearly 20 years ago, Triedman 
et al. suggested an alternative measure of ‘success’ after catheter ablation of atrial 
tachyarrhythmias in CHD patients, rather than procedural outcome and arrhythmia 
recurrence alone.76 This arrhythmia severity score (Table 1 in Chapter 1) not only takes 
into account documented arrhythmia recurrence, but also symptoms, medication use 
and the need for electrical cardioversions. Since the introduction of this clinical score, 
several studies have confirmed that catheter ablation of atrial tachyarrhythmias in 
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CHD patients provides clinical benefit despite arrhythmia recurrence77-80, including the 
study in pediatric CHD patients described in Chapter 6. In line with these findings, two 
studies concluded that quality of life (based on surveys) after AF ablation in non-CHD 
patients had improved significantly, even in patients without total elimination of AF.81,82 
These results suggest that the arrhythmia burden is not only dependent on whether 
or not an arrhythmia recurs.
Box 1. Case
This case concerns a 45-year old female patient after Fontan conversion for 
a failing atriopulmonary connection for tricuspid atresia. Concomitantly, she 
underwent a right-sided maze procedure for paroxysmal AF, which had been 
present for 13 years (Figure 4A). Afterwards, symptomatic episodes of atrial 
tachyarrhythmias recurred. She was scheduled for catheter ablation as beta 
blockers were unable to control the tachyarrhythmias and caused significant sinus 
arrests (Figure 4B). A macroreentrant circuit was identified in the monoatrium. 
It was not possible to identify a suitable target site for ablation according to 
entrainment criteria. Several ablation lines (roof, mitral isthmus, anterior and 
posterolateral right atrium) were constructed, which rendered the tachycardia 
non-inducible. Recurrent atrial tachycardia was documented on Holter recording, 
for which she underwent a redo procedure. A bipolar voltage map showed low 
voltages (<0.5 mV) in the posterolateral right atrium. A sustained atrial tachycardia 
(cycle length similar to clinical tachycardia cycle length) was induced. An activation 
map showed a focal activation pattern with the earliest activation occurring in 
the low voltage area in the posterolateral right atrium. Whereas ablation in this 
area did not terminate the tachycardia (Figure 4C ), a subsequent ablation line 
between the low voltage area and a line of double potentials in the high lateral 
right atrium terminated the tachycardia. She has been asymptomatic afterwards, 
despite documentation of paroxysmal atrial tachycardia on Holter recording, for 









Figure 4. Pre-operative arrhythmias (A/B) and voltage map during atrial tachycardia (C) in 
a Fontan patient. LA: left atrium, PV: pulmonary vein, RA: right atrium.
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Treating structurally remodeled atria: a glimpse into the future
As structural damage forms the basis of arrhythmogenesis in patients with CHD, 
treatments aimed at attenuating, halting or even reversal of structural remodeling 
in these patients are of major potential interest.83 Although data for CHD patients 
is unavailable, studies investigating causes of structural remodeling and potential 
therapeutic targets have been conducted in patients with heart failure or AF. Structural 
tissue damage is caused by failure of protein quality control leading to derailment 
of proteostasis (i.e. a balanced cellular protein production, folding and clearance of 
misfolded or damaged proteins).84 Failure of protein quality control plays an important 
role in cardiovascular diseases, including heart failure and progression of AF.84-86 Various 
processes are involved in protein quality control and it goes beyond the scope of this 
thesis to discuss them all. Instead, two specific processes – heat shock proteins and 
the DNA damage/PARP1/NAD pathway – will be explained as studies focusing on 
therapeutic targets are showing promising results.87-92
Heat shock proteins form the ‘frontline’ protection against damaged or misfolded 
proteins by controlling proteostasis.84,93 Whereas heat shock proteins are initially 
upregulated in response to cardiac disease, they eventually become depleted, thereby 
triggering the progression of structural remodeling – a phenomenon that has been 
observed in response to both chronic heart failure and non-paroxysmal AF.85,94 
Induction of heat shock proteins for example by L-glutamine may protect against 
progression of structural remodeling. Whereas L-glutamine has been shown to be of 
potential benefit in patients with chronic heart failure95, its effects on AF burden still 
require further investigation.96
Another process contributing to structural remodeling is activation of the DNA 
damage/PARP1/NAD pathway. PARP (Poly(ADP-Ribose) Polymerase) is activated 
in response to oxidative stress-induced DNA damage and facilitates repair of DNA 
damage.97 Depletion of NAD+ during this process causes further damage and PARP1 
activation, thereby instigating a vicious cycle.98 Activation of the DNA damage/PARP1/
NAD pathway has also been observed in response to both chronic heart failure and non-
paroxysmal AF.88,90,99,100 Pharmacological inhibition of PARP1 may present a promising 
therapeutic option.88-90 Alternatively, supplementation with NAD+ or its precursors may 
offer therapeutic benefits.92,101
Similar to CHD, chronic heart failure is associated with longstanding cardiac stress 
other than physiological cardiac stress. Therefore, it could be hypothesized that protein 
quality control in CHD patients is also likely to fail, thereby resulting in structural 
damage and subsequent vulnerability to atrial tachyarrhythmias. Yet, as the timeline 
and circumstances of cardiac stress differ considerably between CHD patients and 
adult heart failure patients, it remains in question when and to what extent failure 
of protein quality control and its consequences occur in CHD patients. In addition to 
characterization of the processes involved in protein quality control in response to CHD, 
it may be useful to investigate how these processes ‘behave’ over time. For example, 
does failure of protein quality control (or of certain processes) already occur early in 
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life? In that case, pharmacological treatment should perhaps already be initiated at a 
young age in order to prevent structural remodeling. This unexplored area of research 
in CHD presents a promising future strategy for treatment or even prevention of atrial 
tachyarrhythmias in this population.
Conclusions and future perspectives
The accumulation of arrhythmogenic substrate in patients with CHD is a continuing 
process throughout their lives. Over the past decades, technological advances have 
greatly improved outcomes of treatment of tachyarrhythmias in patients with CHD. 
In addition, these advances provided novel insights into the complex nature of 
tachyarrhythmias in this population. Nevertheless, there is still room for significant 
improvement in the treatment (and prevention) of atrial tachyarrhythmias in these 
patients. In order to be able to modify or design treatment strategies, a thorough 
understanding of the substrate and mechanisms of atrial tachyarrhythmias is 
indispensable. The following approaches, from bench to bedside, are proposed with 
the aim of achieving optimal control of atrial tachyarrhythmias in patients with CHD.
v Translational research: the structural component
As discussed in the previous paragraph, it remains to be studied how the various 
processes involved in protein quality control respond to the altered hemodynamic 
conditions of CHD and how this response varies over time. Eventually, this information 
may be used to determine which processes involved in failure of protein quality control 
may be pharmacologically targeted and at which point in time in order to attenuate, 
halt or reverse structural remodeling.
v Translational research: the electrical component
High-resolution epicardial mapping provides the ideal opportunity to study 
characteristics of cardiac conduction in detail. A study aimed at quantifying the early 
electrophysiological consequences of CHD during sinus rhythm was introduced in this 
thesis. It is essential for future studies to further characterize mechanisms underlying 
AF in these patients. Pacing studies are currently being carried out in non-CHD patients; 
these results may serve as a reference for future pacing studies in CHD patients. The 
degree of endo-epicardial dissociation in CHD patients should be established, both 
during sinus rhythm and AF. Novel theories obtained from currently ongoing research 
into the mechanisms of AF in the general population should also be investigated in 
the CHD population. Although the current high-resolution epicardial mapping tool is 
of use for research purposes and during arrhythmia surgery, a less invasive approach 
is eventually required to map the electrical substrate in a larger number of patients. 
Technological advances are required to implement a high-resolution endocardial 
mapping system in endovascular catheters.
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v Translational research: linking the structural and electrical components
As structural remodeling underlies arrhythmogenesis in patients with CHD, ‘hybrid’ 
studies –linking the structural and electrical components – will be required. These 
studies should investigate whether parameters indicating the degree of structural 
remodeling match the extent of electrophysiological abnormalities. An individual 
‘substrate fingerprint’ (consisting of structural and electrical parameters) may 
indicate which type of treatment is most beneficial. If the substrate is diffusely spread 
throughout the atria rather than limited to restricted areas, successful elimination of 
the substrate by ablation is less likely to occur. Alternatively, pharmacological anti-
arrhythmic treatment aimed at the underlying substrate may be more beneficial.
v Defining target sites for catheter ablation
Currently, the approach to selecting target sites for ablation in case of non-inducible 
or non-sustained atrial tachyarrhythmias is suboptimal. Although voltage mapping is 
the most common strategy applied to identify areas of scar tissue, the use of a static 
bipolar voltage map is being increasingly disputed. As accurate identification of non- 
or slow-conducting diseased atrial tissue is essential, future studies should focus on 
alternative strategies to achieve this (e.g. omnipolar mapping, dynamic voltage mapping, 
mapping of unipolar signal morphology, identification of scar tissue on other imaging 
modalities).
v A uniform approach to atrial arrhythmia surgery
As the role of arrhythmia surgery for atrial tachyarrhythmias is expected to become 
more and more important, uniformity in the surgical approach is essential. For this 
purpose, future studies should clearly report the methodological details of the study 
population and procedures. Results from these studies may also be used to design 
appropriate prophylactic arrhythmia surgery strategies.
v Consider alternative measures of success after ablation of atrial tachyarrhythmias
Even though there is still room for considerable improvement of outcomes of ablative 
therapy in patients with CHD, it is also important to consider alternative measures of 
success after ablation. These alternative measures should not only include documented 
arrhythmia recurrence, but also indirect measures of arrhythmia burden such as 
medication use or frequency/severity of symptoms. Particularly in CHD patients, 
arrhythmia ‘recurrence’ after ablation may be yet another part of their (un)natural 
course of life.
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Chapter 15
Chapter 1 introduces the indisputable relation between congenital heart disease 
(CHD) and atrial tachyarrhythmias. The improved life expectancy of patients with 
CHD goes hand in hand with an increasing prevalence of atrial tachyarrhythmias. 
Outcomes of treatment of atrial tachyarrhythmias in CHD patients are yet suboptimal. 
These unsatisfactory outcomes may be due to incomplete understanding of the 
pathogenesis of atrial tachyarrhythmias in this unique population. The course of atrial 
tachyarrhythmia development in CHD patients is considerably different from that in 
the general population. It is therefore likely that the initiation and perpetuation of atrial 
tachyarrhythmias in CHD patients are mediated by factors that are (at least in part) 
specific to this population. This thesis aims to further characterize factors involved in 
the pathogenesis of atrial tachyarrhythmias in patients with CHD, as this information 
is essential to be able to modify or design treatment strategies and improve treatment 
outcomes.
The first chapters of this thesis (Chapters 2 to 7) provide an outline of the current 
treatment modalities for atrial tachyarrhythmias in CHD patients. Advances, outcomes 
and shortcomings are discussed.
Chapter 2 discusses how advances in mapping and catheter technologies over the past 
years have contributed to improved outcomes of ablative therapy of tachyarrhythmias 
in CHD patients. The introduction of 3-dimensional electroanatomic mapping guiding 
ablative therapy is one of the greatest advances in catheter ablation of the past 
decades. This technology enables visualization of activation patterns on reconstructed 
anatomical models as well as real-time navigation of mapping and ablation catheters. 
It significantly shortened fluoroscopy exposure and procedure duration and resulted 
in improved procedural and long-term outcomes. Moreover, it provided novel insights 
into the mechanisms underlying tachyarrhythmias in CHD patients. Other technological 
advances include remote magnetic navigation, non-fluoroscopic image integration, 
ultra-high-density mapping and irrigated radiofrequency ablation. Cryoenergy has 
emerged as the preferred energy source for ablation of perinodal substrates. Most 
tachyarrhythmias are effectively treated by either transecting crucial pathways of 
conduction between two non-conductive barriers or by isolating areas of ectopic 
activity. However, the approach to ablation of AF in CHD patients is less well established, 
which poses the next great challenge in catheter ablation in CHD patients.
Chapters 3 and 4 summarize current challenges in the treatment of atrial 
tachyarrhythmias in two particularly complex forms of CHD. Patients discussed in 
Chapter 3 underwent the atrial switch operation for transposition of the great arteries, 
a procedure that has nowadays been fully replaced by the arterial switch operation. 
During the atrial switch operation, systemic and pulmonary venous returns are 
redirected via an intra-atrial baffle, thereby restoring the flow of (de)oxygenated blood. 
The extensive atrial surgery predisposes to the development of atrial tachyarrhythmias. 
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Macroreentrant atrial tachycardias are most commonly observed, and often involve the 
cavotricuspid isthmus. As the isthmus may have been transected by the atrial baffle, 
successful ablation requires lesions in both the systemic and the pulmonary venous 
atrium. Scar-related macroreentrant atrial tachycardia also occur in a considerable 
number of patients, whereas the occurrence of focal atrial tachycardia is less often 
reported. The pulmonary venous atrium may be accessed in a retrograde fashion via 
the aorta, although catheter stability and manipulation are often complicated. Another 
access route is via transseptal puncture, which requires puncture through the intra-atrial 
baffle. Three-dimensional image integration, remote magnetic navigation and irrigated-
tip radiofrequency ablation are among the most important technological innovations 
contributing to improved outcomes of ablation in this complex population.
Chapter 4 reviews potential treatment strategies in another subset of patients with 
complex CHD: those with Fontan physiology. This review was written in response to a 
case presentation, which involved a 33-year old woman with complex CHD palliated 
with a lateral tunnel Fontan. She presented with recurrent episodes of atrial tachycardia 
that did not respond to amiodarone or a biatrial maze procedure. She received a dual 
chamber antitachycardia epicardial pacemaker, which successfully terminated recurrent 
atrial tachycardias with the use of custom software (TPARx) enabling patient-activated 
antitachycardia pacing.
The extensive atrial surgery and often dilated atria predispose patients with Fontan 
physiology to the development of atrial tachyarrhythmias – mainly macroreentrant 
atrial tachycardias – at a relatively young age. Recurrent arrhythmias may be treated 
with anti-arrhythmic drugs, although success rates are low, and side-effects are 
considerable. Catheter ablation in Fontan patients is feasible but may be complicated 
by the complex anatomy. Similar to the atrial switch population, atrial tachyarrhythmia 
substrates in Fontan patients may be located in the pulmonary venous atrium, which 
requires alternative access routes (retrograde or via transbaffle puncture). Arrhythmia 
surgery is an alternative solution, which in Fontan patients is often carried out during 
Fontan conversion, resulting in acceptable recurrence rates (9%-25%). Another 
treatment option is antitachycardia pacing. Because antitachycardia pacing devices 
not always recognize the relatively slow atrial tachyarrhythmias in CHD patients, the 
TPARx software allows the patient to activate antitachycardia pacing therapy in case of 
symptomatic tachycardias. Despite the limitations associated with this type of therapy 
(the need for the patient to be conscious and the potential risk of inducing ventricular 
tachyarrhythmias), it may provide adequate anti-arrhythmic therapy in carefully 
selected patients.
Another (less complex) form of CHD associated with atrial tachyarrhythmias is atrial 
septal defect (ASD). ASD is the most frequently diagnosed CHD in adulthood, as patients 
may remain asymptomatic for years. However, older age at ASD closure is associated 
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with a higher risk of AF. In patients with AF and an ASD suitable for percutaneous 
closure, it remains in question at which point in time pulmonary vein isolation for AF 
should be performed: before, after or concomitant with percutaneous ASD closure. 
Chapter 5 presents outcomes of a combined approach of pulmonary vein isolation 
and ASD closure. This pilot study involved 5 patients with symptomatic AF undergoing 
pulmonary vein isolation and percutaneous ASD closure in one procedure. Access to the 
left atrium for pulmonary vein isolation was obtained through the atrial septal defect 
in all patients without the need for additional transseptal puncture. After isolation 
of the pulmonary veins was confirmed, the ASD closure device was placed. No major 
periprocedural complications occurred. At the end of the 1-year follow-up period, 3 
of 5 patients were free from AF recurrence. This study suggests that pulmonary vein 
isolation concomitant with percutaneous ASD closure is feasible, safe and reasonably 
successful (60%). Larger studies are warranted in order to determine whether this 
should become the preferred treatment strategy for patients with AF and an ASD 
suitable for percutaneous closure.
Whereas outcomes of catheter ablation in adult patients with CHD have been 
extensively described, limited information is available for pediatric patients with CHD. 
In adult patients, atrial tachyarrhythmias commonly encountered during ablation 
include macroreentrant atrial tachycardia (cavotricuspid isthmus dependent or scar-
related) and focal atrial tachycardia. However, mechanisms of atrial tachyarrhythmias 
in pediatric patients may be more variable. On the one hand, the substrate for acquired 
arrhythmias such as macroreentrant atrial tachycardia may still be limited at younger 
age. On the other hand, arrhythmias with a congenital substrate (atrioventricular (nodal) 
reentry tachycardia) usually present during childhood and adolescence.
Chapter 6 therefore describes the arrhythmia mechanisms that were encountered 
during electrophysiology studies and outcomes of catheter ablation of these 
arrhythmias in pediatric CHD patients. Case records of 232 consecutive CHD patients 
aged <18 years undergoing catheter ablation between 2007 and 2018 at Boston 
Children’s Hospital or Erasmus Medical Center were retrospectively reviewed. The 
most common types of underlying CHD were Ebstein’s anomaly (n=44), septal defects 
(n=39) and single ventricle (n=36). Mechanisms of arrhythmias in these patients 
were both typical for their age (congenital substrates) and for their underlying heart 
defect (acquired substrates). Although congenital substrates outnumbered acquired 
substrates due to the frequent occurrence of accessory pathways, macroreentrant atrial 
tachycardia was the second most common arrhythmia observed, followed by focal atrial 
tachycardia. Despite high procedural success rates (84%), arrhythmia recurrence was 
observed in as many as 49% of patients during median follow-up of 3.6 years. In nearly 
half of the repeat procedures (45%) different arrhythmias were found, among which 
focal atrial tachycardia was commonly observed. The relatively frequent emergence 
of novel arrhythmia mechanisms after an initially successful procedure has also been 
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reported in adult CHD patients and suggests that progressive myocardial remodeling in 
CHD patients already starts at a young age. However, the arrhythmia burden as defined 
by a clinical arrhythmia severity score decreased significantly after ablation, both in 
patients with and without arrhythmia recurrence, and remained low during follow-up. 
These observations suggest that catheter ablation in this patient population provides 
long-term benefit despite arrhythmia recurrence.
Compared to catheter ablation, surgical ablation currently only plays a small role in 
the treatment of atrial tachyarrhythmias in CHD patients. However, the improved life 
expectancy of CHD patients will likely increase the number of patients requiring redo 
operations, either for their primary defect or for acquired heart disease. Therefore, 
the role of atrial arrhythmia surgery is expected to become more important in this 
population. Although a large body of evidence supports atrial arrhythmia surgery 
during Fontan conversion procedures, evidence-based recommendations for other 
CHD patients are lacking. Chapter 7 describes the outcomes of a comprehensive 
systematic literature review summarizing outcomes of atrial arrhythmia surgery for 
AF or macroreentrant atrial tachycardia in CHD patients undergoing surgery other 
than Fontan conversion. Twenty-eight studies, published over a time span of 25 years, 
were included for analysis. These studies demonstrated a striking variation in surgical 
techniques applied over the past decades. Based on the acquired data, we conclude 
that biatrial lesions are preferred in the treatment of AF. Exclusive right-sided lesions 
may be more appropriate in the treatment of macroreentrant atrial tachyarrhythmias; 
evidence for the superiority of additional left-sided lesions is currently lacking. There 
is not enough data to support the use of exclusive left-sided lesions. Theoretically, 
prophylactic atrial arrhythmia surgery may be beneficial in this population, but current 
evidence is limited. Findings from this review emphasize the need for uniformity 
of surgical techniques. In order to be able to determine which surgical techniques 
should ideally be applied under which circumstances, detailed documentation of 
methodology (indication, underlying CHD, lesion set and energy source) in future 
studies is essential.
Chapters 8 to 13 go into further detail on the role of several factors involved in the 
pathogenesis of atrial tachyarrhythmias in patients with CHD.
The early effects of cardiac surgery on the development of arrhythmias in pediatric 
patients with CHD are investigated in Chapter 8. The intraoperative period is 
associated with many potentially arrhythmogenic factors such as cooling and 
rewarming, surgical manipulation, hypovolemia and diffuse myocardial damage. We 
included 134 consecutive patients aged ≤18 years undergoing cardiac surgery for CHD. 
Continuous rhythm recordings were analyzed from the moment the aortic cross-clamp 
was removed, when cardiopulmonary bypass was stopped or when the sternum was 
closed – depending on whether aortic cross-clamp and/or cardiopulmonary bypass was 
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used – until departure from the operating room. Most patients (85%) had one or more 
intraoperative arrhythmias, including 2nd (47%) and 3rd (25%) degree atrioventricular 
conduction block (AV block), ectopic atrial rhythm (28%), junctional rhythm (26%), 
supraventricular or ventricular ectopy (both 78%). Patients undergoing surgery with 
cardiopulmonary bypass more often had intraoperative arrhythmia(s) than patients 
without (100% vs. 9%, p<0.01). The prevalence of all arrhythmias significantly decreased 
before departure from the operating room and arrhythmias were generally self-
limiting. Death or other major complications did not occur as a result of intraoperative 
arrhythmias. In only 2 patients, an intraoperative arrhythmia persisted during follow-up 
(median 37 months). These findings indicate that intraoperative arrhythmias are mainly 
transient and innocent events. Whether intraoperative arrhythmias, similar to early 
postoperative arrhythmias, predict the development late post-operative arrhythmias 
remains to be studied during long-term follow-up.
Long-term follow-up research is required to study the development of atrial 
tachyarrhythmias in CHD patients, as these arrhythmias may take years or even 
decades to express themselves. Over the course of years, different types of atrial 
arrhythmias may be interrelated or even provoke one another. Chapters 9 and 10 
focus on the long-term consequences of septal defect surgery on the development 
of arrhythmias.
Chapter 9 describes the development of arrhythmias in patients with a complete 
atrioventricular septal defect. This multicenter study included 74 patients with an 
atrioventricular septal defect who underwent surgical repair at a median age of 6 
months between 1986 and 1999, which represents a time period of stable surgical 
experience and encompasses patients currently entering (early) adulthood. Median 
age at last follow-up was 24 years. Sinus node dysfunction occurred a median of 
17 years after initial repair in 23% of patients, of whom 2 (12%) eventually required 
pacemaker implantation. None of the cases of sinus node dysfunction were related to 
redo surgical procedures. AV block was observed in 38% of patients, the majority of 
which was 1st degree AV block (96%). One of these patients developed postoperative 
complete AV block after left atrioventricular valve repair, and another patient developed 
spontaneous type II 2nd degree AV block; both received a pacemaker. Regular atrial 
tachycardia occurred in only 4% of patients and was limited to the perioperative period, 
whereas AF and ventricular tachyarrhythmias were not observed at all, as may be 
expected given the relatively young age of the study population. Continued follow-up 
of this cohort is necessary to evaluate whether bradyarrhythmias will progress and 
whether tachyarrhythmias will become more prevalent.
Chapter 10 describes the development of arrhythmias in patients with a surgically 
repaired ASD. In our multicenter DANARA database, we identified 95 patients with a 
surgically repaired ASD and at least 1 atrial arrhythmia, including sinus node dysfunction 
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(36%), complete AV block (14%), AF (49%), or regular atrial tachycardia (45%). Median 
age at ASD repair was 13 years and patients were followed for a median of 26 years 
after repair. A substantial number of arrhythmias presented only years after ASD repair. 
Late sinus node dysfunction and complete AV block were not caused by redo surgical 
procedures in most cases (100% and 60%). All cases of immediate postoperative AV 
block were related to left atrioventricular valve replacement, which is a known risk factor 
for postoperative AV block. Pacemaker implantation was required in 32% of patients 
with sinus node dysfunction and all patients with persistent complete AV block. Multiple 
arrhythmias occurred in 39% of patients; bradyarrhythmias did not necessarily precede 
tachyarrhythmias (p=0.31) and there was a trend towards regular atrial tachycardia 
preceding AF (p=0.09).
An important observation from the studies described in the previous two chapters 
is that sinus node dysfunction and AV block may have a progressive course in some 
patients after surgical septal defect repair. Although a specific sequence of brady- and 
tachyarrhythmias was not established in Chapter 10, follow-up of patients in Chapter 
9 should be continued to evaluate this interrelationship. As the interaction between 
sinus node dysfunction and atrial tachyarrhythmias works both ways, patterns in 
the occurrence of arrhythmias may potentially be obscured. Development of late 
arrhythmias in patients with surgically repaired ASD or atrioventricular septal defect 
is probably related to multiple factors, including direct surgical damage, residual lesions 
and late fibrosis after surgery.
The final three chapters will go into further detail on characteristics of cardiac 
conduction using high-resolution epicardial mapping. Abnormalities in conduction are 
thought to be crucially involved in the initiation and perpetuation of AF. In order to be 
able to understand the exact role of conduction disorders in this process, it is essential 
to know their characteristics and spatial distribution during sinus rhythm.
As illustrated in several of the previous chapters, age is an important factor in the 
development of arrhythmias in patients with CHD. Previous studies investigating the 
electrophysiological consequences of aging used relatively low-resolution endocardial 
mapping systems, which are not able to measure local conduction disorders. In 
addition, these studies were not able to map Bachmann’s bundle, which is presumed 
to be involved in the pathophysiology of AF. Therefore, Chapter 11 describes the 
electrophysiological consequences of aging using high-resolution epicardial mapping 
of the right atrium, left atrium and Bachmann’s bundle in 216 patients aged between 
36 and 83 years (median 66.7). All patients had ischemic heart disease and underwent 
elective coronary artery bypass grafting; none of the patients had a history of AF. 
BMI was the only cardiovascular risk factor associated with age. Overall prevalence 
of conduction block increased with age (rs 0.158, p=0.020). At regional level, aging was 
associated with more conduction disorders and lower signal voltages in the right atrium 
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and at Bachmann’s bundle. In a subset of patients, activation patterns at Bachmann’s 
bundle were assessed for conduction slowing in transverse versus longitudinal direction, 
as the main direction of myocardial fibers in this area is known. With increasing age, 
slowing of conduction in transverse direction occurred to a greater extent than in 
longitudinal direction, implying lateral uncoupling of myocardial fibers with age. As 
patients in this study had underlying ischemic heart disease, the electrophysiological 
findings may not necessarily be representative of physiological aging. Nevertheless, 
the study population was relatively homogeneous as all patients had similar underlying 
heart disease, and the majority of electrophysiological changes associated with age 
were independent of cardiovascular risk factors, suggesting that the patterns observed 
may be caused by ‘normal human aging’.
In patients with an interatrial shunt (e.g. ASD), conduction disorders are caused by 
longstanding atrial stretch. Characteristics of conduction disorders during sinus rhythm 
in these patients are described in Chapter 12. This study included 31 adult patients 
undergoing surgical correction of a congenital interatrial left-to-right shunt (mainly 
ASD). The right atrium was dilated in most patients (84%) and left atrial dilatation was 
present in 32% of patients. High-resolution epicardial mapping of the right atrium, 
left atrium and Bachmann’s bundle was performed. All patients had some degree 
of atrial conduction disorders, which were most prevalent in the right atrium and 
Bachmann’s bundle and most severe in the right atrium. Older age was associated 
with a higher prevalence of conduction disorders in the right atrium, and increased 
left atrial dimension was associated with a higher prevalence of conduction disorders 
at Bachmann’s bundle. Further analysis of the right atrium revealed a predilection 
site for conduction disorders in the intercaval region, which is most likely related to 
anisotropic conduction properties of the crista terminalis. When comparing patients 
with AF (n=5) to patients without AF (n=26), patients with AF had more conduction 
disorders at Bachmann’s bundle. Future studies should focus on the characteristics of 
conduction disorders in this population in relation to the initiation and perpetuation 
of AF.
Whereas structural and electrical consequences of longstanding hemodynamic 
overload have been quite extensively studied, the effects of abnormal hemodynamic 
conditions during the first weeks, months or years of life on cardiac conduction are yet 
unknown. Chapter 13 presents the rationale and study design of a recently introduced 
high-resolution epicardial mapping study in pediatric patients with CHD, which aims 
to quantify and characterize the early electrophysiological consequences of CHD. To 
this end, intra-operative, high-resolution epicardial mapping of the atria and ventricles 
during sinus rhythm will be performed in 30 pediatric patients with CHD undergoing 
initial surgical correction or palliation of the defect. A 192-electrode array will be used 
to record unipolar electrograms from the atrial and ventricular surface. Reconstructed 
activation maps will be used to evaluate wavefront propagation and heterogeneities in 
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conduction. Parameters describing signal morphology (voltage and signal fractionation) 
will be analyzed. We hypothesize that even relatively short-lasting volume or pressure 
overload at young age leads to electrical abnormalities that might persist beyond CHD 
repair and into adulthood. Over time, these electrical changes aggravate by other 
contributing factors such as surgical scars, aging or volume or pressure overload from 
e.g. residual lesions, until they are severe enough to induce tachyarrhythmias or heart 
failure.
The accumulation of arrhythmogenic substrate in patients with CHD is a continuing 
process throughout their lives. In order to be able to modify or design treatment 
strategies, a thorough understanding of the substrate and mechanisms of atrial 
tachyarrhythmias in this unique population is indispensable. Chapter 14 summarizes 
the implications of findings reported in this thesis with regard to current treatment 
strategies and future perspectives. The identification of target sites during catheter 
ablation should be further investigated and surgical ablation in these patients requires 
a more uniform approach. Pharmacological treatment aimed at attenuating, halting or 
reversing structural remodeling may be a promising therapeutic or even prophylactic 
treatment of atrial tachyarrhythmias in CHD patients, although research on this topic 
is still at an early stage. High-resolution epicardial mapping studies investigating the 
mechanisms of AF in the general population as well as in CHD patients are currently 
ongoing. Novel insights from these studies are expected to enhance ablative therapy 
of AF. Even though there is still room for considerable improvement of outcomes of 
ablative therapy in patients with CHD, alternative measures of success after ablative 
therapy should be considered. Particularly in CHD patients, arrhythmia ‘recurrence’ 
after ablation may be yet another part of their (un)natural course of life.
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Hoofdstuk 1 introduceert de onbetwiste relatie tussen aangeboren hartafwijkingen en 
atriale ritmestoornissen. Naarmate patiënten met een aangeboren hartafwijking ouder 
worden, komen atriale ritmestoornissen vaker voor. Alhoewel er grote vooruitgang is 
geboekt in de behandeling van deze ritmestoornissen, zijn de uitkomsten nog steeds 
suboptimaal. Dit kan komen door een gebrek aan kennis over de onderliggende 
mechanismen van atriale ritmestoornissen in deze unieke populatie. De ontwikkeling 
van atriale ritmestoornissen bij patiënten met een aangeboren hartafwijking 
verloopt anders dan bij mensen met een structureel normaal hart. Het is daarom 
aannemelijk dat er bij patiënten met een aangeboren hartafwijking (in ieder geval 
deels) andere factoren betrokken zijn bij de ontwikkeling van atriale ritmestoornissen. 
Het doel van dit proefschrift is om factoren die bijdragen aan de ontwikkeling van 
atriale ritmestoornissen bij patiënten met een aangeboren hartafwijking verder te 
karakteriseren. Deze kennis kan bijdragen aan het verbeteren of ontwikkelen van 
behandelingen die uiteindelijk leiden tot betere uitkomsten.
In de eerste hoofdstukken van dit proefschrift (Hoofdstuk 2 t/m 7) worden de huidige 
behandelopties voor atriale ritmestoornissen bij patiënten met een aangeboren 
hartafwijking besproken. Ontwikkelingen, tekortkomingen en uitkomsten zullen worden 
behandeld.
Hoofdstuk 2 bespreekt hoe recente vooruitgangen in mapping en katheter 
technologieën hebben bijgedragen aan verbeterde uitkomsten van ablatie bij patiënten 
met een aangeboren hartafwijking. De introductie van 3-dimensionale elektro-
anatomische mapping is één van de belangrijkste ontwikkelingen van de afgelopen 
jaren. Deze technologie maakt het mogelijk om activatiepatronen te projecteren op 
gereconstrueerde anatomische modellen, waarop tevens de positie van de mapping en 
ablatie katheters te zien is. Hierdoor is de blootstelling aan röntgenstraling verminderd, 
duren procedures korter en zijn zowel de korte als lange termijn uitkomsten sterk 
verbeterd. Daarnaast heeft deze technologie nieuwe inzichten in de pathofysiologie 
van hartritmestoornissen bij patiënten met een aangeboren hartafwijking opgeleverd. 
Andere technologische vooruitgangen zijn onder andere robotische magnetische 
navigatie, de integratie van beeldvorming tijdens de ablatie procedure, een verhoging 
van de spatiële resolutie van mapping systemen en nieuwe vormen van radiofrequente 
ablatie. Cryoablatie heeft vanwege de veiligheid de voorkeur bij de behandeling van 
substraten in de buurt van de atrioventriculaire (AV) knoop. De meeste ritmestoornissen 
kunnen effectief behandeld worden door een essentieel deel van het circuit door te 
nemen, of door de bron van ectopische activiteit te isoleren. Het is daarentegen nog 
onbekend waarop de ablatie van AF gericht moet worden. De volgende grote uitdaging 
zal daarom bestaan uit het ontwikkelen van een effectieve aanpak voor de ablatie van 
AF in patiënten met een aangeboren hartafwijking.
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Hoofdstuk 3 en 4 geven een overzicht van uitdagingen in de behandeling van atriale 
ritmestoornissen bij twee groepen patiënten met een zeer complexe aangeboren 
hartafwijking. De patiënten die in Hoofdstuk 3 besproken worden, hebben op 
kinderleeftijd een atriale switch operatie ondergaan vanwege transpositie van de 
grote vaten. Tijdens deze procedure wordt de bloedstroom via een intra-atriale 
tunnel omgeleid, waardoor de normale circulatie van zuurstofarm en -rijk bloed wordt 
hersteld. Patiënten die in het verleden deze operatie hebben ondergaan zijn inmiddels 
op volwassen leeftijd en ervaren diverse problemen ten gevolge van hun eerdere 
operatie(s), waaronder atriale ritmestoornissen. Macro-reentry tachycardieën komen 
het meest frequent voor, en zijn vaak afhankelijk van de isthmus tussen de inferior 
vena cava en de tricuspidaalklep. Het kan voorkomen dat de intra-atriale tunnel tijdens 
de initiële operatie over de isthmus heen is gehecht, waardoor deze zich zowel in 
het systeemveneuze als pulmonaalveneuze atrium bevindt. Ablatie van de isthmus 
in beide atria is dan noodzakelijk om de ritmestoornis te verhelpen. Macro-reentry 
tachycardieën die gerelateerd zijn aan littekenweefsel komen ook vaak voor, terwijl 
focale atriale tachycardieën minder vaak worden gerapporteerd. Het pulmonaalveneuze 
atrium kan bereikt worden via de aorta (retrograad) of via een punctie door de intra-
atriale tunnel. Een aantal recent ontwikkelde technieken, waaronder robotische 
magnetische navigatie, 3D-beeldvorming en ‘gekoelde’ radiofrequente ablatie zorgen 
voor verbeterde uitkomsten van ablatie in deze complexe groep patiënten.
In Hoofdstuk 4 worden behandelopties voor atriale ritmestoornissen in een andere 
groep patiënten met een complexe aangeboren hartafwijking besproken, namelijk 
patiënten na een Fontan operatie. Dit overzicht is geschreven naar aanleiding van 
een casus. Deze casus gaat over een 33-jarige vrouw met een complexe aangeboren 
hartafwijking en een laterale tunnel Fontan. Zij presenteerde zich herhaaldelijk met 
episodes van atriale tachycardieën, die terugkeerden na behandeling met medicatie en 
later ook na chirurgische ablatie. Zij kreeg een anti-tachy-pacemaker, waarbij zij zelf de 
anti-tachy pacing functie kon activeren zodra ze een hartritmestoornis bemerkte. Anti-
tachy pacing heeft bij deze patiënt de daaropvolgende atriale tachycardieën succesvol 
kunnen beëindigen.
Patiënten na een Fontan operatie lopen het risico om al op jonge leeftijd atriale 
ritmestoornissen (vooral macro-reentry tachycardieën) te ontwikkelen vanwege 
de uitgebreide atriale chirurgie. Deze ritmestoornissen kunnen behandeld worden 
met medicatie, maar resultaten zijn vaak teleurstellend en bijwerkingen komen 
regelmatig voor. Katheter ablatie is mogelijk, maar wordt vaak wel bemoeilijkt door de 
complexe anatomie. Net als bij Mustard of Senning patiënten kan het substraat van 
de ritmestoornis bij Fontan patiënten in het pulmonaalveneuze atrium gelegen zijn, 
waarvoor alternatieve toegang noodzakelijk is (retrograad of via punctie door de Fontan 
tunnel). Ritmechirurgie is een alternatieve oplossing. Dit wordt regelmatig uitgevoerd 
bij patiënten die een Fontan conversie procedure ondergaan. In slechts 9% tot 25% 
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van de patiënten keert de ritmestoornis daarna terug. Een andere optie is anti-tachy 
pacing. De patiënt uit de casus kon anti-tachy pacing starten zodra zij symptomen van 
een ritmestoornis herkende. Deze therapie kan in geselecteerde patiënten voor een 
succesvolle behandeling van ritmestoornissen zorgen. Potentiële nadelen van deze 
therapie houden in dat de patiënt bij bewustzijn moet zijn, en dat er een klein risico is 
op het induceren van ventriculaire ritmestoornissen.
Een atriumseptumdefect (ASD) is een minder complexe aangeboren hartafwijking die 
ook geassocieerd is met atriale ritmestoornissen. Een ASD wordt regelmatig pas op 
volwassen leeftijd ontdekt. Het risico op atriale ritmestoornissen neemt toe naarmate 
het ASD op latere leeftijd gesloten wordt. Een secundum ASD komt het meest voor 
en wordt bij voorkeur en indien mogelijk percutaan gesloten. Bij patiënten die tevens 
AF hebben, is vooralsnog onduidelijk wat de optimale timing is voor een pulmonaal 
venen isolatie. In de pilot studie die in Hoofdstuk 5 wordt beschreven, zijn pulmonaal 
venen isolatie en percutane ASD sluiting in dezelfde procedure verricht in 5 patiënten. 
Toegang tot het linker atrium voor de pulmonaal venen isolatie werd verkregen via het 
ASD in alle patiënten. Nadat isolatie van de pulmonaal venen was voltooid, werd het 
ASD gesloten. Er traden geen belangrijke complicaties gerelateerd aan de procedure op. 
Aan het eind van de 1-jaar follow-up periode was bij 3 van de 5 patiënten geen recidief 
van AF opgetreden. De uitkomsten van deze pilot studie laten zien dat de combinatie 
van percutane ASD sluiting en PVI in één procedure haalbaar en veilig is, en redelijk 
succesvol met betrekking tot de behandeling van AF (60%). Er zijn grotere studies nodig 
om te bepalen of dit inderdaad de aangewezen behandelstrategie zou moeten zijn bij 
patiënten met AF en een ASD dat geschikt is voor percutane sluiting.
In tegenstelling tot de volwassen populatie is de hoeveelheid beschikbare informatie 
over katheter ablatie bij kinderen met een aangeboren hartafwijking beperkt. 
Mogelijk zijn mechanismen van atriale ritmestoornissen die bij kinderen voorkomen 
variabeler dan bij volwassenen. Aan de ene kant zou het substraat voor verworven 
ritmestoornissen (zoals macro-reentry atriale tachycardie) nog relatief beperkt kunnen 
zijn op jonge leeftijd. Aan de andere kant presenteren ritmestoornissen met een 
aangeboren substraat (zoals atrioventriculaire (nodale) re-entry tachycardie) zich vaak 
op de kinderleeftijd.
Daarom beschrijft Hoofdstuk 6 mechanismen van ritmestoornissen en de uitkomsten 
van katheter ablatie bij kinderen met een aangeboren hartafwijking. In deze studie 
zijn 232 patiënten <18 jaar met een aangeboren hartafwijking bestudeerd die een 
katheter ablatie procedure hebben ondergaan tussen 2007 en 2018 in het Boston 
Children’s Hospital of het Erasmus Medisch Centrum. De meest voorkomende typen 
aangeboren hartafwijkingen in deze groep waren de ziekte van Ebstein (n=44), septum 
defecten (n=39) en univentriculair hart (n=36). De mechanismen van ritmestoornissen 
die gevonden werden in deze groep waren deels passend bij de leeftijd van de patiënten 
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(aangeboren substraten) en deels passend bij hun onderliggende hartafwijking 
(verworven substraten). Accessoire bundels kwamen het meest voor, gevolgd door 
atriale macro-reentry en focale atriale tachycardieën. De meeste procedures waren 
succesvol (84%), alhoewel recidieven bij een aanzienlijk deel van de patiënten (49%) 
voorkwamen tijdens een mediane follow-up duur van 3.6 jaar. Vergeleken met 
de ritmestoornis die eerder gevonden werd, hadden recidieven vaak een ander 
mechanisme; in veel gevallen was dat een focale atriale tachycardie. Dit zou kunnen 
betekenen dat progressieve remodelering van het hart al plaatsvindt op jonge leeftijd bij 
patiënten met een aangeboren hartafwijking. Onafhankelijk van het al dan niet optreden 
van een recidief zorgde katheter ablatie voor een significante verlaging van de last van 
ritmestoornissen, die gemeten werd op basis van een viertal klinische kenmerken. 
Resultaten van deze studie laten zien dat katheter ablatie een veilige en effectieve 
behandeling is van ritmestoornissen bij kinderen met een aangeboren hartafwijking, 
ondanks het relatief frequent optreden van recidieven.
In vergelijking met katheter ablatie, speelt chirurgische ablatie vooralsnog een 
relatief kleine rol in de behandeling van atriale ritmestoornissen bij patiënten met 
een aangeboren hartafwijking. Naarmate deze patiënten ouder worden, zullen 
zij vaker een (re-)operatie op volwassen leeftijd moeten ondergaan, ofwel voor 
problemen gerelateerd aan hun aangeboren hartafwijking, ofwel voor verworven 
hartaandoeningen. Gezien deze ontwikkelingen is de verwachting dat de rol van 
ritmechirurgie voor atriale ritmestoornissen steeds belangrijker zal worden in deze 
populatie. Alhoewel er duidelijke richtlijnen zijn voor de rol van ritmechirurgie tijdens 
Fontan conversie procedures, zijn hierover geen concrete richtlijnen voor patiënten met 
andere aangeboren hartafwijkingen beschikbaar. Hoofdstuk 7 beschrijft de uitkomsten 
van een systematisch literatuuronderzoek naar de resultaten van atriale ritmechirurgie 
bij patiënten met een aangeboren hartafwijking. Achtentwintig artikelen, gepubliceerd 
over een periode van 25 jaar, zijn geanalyseerd. Hieruit blijkt dat chirurgische technieken 
die zijn toegepast over de afgelopen jaren enorm variëren. Op basis van deze artikelen 
wordt geconcludeerd dat het plaatsen van laesies in zowel het linker als rechter atrium 
de voorkeur heeft in de behandeling van AF. Daarentegen zijn laesies in alleen het 
rechter atrium voldoende in de behandeling van een macro-reentry atriale tachycardie: 
er is geen bewijs voor de toegevoegde waarde van additionele linkszijdige laesies. Er is 
vooralsnog onvoldoende data beschikbaar om een conclusie te trekken over de rol van 
laesies in alleen het linkeratrium. In theorie zou profylactische atriale ritmechirurgie 
van waarde kunnen zijn; echter is er op dit moment nog onvoldoende bewijs om hier 
definitieve conclusies uit te kunnen trekken. De bevindingen benadrukken het belang 
van het ontwikkelen van een eenduidige strategie voor ritmechirurgie in deze populatie, 
zodat concrete richtlijnen kunnen worden opgesteld. Vanuit dit oogpunt doen wij een 
oproep om in toekomstige studies de indicaties, chirurgische technieken en uitkomsten 
van atriale ritmechirurgie bij patiënten met een aangeboren hartafwijking gedetailleerd 
te beschrijven.
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In Hoofdstuk 8 t/m 13 zal dieper ingegaan worden op de rol van een aantal factoren 
in de ontwikkeling van atriale ritmestoornissen bij patiënten met een aangeboren 
hartafwijking.
De vroege effecten van hartchirurgie op de ontwikkeling van ritmestoornissen bij 
kinderen met een aangeboren hartafwijking worden onderzocht in Hoofdstuk 8. 
Diverse omstandigheden tijdens de operatie kunnen ritmestoornissen uitlokken, 
zoals temperatuurschommelingen, chirurgische manipulatie, hypovolemie en diffuse 
myocardschade. We hebben 134 patiënten ≤18 jaar bestudeerd die een operatie 
hebben ondergaan vanwege een aangeboren hartafwijking. Continue opnames van 
het ritme zijn geanalyseerd vanaf het moment dat de aortaklem werd verwijderd, de 
hartlongmachine werd gestopt, of het sternum werd gesloten – afhankelijk van het 
gebruik van de eerste twee – totdat patiënten de operatiekamer verlieten. De meeste 
patiënten hadden één of meer intraoperatieve ritmestoornissen (85%), waaronder 
tweedegraads (47%) en derdegraads (25%) AV blok, ectopisch atriaal ritme (28%), 
junctioneel ritme (26%), supraventriculaire of ventriculaire ectopie (beiden 78%). 
Ritmestoornissen kwamen vaker voor wanneer de hartlongmachine werd gebruikt 
(100% vs. 9%, p<0.01). De prevalentie van alle ritmestoornissen nam aanzienlijk af 
voordat patiënten de operatiekamer verlieten. Intra-operatieve ritmestoornissen 
gingen doorgaans spontaan over en leidden niet tot complicaties. In slechts 2 
patiënten persisteerde de intra-operatieve ritmestoornis tot in de follow-up, die in 
totaal mediaan 37 maanden duurde. Onze bevindingen tonen aan dat intra-operatieve 
ritmestoornissen doorgaans kortdurend en onschuldig zijn. Het is nog de vraag of ze, 
net als vroeg postoperatieve ritmestoornissen, het ontstaan van laat postoperatieve 
ritmestoornissen kunnen voorspellen. Daar is een studie met een langere follow-up 
duur voor nodig.
In het algemeen is voor onderzoek naar de ontwikkeling van atriale ritmestoornissen 
een lange follow-up duur nodig, omdat het vaak (tientallen) jaren kan duren voordat 
deze ritmestoornissen zich openbaren. Daarnaast is het zo dat verschillende atriale 
ritmestoornissen elkaar kunnen uitlokken gedurende deze lange periode. Hoofdstuk 
9 en 10 onderzoeken de ontwikkeling en het verloop van atriale ritmestoornissen op 
de lange termijn na chirurgische correctie van twee soorten septumdefecten.
Hoofdstuk 9 beschrijft de ontwikkeling van ritmestoornissen bij patiënten met 
een chirurgisch gecorrigeerd compleet atrioventriculair septumdefect. In deze 
studie hebben we 74 patiënten bestudeerd bij wie in de periode tussen 1986 en 
1999 het atrioventriculair septumdefect op een mediane leeftijd van 6 maanden is 
gesloten. In deze periode was de chirurgische ervaring met het opereren van deze 
defecten relatief stabiel. Daarnaast zijn de patiënten die destijds geopereerd zijn nu 
jongvolwassen, en begint het risico op het ontwikkelen van ritmestoornissen toe te 
nemen. Op het laatste follow-up moment in deze studie waren patiënten mediaan 
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24 jaar oud. Sinusknoopdysfunctie presenteerde zich mediaan 17 jaar na operatie 
bij 23% van de patiënten, waarvan er 2 (12%) een pacemaker nodig hadden. In geen 
enkel geval was sinusknoopdysfunctie gerelateerd aan directe chirurgische schade. AV 
blok werd gezien bij 38% van de patiënten, waarvan de meesten een eerstegraads AV 
blok hadden (96%). Eén van deze patiënten ontwikkelde een postoperatief compleet 
AV blok na een operatie aan de linker AV klep, en een ander ontwikkelde spontaan 
een type II tweedegraads AV blok. Beide patiënten kregen een pacemaker. Regulaire 
atriale tachycardie werd bij slechts 4% van de patiënten gezien, bij allen beperkt tot 
de perioperatieve periode. AF en ventriculaire tachycardieën werden bij geen van de 
patiënten gezien. Deze patiënten moeten langer gevolgd worden om te kijken of brady-
aritmieën progressie gaan vertonen en tachy-aritmieën vaker zullen optreden.
Hoofdstuk 10 beschrijft de ontwikkeling van ritmestoornissen bij patiënten met een 
ASD. In onze multicenter DANARA database hebben we 95 patiënten geïdentificeerd 
met een ASD en minimaal 1 ritmestoornis, waaronder sinusknoopdysfunctie (36%), 
compleet AV blok (14%), AF (49%) of regulaire atriale tachycardie (45%). Mediane leeftijd 
ten tijde van ASD sluiting was 13 jaar en patiënten zijn mediaan 26 jaar na operatie 
gevolgd. Een groot deel van de ritmestoornissen ontstond pas meerdere jaren na ASD 
sluiting. Sinusknoopdysfunctie en AV blok waren beiden in de meeste gevallen (100% 
en 60%) niet direct gerelateerd aan operaties, maar ontstonden spontaan. Alle gevallen 
van postoperatief AV blok traden op na vervanging van de linker AV klep, een bekende 
complicatie van deze chirurgische procedure. Een pacemaker werd geïmplanteerd in 
32% van de patiënten met sinusknoopdysfunctie en alle patiënten met persisterend AV 
blok. Bij 39% van de patiënten werd meer dan 1 ritmestoornis vastgelegd: in die gevallen 
was er geen specifieke relatie tussen tachy-aritmiën en brady-aritmieën (p=0.31). Er 
was slechts een niet significante trend waarbij regulaire atriale tachycardie ontstond 
vόόr AF (p=0.09).
Een belangrijke bevinding van bovenstaande twee studies is dat sinusknoopdysfunctie 
en AV blok een progressief beloop kunnen hebben in een deel van de patiënten na 
chirurgische correctie van een septumdefect. In Hoofdstuk 10 werd geen specifiek 
verband gevonden tussen tachy- en brady-aritmieën, terwijl de follow-up van patiënten 
in Hoofdstuk 9 gecontinueerd moet worden om dit verband verder te kunnen 
onderzoeken. De wisselwerking tussen sinusknoopdysfunctie en atriale tachycardieën 
werkt beide kanten op. Dat kan ervoor zorgen dat er geen specifieke patronen in de 
volgorde van optreden worden gezien. De ontwikkeling van late ritmestoornissen bij 
patiënten na chirurgische correctie van een ASD of atrioventriculair septumdefect wordt 
waarschijnlijk veroorzaakt door verschillende factoren, waaronder directe chirurgische 
schade, residuele afwijkingen en late littekenvorming.
De laatste drie hoofdstukken zullen verder ingaan op de kenmerken van de elektrische 
geleiding met behulp van hoge-resolutie epicardiale mapping. Afwijkingen in de 
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geleiding spelen een belangrijke rol bij het initiëren en onderhouden van AF. Om de 
precieze rol van geleidingsstoornissen in dit proces te kunnen begrijpen, is het van 
belang om de geleiding eerst te bestuderen tijdens sinusritme.
Zoals ook uit de voorgaande hoofdstukken blijkt, speelt leeftijd een belangrijke 
rol bij de ontwikkeling van ritmestoornissen bij patiënten met een aangeboren 
hartafwijking. Eerdere studies die de elektrofysiologische gevolgen van veroudering 
hebben bestudeerd, maakten gebruik van mapping systemen met een relatief lage 
resolutie. Deze methode is niet in staat om lokale geleidingsstoornissen te meten. 
Daarnaast is het niet mogelijk om Bachmanns bundel te meten, een structuur 
waarvan gedacht wordt dat deze een rol speelt in de pathofysiologie van AF. Daarom 
beschrijft Hoofdstuk 11 de resultaten van hoge-resolutie epicardiale mapping van 
het rechter atrium, linker atrium en Bachmanns bundel in 216 patiënten met een 
leeftijd tussen de 36 en 83 jaar (mediaan 66.7). Alle patiënten ondergingen een 
operatie vanwege kransslagaderlijden en geen van de patiënten had eerder AF gehad. 
BMI was als enige van de cardiovasculaire risicofactoren gerelateerd aan leeftijd. De 
hoeveelheid geleidingsblok in de boezems nam toe naarmate de leeftijd vorderde (rs 
0.158, p=0.020). Op regionaal niveau was een hogere leeftijd geassocieerd met meer 
geleidingsstoornissen en lagere signaalvoltages in het rechteratrium en op Bachmanns 
bundel. In een deel van de patiënten werden activatiepatronen van Bachmanns bundel 
bestudeerd om de mate van transversale en longitudinale geleidingsvertraging te 
bepalen, omdat de richting van de vezels in dit gebied grotendeels bekend is. Naarmate 
de leeftijd vorderde, trad geleidingsvertraging in de transversale richting in hogere 
mate op dan in de longitudinale richting. Dit suggereert dat er sprake is van laterale 
ontkoppeling van myocardcellen bij een toename van de leeftijd. Omdat patiënten in 
deze studie kransslagaderlijden hadden, kan het zijn dat bovenstaande bevindingen niet 
representatief zijn voor fysiologische veroudering. Daarentegen was de studiepopulatie 
relatief homogeen omdat alle patiënten hetzelfde onderliggend lijden hadden, en 
waren de elektrische veranderingen ten gevolge van leeftijd onafhankelijk van andere 
cardiovasculaire risicofactoren. Dit maakt het waarschijnlijker dat de elektrische 
veranderingen die gevonden zijn in deze studie in ieder geval voor een deel verklaard 
kunnen worden door ‘normale veroudering’.
Bij patiënten met een links-rechts shunt op atriaal niveau (bijvoorbeeld een ASD), 
worden atriale geleidingsstoornissen veroorzaakt door langdurige volume overbelasting. 
Hoofdstuk 12 beschrijft de kenmerken van geleidingsstoornissen tijdens sinusritme 
in deze patiëntengroep. Deze studie betreft 31 volwassen patiënten die voor het eerst 
worden geopereerd aan een aangeboren links-rechtsshunt op atriaal niveau (met 
name ASD). Bij deze patiënten werd tijdens de operatie hoge-resolutie epicardiale 
mapping verricht van het rechter atrium, linker atrium en Bachmanns bundel. Bij alle 
patiënten kwamen geleidingsstoornissen in meer of mindere mate voor. Over het 
algemeen kwamen geleidingsstoornissen het meest voor in het rechter atrium en op 
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Bachmanns bundel en waren ze het ernstigst in het rechter atrium. Een hogere leeftijd 
was geassocieerd met meer geleidingsstoornissen in het rechter atrium, en een grotere 
linker atrium dimensie met meer geleidingsstoornissen op Bachmanns bundel. In het 
rechter atrium waren geleidingsstoornissen vooral gelokaliseerd in de regio tussen de 
bovenste en onderste holle aders, en in mindere mate op de vrije wand van het rechter 
atrium. Dit heeft waarschijnlijk te maken met de anatomie en specifieke kenmerken 
van geleiding in deze gebieden. Tot slot hebben we gekeken of er verschillen waren 
tussen patiënten met (n=5) en zonder AF (n=26). Het enige verschil dat werd gezien, was 
dat patiënten met AF meer geleidingsstoornissen hadden op Bachmanns bundel. De 
kenmerken van geleidingsstoornissen tijdens AF in deze populatie zullen bestudeerd 
moeten worden in toekomstige studies.
In tegenstelling tot langdurige overbelasting zijn de elektrische gevolgen van 
kortdurende overbelasting die vroeg in het leven plaatsvindt nog onbekend. Hoofdstuk 
13 beschrijft de rationale en de opzet van een recent geïntroduceerde studie naar de 
kenmerken van geleidingsstoornissen bij kinderen met een aangeboren hartafwijking. 
Deze studie heeft als doel om de vroege gevolgen van aangeboren hartafwijkingen 
op de atriale en ventriculaire geleiding te beschrijven en afwijkingen te kwantificeren. 
Om dit te bewerkstelligen zal hoge-resolutie epicardiale mapping van de atria en 
ventrikels uitgevoerd worden bij 30 kinderen met een aangeboren hartafwijking die 
hun eerste openhartoperatie ondergaan. Een 192-elektrode array wordt gebruikt 
om unipolaire electrogrammen van de atria en ventrikels op te nemen. Op basis 
van deze electrogrammen worden activatiemappen gemaakt, die worden gebruikt 
om activatiepatronen en geleidingsstoornissen te bestuderen. Daarnaast worden 
kenmerken van signaalmorfologie (voltage en signaal fractionatie) geanalyseerd. De 
hypothese is dat zelfs kortdurende overbelasting van het hart op jonge leeftijd al kan 
leiden tot elektrische afwijkingen die mogelijk kunnen persisteren tot na correctie 
van de aangeboren hartafwijking. Op de lange termijn nemen deze afwijkingen 
verder toe door factoren als chirurgische littekens, veroudering of langdurige 
volume of druk overbelasting door bijvoorbeeld een residueel defect. Zodra deze 
elektrische afwijkingen ernstig genoeg zijn, kunnen ze bijdragen aan het ontstaan van 
hartritmestoornissen of hartfalen.
De opbouw van het substraat van atriale ritmestoornissen bij patiënten met een 
aangeboren hartafwijking vindt gedurende hun gehele leven plaats. Om behandelingen 
te kunnen vernieuwen of ontwikkelen, is het noodzakelijk om het ontstaan van dit 
substraat goed te begrijpen. Hoofdstuk 14 vat de implicaties van de bevindingen 
van deze thesis samen met betrekking tot huidige en eventuele toekomstige 
behandelstrategieën. Er moet verder onderzoek gedaan worden naar de identificatie 
van gebieden die behandeld dienen te worden met katheter ablatie. Daarnaast moet 
er een eenduidige strategie komen voor de behandeling van ritmestoornissen met 
chirurgische ablatie. Medicatie gericht op het afremmen, stoppen of terugdraaien van 
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structurele veranderingen in het myocard zou een veelbelovende therapeutische of 
zelfs profylactische behandeling van atriale ritmestoornissen kunnen zijn, alhoewel het 
onderzoek hiernaar zich nog in een vroeg stadium bevindt. Hoge-resolutie epicardiale 
mapping studies naar het mechanisme van AF in zowel de algemene populatie als 
in patiënten met een aangeboren hartafwijking worden op dit moment verricht. Met 
nieuwe inzichten uit deze studies zouden de uitkomsten van ablatie van AF verbeterd 
kunnen worden. Er is dus nog voldoende ruimte voor verbetering van de behandeling 
van atriale ritmestoornissen bij patiënten met een aangeboren hartafwijking. 
Desondanks zou overwogen kunnen worden om het succes van behandeling op 
een andere manier te beoordelen: in plaats van alleen te kijken naar het al dan niet 
optreden van een recidief, zou ook gekeken kunnen worden naar bijvoorbeeld de ernst 
van de symptomen of het medicatiegebruik. Zeker bij patiënten met een aangeboren 
hartafwijking zouden ‘recidieven’ van atriale ritmestoornissen na behandeling een 
onvermijdelijk onderdeel van hun (on)natuurlijke levensloop kunnen zijn.
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ASD Atrial septal defect
AV Atrioventricular
AVB Atrioventricular conduction block
AV(N)RT Atrioventricular (nodal) reentry tachycardia
AVSD/cAVSD Complete atrioventricular septal defect
BB Bachmann’s bundle
BMI Body mass index
cAVB Complete atrioventricular conduction block
CB/D/V Conduction block
CD Conduction delay
CHD Congenital heart disease
CMI Cavomitral isthmus






ePOAF Early postoperative atrial fibrillation
EPS Electrophysiology study
FAT Focal atrial tachycardia
IART Intra-atrial reentry tachycardia
ICE Intracardiac echocardiography
ICU Intensive care unit
IQR Interquartile range
LA Left atrium
LAVG Left atrioventricular groove
M(R)AT Macroreentrant atrial tachycardia
NOAC Novel oral anticoagulant
pAVSD Partial atrioventricular septal defect
PVA* Pulmonary venous atrium
PVA* Pulmonary vein area
PVC Premature ventricular contraction
PVI Pulmonary vein isolation
RA Right atrium




RMN Remote magnetic navigation
SND Sinus node dysfunction
SV(PB) Supraventricular (premature beat)
SVA Systemic venous atrium
SVD Sinus venosus defect
SVT Supraventricular tachycardia/tachyarrhythmia
TGA Transposition of the great arteries
V(PB) Ventricular (premature beat)
VSD Ventricular septal defect
VT Ventricular tachycardia/tachyarrhythmia
* context dependent
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